Antiinflammatory | 0.992(CHEMBL1473;CHEMBL1504;DB00588;DB00620;DB00764;DB01234;DB08906;DB11921;METXBIODB00696) 0.991(DB06781) 0.990(CHEMBL1512;DB14669)
| 0.994(DBMET02573) 0.992(CHEMBL3542337;DB00443;DBMET00450;DBMET01644;DBMET01645;DBMET02361;DBMET02591;DBMET02758;METXBIODB00697;METXBIODB00698) 0.991(CHEMBL3542318;DBMET00837
)
|
Ulceration | 0.960(DB00605) 0.948(CHEMBL6;DB00328;METXBIODB00921) 0.936(DB13783)
| 0.948(DBMET01882) 0.941(DBMET01003) 0.929(CHEMBL800;DBMET00156;METXBIODB00922
)
|
CYP2C9 substrate | 0.992(METXBIODB01048) 0.988(CHEMBL269732;DB00864;METXBIODB00828;METXBIODB00831) 0.983(CHEMBL92;DB01248;METXBIODB01531)
| 0.990(METXBIODB01049) 0.989(CHEMBL3706531) 0.988(CHEMBL3544602;CHEMBL3544709;CHEMBL3544837;METXBIODB00832
)
|
Analgesic | 0.993(DB01294) 0.992(DB00921;METXBIODB01912) 0.988(DB00704)
| 0.992(DBMET00174) 0.987(DBMET00424) 0.986(DBMET00321;METXBIODB01140
)
|
Rheumatoid arthritis treatment | 0.996(DB01294) 0.954(DB08877) 0.936(DB06670)
| 0.959(DBMET03261) 0.945(DBMET02573) 0.944(DBMET00219
)
|
Analgesic, non-opioid | 0.989(DB00727) 0.958(DB00673) 0.941(DB01221;DB11823;METXBIODB00118)
| 0.989(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.969(DBMET01506) 0.943(DBMET01503
)
|
Antipyretic | 0.958(DB04817) 0.907(DB01452) 0.899(METXBIODB00798)
| 0.930(METXBIODB02935) 0.928(METXBIODB03001) 0.924(DBMET00153;METXBIODB03085
)
|
CYP2C19 substrate | 0.992(METXBIODB01048) 0.986(METXBIODB01531) 0.983(DB00361)
| 0.990(METXBIODB01049) 0.983(DBMET02029) 0.982(METXBIODB01532
)
|
Cardiovascular analeptic | 0.979(DB01744;DB11345;METXBIODB01913) 0.967(DB01102;DB09081) 0.957(METXBIODB00781;METXBIODB02214)
| 0.974(DBMET02830) 0.970(METXBIODB01914) 0.967(DBMET01521;DBMET01522;DBMET01523
)
|
UGT1A9 substrate | 0.972(METXBIODB02133) 0.963(DB11638) 0.962(DB00783;METXBIODB01814)
| 0.991(DBMET00581;METXBIODB02222) 0.990(METXBIODB02134;METXBIODB02135) 0.989(DBMET00571;METXBIODB02217
)
|
Gout treatment | 0.849(DB04854) 0.812(DB01138) 0.732(METXBIODB00230)
| 0.853(DBMET03281) 0.842(DBMET03279) 0.821(DBMET03280
)
|
GST A substrate | 0.991(DB00929) 0.982(DB00770) 0.977(METXBIODB03135)
| 0.990(DBMET02637) 0.989(METXBIODB01072) 0.982(DBMET02086
)
|
CYP3A4 substrate | 0.996(DB06287) 0.995(DB00778;METXBIODB01048;METXBIODB01286) 0.990(METXBIODB00817)
| 0.996(DBMET03414;DBMET03415) 0.994(METXBIODB00819;METXBIODB01287) 0.990(CHEMBL3544670;DBMET01750;METXBIODB01378
)
|
5 Hydroxytryptamine release inhibitor | 0.970(DB12095) 0.842(CHEMBL25;DB00945) 0.773(DB11994)
| 0.953(DBMET03552) 0.951(DBMET03555) 0.937(DBMET03554
)
|
UGT2B4 substrate | 0.971(DB04630) 0.954(DB00741;METXBIODB01729) 0.922(METXBIODB01980)
| 0.946(DBMET02900;DBMET02901;DBMET02902) 0.934(METXBIODB01981) 0.932(DB14681
)
|
5 Hydroxytryptamine release stimulant | 0.948(DB04844) 0.944(METXBIODB00577) 0.943(METXBIODB01523)
| 0.941(METXBIODB00578) 0.930(METXBIODB01524) 0.908(DBMET01359
)
|
Antithrombotic | 0.964(CHEMBL1783834;DB01240) 0.935(DB00770) 0.878(DB11660)
| 0.970(CHEMBL3542282;CHEMBL3542283) 0.956(CHEMBL3542263) 0.951(DB00917
)
|
Teratogen | 0.996(DB06781) 0.995(DB00394;DB14669;METXBIODB01048) 0.994(DB00764)
| 0.996(DBMET00837) 0.995(DBMET02589;DBMET02590) 0.994(CHEMBL4525798;DBMET02361;DBMET02913
)
|
UDP-glucuronosyltransferase substrate | 0.999(METXBIODB02451) 0.994(DB04630) 0.992(METXBIODB02206)
| 0.999(DBMET00862) 0.994(DBMET03144) 0.992(DBMET00827;DBMET01587;DBMET02862
)
|
GABA C receptor rho-3 antagonist | 0.850(DB00829) 0.825(METXBIODB03108) 0.824(METXBIODB02828)
| 0.824(CHEMBL117) 0.806(DBMET00980) 0.792(DB14028;DBMET00831
)
|
Embryotoxic | 0.996(DB06781) 0.995(DB00394;DB14669;METXBIODB01048) 0.994(CHEMBL1370;DB00764;DB01222;METXBIODB01745)
| 0.996(DBMET00837) 0.995(DBMET02589;DBMET02590) 0.994(CHEMBL4525798;DBMET02361;DBMET02904;DBMET02913
)
|
Uric acid excretion stimulant | 0.790(DB04854) 0.784(DB01138) 0.680(METXBIODB01647)
| 0.960(DBMET01434) 0.784(METXBIODB01648) 0.751(DBMET03281
)
|
CYP2C9 inhibitor | 0.952(DB08881) 0.888(DB00582) 0.820(DB13345)
| 0.862(DBMET00072) 0.838(DBMET02840) 0.835(CHEMBL3526986
)
|
FMO1 substrate | 0.974(METXBIODB02033) 0.970(CHEMBL1064;DB00641;METXBIODB01371;METXBIODB01928) 0.960(METXBIODB02065)
| 0.967(CHEMBL3544679) 0.956(CHEMBL3544664) 0.948(DBMET01002
)
|
Pancreatic disorders treatment | 0.914(CHEMBL1201772;DB06209) 0.871(DB00347) 0.858(DB09031)
| 0.966(CHEMBL3527031;DBMET00096) 0.721(DBMET03117) 0.696(DBMET03118
)
|
Platelet aggregation inhibitor | 0.986(DB09282) 0.975(METXBIODB01752) 0.974(METXBIODB00481;METXBIODB01307)
| 0.993(METXBIODB00716) 0.988(DB13400) 0.975(CHEMBL3526430
)
|
Autoimmune disorders treatment | 0.992(DB01294) 0.963(DB08877) 0.951(DB11703)
| 0.957(DBMET03261) 0.938(CHEMBL219497;DBMET00655;DBMET02004;DBMET03581) 0.929(DBMET03262
)
|
Non-steroidal antiinflammatory agent | 0.980(DB00605) 0.921(DB00533) 0.883(METXBIODB02492)
| 0.987(DBMET01003) 0.978(CHEMBL3544878;METXBIODB02493) 0.967(DBMET00813
)
|
Antiarthritic | 0.985(CHEMBL1473;DB00588) 0.984(DB08906) 0.976(DB11921)
| 0.992(METXBIODB02429) 0.981(DBMET02573) 0.971(CHEMBL3542318
)
|
UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.560(DB00130) 0.522(DB09144) 0.515(DB06819)
| 0.850(DB01861;DB03501) 0.758(CHEMBL590981;DBMET03589) 0.745(CHEMBL1774;CHEMBL474163;DBMET02000;DBMET03586;DBMET03590
)
|
Histamine release inhibitor | 0.975(DB13751) 0.841(METXBIODB03137) 0.840(CHEMBL151;METXBIODB03066)
| 0.959(METXBIODB03068) 0.950(METXBIODB02705) 0.948(METXBIODB02137
)
|
Immunosuppressant | 0.991(CHEMBL269732;DB00864;METXBIODB00828) 0.988(CHEMBL413;DB00877;METXBIODB01375) 0.965(METXBIODB00817)
| 0.989(CHEMBL3544693;CHEMBL3544708;DBMET00390;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.988(DBMET00628;METXBIODB00818) 0.987(CHEMBL3544688;CHEMBL3544838;DBMET01749;METXBIODB01377
)
|
Antipruritic, allergic | 0.993(CHEMBL1473;DB00588) 0.987(DB06781) 0.982(DB08906)
| 0.987(DBMET00837) 0.947(DBMET02589) 0.937(DBMET02590
)
|
Electrolyte absorption antagonist | 0.882(DB00695) 0.765(DB00808) 0.649(DB04831;METXBIODB01466)
| 0.751(DBMET00729) 0.706(DBMET01334) 0.659(DBMET01337
)
|
GST M1-1 substrate | 0.975(METXBIODB02869) 0.956(DB00929) 0.900(METXBIODB03125)
| 0.975(METXBIODB00355) 0.930(METXBIODB01656) 0.918(DBMET02637
)
|
Ankylosing spondylitis treatment | 0.516(DB05676) 0.444(DB01097;METXBIODB01809) 0.366(CHEMBL101)
| 0.509(DBMET00219) 0.480(DBMET01392) 0.473(CHEMBL3526838
)
|
Antibacterial | 0.992(DB00778;METXBIODB01286) 0.982(CHEMBL532;DB00199) 0.976(CHEMBL1741;DB01211;METXBIODB00619)
| 0.989(METXBIODB01287) 0.986(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.984(CHEMBL3706534
)
|
Cytostatic | 0.990(DB00570) 0.988(CHEMBL417;CHEMBL53463;DB00997) 0.987(DB00773;METXBIODB00808)
| 0.993(CHEMBL3508142) 0.992(CHEMBL3508145) 0.991(DBMET00853
)
|
Spasmolytic | 0.994(METXBIODB00475) 0.977(DB13345) 0.969(METXBIODB00334)
| 0.995(METXBIODB00477) 0.971(METXBIODB00336) 0.953(METXBIODB00476
)
|
Carcinogenic, group 3 | 0.994(METXBIODB01256) 0.993(DB01181;METXBIODB00963) 0.989(METXBIODB01359)
| 0.997(METXBIODB01257) 0.995(METXBIODB01362) 0.992(METXBIODB01258
)
|
Platelet antagonist | 0.984(METXBIODB01752) 0.979(DB01240) 0.977(CHEMBL1201772;DB06209)
| 0.987(METXBIODB00716) 0.984(CHEMBL3526430) 0.978(CHEMBL3526431
)
|
5 Hydroxytryptamine uptake stimulant | 0.753(DB00182;DB01576;METXBIODB01904) 0.721(METXBIODB00536) 0.714(METXBIODB00025)
| 0.797(CHEMBL3250637;DBMET00785;METXBIODB00120) 0.785(CHEMBL3544653;DBMET00704;METXBIODB00538) 0.753(DBMET00621;METXBIODB01525;METXBIODB01529;METXBIODB01799
)
|
Carcinogenic | 0.990(CHEMBL1370;DB01222;METXBIODB01745) 0.985(DB01181;METXBIODB00694;METXBIODB00963) 0.984(CHEMBL1504)
| 0.995(METXBIODB01257;METXBIODB02752) 0.993(METXBIODB02751) 0.991(METXBIODB01362
)
|
UGT2B7 substrate | 0.983(DB04630) 0.972(DB00741;METXBIODB01729) 0.971(DB00921)
| 0.982(DBMET02855;DBMET02858) 0.972(DBMET02856) 0.968(DBMET02900;DBMET02901;DBMET02902
)
|
CTGF expression inhibitor | 0.962(CHEMBL160;DB00091) 0.940(CHEMBL691;DB00977;METXBIODB01784) 0.928(DB00605)
| 0.953(CHEMBL2407584;CHEMBL3544881;CHEMBL3544883;DBMET02217) 0.952(CHEMBL3544879) 0.947(CHEMBL1614648
)
|
Abortion inducer | 0.971(METXBIODB01739) 0.963(DB00929) 0.960(METXBIODB01134)
| 0.967(DB00917) 0.960(DBMET02637) 0.936(DBMET02086
)
|
Antihypertensive | 0.993(DB00727) 0.987(DB06154;DB09282) 0.986(CHEMBL191)
| 0.993(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.991(DB13400) 0.987(DBMET00009;DBMET00303
)
|
Sedative | 0.982(METXBIODB01912) 0.973(DB00921) 0.965(DB01452)
| 0.995(DBMET00176;METXBIODB02676) 0.992(METXBIODB02827) 0.989(METXBIODB00483
)
|
Cyclooxygenase 1 inhibitor | 0.972(DB00727) 0.955(DB00533) 0.936(METXBIODB01002)
| 0.972(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.935(METXBIODB01003) 0.841(DBMET00161;DBMET01344
)
|
Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.859(DB06595) 0.671(DB12874) 0.670(DB00398)
| 0.785(DBMET01441) 0.700(DBMET01440) 0.641(DBMET03531
)
|
Cholesterol antagonist | 0.960(DB01586;METXBIODB00939) 0.956(METXBIODB01980) 0.948(DB02659;METXBIODB00251)
| 0.966(DBMET00553) 0.961(DBMET00592;METXBIODB02280) 0.960(DB06777
)
|
Ferrochelatase inhibitor | 0.636(DB03766) 0.617(METXBIODB01209) 0.609(DB03793;METXBIODB02476)
| 0.640(DBMET00510) 0.636(DBMET02012) 0.609(DBMET01437
)
|
P-glycoprotein inhibitor | 0.941(CHEMBL428647;DB01229) 0.938(DB06772) 0.931(METXBIODB01414)
| 0.936(CHEMBL122465;CHEMBL307088;DBMET01760) 0.934(DBMET00998) 0.929(DBMET00633
)
|
Gastrin inhibitor | 0.837(DB00929) 0.675(DB00770) 0.656(CHEMBL1783834)
| 0.899(DBMET02637) 0.747(DB00917) 0.675(DBMET02086
)
|
Cyclooxygenase inhibitor | 0.977(DB00533) 0.976(DB00727) 0.873(DB06154)
| 0.976(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.952(DBMET00169;DBMET01838) 0.834(DBMET01003
)
|
Septic shock treatment | 0.770(DB05676) 0.743(DB00581) 0.691(METXBIODB02587)
| 0.823(DBMET02708) 0.794(DBMET02625) 0.791(DBMET01392
)
|
GST P1-1 substrate | 0.963(DB00929) 0.955(DB00770) 0.904(METXBIODB03135)
| 0.973(DB00917) 0.961(DBMET02637) 0.955(DBMET02086
)
|
Antiparkinsonian, rigidity relieving | 0.956(CHEMBL71;DB00477;METXBIODB00583) 0.952(DB00420) 0.951(CHEMBL643;DB01069;METXBIODB02397)
| 0.934(DBMET02437) 0.873(DBMET00051;METXBIODB00392) 0.870(METXBIODB00127
)
|
Phospholipase A2 inhibitor | 0.681(DB09031) 0.544(DB00755;DB00982;METXBIODB00937) 0.491(METXBIODB00762)
| 0.561(DBMET01594;DBMET01595;DBMET01596;METXBIODB00408;METXBIODB00409;METXBIODB00410) 0.544(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.521(CHEMBL3706517
)
|
Tyrosine 3 hydroxylase inhibitor | 0.937(CHEMBL459;DB00968) 0.928(DB00279;METXBIODB02434) 0.925(DB00451;DB00509;METXBIODB02811)
| 0.935(DBMET02273) 0.934(DBMET02274) 0.926(DBMET02578
)
|
Caspase 9 stimulant | 0.952(CHEMBL1783834) 0.927(METXBIODB02194) 0.924(METXBIODB03141)
| 0.939(CHEMBL3526295) 0.938(METXBIODB02872) 0.936(CHEMBL3542278;CHEMBL3542282;CHEMBL3542283;CHEMBL3542372
)
|
Antidiarrheal | 1.000(DB13960) 0.999(DB01294) 0.847(CHEMBL104)
| 0.829(DBMET02617) 0.822(DBMET00321;METXBIODB01140) 0.812(DBMET00427;DBMET02514
)
|
Flavin-containing monooxygenase substrate | 0.989(DB00863;METXBIODB01235;METXBIODB02033) 0.988(METXBIODB01928) 0.984(CHEMBL1064;DB00641;METXBIODB01359;METXBIODB01371)
| 0.980(DBMET00506) 0.979(CHEMBL3544679) 0.978(DBMET00486
)
|
Antituberculosic | 0.992(DB05154) 0.986(DB11637) 0.896(DB08903)
| 0.928(DBMET00726) 0.900(CHEMBL3544543) 0.888(METXBIODB02328
)
|
Pneumotoxic | 0.966(CHEMBL633;DB01118) 0.948(DB00907;METXBIODB00058;METXBIODB01359) 0.902(METXBIODB01256)
| 0.966(CHEMBL4525130;CHEMBL4525131;CHEMBL4525132;CHEMBL4525133;CHEMBL4525134;CHEMBL4525135;CHEMBL4525136;CHEMBL4525137;CHEMBL4525138) 0.963(CHEMBL3526948) 0.953(CHEMBL3526986
)
|
Antiulcerative | 0.997(DB01294) 0.967(CHEMBL1503;DB00338;DB00736;METXBIODB00771) 0.959(CHEMBL902;DB00927)
| 0.954(DBMET00186;DBMET01657;METXBIODB00774) 0.949(DBMET02952) 0.938(DBMET02637
)
|
Antihypotensive | 0.937(DB09059) 0.861(CHEMBL3527416) 0.842(DB00687)
| 0.868(CHEMBL3526995;METXBIODB01734) 0.861(CHEMBL4525115) 0.858(CHEMBL3526455
)
|
Anesthetic general | 0.962(DB00390) 0.947(METXBIODB00730) 0.940(DB00802)
| 0.962(DBMET02502;METXBIODB00731) 0.911(DBMET03598;DBMET03599) 0.905(DBMET01727;METXBIODB01197
)
|
Antiglaucomic | 0.993(DB00869) 0.987(DB01194) 0.965(DB08819)
| 0.995(DBMET03010) 0.993(DBMET03671) 0.967(DBMET00481
)
|
Sodium/bile acid cotransporter inhibitor | 0.915(DB02659;METXBIODB00251) 0.907(METXBIODB01504) 0.897(DB01586;METXBIODB00939)
| 0.897(DB06777) 0.870(METXBIODB01505) 0.832(METXBIODB00252
)
|
5 Hydroxytryptamine 1E antagonist | 0.934(DB00669) 0.741(METXBIODB01089) 0.688(DB06148;METXBIODB01228;METXBIODB01848)
| 0.709(DBMET01362) 0.706(DBMET01361;METXBIODB01090) 0.684(DBMET01824
)
|
Antimycobacterial | 0.993(DB05154) 0.985(DB11637) 0.926(CHEMBL374478)
| 0.934(CHEMBL3323549) 0.928(CHEMBL446290) 0.927(DBMET00726;DBMET02189
)
|
Interleukin 2 agonist | 0.820(CHEMBL160;DB00091) 0.797(METXBIODB00667) 0.768(DB00480)
| 0.817(CHEMBL3544879) 0.805(CHEMBL2407584;CHEMBL3544881;CHEMBL3544883;DBMET02217) 0.802(CHEMBL3544638
)
|
FMO3 substrate | 0.985(DB00863;METXBIODB01235) 0.957(METXBIODB01341) 0.934(DB00518)
| 0.969(DBMET00506) 0.968(DBMET00486) 0.967(DBMET01735;METXBIODB01236
)
|
Thioredoxin glutathione reductase inhibitor | 0.889(METXBIODB00858) 0.824(METXBIODB02308) 0.779(DB00993)
| 0.901(CHEMBL3544542) 0.893(METXBIODB01072) 0.846(METXBIODB00089
)
|
Diuretic | 0.981(CHEMBL1393;DB00421) 0.969(DB00700) 0.953(DB01395)
| 0.943(CHEMBL3544705;DBMET02483) 0.894(DBMET02484;DBMET02485) 0.892(DBMET01655
)
|
Vasodilator, peripheral | 0.991(DB01240) 0.975(DB00770) 0.973(DB11660)
| 0.986(DB00917) 0.975(DBMET02086) 0.959(DBMET02588
)
|
Uterine stimulant | 0.625(DB09059) 0.519(DB00929) 0.493(DB00770;DB13345)
| 0.532(DB00917) 0.513(DBMET02637) 0.493(DBMET02086
)
|
Insulysin inhibitor | 0.521(DB11296) 0.470(METXBIODB01173) 0.451(DB00121)
| 0.568(CHEMBL3526373) 0.506(CHEMBL3544779) 0.491(DBMET03072
)
|
Antialcoholic | 0.992(DB00921) 0.985(DB06230) 0.961(DB00704)
| 0.952(DBMET00176) 0.944(CHEMBL3526502) 0.935(DBMET00760;DBMET01858
)
|
Antirickettsial | 0.956(METXBIODB01048) 0.952(CHEMBL532;DB00199) 0.945(CHEMBL1741;DB01211;METXBIODB00619)
| 0.921(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.917(METXBIODB01049) 0.912(CHEMBL1947257
)
|
GABA C receptor antagonist | 0.778(METXBIODB01947) 0.503(CHEMBL1046;DB00513) 0.465(METXBIODB02828)
| 0.576(METXBIODB01948) 0.556(METXBIODB00005) 0.466(DB14028;DBMET00831;DBMET01434
)
|
Antiparkinsonian, tremor relieving | 0.994(METXBIODB00475) 0.976(DB00424) 0.843(DB00245)
| 0.991(METXBIODB00477) 0.978(METXBIODB00476) 0.976(DBMET03252;DBMET03253
)
|
Anticoagulant | 0.933(CHEMBL169901;DB04840) 0.865(DB06695) 0.677(DB12364)
| 0.946(DBMET01535) 0.879(CHEMBL1710849;DBMET01641) 0.876(DB14726
)
|
Prostaglandin dehydrogenase inhibitor | 0.673(METXBIODB02548) 0.602(METXBIODB02153) 0.573(METXBIODB02879)
| 0.857(CHEMBL3527192) 0.830(CHEMBL3544771) 0.661(DBMET03309
)
|
Protein kinase stimulant | 0.692(DB00385) 0.689(METXBIODB00677) 0.669(CHEMBL1783834)
| 0.670(CHEMBL3542282;CHEMBL3542283) 0.649(CHEMBL3526295) 0.639(CHEMBL3526454
)
|
Sphingosine 1-phosphate receptor 5 antagonist | 0.400(DB08868) 0.341(DB05016) 0.269(DB01050;DB09213;METXBIODB00134;METXBIODB01970)
| 0.952(DBMET03096) 0.281(METXBIODB00722) 0.280(METXBIODB00593
)
|
Raynaud's phenomenon treatment | 0.542(DB00374) 0.526(DB00770) 0.473(DB00727)
| 0.526(DBMET02086) 0.486(DBMET03614) 0.473(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598
)
|
UGT2B10 substrate | 0.966(DB04630) 0.818(METXBIODB02212) 0.737(METXBIODB02214)
| 0.838(DBMET02837) 0.818(METXBIODB02213) 0.806(DBMET03007
)
|
Succinate dehydrogenase inhibitor | 0.970(METXBIODB01756) 0.883(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450) 0.776(DB03766)
| 0.978(METXBIODB01757) 0.913(CHEMBL3706508;DBMET01107) 0.911(DBMET01108
)
|
Osteoarthritis treatment | 0.935(DB00727) 0.916(DB06725) 0.910(METXBIODB01002)
| 0.935(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.913(METXBIODB01003) 0.861(DBMET00161
)
|
Antipruritic, non-allergic | 0.985(CHEMBL1473;DB00588) 0.981(DB08906) 0.977(DB06781)
| 0.977(DBMET00837) 0.914(DBMET02589) 0.897(DBMET02590
)
|
GABA C receptor rho-2 antagonist | 0.675(DB00829) 0.661(METXBIODB02828) 0.645(METXBIODB03108)
| 0.661(CHEMBL117) 0.609(CHEMBL210635) 0.586(CHEMBL214321;CHEMBL90568
)
|
Interleukin agonist | 0.988(CHEMBL160;DB00091) 0.985(CHEMBL269732;DB00864;METXBIODB00828) 0.947(METXBIODB00831)
| 0.986(CHEMBL2407584;CHEMBL3544881;CHEMBL3544883;DBMET02217) 0.985(CHEMBL2407580;DBMET00359) 0.984(CHEMBL3544879
)
|
Antiviral (Poxvirus) | 0.951(DB12151) 0.853(DB00718) 0.837(DB09299)
| 0.960(DBMET03374) 0.917(CHEMBL3526610) 0.915(DBMET00485;DBMET03265
)
|
Sphingosine 1-phosphate receptor 4 antagonist | 0.589(DB08868) 0.356(DB05016) 0.347(DB12016)
| 0.968(DBMET03096) 0.376(METXBIODB00722) 0.374(METXBIODB00593
)
|
Acetylcholine release stimulant | 0.353(METXBIODB02226) 0.345(DB09173) 0.338(METXBIODB00196;METXBIODB02228)
| 0.516(DBMET00511;METXBIODB03127) 0.466(DBMET00788) 0.330(DBMET00709
)
|
CNS active muscle relaxant | 0.934(CHEMBL1233;DB00395) 0.890(DB13872) 0.810(METXBIODB00635)
| 0.825(CHEMBL3706483) 0.779(METXBIODB00845) 0.758(CHEMBL979
)
|
Carcinogenic, group 1 | 0.993(DB00773;METXBIODB00808) 0.987(CHEMBL88;DB00531;METXBIODB00960) 0.978(CHEMBL160;DB00091)
| 0.992(DBMET00367;DBMET01264;METXBIODB00809) 0.988(DBMET01265) 0.987(DBMET01683
)
|
Arachidonic acid antagonist | 0.982(CHEMBL1473;DB00588) 0.965(DB06781) 0.963(DB08906)
| 0.965(DBMET00837) 0.875(DBMET02589) 0.865(DBMET02590
)
|
Mutagenic | 0.993(DB01181;METXBIODB00963) 0.991(CHEMBL1117;CHEMBL417;CHEMBL53463;DB00997) 0.990(METXBIODB03049)
| 0.995(CHEMBL731;DBMET00019;METXBIODB01257) 0.993(CHEMBL3508145) 0.992(CHEMBL1593;DBMET00658;METXBIODB01362
)
|
Psychostimulant | 0.981(DB01452) 0.968(DB00295;DB00318;DB00570;METXBIODB00641;METXBIODB00642) 0.962(METXBIODB01535)
| 0.984(DBMET01172) 0.980(METXBIODB02827) 0.971(DB06409;DBMET00660;METXBIODB02727;METXBIODB02826
)
|
Photosensitizer | 0.636(METXBIODB01034) 0.626(METXBIODB00452) 0.611(METXBIODB01203)
| 0.577(METXBIODB02154) 0.506(CHEMBL3526454) 0.487(METXBIODB02166
)
|
Cathepsin H inhibitor | 0.795(DB06670) 0.411(DB01255) 0.325(DB11296)
| 0.831(DBMET01475) 0.577(DBMET01472) 0.571(CHEMBL3526373
)
|
Muscle relaxant | 0.931(DB01062;METXBIODB00150) 0.923(METXBIODB00481) 0.914(DB00690)
| 0.940(DBMET00882) 0.908(DBMET00381;METXBIODB00153) 0.906(METXBIODB00482
)
|
Prolactin inhibitor | 0.943(DB13345) 0.922(METXBIODB00475) 0.822(DB00248)
| 0.833(METXBIODB00477) 0.803(METXBIODB00476) 0.744(DBMET02090
)
|
Lipocortins synthesis antagonist | 0.917(DB04839) 0.884(DB00834) 0.844(METXBIODB01044)
| 0.903(DBMET00672) 0.892(CHEMBL3544565) 0.885(METXBIODB02005
)
|
Neurotrophic factor enhancer | 0.692(DB05087) 0.640(DB02789;METXBIODB01189) 0.636(DB11217)
| 0.661(METXBIODB02147) 0.650(METXBIODB02216) 0.630(METXBIODB02148
)
|
Skeletal muscle relaxant | 0.908(DB13872) 0.896(CHEMBL1233;DB00395) 0.893(METXBIODB00635)
| 0.932(DBMET00882) 0.893(CHEMBL3706483) 0.863(DBMET03600;METXBIODB00217
)
|
GST T1-1 substrate | 0.978(DB00493) 0.728(METXBIODB03119) 0.708(METXBIODB02349)
| 0.690(CHEMBL276521) 0.602(METXBIODB01097) 0.584(METXBIODB00485
)
|
TRPA1 agonist | 0.946(DB00470) 0.923(CHEMBL428647;DB01229) 0.856(METXBIODB00199)
| 0.943(CHEMBL122465;CHEMBL307088;DBMET01760) 0.906(DBMET01221) 0.819(METXBIODB00716
)
|
Sphingosine 1-phosphate receptor 2 antagonist | 0.437(DB08868) 0.328(CHEMBL54;DB00502) 0.323(METXBIODB00517)
| 0.860(DBMET03096) 0.328(CHEMBL4525086;METXBIODB00519) 0.323(CHEMBL1036;DBMET00104
)
|
Cyclooxygenase 2 inhibitor | 0.974(DB00727) 0.969(DB00533) 0.848(DB06154)
| 0.974(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.939(DBMET00169;DBMET01838) 0.767(DBMET01294
)
|
TNF expression inhibitor | 0.995(CHEMBL1370;CHEMBL92;DB01222;DB01248;METXBIODB01745) 0.994(CHEMBL1504;CHEMBL269732;DB00864;METXBIODB00828) 0.993(DB06772)
| 0.995(CHEMBL3542373;CHEMBL3544693;CHEMBL3706530;DBMET00390;DBMET00633;DBMET00998;DBMET00999;DBMET01649;DBMET02914) 0.994(CHEMBL3542193;CHEMBL3542395;CHEMBL3544838;DBMET00476;DBMET02915;METXBIODB01746) 0.993(CHEMBL3544708;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830
)
|
Ca2+-transporting ATPase inhibitor | 0.405(CHEMBL417;CHEMBL53463;DB00997) 0.403(CHEMBL1117) 0.376(CHEMBL178;DB00694)
| 0.351(CHEMBL3544590) 0.332(CHEMBL3508145) 0.329(CHEMBL3508141;CHEMBL3508146;DBMET00647
)
|
Antiviral (West Nile virus) | 0.376(CHEMBL184) 0.366(DB01255) 0.364(DB00432)
| 0.380(DBMET00720) 0.363(DBMET03515) 0.350(DBMET02067
)
|
Cell wall synthesis inhibitor | 0.975(DB06590) 0.939(DB00493) 0.920(DB01413)
| 0.855(CHEMBL3526531) 0.815(DBMET00646) 0.793(DBMET03003
)
|
Excitatory amino acid transporter EAAC1 inhibitor | 0.678(DB00130) 0.612(DB00129) 0.609(METXBIODB02624)
| 0.685(DB00142) 0.587(DB09269;DBMET01431;METXBIODB03146) 0.586(DB00123
)
|
Hair growth stimulant | 0.940(DB00287) 0.919(DB00741;METXBIODB01729) 0.911(CHEMBL710;DB01216)
| 0.944(DB00917) 0.928(DBMET02900;DBMET02901) 0.927(METXBIODB00940
)
|
Creatine kinase inhibitor | 0.906(METXBIODB03137) 0.893(METXBIODB01399) 0.857(METXBIODB02136)
| 0.925(METXBIODB03144) 0.777(DBMET00253) 0.749(CHEMBL117
)
|
Androgen agonist | 0.994(METXBIODB00694) 0.990(DB00294;DB06781) 0.986(METXBIODB02972)
| 0.994(DBMET00723;DBMET00724;DBMET01642;DBMET01643;METXBIODB00695;METXBIODB02752) 0.990(DBMET00837) 0.986(DBMET01371
)
|
Neurotensin receptor agonist | 0.357(DB01255) 0.337(DB00129) 0.316(DB11296)
| 0.755(CHEMBL3526373) 0.445(DBMET02065) 0.431(DBMET00502
)
|
SULT1A3 substrate | 0.960(METXBIODB03137) 0.957(DB01001) 0.948(METXBIODB02136)
| 0.976(DBMET00975;DBMET01000) 0.968(CHEMBL1208633) 0.965(DBMET00565;DBMET00573;DBMET02448;DBMET02449;METXBIODB02238
)
|
GABA C receptor agonist | 0.926(CHEMBL1046;DB00513) 0.843(DB00129) 0.734(DB03766)
| 0.862(DB01677) 0.859(DBMET01483) 0.857(DBMET01477
)
|
Acaricide | 0.958(DB11431) 0.948(METXBIODB00942) 0.935(DB13600;METXBIODB01687)
| 0.986(DBMET03414) 0.981(DBMET03415) 0.948(DBMET02119;DBMET02120
)
|
Calpain inhibitor | 0.385(DB06218) 0.384(DB09292) 0.332(DB00121)
| 0.527(CHEMBL3544766) 0.454(DBMET01081) 0.418(DBMET02065
)
|
SULT1A1 substrate | 0.955(CHEMBL691;DB00977;METXBIODB01784) 0.944(DB00367) 0.943(DB00279;METXBIODB02434)
| 0.985(CHEMBL1614648) 0.976(DBMET00567) 0.973(DBMET00559
)
|
Interferon gamma antagonist | 0.991(CHEMBL269732;DB00864;METXBIODB00828) 0.984(METXBIODB00831) 0.902(CHEMBL1370;DB01222;METXBIODB01745)
| 0.990(CHEMBL3544693;CHEMBL3544708;DBMET00390;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.987(CHEMBL3544838) 0.984(CHEMBL3544602;CHEMBL3544709;CHEMBL3544837;METXBIODB00832
)
|
Antileprosy | 0.990(CHEMBL374478) 0.963(DB11753) 0.938(METXBIODB01265)
| 0.986(CHEMBL446290) 0.884(DBMET02189) 0.829(METXBIODB01268
)
|
Glycine receptor antagonist | 0.661(CHEMBL1783834) 0.553(METXBIODB01947) 0.502(DB02789;METXBIODB01189)
| 0.732(DBMET00511;METXBIODB03127) 0.714(DBMET00518) 0.594(DBMET00500
)
|
DNA polymerase I inhibitor | 0.600(DB02377) 0.594(DB00352) 0.585(METXBIODB02136)
| 0.807(DBMET01175) 0.771(DBMET01174) 0.770(DBMET01177
)
|
RNA-directed DNA polymerase inhibitor | 0.966(DB11753) 0.953(DB00300) 0.921(CHEMBL1076930)
| 0.996(CHEMBL3526610) 0.993(DBMET00677) 0.987(DBMET01157
)
|
Calpain 2 inhibitor | 0.560(DB00499) 0.535(DB06218) 0.511(CHEMBL2095212;DB08893)
| 0.644(CHEMBL3544766) 0.623(DBMET01081) 0.533(DBMET03168
)
|
Glutamate (mGluR7) antagonist | 0.170(CHEMBL109;DB00313;METXBIODB01559) 0.167(METXBIODB01812) 0.161(METXBIODB02611)
| 0.152(DBMET02273) 0.149(CHEMBL3527191;CHEMBL3706509;DBMET01108;DBMET01109;DBMET02274) 0.144(DBMET01695
)
|
Antispirochetal | 0.978(CHEMBL532;DB00199) 0.975(CHEMBL1741;DB01211;METXBIODB00619) 0.963(METXBIODB01048)
| 0.964(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.961(CHEMBL2063468;DBMET01656) 0.956(CHEMBL2022715;DBMET00357;METXBIODB00621
)
|
Vasodilator, coronary | 0.989(CHEMBL633;DB01118) 0.985(CHEMBL1064;DB00641;METXBIODB01371) 0.980(CHEMBL503;DB00227;DB00343;METXBIODB01008)
| 0.991(CHEMBL3526948) 0.989(CHEMBL4525130;CHEMBL4525131;CHEMBL4525132;CHEMBL4525133;CHEMBL4525134;CHEMBL4525135;CHEMBL4525136;CHEMBL4525137;CHEMBL4525138) 0.987(CHEMBL1600;DBMET00012
)
|
Phospholipase C inhibitor | 0.957(DB02659;METXBIODB00251) 0.947(METXBIODB00249) 0.940(DB01586;METXBIODB00939)
| 0.940(DB06777) 0.936(METXBIODB00250) 0.923(DBMET03598
)
|
Peroxidase inhibitor | 0.902(DB00126) 0.892(CHEMBL49563;DB00163) 0.884(METXBIODB02879)
| 0.892(DBMET00503) 0.860(DBMET02035;DBMET02036;DBMET02037;DBMET02311;DBMET02320;DBMET02321) 0.858(DBMET02038;DBMET02322
)
|
GABA C receptor rho-1 antagonist | 0.438(METXBIODB02828) 0.419(METXBIODB03108) 0.386(CHEMBL1046;DB00513)
| 0.438(CHEMBL117) 0.388(METXBIODB00005) 0.357(CHEMBL3527154
)
|
Antifungal enhancer | 0.875(DB11431) 0.848(METXBIODB00942) 0.775(CHEMBL532;DB00199)
| 0.988(DBMET03415) 0.981(DBMET03414) 0.863(METXBIODB00943
)
|
Cholesterol synthesis inhibitor | 0.821(CHEMBL503;DB00227;METXBIODB01008) 0.820(CHEMBL1064;DB00641;METXBIODB01371) 0.806(DB00175)
| 0.814(CHEMBL3544679) 0.809(CHEMBL3544664) 0.806(DBMET01699;DBMET02472
)
|
Xanthine oxidase inhibitor | 0.984(DB04854) 0.968(CHEMBL3527416) 0.942(METXBIODB03141)
| 0.994(DBMET03278) 0.993(CHEMBL3526749;CHEMBL3526994) 0.991(CHEMBL3526996
)
|
Electron transport complex I inhibitor | 0.843(METXBIODB01756) 0.583(DB09081) 0.563(DB01022)
| 0.785(METXBIODB01757) 0.730(METXBIODB02098) 0.686(METXBIODB00665
)
|
Hearing loss treatment | 0.520(DB01234;METXBIODB00696) 0.500(DB14669) 0.462(DB01132)
| 0.520(DB00443) 0.473(CHEMBL3706469) 0.381(DB00166
)
|
Lipoxygenase inhibitor | 0.946(DB00744) 0.939(METXBIODB00090;METXBIODB03094) 0.877(CHEMBL2105653)
| 0.866(DBMET02036;DBMET02320) 0.859(METXBIODB00659) 0.847(DBMET02038;DBMET02322
)
|
CF transmembrane conductance regulator agonist | 0.808(DB08820) 0.635(METXBIODB00464;METXBIODB02430) 0.624(DB01645;METXBIODB00465)
| 0.654(DBMET02319) 0.616(DBMET02318) 0.558(METXBIODB00928
)
|
CYP2B6 inhibitor | 0.871(CHEMBL633;DB01118) 0.832(DB01611) 0.827(DB00608;METXBIODB00114)
| 0.871(CHEMBL4525130;CHEMBL4525131;CHEMBL4525132;CHEMBL4525133;CHEMBL4525134;CHEMBL4525135;CHEMBL4525136;CHEMBL4525137;CHEMBL4525138) 0.863(CHEMBL3526948) 0.827(CHEMBL3527235
)
|
AR expression inhibitor | 0.989(METXBIODB00715) 0.987(DB00957) 0.981(DB04839)
| 0.987(DBMET01476) 0.984(DBMET03015) 0.980(DB09389
)
|
Antiprotozoal (Coccidial) | 0.853(METXBIODB00454) 0.850(DB06697) 0.831(DB11638)
| 0.831(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.819(METXBIODB00455) 0.777(DBMET01913;DBMET03143
)
|
Sphingosine 1-phosphate receptor 4 agonist | 0.792(DB12016) 0.729(DB12612) 0.489(DB08868)
| 0.965(DBMET03096) 0.859(DBMET03312) 0.603(DBMET03311
)
|
Histone acetyltransferase inhibitor | 0.631(DB06176) 0.499(DB01015;METXBIODB01391) 0.458(METXBIODB02919)
| 0.562(DBMET03512) 0.458(DBMET01049) 0.421(DBMET00016
)
|
Antidote, mercury | 0.402(METXBIODB00446) 0.382(METXBIODB00715) 0.363(DB00763)
| 0.650(DBMET01434) 0.426(CHEMBL2158192;DBMET01416) 0.356(DBMET00503
)
|
Interleukin 5 antagonist | 0.720(CHEMBL269732;DB00864;METXBIODB00828) 0.690(CHEMBL1370;DB01222;METXBIODB01745) 0.687(METXBIODB00831)
| 0.718(CHEMBL3544693;DBMET00390) 0.716(CHEMBL3544708;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.714(CHEMBL3544838
)
|
Anabolic | 0.990(METXBIODB00694) 0.987(DB00294) 0.983(METXBIODB02972)
| 0.994(METXBIODB02752) 0.990(DBMET00723;DBMET00724;DBMET01642;DBMET01643;METXBIODB00695) 0.987(CHEMBL3638297;CHEMBL3638299;CHEMBL3638301;CHEMBL3638303
)
|
Sphingomyelinase inhibitor | 0.677(DB09031) 0.483(DB01142;METXBIODB00751;METXBIODB02406) 0.449(METXBIODB00752)
| 0.478(DBMET02089) 0.449(DBMET00315) 0.406(DBMET00873;METXBIODB00753
)
|
Calcium channel activator | 0.807(CHEMBL193;DB01115) 0.795(CHEMBL846;DB00136) 0.787(METXBIODB00247)
| 0.790(DBMET01832) 0.758(DBMET02975) 0.749(DBMET01949
)
|
Vanilloid 4 agonist | 0.167(METXBIODB02515) 0.150(CHEMBL498;DB00672) 0.147(METXBIODB01129)
| 0.174(DBMET01607;DBMET01608;DBMET01609;DBMET01610;METXBIODB00421;METXBIODB00422;METXBIODB00423;METXBIODB00424) 0.159(DBMET01593;DBMET01606;DBMET02087;METXBIODB00407;METXBIODB00420) 0.153(DBMET01601;METXBIODB00415
)
|
Cyclic AMP phosphodiesterase inhibitor | 0.921(DB12406) 0.902(CHEMBL628;DB00806) 0.890(DB00922)
| 0.925(DBMET03235) 0.921(CHEMBL1514176;DBMET03229) 0.907(CHEMBL3544675;DBMET03234
)
|
Falcipain 3 inhibitor | 0.268(DB01079;METXBIODB01419) 0.248(DB01065) 0.247(METXBIODB00946)
| 0.497(CHEMBL3526373) 0.265(CHEMBL3544766) 0.252(CHEMBL1442231;METXBIODB01420
)
|
Aldehyde oxidase inhibitor | 0.985(CHEMBL691;DB00977;METXBIODB01784) 0.982(DB01357) 0.974(DB00850)
| 0.985(CHEMBL1627649;CHEMBL3544577;DBMET00457;DBMET03022) 0.984(CHEMBL3544698;DBMET00366;METXBIODB01785) 0.983(DBMET03024
)
|
CC chemokine 5 receptor agonist | 0.180(DB00704) 0.170(DB00813;METXBIODB00823) 0.169(DB06230)
| 0.235(DBMET00081) 0.178(METXBIODB00187) 0.176(DBMET02691
)
|
Eye irritation, high | 0.997(CHEMBL1473;DB00588) 0.996(DB06781) 0.995(CHEMBL1504;CHEMBL1512;DB01181;DB08819;METXBIODB00963)
| 0.996(DBMET00837) 0.994(DBMET00883) 0.992(CHEMBL3542318
)
|
Adenylate cyclase stimulant | 0.470(DB01240) 0.363(DB01001) 0.360(DB06755)
| 0.361(DBMET02979) 0.359(DBMET00298;DBMET02549;DBMET02554) 0.356(DB00523;DBMET02046;DBMET02444;DBMET02548;METXBIODB00324;METXBIODB01253
)
|
Antimutagenic | 0.982(CHEMBL3527416) 0.981(METXBIODB03141) 0.967(METXBIODB01398;METXBIODB02194;METXBIODB03058)
| 0.988(CHEMBL3526996) 0.985(CHEMBL3526995) 0.984(CHEMBL3526994
)
|
Antihypercholesterolemic | 0.992(CHEMBL1064;DB00641;METXBIODB01371) 0.991(CHEMBL503;DB00227;METXBIODB01008) 0.989(METXBIODB01748)
| 0.996(DBMET02475) 0.995(CHEMBL3544664) 0.992(CHEMBL3544679
)
|
Sensitization | 0.995(METXBIODB01048) 0.987(DB00410) 0.976(DB15566)
| 0.991(METXBIODB01049) 0.970(CHEMBL131;DBMET00627) 0.968(CHEMBL4525798;DBMET02913
)
|
Bile acid receptor antagonist | 0.978(DB01586;METXBIODB00939) 0.960(DB02659;METXBIODB00251) 0.953(METXBIODB01980)
| 0.978(DB06777) 0.953(DBMET03598) 0.918(METXBIODB01981
)
|
Glycine receptor agonist | 0.742(METXBIODB00942) 0.611(DB11431) 0.508(DB02789;METXBIODB01189)
| 0.991(DBMET03414) 0.986(DBMET03415) 0.702(METXBIODB00943
)
|
Cyclooxygenase 3 inhibitor | 0.977(DB06772) 0.967(DB13751) 0.960(CHEMBL92;DB01248)
| 0.978(DBMET00998) 0.970(METXBIODB03005) 0.966(DBMET00999
)
|
ATPase inhibitor | 0.737(METXBIODB00730) 0.671(DB00390) 0.670(METXBIODB00942)
| 0.834(DBMET03415) 0.814(DBMET03414) 0.692(METXBIODB00943
)
|
Cholesterol esterase inhibitor | 0.193(METXBIODB02133) 0.179(DB00825;METXBIODB01997;METXBIODB02957) 0.152(METXBIODB02136)
| 0.193(DBMET01971) 0.147(DBMET01968;DBMET01969;DBMET01970) 0.113(METXBIODB01152
)
|
Neuropeptide Y2 antagonist | 0.332(DB01255) 0.322(DB01018) 0.321(DB09173)
| 0.598(DBMET02065) 0.582(CHEMBL3526373) 0.331(CHEMBL3544766
)
|
NOS2 expression inhibitor | 0.981(DB00394) 0.969(DB01234;METXBIODB00696) 0.966(DB00764)
| 0.982(DBMET02589) 0.978(DBMET02590) 0.973(DBMET02591
)
|
NAT2 substrate | 0.960(METXBIODB02653) 0.953(METXBIODB02206) 0.937(METXBIODB02319)
| 0.962(DBMET00301) 0.951(METXBIODB01390) 0.935(DBMET00612
)
|
Coagulant | 0.935(DB01022) 0.835(DB00126) 0.591(CHEMBL1046;DB00513)
| 0.935(DBMET00799) 0.933(DBMET03366) 0.927(DBMET03368
)
|
UGT2B11 substrate | 0.938(DB04630) 0.880(DB00741;METXBIODB01729) 0.736(METXBIODB02993)
| 0.908(DBMET02902) 0.901(DBMET02900;DBMET02901) 0.838(DBMET02903
)
|
Acetylcholine M5 receptor agonist | 0.450(DB00185;METXBIODB00507) 0.220(DB01085;METXBIODB01181) 0.218(DB01184)
| 0.450(DBMET00430;DBMET00431;DBMET00433) 0.215(DBMET03252;DBMET03253) 0.188(METXBIODB00508
)
|
Toll-Like receptor 2 antagonist | 0.477(DB11677) 0.435(METXBIODB03031) 0.377(DB13966)
| 0.626(DBMET01886;DBMET01887) 0.449(DBMET01600;METXBIODB00414) 0.416(DBMET01599;METXBIODB00413
)
|
Analeptic | 0.995(CHEMBL250785;CHEMBL428647;DB01229) 0.990(DB06772) 0.986(DB01183)
| 0.995(CHEMBL122465;CHEMBL307088;DBMET01760) 0.994(CHEMBL3526207;DBMET03369) 0.993(CHEMBL517341;DB06409;METXBIODB02826
)
|
Prostaglandin F2 alpha antagonist | 0.777(DB00287) 0.742(DB00905) 0.710(DB00654)
| 0.897(DBMET02588) 0.827(DBMET02216) 0.790(DBMET02771
)
|
Antifungal (Candida) | 0.982(CHEMBL64391;DB01167;METXBIODB00524) 0.895(DB11638) 0.873(METXBIODB00454)
| 0.982(CHEMBL4525087;CHEMBL4525088) 0.914(CHEMBL4525795;DBMET00374;METXBIODB00525) 0.895(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713
)
|
Chemoprotective | 0.985(METXBIODB03141) 0.974(DB09298) 0.970(CHEMBL3527416)
| 0.993(CHEMBL3988904) 0.990(CHEMBL3542279;CHEMBL3542281;DBMET03632;METXBIODB02134) 0.986(CHEMBL4106241;METXBIODB02135
)
|
Vanilloid 1 agonist | 0.720(METXBIODB02498) 0.693(DB14001) 0.621(DB06716)
| 0.645(DBMET02036;DBMET02320) 0.636(CHEMBL3526360) 0.611(DBMET02038;DBMET02322
)
|
UGT2B1 substrate | 0.989(DB00921) 0.981(METXBIODB01912) 0.970(METXBIODB01980)
| 0.981(DBMET00174) 0.975(DB00917) 0.971(DBMET00760
)
|
Alpha-N-acetylglucosaminidase inhibitor | 0.937(DB01914;DB09419;DB11735) 0.927(DB00742;DB11195) 0.870(DB03793;METXBIODB02476)
| 0.941(DBMET02088) 0.915(DBMET00488) 0.896(DBMET03076
)
|
Nav1.6 sodium channel blocker | 0.505(METXBIODB01341) 0.494(CHEMBL643;DB01069;METXBIODB02397) 0.484(DB00836)
| 0.422(DBMET01213) 0.412(DBMET00108;DBMET01728) 0.397(DBMET01616
)
|
Restless leg syndrome treatment | 0.764(DB00248) 0.640(DB00451;DB00509;METXBIODB02811) 0.554(DB13345)
| 0.887(DBMET00559) 0.886(DBMET00555) 0.825(DBMET02090
)
|
Choleretic | 0.915(DB02659;METXBIODB00251) 0.884(DB01586;METXBIODB00939) 0.852(METXBIODB00249)
| 0.979(DBMET00553) 0.970(METXBIODB02279) 0.926(METXBIODB00252
)
|
Growth hormone agonist | 0.958(DB00121) 0.673(DB00191) 0.648(DB03852;METXBIODB00171)
| 0.947(DBMET03073) 0.935(DBMET03072) 0.682(DB00166
)
|
Antiviral (Influenza B) | 0.891(DB13997) 0.594(DB00198) 0.530(DB00640)
| 0.809(DB15675) 0.770(DB00171) 0.686(CHEMBL3638285
)
|
Interferon agonist | 0.367(DB14001) 0.346(CHEMBL49563;DB00163) 0.341(DB14002)
| 0.378(METXBIODB02530) 0.362(METXBIODB02462) 0.361(DBMET00509
)
|
Sigma receptor agonist | 0.757(CHEMBL52440;DB00514;METXBIODB00707) 0.715(DB01074;DB09089;METXBIODB00067) 0.707(CHEMBL259209;DB04896;DB08918)
| 0.759(CHEMBL1254766;DB14682;METXBIODB00708) 0.747(DBMET01507) 0.744(DBMET01505
)
|
Posttraumatic stress disorder treatment | 0.711(DB05087) 0.595(DB00273) 0.520(DB09059)
| 0.530(DBMET03442) 0.503(CHEMBL3527303) 0.475(DBMET00120;DBMET01785
)
|
Immunostimulant | 0.820(CHEMBL269732;DB00864;METXBIODB00828) 0.768(METXBIODB00831) 0.759(CHEMBL1783834)
| 0.963(CHEMBL3706513) 0.952(CHEMBL3706514) 0.931(CHEMBL4106241
)
|
Adenylate kinase inhibitor | 0.630(DB00640) 0.531(DB00118) 0.462(METXBIODB01129)
| 0.988(DBMET03175) 0.987(DB03699) 0.979(DB02912;DBMET03176
)
|
Oleamide hydrolase inhibitor | 0.239(DB08887) 0.206(METXBIODB00237;METXBIODB01309) 0.186(METXBIODB02655)
| 0.210(DBMET01607;DBMET01608;DBMET01609;DBMET01610;METXBIODB00421;METXBIODB00422;METXBIODB00423;METXBIODB00424) 0.209(DBMET01593;DBMET01606;DBMET02087;METXBIODB00407;METXBIODB00420) 0.198(DBMET01601;METXBIODB00415
)
|
Nicotinic acid receptor agonist | 0.251(METXBIODB02568;METXBIODB02799) 0.211(DB00627) 0.205(DB03793;METXBIODB02476)
| 0.308(DB14132) 0.241(CHEMBL3544508;DBMET00728) 0.205(DBMET01437
)
|
CYP3A4 inhibitor | 0.974(CHEMBL163;DB00503) 0.858(DB00778;METXBIODB01286) 0.852(CHEMBL1473;DB00588)
| 0.926(CHEMBL317192) 0.914(CHEMBL3544628;DBMET00385) 0.905(CHEMBL3544832
)
|
Antihelmintic (Trematoda) | 0.958(DB06697) 0.938(DB09274;METXBIODB01712) 0.884(DB11638)
| 0.886(METXBIODB00455) 0.884(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.612(CHEMBL75589
)
|
Antiviral (Parainfluenza) | 0.297(DB11677) 0.286(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450) 0.277(CHEMBL853)
| 0.286(DB03796;DB08231;DBMET03460) 0.282(DB03704) 0.272(DB01440
)
|
Antianorexic | 0.756(DB00470) 0.716(DB09059) 0.671(DB01255)
| 0.766(CHEMBL3526373) 0.705(DBMET00120;DBMET01785) 0.670(DBMET01221
)
|
Corticotropin releasing factor 2 receptor antagonist | 0.184(METXBIODB00046) 0.152(DB01628) 0.145(METXBIODB00471)
| 0.139(DBMET02741;DBMET03063;METXBIODB01837;METXBIODB02047) 0.138(DBMET02967) 0.125(DBMET03446
)
|
Interferon inducer | 0.290(CHEMBL49563;DB00163) 0.289(DB14001) 0.285(DB14002)
| 0.307(METXBIODB02530) 0.291(METXBIODB02462) 0.290(DBMET00509
)
|
Movement disorders treatment | 0.558(DB00697;METXBIODB02082) 0.409(METXBIODB02657) 0.373(DB00537)
| 0.352(DBMET00341;METXBIODB00824) 0.334(CHEMBL3542349) 0.329(DB12148
)
|
Toxic, respiratory center | 0.965(CHEMBL651;DB00333;METXBIODB02006) 0.902(DB00295;METXBIODB00642) 0.889(DB00318;METXBIODB00641)
| 0.902(DBMET00313;METXBIODB00800) 0.892(DBMET00649) 0.885(DBMET00427;DBMET02514
)
|
Proliferative diseases treatment | 0.991(DB06287) 0.983(CHEMBL413;DB00877;METXBIODB01375) 0.976(METXBIODB00817)
| 0.990(DBMET00609) 0.986(METXBIODB02720) 0.984(CHEMBL3544688;DBMET01749;DBMET01753;METXBIODB01377;METXBIODB01381;METXBIODB02763
)
|
DNA damaging | 0.966(DB01181;METXBIODB00963) 0.956(METXBIODB03049) 0.955(DB05109)
| 0.957(CHEMBL731;DBMET00019) 0.956(DBMET00024;METXBIODB00966) 0.951(DBMET01136
)
|
Phospholipase D inhibitor | 0.197(DB01184) 0.188(METXBIODB01183) 0.178(METXBIODB00747)
| 0.194(DBMET00364;METXBIODB00749) 0.190(METXBIODB01184) 0.163(METXBIODB03035
)
|
Neurotrophic factor | 0.687(METXBIODB02965;METXBIODB03088) 0.618(METXBIODB00323;METXBIODB01252) 0.587(METXBIODB00199)
| 0.745(DBMET00094;METXBIODB01465) 0.742(METXBIODB00859) 0.618(DBMET01736
)
|
Nitric-oxide synthase stimulant | 0.991(DB00778;METXBIODB01286) 0.943(CHEMBL532;DB00199) 0.931(CHEMBL1741;DB01211;METXBIODB00619)
| 0.984(METXBIODB01287) 0.976(DBMET00944) 0.973(DBMET00828
)
|
Paget's disease treatment | 0.851(DB00169) 0.839(CHEMBL846;DB00136) 0.712(DB00153;METXBIODB01575;METXBIODB02762)
| 0.865(CHEMBL3544529;DBMET00575) 0.830(CHEMBL3351075;CHEMBL3542403) 0.809(DBMET02435
)
|
5 Hydroxytryptamine 3E antagonist | 0.481(METXBIODB01089) 0.478(METXBIODB00010) 0.472(DB00918)
| 0.546(DBMET01362) 0.461(DBMET01361;METXBIODB01090) 0.458(METXBIODB00011
)
|
Triose-phosphate isomerase inhibitor | 0.804(DB00581) 0.795(DB01914;DB09419;DB11735) 0.695(DB00742;DB11195)
| 0.945(DBMET01478) 0.764(DBMET02089) 0.710(DB04272
)
|
Antihyperlipoproteinemic | 0.977(DB00175) 0.975(CHEMBL503;DB00227;METXBIODB01008) 0.932(CHEMBL1064;DB00641;METXBIODB01371)
| 0.977(DBMET02472) 0.972(CHEMBL1201373) 0.962(DBMET01699
)
|
Lanosterol 14 alpha demethylase inhibitor | 0.989(CHEMBL64391;DB01167;METXBIODB00524) 0.952(DB00582) 0.942(DB01026)
| 0.989(CHEMBL4525087;CHEMBL4525088) 0.988(DBMET00374;METXBIODB00525) 0.978(METXBIODB00526
)
|
UGT2B9 substrate | 0.971(DB00921) 0.955(METXBIODB01912) 0.930(DB04630)
| 0.955(DBMET00174) 0.910(DBMET03370) 0.896(DBMET00760
)
|
Narcotic antagonist | 0.981(DB00921) 0.911(DB06230) 0.901(METXBIODB03062)
| 0.992(DBMET00176) 0.985(DBMET01858;DBMET03369;METXBIODB03063) 0.867(DBMET03370
)
|
Sphingosine kinase inhibitor | 0.503(DB08868) 0.237(METXBIODB02270) 0.229(DB09494;METXBIODB02529;METXBIODB02655)
| 0.413(CHEMBL80254) 0.391(DBMET03096) 0.312(METXBIODB02656
)
|
SULT1A2 substrate | 0.930(METXBIODB03110) 0.898(METXBIODB01202) 0.882(METXBIODB03128)
| 0.973(DBMET02101) 0.963(DBMET01312;METXBIODB02868) 0.959(CHEMBL1208633;METXBIODB02254
)
|
Respiratory analeptic | 0.996(CHEMBL428647;DB01229) 0.995(CHEMBL250785) 0.994(METXBIODB01048;METXBIODB01414)
| 0.996(CHEMBL122465;CHEMBL307088;DBMET01760) 0.995(CHEMBL3526207;DB06409;DBMET03369;METXBIODB02826) 0.994(CHEMBL3706543;CHEMBL3706544;CHEMBL517341;DBMET00660;DBMET01759;DBMET02904;METXBIODB01416;METXBIODB02727;METXBIODB02827
)
|
Antiviral (Ebola) | 0.962(DB14761) 0.886(DB15661) 0.776(DB08934)
| 0.860(DB15660) 0.796(DB15686) 0.620(METXBIODB02223
)
|
Glutamate (mGluR6) antagonist | 0.467(CHEMBL109;DB00313;METXBIODB01559) 0.382(DB00130) 0.369(DB00129)
| 0.743(DB00142) 0.541(CHEMBL3706509;DBMET01109) 0.540(CHEMBL3544524
)
|
Antihistaminic | 0.990(DB00501) 0.914(DB01084) 0.882(DB00863;METXBIODB01235)
| 0.990(DBMET03242;DBMET03243) 0.832(DBMET02354) 0.790(DBMET00959
)
|
Cathepsin L inhibitor | 0.947(DB06670) 0.665(DB05521) 0.260(DB00188)
| 0.967(DBMET01475) 0.880(DBMET01472) 0.483(CHEMBL3526373
)
|
Aminopeptidase B inhibitor | 0.712(CHEMBL1430) 0.624(DB01197) 0.581(DB00129)
| 0.753(DBMET00502) 0.690(DBMET00503) 0.687(DBMET00506
)
|
Acyl-CoA dehydrogenase inhibitor | 0.380(DB00640) 0.294(DB09357;DB11204) 0.283(DB11936)
| 0.901(DB03699) 0.879(DB02912;DBMET03176) 0.783(DBMET03175
)
|
Actinic keratosis treatment | 0.834(CHEMBL428647;DB01229) 0.731(METXBIODB01414) 0.698(CHEMBL92;DB01248)
| 0.820(CHEMBL122465;CHEMBL307088;DBMET01760) 0.712(METXBIODB01416) 0.698(DBMET00633
)
|
Histamine H2 receptor agonist | 0.638(DB00501) 0.322(DB00585) 0.261(DB00863;METXBIODB01235)
| 0.638(DBMET03242;DBMET03243) 0.601(CHEMBL901) 0.286(DBMET00959
)
|
Fatty acid synthase inhibitor | 0.635(METXBIODB02133) 0.493(METXBIODB02136) 0.431(METXBIODB02879)
| 0.426(METXBIODB02134) 0.356(METXBIODB02135) 0.337(DBMET00251;METXBIODB00869
)
|
Cytokine production stimulant | 0.254(DB14126) 0.136(METXBIODB00221) 0.127(DB09494;METXBIODB02529)
| 0.277(DBMET01173;METXBIODB01188) 0.254(DBMET01425) 0.206(DBMET00509
)
|
Antiviral (Herpesvirus 3, Human) | 0.982(DB12151) 0.652(DB00718) 0.619(DB00441)
| 0.888(DBMET03374) 0.885(DBMET03375) 0.709(DB00369
)
|
Prostaglandin D2 agonist | 0.624(DB01240) 0.538(DB00770) 0.470(DB00287)
| 0.613(DB00917) 0.610(DBMET02588) 0.538(DBMET02086
)
|
Insulin sensitizer | 0.991(DB08822) 0.946(DB09198) 0.919(DB01132)
| 0.979(DBMET01305) 0.972(DBMET01301) 0.965(DBMET01517
)
|
Cystathionine beta-synthase inhibitor | 0.960(METXBIODB03141) 0.949(METXBIODB02879) 0.946(METXBIODB01399)
| 0.946(METXBIODB02880) 0.942(METXBIODB03033) 0.932(METXBIODB02508
)
|
Antidote, organophosphates | 0.406(DB00424) 0.219(DB00245) 0.189(METXBIODB00446)
| 0.406(DBMET03252;DBMET03253) 0.189(CHEMBL3542326;DBMET02633) 0.181(DBMET02632
)
|
Glutamate (mGluR3) antagonist | 0.351(DB13848) 0.337(CHEMBL109;DB00313;METXBIODB01559) 0.331(DB00130)
| 0.370(CHEMBL3544524) 0.347(DB00142) 0.328(DB00123
)
|
Immunoglobulin Fc receptor antagonist | 0.127(DB02546) 0.117(DB01577;METXBIODB01797) 0.102(DB00182;DB01576;METXBIODB01904)
| 0.117(DB09571;DBMET00634;DBMET02228) 0.110(METXBIODB01762) 0.104(CHEMBL3544671;DBMET02537
)
|
Delayed rectifier potassium channel blocker | 0.585(METXBIODB02111) 0.123(METXBIODB02595) 0.104(DB00829)
| 0.329(METXBIODB02112) 0.264(METXBIODB02113) 0.120(CHEMBL3526841
)
|
Nicotinic acid receptor 2 antagonist | 0.136(METXBIODB02370) 0.109(METXBIODB02368) 0.094(DB03793;METXBIODB02476)
| 0.139(DB00312) 0.106(CHEMBL1222314) 0.094(DBMET01437
)
|
Anesthetic inhalation | 0.970(DB00228;METXBIODB00116) 0.958(DB01189) 0.942(DB01236)
| 0.699(DBMET02381;DBMET02382;DBMET02832;DBMET02833;DBMET02834) 0.693(DBMET01560;METXBIODB00117) 0.666(DBMET00862
)
|
Anesthetic local | 0.880(DB09085) 0.849(DB00721) 0.823(DB00866;DB00907;METXBIODB00058)
| 0.925(DBMET00645) 0.821(DBMET00386;METXBIODB01304) 0.790(DBMET01394
)
|
Angiotensin AT1 receptor antagonist | 0.988(DB00678;METXBIODB01004;METXBIODB01006) 0.981(CHEMBL191) 0.895(DB01029;METXBIODB00929)
| 0.995(CHEMBL907;METXBIODB01005) 0.993(DBMET00303) 0.988(CHEMBL308493
)
|
Acid ceramidase inhibitor | 0.055(METXBIODB00891) 0.050(METXBIODB02655) 0.048(CHEMBL185)
| 0.052(METXBIODB01640) 0.048(DB00544;DBMET00449;DBMET03527) 0.047(DBMET01195;METXBIODB00605
)
|
Argininosuccinate synthase inhibitor | 0.777(DB00640) 0.550(DB00118) 0.518(DB01262)
| 0.968(DB00171) 0.944(DBMET00485;DBMET03265) 0.904(DBMET00677
)
|
Histamine antagonist | 0.989(DB00501) 0.911(DB01084) 0.879(DB00863;METXBIODB01235)
| 0.989(DBMET03242;DBMET03243) 0.828(DBMET02354) 0.787(DBMET00959
)
|
Antineoplastic (pancreatic cancer) | 0.971(DB12473) 0.966(DB06176) 0.940(METXBIODB01643)
| 0.941(CHEMBL525;DBMET01147) 0.923(CHEMBL3706540;DBMET01123) 0.919(CHEMBL1593;DBMET00658
)
|
UGT2B15 substrate | 0.983(DB04630) 0.978(DB00741;METXBIODB01729) 0.975(DB00687)
| 0.983(DBMET00372;METXBIODB01730) 0.981(DBMET02846) 0.972(DBMET02851;DBMET02853;DBMET02863;DBMET02864
)
|
Superoxide dismutase inhibitor | 0.930(CHEMBL1430) 0.816(DB00129) 0.800(METXBIODB02168)
| 0.917(DBMET00502) 0.848(METXBIODB02504) 0.818(DB00123
)
|
Sphingosine 1-phosphate receptor 2 agonist | 0.723(DB12612) 0.673(DB08868) 0.357(DB05016)
| 0.910(DBMET03096) 0.638(METXBIODB00593) 0.480(DBMET01478
)
|
Membrane dipeptidase inhibitor | 0.740(DB06211) 0.263(DB00303) 0.187(DB06151)
| 0.218(CHEMBL3706517) 0.205(DBMET02123) 0.181(CHEMBL3706515;CHEMBL3706516
)
|
Lipase inhibitor | 0.335(METXBIODB01756) 0.276(METXBIODB02136) 0.270(METXBIODB02133)
| 0.409(DBMET03543) 0.386(CHEMBL3706470) 0.320(METXBIODB01757
)
|
Antimycoplasmal | 0.984(METXBIODB01048) 0.975(CHEMBL532;DB00199) 0.968(CHEMBL1741;DB01211;METXBIODB00619)
| 0.950(METXBIODB01049) 0.920(CHEMBL2063468;DBMET01656) 0.905(CHEMBL2022715;DBMET00357;METXBIODB00621
)
|
Gaucher disease treatment | 0.741(DB09039) 0.641(CHEMBL3527223) 0.246(METXBIODB00379)
| 0.638(CHEMBL80254) 0.497(DBMET03455) 0.468(DBMET03450;DBMET03451;DBMET03454
)
|
MDM2 inhibitor | 0.145(METXBIODB02370) 0.134(METXBIODB02368) 0.120(METXBIODB01859)
| 0.175(DBMET01117) 0.139(DBMET01116) 0.127(CHEMBL3544833
)
|
Adenosine A3 receptor antagonist | 0.759(DB00640) 0.737(DB00242) 0.643(DB01280)
| 0.824(CHEMBL3526900) 0.656(DBMET00496) 0.610(DBMET01160
)
|
Antihelmintic | 0.943(DB11431) 0.818(METXBIODB00942) 0.779(METXBIODB01048)
| 0.985(DBMET03414) 0.978(DBMET03415) 0.944(DBMET02119
)
|
VEGF expression inhibitor | 0.944(CHEMBL1504) 0.611(DB05294) 0.528(METXBIODB02986;METXBIODB03010)
| 0.885(CHEMBL3542217) 0.873(CHEMBL3542337) 0.855(CHEMBL3542299
)
|
12-Lipoxygenase inhibitor | 0.896(METXBIODB01398;METXBIODB03058) 0.879(METXBIODB02879) 0.877(METXBIODB02194)
| 0.888(DBMET00251;METXBIODB00869) 0.884(CHEMBL75589) 0.865(CHEMBL74898
)
|
Tocolytic | 0.983(DB09059) 0.293(DB00378;DB00816) 0.280(DB00871)
| 0.401(DBMET00840) 0.280(DBMET03275;DBMET03276) 0.278(DBMET02067
)
|
SULT2A1 substrate | 0.770(DB00279;METXBIODB02434) 0.735(DB00451;DB00509;METXBIODB02811) 0.656(CHEMBL691;DB00977;METXBIODB01784)
| 0.924(CHEMBL1614648) 0.903(DBMET00559) 0.896(DBMET00555
)
|
Antiinfertility, female | 0.953(METXBIODB02070) 0.901(CHEMBL83;DB00675;METXBIODB01400) 0.897(DB00539)
| 0.953(DBMET00032) 0.944(CHEMBL50995;DBMET02716) 0.821(CHEMBL2137046;DBMET00030;METXBIODB01402
)
|
Lysophosphatidic acid 3 receptor antagonist | 0.268(DB11677) 0.211(METXBIODB01129) 0.195(DB08887;METXBIODB00762)
| 0.195(DBMET00546;METXBIODB00763) 0.194(DB00154) 0.191(CHEMBL3544766
)
|
Endocannabinoid uptake inhibitor | 0.332(METXBIODB02515) 0.300(DB11677) 0.293(METXBIODB02270)
| 0.395(DBMET01593;DBMET01606;DBMET02087;METXBIODB00407;METXBIODB00420) 0.333(DBMET01601;METXBIODB00415) 0.294(DBMET01607;DBMET01608;DBMET01609;DBMET01610;METXBIODB00421;METXBIODB00422;METXBIODB00423;METXBIODB00424
)
|
CYP2D6 substrate | 0.996(CHEMBL269732;DB00864;METXBIODB00828;METXBIODB00831) 0.992(METXBIODB01048) 0.977(DB00390;METXBIODB00798)
| 0.997(CHEMBL3544708;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.996(CHEMBL3544602;CHEMBL3544693;CHEMBL3544709;CHEMBL3544837;CHEMBL3544838;DBMET00390;METXBIODB00832) 0.988(METXBIODB01049
)
|
UGT1A1 substrate | 0.985(DB00921) 0.970(METXBIODB01912) 0.959(DB01183)
| 0.995(DBMET00176) 0.991(METXBIODB02676) 0.989(DBMET03369
)
|
Sphingosine 1-phosphate receptor 3 antagonist | 0.331(DB08868) 0.267(DB12371) 0.206(DB06716)
| 0.850(DBMET03096) 0.207(METXBIODB00593) 0.204(METXBIODB00722
)
|
Antiviral (Rhinovirus) | 0.213(METXBIODB00458) 0.206(DB01022) 0.204(DB01086)
| 0.241(CHEMBL3988903) 0.210(CHEMBL3544766) 0.188(DB12148;DBMET01630;METXBIODB00604
)
|
UGT1A3 substrate | 0.990(DB00921) 0.987(METXBIODB01912) 0.981(DB01183)
| 0.987(DBMET00174) 0.968(DBMET00321;METXBIODB01140) 0.967(METXBIODB01981
)
|
Radioprotector | 0.910(CHEMBL3527416) 0.885(METXBIODB03141) 0.879(DB11296)
| 0.994(CHEMBL3988904) 0.991(CHEMBL3526780) 0.974(DBMET01883
)
|
Leukotriene C antagonist | 0.924(CHEMBL787;DB00471) 0.193(METXBIODB02380) 0.155(DB01241;METXBIODB03090)
| 0.937(CHEMBL3526239) 0.849(CHEMBL3526481;DBMET01248;DBMET01249;DBMET01709) 0.844(CHEMBL3526240
)
|
Pregnane X receptor antagonist | 0.133(DB01536;METXBIODB00393) 0.128(DB01024;METXBIODB01063) 0.124(DB00624;METXBIODB02276)
| 0.141(DBMET03366) 0.134(DBMET03211) 0.130(DBMET01766;DBMET01767
)
|
15-Lipoxygenase inhibitor | 0.882(METXBIODB02879) 0.872(METXBIODB01398;METXBIODB03058) 0.865(METXBIODB01399)
| 0.880(DBMET00251;METXBIODB00869) 0.871(CHEMBL446290) 0.862(CHEMBL75589
)
|
Sphingosine kinase 1 inhibitor | 0.446(DB08868) 0.191(METXBIODB02270) 0.186(DB09494;METXBIODB02529)
| 0.400(CHEMBL80254) 0.356(DBMET03096) 0.224(DBMET02693
)
|
UGT1A6 substrate | 0.994(DB00390) 0.989(METXBIODB00730) 0.974(DB00783;METXBIODB01814)
| 0.994(DBMET02502;METXBIODB00731) 0.979(DBMET01658;METXBIODB00779) 0.978(DBMET03007
)
|
Antidiabetic (type 2) | 0.972(CHEMBL385517;DB06335) 0.952(DB04876) 0.924(DB01261)
| 0.968(CHEMBL3350936;DBMET00459) 0.939(DB09401) 0.929(CHEMBL3542418
)
|
Histone deacetylase SIRT3 inhibitor | 0.154(CHEMBL1140) 0.147(DB01255) 0.119(DB00339)
| 0.167(DBMET01063) 0.154(DBMET02629) 0.147(DBMET02067
)
|
Kainate receptor agonist | 0.264(METXBIODB02453) 0.219(CHEMBL109;DB00313;DB01235;METXBIODB01559) 0.200(DB00130)
| 0.395(CHEMBL1367;DBMET00060;METXBIODB01563) 0.267(CHEMBL3706503;DBMET00066;DBMET00067) 0.264(CHEMBL116111;CHEMBL3706507;DB00142;DBMET01106
)
|
Phosphodiesterase 1A inhibitor | 0.929(DB00203) 0.697(DB00862) 0.625(METXBIODB00471)
| 0.671(DBMET03640) 0.668(DBMET00182) 0.564(DBMET00421;METXBIODB01331
)
|
Hepatic disorders treatment | 0.907(DB13853) 0.865(METXBIODB02278) 0.861(DB01586;METXBIODB00939)
| 0.931(DBMET02057) 0.865(METXBIODB00941) 0.863(CHEMBL3706475
)
|
Cyclophilin D inhibitor | 0.985(METXBIODB01947) 0.984(DB01132) 0.978(CHEMBL1770248;DB11827)
| 0.992(DBMET01300) 0.991(DBMET01365) 0.985(DBMET00942
)
|
Antidiabetic | 0.985(METXBIODB01947) 0.984(DB01132) 0.978(CHEMBL1770248;DB11827)
| 0.992(DBMET01300) 0.991(DBMET01365) 0.985(DBMET00942
)
|
Proteasome inhibitor | 0.836(DB00188) 0.280(DB05521) 0.277(DB06218)
| 0.455(DBMET01081) 0.358(CHEMBL3526373) 0.341(CHEMBL3544766
)
|
Vanilloid 2 agonist | 0.097(DB08921;DB11217;DB11365;METXBIODB00055) 0.084(DB00470) 0.080(METXBIODB02655)
| 0.129(METXBIODB02802) 0.117(METXBIODB03030) 0.111(METXBIODB02714
)
|
GABA B receptor agonist | 0.590(DB00181) 0.366(CHEMBL1046;DB00513) 0.292(METXBIODB02458)
| 0.365(CHEMBL3544571;DBMET00855;DBMET02006;DBMET03583) 0.309(DB01440) 0.290(DB03704
)
|
Angiotensin II receptor antagonist | 0.984(DB00678;METXBIODB01004;METXBIODB01006) 0.976(CHEMBL191) 0.935(DB00796)
| 0.992(CHEMBL907;METXBIODB01005) 0.990(DBMET00303) 0.984(CHEMBL308493
)
|
Aldosterone antagonist | 0.975(CHEMBL1393;DB00421) 0.964(DB00700) 0.923(DB01395)
| 0.947(CHEMBL3544705;DBMET02483) 0.896(CHEMBL3638292) 0.822(DBMET01655
)
|
Nicotinic acid receptor 1 antagonist | 0.075(METXBIODB02907) 0.061(METXBIODB03029) 0.060(CHEMBL898)
| 0.057(CHEMBL3544508;DBMET00728) 0.053(CHEMBL424;DBMET02419) 0.052(CHEMBL1461;DBMET02420;METXBIODB01302
)
|
Calcium-independent phospholipase A2 inhibitor | 0.089(METXBIODB02304) 0.069(METXBIODB00891) 0.068(DB01240)
| 0.198(CHEMBL1398) 0.098(DBMET03078) 0.077(CHEMBL3544571;DBMET00855;DBMET02006;DBMET03583
)
|
Sphingosine kinase 2 inhibitor | 0.375(DB08868) 0.219(METXBIODB02655) 0.212(METXBIODB02270)
| 0.395(DBMET03096) 0.259(CHEMBL1710849;DBMET01641) 0.231(CHEMBL3527068
)
|
Adenosine uptake inhibitor | 0.307(CHEMBL628;DB00806) 0.100(DB00201;METXBIODB00486) 0.094(METXBIODB00046)
| 0.165(CHEMBL3544675;DBMET03234) 0.100(DBMET00535) 0.073(DBMET03232
)
|
Antiparasitic | 0.951(DB11431) 0.845(METXBIODB00942) 0.842(METXBIODB01833)
| 0.987(DBMET03414) 0.981(DBMET03415) 0.952(DBMET02120
)
|
Amidase inhibitor | 0.188(DB04557;DB13854;METXBIODB00406;METXBIODB01977) 0.186(CHEMBL6;DB00328;METXBIODB00921) 0.184(DB13783)
| 0.292(DBMET03492) 0.265(CHEMBL3526518) 0.260(CHEMBL3544600
)
|
Phosphodiesterase 6D inhibitor | 0.867(DB00203) 0.753(DB00862) 0.700(DB00820)
| 0.721(DBMET00421;METXBIODB01331) 0.700(DBMET03416) 0.682(DBMET00182
)
|
Phobic disorders treatment | 0.882(DB00285;METXBIODB00162) 0.716(DB00176) 0.682(METXBIODB01592)
| 0.716(DBMET00055;METXBIODB00163) 0.625(METXBIODB00164) 0.618(DBMET02781;DBMET03704
)
|
Estrogen-related receptor beta agonist | 0.670(METXBIODB01404) 0.657(METXBIODB00268) 0.520(CHEMBL83;DB00675;METXBIODB01400)
| 0.657(CHEMBL2137046;DBMET00030;METXBIODB01402) 0.591(CHEMBL4525766;METXBIODB00270) 0.442(METXBIODB01709
)
|
Melanin inhibitor | 0.938(DB09298) 0.872(METXBIODB03141) 0.813(CHEMBL464825)
| 0.923(DBMET01841) 0.917(METXBIODB02188) 0.894(METXBIODB02189
)
|
Exportin-1 inhibitor | 0.199(DB06799) 0.176(CHEMBL672;DB01039) 0.174(METXBIODB00350)
| 0.201(DBMET03181) 0.169(DBMET03180) 0.164(DBMET01591
)
|
Nicotinic alpha3beta2 receptor antagonist | 0.985(METXBIODB01541) 0.651(DB01156;METXBIODB00109;METXBIODB01854) 0.416(METXBIODB01741)
| 0.975(METXBIODB01542) 0.903(DBMET03469;DBMET03471) 0.467(METXBIODB00113;METXBIODB01858
)
|
Hedgehog signaling activator | 0.284(METXBIODB01504) 0.186(DB01586;METXBIODB00939;METXBIODB02278) 0.179(DB05812)
| 0.236(METXBIODB01981) 0.186(DB06777;METXBIODB00941) 0.165(DBMET03598
)
|
Aconitate hydratase inhibitor | 0.638(DB03793;METXBIODB02476) 0.590(CHEMBL109;DB00313;METXBIODB01559) 0.477(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450)
| 0.890(DBMET03078) 0.861(DB04272) 0.818(DBMET01108
)
|
VCAM1 expression inhibitor | 0.964(CHEMBL1064;DB00641;METXBIODB01371) 0.941(DB01234;METXBIODB00696) 0.835(METXBIODB01748)
| 0.941(DB00443) 0.934(CHEMBL3544664) 0.928(DBMET01699
)
|
Antiviral (Enterovirus) | 0.128(DB00737) 0.084(DB00557) 0.078(DB01097;METXBIODB01809)
| 0.085(DBMET01193;METXBIODB00603) 0.074(CHEMBL4525085) 0.073(DBMET02576;METXBIODB01624
)
|
Antihemophilic | 0.440(DB05016) 0.380(DB09059) 0.193(DB03088)
| 0.167(DBMET00494) 0.145(DBMET03379) 0.142(DBMET01535
)
|
Na+ K+ transporting ATPase inhibitor | 0.932(DB00390) 0.914(METXBIODB00730) 0.593(CHEMBL250785)
| 0.932(DBMET02502;METXBIODB00731) 0.917(DBMET02501) 0.793(DBMET03414
)
|
Prostaglandin F2 alpha agonist | 0.944(DB00287) 0.926(DB08819) 0.522(DB00770)
| 0.762(DBMET02216) 0.718(DB00917) 0.674(DBMET00481
)
|
Melatonin receptor 1A agonist | 0.676(DB01065) 0.297(METXBIODB01089) 0.215(METXBIODB01023)
| 0.264(DBMET00411) 0.212(METXBIODB00012) 0.204(DBMET01359
)
|
Granulocyte macrophage colony stimulating factor agonist | 0.250(METXBIODB02513) 0.238(DB01086) 0.228(METXBIODB00233)
| 0.260(CHEMBL3542349) 0.248(METXBIODB02806) 0.240(DBMET00691;DBMET02359
)
|
Muscular dystrophy treatment | 0.964(CHEMBL160;DB00091) 0.927(DB11921) 0.891(DB15566)
| 0.971(CHEMBL3544640) 0.964(CHEMBL3526346) 0.952(CHEMBL2407580;CHEMBL3544638;CHEMBL3544879;DBMET00359
)
|
Protease 3C (Human rhinovirus) inhibitor | 0.227(DB09292) 0.223(CHEMBL1233;DB00395) 0.153(METXBIODB00458)
| 0.230(CHEMBL3988903) 0.218(CHEMBL3544766) 0.191(CHEMBL3526717
)
|
Lysophosphatidic acid receptor 1 agonist | 0.236(DB11677) 0.139(METXBIODB01129) 0.130(DB13966)
| 0.152(DBMET03096) 0.125(DBMET01594;DBMET01595;DBMET01596;METXBIODB00408;METXBIODB00409;METXBIODB00410) 0.124(METXBIODB01130
)
|
5 Hydroxytryptamine 3A agonist | 0.678(DB00889;METXBIODB00874) 0.411(METXBIODB00288) 0.383(CHEMBL2104993;DB09068)
| 0.555(DBMET00406;METXBIODB00876) 0.492(DBMET01778) 0.475(METXBIODB00875
)
|
Pregnane X receptor agonist | 0.988(CHEMBL374478) 0.928(DB11753) 0.758(CHEMBL444633;DB00615)
| 0.979(CHEMBL446290) 0.928(CHEMBL3323549) 0.890(DBMET02189
)
|
Alcohol dehydrogenase substrate | 0.996(METXBIODB02531) 0.914(METXBIODB03135) 0.902(METXBIODB00323;METXBIODB01252)
| 0.996(DB02325) 0.986(METXBIODB00859) 0.977(CHEMBL731;DBMET00019
)
|
Cholesterol absorption inhibitor | 0.483(CHEMBL1064;CHEMBL503;DB00227;DB00641;METXBIODB01008;METXBIODB01371) 0.413(DB00175) 0.382(METXBIODB01748)
| 0.726(DBMET02118) 0.695(DBMET02115;METXBIODB02286) 0.677(DBMET02475
)
|
Peptide deformylase inhibitor | 0.114(DB01197) 0.099(DB02546) 0.084(DB06151)
| 0.104(CHEMBL3527294) 0.088(CHEMBL3544766) 0.083(DBMET01108
)
|
5 Hydroxytryptamine 4 antagonist | 0.859(DB06480) 0.650(DB00604) 0.536(DB13345)
| 0.788(DBMET02197) 0.579(DBMET02198) 0.576(DBMET02203
)
|
Aldehyde dehydrogenase substrate | 0.785(CHEMBL88;DB00531;METXBIODB00960) 0.756(METXBIODB03135) 0.742(METXBIODB00323;METXBIODB01252)
| 0.940(CHEMBL731;DBMET00019) 0.928(METXBIODB00859) 0.920(DBMET02013
)
|
Antiseptic | 0.954(DB01294) 0.869(DB13960) 0.846(METXBIODB03031)
| 0.888(DBMET00809) 0.861(DBMET01394) 0.859(CHEMBL3544545
)
|
Sodium/glucose cotransporter 1 inhibitor | 0.817(CHEMBL1770248;DB11827) 0.746(DB12713) 0.704(DB06292)
| 0.824(CHEMBL3526185;CHEMBL3527604;DBMET01910;DBMET01911) 0.753(DBMET01912) 0.704(DBMET01909
)
|
Glutathione S-transferase substrate | 0.986(CHEMBL88;DB00175;DB00531;METXBIODB00960) 0.983(METXBIODB01071) 0.981(METXBIODB02869)
| 0.991(CHEMBL3706541) 0.989(CHEMBL3706539;METXBIODB01072) 0.986(DBMET01683;DBMET02472
)
|
Glutamate (mGluR8) antagonist | 0.125(DB06739;METXBIODB00580;METXBIODB03056) 0.123(CHEMBL109;DB00313;METXBIODB01559) 0.113(DB00129;DB00130)
| 0.165(DBMET01507) 0.147(DB00142) 0.118(CHEMBL3706509;DBMET01109
)
|
Prostaglandin agonist | 0.921(DB01240) 0.893(DB08819) 0.881(DB00287)
| 0.905(DB00917) 0.821(DBMET02588) 0.817(DBMET00481
)
|
Hypercalcemia treatment | 0.687(CHEMBL846;DB00136) 0.574(DB06670) 0.568(DB00169)
| 0.628(CHEMBL3542380;CHEMBL3542386) 0.627(DBMET02435) 0.621(CHEMBL3544529;DBMET00575
)
|
Prostaglandin EP2 agonist | 0.689(DB00770) 0.626(DB00287) 0.597(DB00929)
| 0.824(DB00917) 0.705(DBMET02637) 0.689(DBMET02086
)
|
Ca(v)3.1 blocker | 0.591(DB13853) 0.383(METXBIODB03053) 0.377(METXBIODB02470)
| 0.622(DBMET02057) 0.333(CHEMBL117487;CHEMBL3706510;DBMET00065) 0.293(DB12148
)
|
Aldehyde dehydrogenase inhibitor | 0.826(METXBIODB00925) 0.810(METXBIODB00855) 0.788(DB01645;METXBIODB00465)
| 0.964(DB00171) 0.939(DBMET00485;DBMET03265) 0.903(METXBIODB00928
)
|
Glucose-6-phosphate isomerase inhibitor | 0.473(DB00581) 0.442(DB01914;DB09419;DB11735) 0.319(DB00742;DB11195)
| 0.847(DBMET01478) 0.512(DBMET02088) 0.396(DB03947
)
|
UDP-glucose 4-epimerase inhibitor | 0.653(DB09144) 0.632(DB00581) 0.629(DB00432)
| 0.965(DB01861;DB03501) 0.740(CHEMBL1774;DBMET02000;DBMET03590) 0.736(DB00171
)
|
Cardiodepressant | 0.992(CHEMBL1512) 0.987(DB00866) 0.984(CHEMBL633;DB01118)
| 0.987(CHEMBL3542209;DBMET00740) 0.984(CHEMBL4525130;CHEMBL4525131;CHEMBL4525132;CHEMBL4525133;CHEMBL4525134;CHEMBL4525135;CHEMBL4525136;CHEMBL4525137;CHEMBL4525138) 0.983(CHEMBL4525792
)
|
Glutamate (mGluR7) agonist | 0.266(METXBIODB01417) 0.263(METXBIODB00039) 0.202(DB06218)
| 0.416(CHEMBL3706469) 0.257(DB00142) 0.228(DBMET01652
)
|
Antismoking | 0.866(DB00273) 0.812(CHEMBL3;DB00184;METXBIODB02230) 0.804(CHEMBL52440;DB00514;METXBIODB00707)
| 0.828(DBMET03469;DBMET03471) 0.801(CHEMBL1254766;DB14682;METXBIODB00708) 0.792(CHEMBL6200;DBMET00520
)
|
Acetylcholine M4 receptor antagonist | 0.621(DB01062;METXBIODB00150) 0.531(CHEMBL715;DB00334;METXBIODB01125) 0.477(DB01074;METXBIODB00067)
| 0.706(CHEMBL440512;METXBIODB01127) 0.506(DBMET01734;DBMET01826;METXBIODB01231;METXBIODB01851) 0.398(METXBIODB01314
)
|
Histamine H1 receptor agonist | 0.169(DB06698) 0.133(DB01620) 0.117(METXBIODB02408)
| 0.195(DBMET02635) 0.152(DBMET02636) 0.095(DBMET00377;METXBIODB00149;METXBIODB01001
)
|
Leukotriene C4 antagonist | 0.923(CHEMBL787;DB00471) 0.172(METXBIODB02380) 0.133(DB01241;METXBIODB03090)
| 0.931(CHEMBL3526239) 0.850(CHEMBL3526481;DBMET01248;DBMET01249;DBMET01709) 0.844(CHEMBL3526240
)
|
Free fatty acid receptor 1 antagonist | 0.131(DB00573) 0.130(METXBIODB00301) 0.123(DB06819)
| 0.161(DBMET00510) 0.128(DBMET00869;METXBIODB03151) 0.120(DBMET00808
)
|
Cathepsin G inhibitor | 0.732(DB09059) 0.631(DB06176) 0.471(DB00188)
| 0.481(CHEMBL3526373) 0.470(CHEMBL3544766) 0.462(CHEMBL3544779
)
|
Purinergic P2Y15 antagonist | 0.181(DB00640) 0.088(DB00118) 0.075(DB00242)
| 0.113(DBMET00485;DBMET03265) 0.094(DBMET00514) 0.090(DB00171
)
|
Antihelmintic (Nematodes) | 0.899(DB11431) 0.635(METXBIODB01151) 0.596(DB00518)
| 0.996(DBMET03414;DBMET03415) 0.925(DBMET02119) 0.703(DBMET02120
)
|
Glucosylceramidase stimulant | 0.043(DB12911;METXBIODB01812) 0.041(METXBIODB00891) 0.039(METXBIODB01220)
| 0.041(METXBIODB01813) 0.040(CHEMBL3526371) 0.038(DBMET02629
)
|
Porphobilinogen synthase inhibitor | 0.836(METXBIODB01209) 0.831(DB11145) 0.821(METXBIODB01301)
| 0.865(DBMET01974) 0.829(CHEMBL3542351) 0.821(CHEMBL424;DBMET02419
)
|
Glutamate (mGluR group III) antagonist | 0.339(METXBIODB02368) 0.297(METXBIODB02370) 0.256(DB00627)
| 0.398(CHEMBL3544524) 0.318(DB00142) 0.205(DB00123
)
|
Corneal wound healing stimulator | 0.563(METXBIODB02515) 0.503(DB02546) 0.481(DB08908)
| 0.674(DB01677) 0.548(DB14219) 0.540(DBMET01593;DBMET01606;DBMET02087;METXBIODB00407;METXBIODB00420
)
|
Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.328(METXBIODB02615) 0.294(DB00737) 0.222(METXBIODB02655)
| 0.459(DBMET02576) 0.299(CHEMBL446290) 0.286(DBMET01194;DBMET01196;METXBIODB00601;METXBIODB00602
)
|
Cannabinoid CB2 receptor antagonist | 0.892(DB00470) 0.827(METXBIODB00199) 0.399(METXBIODB00070)
| 0.868(DBMET00120;DBMET01785) 0.743(METXBIODB00200) 0.686(DBMET01221
)
|
3C-Like protease (SARS coronavirus) inhibitor | 0.206(DB08908) 0.178(DB01914;DB09419;DB11735) 0.176(DB00188)
| 0.457(METXBIODB00859) 0.392(DBMET03077) 0.352(DB03947
)
|
Aminopeptidase I inhibitor | 0.356(DB06151) 0.337(CHEMBL1314;DB06823) 0.321(DB00230)
| 0.416(DBMET00503) 0.387(CHEMBL3527294) 0.366(DBMET00508
)
|
Thromboxane A2 agonist | 0.291(DB00770) 0.113(DB01240) 0.097(METXBIODB02515)
| 0.330(DB00917) 0.291(DBMET02086) 0.220(DBMET02588
)
|
ATP citrate lysase inhibitor | 0.365(DB11936) 0.257(METXBIODB02697) 0.221(METXBIODB02172)
| 0.263(DB04272) 0.215(DBMET03614) 0.209(DBMET01600;METXBIODB00414
)
|
Catalase inhibitor | 0.507(DB06151) 0.503(DB00126) 0.459(DB00130)
| 0.546(DBMET00503) 0.512(DBMET00799) 0.508(DBMET00508
)
|
Angiotensin AT1A receptor antagonist | 0.958(METXBIODB01006) 0.953(DB00678;METXBIODB01004) 0.881(DB01029;METXBIODB00929)
| 0.958(CHEMBL308493) 0.936(CHEMBL907;METXBIODB01005) 0.791(DBMET01053;METXBIODB00932
)
|
Transcription factor NF kappa B inhibitor | 0.991(DB00778;METXBIODB01286) 0.987(CHEMBL532;DB00199) 0.981(CHEMBL1741;DB01211;METXBIODB00619)
| 0.990(METXBIODB01287) 0.986(CHEMBL2063468;CHEMBL3542282;CHEMBL3542283;DBMET01656) 0.983(CHEMBL3542263
)
|
Chemopreventive | 0.989(CHEMBL3542194) 0.987(CHEMBL1783834) 0.984(DB13751)
| 0.989(CHEMBL4525142;CHEMBL4525143) 0.988(CHEMBL3542278;CHEMBL3542372) 0.987(CHEMBL3542263
)
|
Neuraminidase (Influenza B) inhibitor | 0.367(DB00198) 0.052(DB03088) 0.047(DB03793;METXBIODB02476)
| 0.709(DBMET02218) 0.102(DBMET03118) 0.070(DBMET03290
)
|
Antineoplastic antimetabolite | 0.956(DB00631) 0.930(DB00242) 0.913(DB00441)
| 0.992(DBMET00677) 0.991(DBMET01155;DBMET01157) 0.990(DBMET00419
)
|
Oxytocin agonist | 0.149(DB09059) 0.064(DB01255;METXBIODB03110) 0.060(METXBIODB01512)
| 0.085(CHEMBL3526373) 0.078(CHEMBL3527294) 0.076(DBMET02067
)
|
Neuropeptide Y1 antagonist | 0.346(METXBIODB00247) 0.322(DB01023;METXBIODB00100) 0.303(METXBIODB00020)
| 0.344(DBMET03491) 0.315(DBMET00368;METXBIODB00101) 0.314(DBMET03492
)
|
Genotoxic | 0.993(DB00773;METXBIODB00808) 0.987(METXBIODB01256) 0.980(METXBIODB02869)
| 0.994(DBMET00367;DBMET00853;DBMET01264;METXBIODB00809;METXBIODB01257) 0.991(DBMET01265) 0.990(METXBIODB01362
)
|
UGT1A4 substrate | 0.969(METXBIODB01980) 0.966(METXBIODB02993) 0.963(METXBIODB00249)
| 0.974(METXBIODB01981) 0.972(DBMET03599) 0.971(METXBIODB00940
)
|
Antidote | 0.954(CHEMBL269732;DB00864;METXBIODB00828) 0.888(METXBIODB00831) 0.886(CHEMBL3527416)
| 0.994(CHEMBL3988904) 0.942(CHEMBL3544693;DBMET00390) 0.937(CHEMBL3544708;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830
)
|
Melanocortin 1 antagonist | 0.179(DB09059) 0.165(DB11296) 0.121(DB01255)
| 0.145(DBMET02067) 0.136(DBMET00840) 0.111(CHEMBL3526373
)
|
Skin irritative effect | 0.995(CHEMBL1473;DB00588) 0.993(CHEMBL1370;DB01222;METXBIODB01745) 0.990(CHEMBL1504;DB06781;METXBIODB01928;METXBIODB02965;METXBIODB03088)
| 0.994(METXBIODB02066) 0.993(CHEMBL3542373;CHEMBL3542395;DBMET00476;DBMET02914;METXBIODB01746) 0.991(METXBIODB02569
)
|
Phosphofructokinase-1 inhibitor | 0.870(DB00640) 0.754(DB00581) 0.628(DB01914;DB09419;DB11735)
| 0.977(DB03699) 0.974(DB00171) 0.971(DB04045
)
|
Kainate receptor 2 antagonist | 0.265(CHEMBL109;DB00313;METXBIODB01559) 0.195(DB00129) 0.177(DB00268)
| 0.489(CHEMBL1367;DBMET00060;METXBIODB01563) 0.301(CHEMBL3706503;DBMET00066;DBMET00067) 0.294(DBMET02986
)
|
3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.552(DB00655;METXBIODB02494) 0.479(METXBIODB00781) 0.469(DB00783;METXBIODB01814)
| 0.552(DBMET00490) 0.479(DBMET00248;DBMET01659) 0.469(DBMET00491;METXBIODB00083
)
|
Acetylcholine M4 receptor agonist | 0.486(DB00185;METXBIODB00507) 0.377(DB01591) 0.318(DB01184)
| 0.486(DBMET00430;DBMET00431;DBMET00433) 0.236(DBMET00746) 0.200(METXBIODB01386
)
|
Prolyl endopeptidase inhibitor | 0.225(DB00178;DB00519) 0.207(DB00584) 0.200(DB00881)
| 0.244(DBMET00995;DBMET01014) 0.224(DBMET01269) 0.216(DBMET01141
)
|
Acetylcholine M1 receptor antagonist | 0.814(DB00185;METXBIODB00507) 0.809(METXBIODB01623) 0.782(DB01062;METXBIODB00150)
| 0.814(DBMET00430;DBMET00431;DBMET00433) 0.737(DBMET00645) 0.724(DBMET00746
)
|
Calcium channel P-type blocker | 0.267(DB00737) 0.182(DB00874) 0.169(METXBIODB00531)
| 0.215(DBMET02576) 0.182(DBMET02245) 0.176(DBMET02577
)
|
Glucosylceramidase inhibitor | 0.337(CHEMBL3527223) 0.213(DB01914;DB09419;DB11735) 0.199(METXBIODB00379)
| 0.649(CHEMBL80254) 0.350(CHEMBL3526603) 0.201(DBMET02088
)
|
Dopamine D1 antagonist | 0.995(DB13345) 0.984(METXBIODB00475) 0.972(DB06077)
| 0.924(DBMET03129) 0.897(DBMET03128) 0.895(DBMET01824
)
|
Thromboxane agonist | 0.691(DB00770) 0.228(DB00287) 0.207(DB00654)
| 0.891(DB00917) 0.741(DBMET02588) 0.691(DBMET02086
)
|
Nicotinic acid receptor 2 agonist | 0.259(DB03793;METXBIODB02476) 0.210(DB00627) 0.193(METXBIODB02564)
| 0.446(DB14132) 0.342(CHEMBL3526166) 0.303(CHEMBL3544508;DBMET00728;DBMET00993
)
|
Cannabinoid CB1 receptor agonist | 0.397(DB00470) 0.243(METXBIODB02270) 0.241(DB09084)
| 0.372(DBMET00120;DBMET01785) 0.345(METXBIODB00200) 0.297(DBMET01221
)
|
AMPA 4 receptor antagonist | 0.481(DB00129) 0.342(DB00130) 0.300(DB00177)
| 0.505(DB00123) 0.311(DB00142) 0.262(DBMET02986
)
|
NADPH oxidase inhibitor | 0.731(METXBIODB01398;METXBIODB03058) 0.725(METXBIODB02194) 0.717(METXBIODB02821)
| 0.741(METXBIODB03059) 0.726(METXBIODB02823) 0.720(CHEMBL75589
)
|
Alcohol dehydrogenase inhibitor | 0.602(CHEMBL1430) 0.550(CHEMBL3527416) 0.525(CHEMBL898)
| 0.747(CHEMBL3638284) 0.719(DBMET00769) 0.717(CHEMBL1237125;CHEMBL3638285;DBMET00657
)
|
Prostaglandin E2 agonist | 0.881(DB01240) 0.876(DB00287) 0.775(DB00770)
| 0.885(DB00917) 0.830(DBMET02588) 0.829(DBMET02216
)
|
Anesthetic | 0.923(DB05087) 0.915(CHEMBL250785) 0.892(DB01062;METXBIODB00150)
| 0.908(DBMET03442) 0.886(DBMET03598;METXBIODB00336) 0.883(DBMET03212
)
|
Lysophosphatidic acid receptor 3 agonist | 0.272(DB11677) 0.132(METXBIODB02270) 0.118(DB13966)
| 0.111(DBMET02072) 0.110(METXBIODB00722) 0.108(METXBIODB00593
)
|
Potassium channel (Tandem pore domain) blocker | 0.153(DB01171) 0.120(DB04841) 0.119(DB01097;METXBIODB01809)
| 0.153(DBMET02153) 0.149(DBMET01777) 0.128(METXBIODB01823
)
|
Carbonic anhydrase stimulant | 0.586(DB11296) 0.525(DB00273) 0.482(DB01124)
| 0.492(DBMET01483) 0.471(DBMET02909;DBMET02910) 0.380(CHEMBL3544766
)
|
Toll-Like receptor 4 agonist | 0.197(DB03852;METXBIODB00171) 0.082(DB09031) 0.056(DB00581)
| 0.342(DBMET02089) 0.266(METXBIODB00593) 0.130(DBMET00509
)
|
Farnesoid X receptor antagonist | 0.962(CHEMBL104) 0.640(METXBIODB01504) 0.604(DB01241;METXBIODB03090)
| 0.626(METXBIODB00250) 0.622(DBMET02786) 0.569(METXBIODB01505
)
|
Angiotensin AT2 receptor antagonist | 0.985(METXBIODB01006) 0.984(DB00678;METXBIODB01004) 0.804(CHEMBL191)
| 0.985(CHEMBL308493) 0.961(CHEMBL907;METXBIODB01005) 0.804(CHEMBL4525128;CHEMBL4525129
)
|
Thromboxane synthase inhibitor | 0.739(METXBIODB00744) 0.649(METXBIODB00097) 0.496(METXBIODB01452)
| 0.510(CHEMBL3544626) 0.508(METXBIODB00746) 0.504(DBMET01879
)
|
Complement factor 1s inhibitor | 0.063(DB00250) 0.044(METXBIODB01387) 0.043(METXBIODB01430;METXBIODB02349;METXBIODB03012)
| 0.043(DBMET00070;DBMET01043;DBMET03118) 0.042(CHEMBL1222314) 0.037(DBMET01162;DBMET02964
)
|
Acetylcholine M5 receptor antagonist | 0.366(DB01062;METXBIODB00150) 0.351(DB00983) 0.325(DB00342;METXBIODB00571)
| 0.376(DBMET02956) 0.315(DBMET01734;DBMET01826;METXBIODB01231;METXBIODB01851) 0.307(CHEMBL440512;METXBIODB01127
)
|
Adenosine deaminase inhibitor | 0.983(DB00640) 0.972(DB00242) 0.815(DB01280)
| 0.981(DB00171) 0.967(DBMET00677) 0.966(DBMET00485;DBMET03265
)
|
Death-associated protein kinase 1 inhibitor | 0.538(DB06595) 0.449(METXBIODB03012) 0.376(DB00437)
| 0.467(DBMET01440) 0.449(DBMET01043) 0.446(DBMET01441
)
|
Glutamate (mGluR1) agonist | 0.224(DB00130) 0.188(DB01235) 0.177(DB13848)
| 0.328(DBMET00486) 0.327(DB00142) 0.309(DBMET01324
)
|
Antiviral (Papilloma) | 0.892(DB12151) 0.871(DB09299) 0.742(CHEMBL160;DB00091)
| 0.874(DBMET03374) 0.848(DBMET03375) 0.839(DBMET03569
)
|
Radiosensitizer | 0.981(CHEMBL92;DB01248) 0.973(DB06772) 0.964(CHEMBL428647;DB01229)
| 0.981(DBMET00633) 0.975(CHEMBL3706530;DBMET01649) 0.974(DBMET00999
)
|
Lysophosphatidic acid 1 receptor antagonist | 0.100(METXBIODB00762) 0.096(DB04557;DB13854;METXBIODB00406;METXBIODB01977) 0.093(DB03756)
| 0.100(DBMET00546;METXBIODB00763) 0.096(DB00154) 0.078(DBMET01594;DBMET01595;DBMET01596;DBMET01599;METXBIODB00408;METXBIODB00409;METXBIODB00410;METXBIODB00413
)
|
Sphingosine 1-phosphate receptor antagonist | 0.459(DB12371) 0.412(DB05016) 0.317(DB08868)
| 0.949(DBMET03096) 0.282(DBMET03312) 0.200(DBMET01341
)
|
Biliverdin reductase inhibitor | 0.706(METXBIODB02273) 0.647(DB00640) 0.424(DB03793;METXBIODB02476)
| 0.825(DB00171;DBMET00485;DBMET03265) 0.621(CHEMBL1237125;DBMET00657;DBMET00769) 0.601(DBMET01158;DBMET02967
)
|
Apical sodium codependent bile acid transporter inhibitor | 0.139(METXBIODB03034) 0.131(DB02659;METXBIODB00251) 0.130(DB01586;METXBIODB00939;METXBIODB01504)
| 0.142(DBMET01434) 0.137(METXBIODB03035) 0.132(CHEMBL3186899;DBMET01884
)
|
DNA synthesis inhibitor | 0.954(DB00631) 0.937(DB00242) 0.932(DB00441)
| 0.995(CHEMBL3526610) 0.994(DBMET00677) 0.993(DBMET00859
)
|
Isoleucine-tRNA ligase inhibitor | 0.513(DB00410) 0.129(DB00640) 0.101(DB00242)
| 0.098(DBMET00514) 0.093(DBMET00912) 0.058(DBMET01435
)
|
Cannabinoid receptor antagonist | 0.686(DB00470) 0.629(CHEMBL2103817) 0.615(METXBIODB00199)
| 0.610(DBMET00120;DBMET01785) 0.512(METXBIODB00200) 0.401(DBMET01221
)
|
5-Alpha-reductase inhibitor | 0.897(CHEMBL710;DB01216) 0.710(METXBIODB02993) 0.677(DB00603;METXBIODB02099)
| 0.976(CHEMBL3542374) 0.875(CHEMBL4525755) 0.812(METXBIODB00940
)
|
Ornithine decarboxylase inhibitor | 0.932(DB00799) 0.805(DB00755;DB00982;METXBIODB00937) 0.744(METXBIODB00323;METXBIODB01252)
| 0.904(DBMET00454) 0.879(DBMET01005) 0.805(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253
)
|
5 Hydroxytryptamine 4 agonist | 0.949(DB06480) 0.676(DB00604) 0.140(DB01233)
| 0.976(DBMET02201) 0.826(DBMET02197) 0.736(DBMET00355
)
|
S-adenosyl-L-methionine decarboxylase inhibitor | 0.393(DB00640) 0.325(METXBIODB00880) 0.301(DB01438)
| 0.317(DB13410;METXBIODB00881) 0.225(DBMET00514) 0.192(DBMET00485;DBMET03265
)
|
Tourette's syndrome treatment | 0.510(DB11915) 0.441(METXBIODB00923) 0.353(DB04844)
| 0.441(DBMET00323;METXBIODB01276) 0.397(DBMET01447) 0.382(DBMET00458;DBMET00800;DBMET01448
)
|
mTOR complex 2 inhibitor | 0.858(CHEMBL413;DB00877;METXBIODB01375) 0.850(METXBIODB00817) 0.825(DB06287)
| 0.858(DBMET00628;METXBIODB00818) 0.855(CHEMBL3544651;DBMET00389;DBMET01748;METXBIODB01376) 0.853(METXBIODB00819
)
|
Toll-Like receptor 8 agonist | 0.089(CHEMBL585;DB00384) 0.081(DB09494;METXBIODB02529) 0.069(METXBIODB02461)
| 0.093(DBMET02122) 0.082(DBMET03096) 0.068(DBMET02072
)
|
GABA aminotransferase inhibitor | 0.763(METXBIODB02368) 0.699(METXBIODB02370) 0.649(CHEMBL1046;DB00513)
| 0.760(DBMET01955) 0.624(DB02362;DBMET01429) 0.587(DBMET01108
)
|
Alcohol oxidase inhibitor | 0.913(DB03793;METXBIODB02476) 0.911(DB11145) 0.905(METXBIODB02513)
| 0.913(DBMET01437) 0.910(DBMET03076) 0.902(METXBIODB03149
)
|
Mental retardation treatment | 0.448(CHEMBL661;DB00404) 0.441(DB00897) 0.433(DB01215)
| 0.433(DBMET00632) 0.216(CHEMBL3246317;DBMET00112) 0.210(DBMET00396
)
|
Alpha-mannosidase inhibitor | 0.906(CHEMBL3527223) 0.603(DB11217) 0.548(DB01914;DB09419;DB11735)
| 0.847(DBMET02088) 0.801(DBMET00509) 0.744(CHEMBL80254
)
|
1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.093(DB02546) 0.032(METXBIODB00189) 0.030(METXBIODB02729)
| 0.060(METXBIODB00349) 0.026(DBMET02228;METXBIODB01143) 0.023(DB02083
)
|
Androgen antagonist | 0.995(CHEMBL1473;DB00588) 0.993(DB00687) 0.987(DB00959)
| 0.985(DB00443) 0.979(DBMET02900;DBMET02901) 0.978(DBMET02920
)
|
Angiotensin AT1B receptor antagonist | 0.980(DB00678;METXBIODB01004) 0.961(METXBIODB01006) 0.876(DB01029;METXBIODB00929)
| 0.993(CHEMBL907;METXBIODB01005) 0.961(CHEMBL308493) 0.807(DBMET01053;METXBIODB00932
)
|
Cannabinoid CB1 receptor antagonist | 0.655(CHEMBL2103817) 0.592(DB00470) 0.550(METXBIODB00199)
| 0.532(DBMET00120;DBMET01785) 0.452(CHEMBL3526890) 0.448(METXBIODB00200
)
|
Contraceptive female | 0.985(DB00294) 0.984(METXBIODB00694;METXBIODB01137) 0.963(DB00304;METXBIODB00693)
| 0.984(DBMET00723;DBMET00724;DBMET01642;DBMET01643;METXBIODB00695) 0.969(DBMET01704) 0.900(METXBIODB01138
)
|
Macrophage migration inhibitory factor inhibitor | 0.825(METXBIODB01731) 0.718(METXBIODB02959) 0.656(METXBIODB00854)
| 0.765(METXBIODB01732) 0.745(METXBIODB00242) 0.583(METXBIODB00926
)
|
3C-Like protease (MERS coronavirus) inhibitor | 0.040(DB01247) 0.016(DB14187) 0.013(DB01914;DB08908;DB09419;DB11735)
| 0.079(METXBIODB00859) 0.036(DBMET01630;METXBIODB00604) 0.034(CHEMBL721;DBMET01126
)
|
Benzodiazepine antagonist | 0.591(DB00425) 0.388(DB00683;METXBIODB01040) 0.364(CHEMBL512306)
| 0.301(DBMET01242) 0.297(DBMET01241) 0.243(DBMET01238
)
|
Histone deacetylase 9 inhibitor | 0.790(CHEMBL483254) 0.767(DB06176) 0.528(DB02546)
| 0.605(CHEMBL3527527) 0.458(DBMET01443) 0.358(DBMET01414
)
|
Protease (Human cytomegalovirus) inhibitor | 0.083(METXBIODB01812) 0.082(DB00865;METXBIODB01761) 0.077(DB06218)
| 0.120(DBMET00965) 0.050(METXBIODB01762) 0.045(CHEMBL3544766;DB09571;DBMET00634;DBMET01457
)
|
Carbamoyl phosphate synthetase inhibitor | 0.772(DB00640) 0.705(DB00118) 0.566(DB00242)
| 0.937(DB00171) 0.895(DBMET00485;DBMET03265) 0.795(DBMET00769
)
|
Antifungal (Pneumocystis) | 0.430(DB00440) 0.259(METXBIODB02593) 0.258(DB00250)
| 0.426(DBMET03021) 0.413(DBMET03026) 0.309(DBMET03027
)
|
Corticotropin releasing factor antagonist | 0.048(METXBIODB00046) 0.032(METXBIODB00228) 0.027(METXBIODB01792)
| 0.025(CHEMBL3526547) 0.018(METXBIODB00048) 0.009(DBMET00535;METXBIODB00955
)
|
CDC25A inhibitor | 0.577(DB00169) 0.415(METXBIODB02278) 0.400(METXBIODB01980)
| 0.666(METXBIODB02429) 0.470(METXBIODB01981) 0.457(METXBIODB01168
)
|
Leukocyte elastase inhibitor | 0.285(DB00417) 0.282(DB00790) 0.269(CHEMBL29;DB01053)
| 0.338(DBMET01312;METXBIODB02868) 0.331(METXBIODB02601) 0.288(METXBIODB02253
)
|
Sirtuin 2 inhibitor | 0.201(DB04665) 0.176(METXBIODB00307) 0.155(METXBIODB00237;METXBIODB01309)
| 0.124(DBMET01637;METXBIODB00308) 0.104(DBMET03101;DBMET03197) 0.101(METXBIODB00309
)
|
Nicotinic alpha4beta2 receptor antagonist | 0.648(CHEMBL3;DB00184;METXBIODB02230) 0.374(DB01156;METXBIODB00109;METXBIODB01854) 0.370(METXBIODB01383)
| 0.629(CHEMBL6200;DBMET00520) 0.603(DBMET03469;DBMET03471) 0.434(CHEMBL3544718;DBMET00533
)
|
Phosphodiesterase 1C inhibitor | 0.867(DB00862) 0.853(DB00203) 0.520(METXBIODB00046)
| 0.856(DBMET03640) 0.696(DBMET00182) 0.640(DBMET00421;METXBIODB01331
)
|
Estrogen receptor alpha antagonist | 0.983(METXBIODB00549) 0.938(CHEMBL691;DB00977;METXBIODB01784) 0.915(DB00481;METXBIODB01232)
| 0.951(DBMET03029) 0.941(METXBIODB01234) 0.938(DBMET00457
)
|
Lysophosphatidic acid 2 receptor antagonist | 0.417(DB11677) 0.369(METXBIODB02270) 0.355(METXBIODB01129)
| 0.358(METXBIODB01130) 0.323(METXBIODB00722) 0.321(DBMET00546;METXBIODB00763
)
|
Baculoviral IAP repeat-containing protein 4 inhibitor | 0.056(DB01255) 0.037(DB01577;DB05521;METXBIODB01797) 0.031(DB00130)
| 0.654(CHEMBL3526373) 0.061(CHEMBL3544766) 0.050(DBMET01269
)
|
Aldehyde oxidase substrate | 0.965(DB11421) 0.957(CHEMBL34259) 0.951(DB00426)
| 0.978(CHEMBL731;DBMET00019) 0.960(DBMET00464) 0.956(DBMET03673;DBMET03706
)
|
Histone deacetylase 7 inhibitor | 0.813(CHEMBL483254) 0.760(DB06176) 0.554(DB02546)
| 0.604(CHEMBL3527527) 0.449(DBMET01443) 0.422(DBMET01414
)
|
Ryanodine receptor antagonist | 0.362(DB01219) 0.335(DB13853) 0.195(DB00698)
| 0.249(DBMET02057) 0.195(METXBIODB02112) 0.173(DBMET00751
)
|
Cholecystokinin A antagonist | 0.867(METXBIODB00496) 0.670(METXBIODB00500) 0.431(DB09268)
| 0.924(DB11100) 0.811(METXBIODB00499) 0.807(METXBIODB00497;METXBIODB00498
)
|
Melatonin 2 antagonist | 0.396(DB01065) 0.031(METXBIODB00287) 0.026(METXBIODB01023;METXBIODB01089)
| 0.051(DBMET00411) 0.045(METXBIODB00012) 0.034(METXBIODB00534
)
|
Glutamate (mGluR8) agonist | 0.193(DB00130) 0.185(DB00129) 0.179(METXBIODB00273)
| 0.389(DB00142) 0.176(DB03091) 0.172(DBMET01477
)
|
Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.840(DB00640) 0.649(DB01280) 0.615(DB00242)
| 0.982(DBMET00769) 0.974(DB00171) 0.973(CHEMBL1237125;DBMET00657
)
|
Vanilloid 3 antagonist | 0.162(METXBIODB00169) 0.111(DB01656) 0.082(METXBIODB01030)
| 0.240(METXBIODB00170) 0.096(DBMET00376) 0.091(DBMET01607;DBMET01608;DBMET01609;DBMET01610;METXBIODB00421;METXBIODB00422;METXBIODB00423;METXBIODB00424
)
|
Cyclin D2 inhibitor | 0.972(DB09073) 0.023(DB00592) 0.021(METXBIODB00176)
| 0.905(DBMET02380) 0.843(DBMET02373) 0.756(DBMET02363;DBMET02364
)
|
Carbonic anhydrase X inhibitor | 0.119(CHEMBL1046;DB00513) 0.112(DB13966) 0.109(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450)
| 0.109(DB03796;DB08231;DBMET03460) 0.098(CHEMBL1157;DBMET00501) 0.090(DBMET01477
)
|
Carbonic anhydrase VIII inhibitor | 0.119(CHEMBL1046;DB00513) 0.112(DB13966) 0.109(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450)
| 0.109(DB03796;DB08231;DBMET03460) 0.098(CHEMBL1157;DBMET00501) 0.090(DBMET01477
)
|
Sulfotransferase substrate | 0.984(CHEMBL691;DB00977;METXBIODB01784) 0.983(DB04574) 0.979(DB04575)
| 0.995(CHEMBL1614648) 0.994(CHEMBL3544597;DBMET03018) 0.992(DBMET00606
)
|
RNA-directed RNA polymerase stimulant | 0.604(DB02901) 0.549(DB00624;METXBIODB02276) 0.539(DB01536;METXBIODB00393)
| 0.631(CHEMBL261514) 0.610(DBMET02830) 0.604(DBMET00558
)
|
Myeloperoxidase inhibitor | 0.544(DB01275) 0.538(METXBIODB00288) 0.488(METXBIODB00287)
| 0.488(DBMET01359) 0.433(DBMET01361;METXBIODB01090) 0.396(DBMET00534
)
|
Antihypoxic | 0.954(CHEMBL3527416) 0.929(CHEMBL1783834) 0.920(METXBIODB03141)
| 0.954(CHEMBL4525115) 0.950(CHEMBL3526994) 0.947(CHEMBL3526995
)
|
Melatonin receptor 1A antagonist | 0.618(DB01065) 0.102(METXBIODB01089) 0.067(METXBIODB00287)
| 0.138(DBMET00411) 0.112(METXBIODB00012) 0.110(METXBIODB00534
)
|
Nav1.2 sodium channel blocker | 0.769(DB00836) 0.657(METXBIODB01173) 0.550(DB12532)
| 0.740(DBMET01697) 0.575(DBMET01778) 0.562(METXBIODB01174
)
|
Prostaglandin EP4 agonist | 0.511(DB00770) 0.510(DB00287) 0.395(DB01240)
| 0.640(DB00917) 0.521(DBMET02588) 0.511(DBMET02086
)
|
Methionyl aminopeptidase 1 inhibitor | 0.256(DB00730) 0.106(METXBIODB01220) 0.096(DB00507)
| 0.200(DBMET01768) 0.194(CHEMBL3988902) 0.159(DBMET01944
)
|
Geranyltranstransferase inhibitor | 0.133(METXBIODB02568;METXBIODB02799) 0.130(DB09031) 0.120(METXBIODB02681)
| 0.140(DBMET01174) 0.138(DBMET01175) 0.137(DBMET01176
)
|
Heat shock protein 70 antagonist | 0.654(DB00640) 0.341(METXBIODB02838) 0.337(METXBIODB02861;METXBIODB03112)
| 0.970(DB00171) 0.897(DBMET02967) 0.867(DBMET00485;DBMET03265
)
|
CYP1A2 substrate | 0.993(CHEMBL269732;DB00864;METXBIODB00828;METXBIODB00831;METXBIODB01048) 0.985(METXBIODB02869) 0.983(DB00361)
| 0.993(CHEMBL3544602;CHEMBL3544709;CHEMBL3544837;METXBIODB00832) 0.992(CHEMBL3544693;CHEMBL3544708;DBMET00390;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.991(CHEMBL3544838;METXBIODB01049
)
|
Dopamine D3 antagonist | 0.810(DB06016) 0.737(DB06077) 0.686(DB13345)
| 0.742(DBMET03491) 0.666(DBMET03492) 0.547(METXBIODB00900
)
|
Dopamine D4 antagonist | 0.982(DB06077) 0.952(DB01238) 0.892(DB00246)
| 0.889(DBMET00106) 0.887(DBMET02464) 0.791(DBMET01611
)
|
Angiotensin AT2 receptor agonist | 0.045(DB01124) 0.023(METXBIODB01087) 0.018(CHEMBL498;DB00672)
| 0.027(DBMET00289) 0.024(CHEMBL3544766) 0.012(DBMET00502
)
|
Sodium/glucose cotransporter inhibitor | 0.953(DB09038) 0.948(CHEMBL1770248;DB11827) 0.889(DB06292)
| 0.995(CHEMBL3526185;CHEMBL3527604;DBMET01910;DBMET01911) 0.977(DBMET01912) 0.962(DBMET02142
)
|
Glutamate release inhibitor | 0.735(DB00740) 0.713(CHEMBL741;DB00555) 0.470(DB01043)
| 0.529(DBMET01737) 0.515(DBMET01738) 0.449(DBMET01739
)
|
Lipoprotein disorders treatment | 0.993(CHEMBL1064;DB00641;METXBIODB01371;METXBIODB01748) 0.989(CHEMBL503;DB00227;METXBIODB01008) 0.975(DB00175)
| 0.993(CHEMBL1201391;DBMET00388) 0.989(CHEMBL3544679;DBMET01699) 0.988(CHEMBL3544664
)
|
NOS3 expression inhibitor | 0.973(CHEMBL1454) 0.969(CHEMBL413;DB00877;METXBIODB01375) 0.966(METXBIODB00817)
| 0.996(DB03947) 0.993(DBMET03077) 0.969(CHEMBL3544651;DBMET00389;DBMET00628;DBMET01748;DBMET03075;METXBIODB00818;METXBIODB01376
)
|
Methylmalonyl-CoA mutase inhibitor | 0.066(DB00640) 0.037(DB09357;DB11204) 0.033(DB00118;DB00242)
| 0.893(DB04045) 0.731(DB03699) 0.548(DBMET03175
)
|
HCV NS3/NS4A protease inhibitor | 0.871(DB11586) 0.593(DB05521) 0.131(DB00188)
| 0.843(DBMET02051) 0.766(DBMET02050) 0.600(DBMET02049
)
|
Dopamine D5 agonist | 0.399(DB00988;METXBIODB01513) 0.364(METXBIODB01512) 0.247(METXBIODB02244)
| 0.339(DBMET03133) 0.282(DBMET00534) 0.269(DBMET02440
)
|
Sphingosine 1-phosphate receptor 1 antagonist | 0.290(DB05016) 0.272(DB08868) 0.271(DB12612)
| 0.907(DBMET03096) 0.273(DBMET03312) 0.193(DBMET01879
)
|
Antibiotic Carbapenem-like | 0.952(DB06211) 0.721(DB00303) 0.003(DB03088;METXBIODB02370)
| 0.009(DBMET01407) 0.004(DBMET00494) 0.003(DBMET03577
)
|
2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.348(DB00857) 0.206(METXBIODB02568;METXBIODB02799) 0.205(DB00175)
| 0.249(DBMET00068) 0.205(DBMET02472) 0.193(DBMET01204
)
|
Ornithine carbamoyltransferase inhibitor | 0.796(DB00129) 0.785(DB00118) 0.751(DB00130)
| 0.972(DB00171) 0.937(DBMET00485;DBMET03265) 0.899(DBMET00514
)
|
Glutamate (mGluR1a) agonist | 0.205(DB00130) 0.184(DB00129) 0.143(METXBIODB02509)
| 0.304(DB00142) 0.234(DBMET00486) 0.213(DBMET03688
)
|
Calcium antagonist | 0.980(DB00622) 0.963(METXBIODB02115) 0.954(METXBIODB02040)
| 0.923(DBMET01949) 0.859(DBMET01832) 0.832(METXBIODB00443
)
|
Caspase 3 inhibitor | 0.239(DB09292) 0.211(DB06819) 0.209(DB06218)
| 0.291(CHEMBL3544766) 0.256(DBMET01476) 0.252(CHEMBL3988902
)
|
Neuropathy treatment | 0.689(DB00922) 0.461(DB01017) 0.459(DB01234;METXBIODB00696)
| 0.578(CHEMBL4525758;DBMET00595) 0.531(DBMET01319;METXBIODB02245) 0.525(DBMET03456
)
|
Integrin alpha5beta6 antagonist | 0.013(CHEMBL1046;DB00513) 0.012(DB00181) 0.009(DB03766)
| 0.018(DBMET00502) 0.015(CHEMBL1157;DBMET00501;DBMET00688) 0.014(DBMET00505;DBMET01477
)
|
Arginase inhibitor | 0.259(DB00129) 0.185(CHEMBL1046;DB00513) 0.160(METXBIODB03141)
| 0.954(CHEMBL3526838) 0.355(DBMET00502) 0.291(DBMET00508
)
|
Dihydroorotate dehydrogenase inhibitor | 0.431(CHEMBL686;DB00784) 0.313(DB09216) 0.257(CHEMBL898)
| 0.684(CHEMBL237987) 0.650(DBMET00226) 0.606(CHEMBL3544804
)
|
NMDA receptor phencyclidine site antagonist | 0.768(METXBIODB02244) 0.530(CHEMBL52440;DB00514;METXBIODB00707) 0.206(METXBIODB01170)
| 0.768(CHEMBL2105152;DBMET01318) 0.682(CHEMBL1254766;DB14682;METXBIODB00708) 0.663(CHEMBL1638;DBMET00225;METXBIODB00709
)
|
Thyroid hormone agonist | 0.705(DB00279;METXBIODB02434) 0.676(DB00451;DB00509;METXBIODB02811) 0.140(METXBIODB03150)
| 0.809(DBMET00559) 0.727(DBMET02275) 0.689(DBMET02578
)
|
Vesicular glutamate transport inhibitor | 0.138(DB03793;METXBIODB02476) 0.084(METXBIODB01594) 0.078(METXBIODB01093)
| 0.179(DBMET01180;METXBIODB02015) 0.148(METXBIODB00322) 0.138(DB02746;DBMET01437
)
|
Phosphodiesterase I inhibitor | 0.980(DB00203) 0.835(DB00862) 0.732(METXBIODB00471)
| 0.818(DBMET00182) 0.788(DBMET03640) 0.676(DBMET00421;METXBIODB01331
)
|
Fumarate hydratase inhibitor | 0.842(DB00640) 0.538(DB01280) 0.496(DB08908)
| 0.975(DB00171) 0.958(DBMET00485;DBMET03265) 0.907(CHEMBL3638285
)
|
Antineoplastic, alkylator | 0.970(METXBIODB03049) 0.963(DB01181;METXBIODB00963) 0.932(DB12902;METXBIODB00967)
| 0.970(DBMET00024;METXBIODB00966) 0.951(DBMET01682) 0.926(CHEMBL3706539
)
|
Papain-like protease (SARS coronavirus) inhibitor | 0.431(METXBIODB02568;METXBIODB02799) 0.409(METXBIODB00855) 0.392(DB01012)
| 0.576(METXBIODB03144) 0.524(DB12148) 0.416(DBMET01841
)
|
Glutamate (mGluR4) antagonist | 0.341(METXBIODB02368) 0.312(DB00129) 0.297(METXBIODB02370)
| 0.368(DB00142) 0.290(DB00123) 0.233(CHEMBL3544626
)
|
Carbonic anhydrase XI inhibitor | 0.040(CHEMBL1046;DB00513;DB13966) 0.038(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450;METXBIODB02370) 0.034(DB11677)
| 0.064(CHEMBL804;DBMET00977) 0.052(CHEMBL574) 0.038(CHEMBL1157;DB03796;DB08231;DBMET00501;DBMET03460
)
|
Ileal bile acid transport inhibitor | 0.407(METXBIODB03034) 0.305(DB02659;METXBIODB00251) 0.271(DB01586;METXBIODB00939)
| 0.300(DBMET00553) 0.271(DB06777) 0.204(DBMET03598
)
|
Plasmepsin II inhibitor | 0.419(DB01601) 0.141(METXBIODB00531) 0.107(CHEMBL24;DB00335)
| 0.312(DBMET03071) 0.132(DBMET03070) 0.129(CHEMBL3544766
)
|
Glutamate dehydrogenase inhibitor | 0.851(DB00640) 0.824(DB00130) 0.806(DB00129)
| 0.974(DB00171) 0.948(DBMET00485;DBMET03265) 0.914(DBMET00769
)
|
Glutamate (mGluR1a) antagonist | 0.136(DB00339) 0.135(DB12911) 0.125(METXBIODB00917)
| 0.191(CHEMBL3706537) 0.113(DBMET03522) 0.105(DBMET01777;DBMET01958
)
|
Prostaglandin EP4 antagonist | 0.828(DB00770) 0.691(DB00287) 0.661(DB00929)
| 0.871(DB00917) 0.841(DBMET02588) 0.828(DBMET02086
)
|
Vasodilator | 0.996(DB00727;DB06154) 0.981(DB09282) 0.964(DB01020)
| 0.996(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.987(DB13400) 0.953(DBMET02011
)
|
Epoxide hydrolase 1 inhibitor | 0.070(CHEMBL1076347) 0.057(METXBIODB00891) 0.056(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450)
| 0.061(DBMET02688) 0.058(DBMET00341;METXBIODB00824) 0.057(DBMET03290
)
|
Antifungal (Aspergillus) | 0.593(CHEMBL64391;DB01167;METXBIODB00524) 0.358(DB06697) 0.347(METXBIODB00454)
| 0.593(CHEMBL4525087;CHEMBL4525088) 0.409(METXBIODB00526) 0.356(DBMET00374;METXBIODB00525
)
|
Mannosidase inhibitor | 0.899(CHEMBL3527223) 0.596(DB11217) 0.535(DB01914;DB09419;DB11735)
| 0.856(DBMET02088) 0.806(DBMET00509) 0.766(CHEMBL80254
)
|
Prostacyclin agonist | 0.939(DB01240) 0.481(DB00374) 0.469(DB00770)
| 0.515(DB00917) 0.472(DBMET03506) 0.469(DBMET02086
)
|
Acetylcholine muscarinic agonist | 0.829(DB00185;METXBIODB00507) 0.528(DB01591) 0.525(METXBIODB01623)
| 0.829(DBMET00430;DBMET00431;DBMET00433) 0.779(METXBIODB00508) 0.436(METXBIODB01624
)
|
Irritable Bowel syndrome treatment | 0.919(DB09089) 0.918(METXBIODB00334) 0.902(DB01062;METXBIODB00150)
| 0.936(DBMET01398) 0.931(DBMET01568;DBMET03354;METXBIODB00151) 0.921(DBMET01505
)
|
Postcoital contraceptive | 0.849(METXBIODB01739) 0.834(DB00834) 0.723(DB00367)
| 0.803(DBMET03029) 0.783(METXBIODB01138) 0.742(METXBIODB01740
)
|
5-Alpha-reductase 2 inhibitor | 0.912(CHEMBL710;DB01216) 0.584(METXBIODB01980) 0.578(DB02789;METXBIODB01189)
| 0.834(CHEMBL3542374) 0.709(CHEMBL4525755) 0.584(DBMET03598
)
|
Myristoyl transferase inhibitor | 0.064(DB09225) 0.062(METXBIODB02333) 0.057(METXBIODB01158)
| 0.098(DBMET03527) 0.091(DBMET01795) 0.062(DB00891
)
|
Carcinogenic, group 2A | 0.993(DB00773;METXBIODB00808) 0.990(DB00444) 0.971(CHEMBL417;CHEMBL53463;DB00997)
| 0.992(DBMET00367;DBMET01264;METXBIODB00809) 0.989(DBMET01265) 0.988(DBMET01262;DBMET01761
)
|
Nicotinic acid receptor 1 agonist | 0.456(METXBIODB02587) 0.406(METXBIODB02059) 0.403(DB00900)
| 0.539(DB14132) 0.394(DBMET00496) 0.368(METXBIODB02060
)
|
Anticataract | 0.689(DB14001) 0.672(CHEMBL49563;DB00163) 0.613(METXBIODB01980)
| 0.784(DBMET00599;METXBIODB02578) 0.764(CHEMBL4106241) 0.756(DBMET03361
)
|
Antineoplastic (insulinoma) | 0.178(METXBIODB00565) 0.080(METXBIODB00273) 0.071(METXBIODB00276)
| 0.250(METXBIODB00566) 0.104(DBMET01591) 0.069(CHEMBL804;DBMET00977
)
|
Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.691(DB00655;METXBIODB02494) 0.677(DB05087) 0.646(METXBIODB00781)
| 0.691(DBMET00490) 0.646(DBMET00248;DBMET01659) 0.624(DBMET03006;METXBIODB02215
)
|
Acetylcholine M1 receptor agonist | 0.832(DB00185;METXBIODB00507) 0.522(DB01591) 0.517(METXBIODB01623)
| 0.832(DBMET00430;DBMET00431;DBMET00433) 0.794(METXBIODB00508) 0.414(METXBIODB01624
)
|
Antibiotic Rifamycin-like | 0.664(CHEMBL444633;DB00615) 0.567(CHEMBL374478) 0.562(METXBIODB01265)
| 0.536(CHEMBL3544548) 0.459(CHEMBL3544697) 0.416(METXBIODB01267
)
|
LDLR expression enhancer | 0.947(CHEMBL1064;DB00641;METXBIODB01371) 0.890(CHEMBL503;DB00227;METXBIODB01008) 0.858(DB00294)
| 0.917(DBMET01699) 0.845(DBMET03024) 0.830(CHEMBL1627649;CHEMBL3544577;DBMET03022
)
|
Acetyl-CoA transferase 1 inhibitor | 0.259(METXBIODB01434) 0.247(METXBIODB00891) 0.203(DB00818;METXBIODB01201)
| 0.252(CHEMBL3526310) 0.209(DBMET02251) 0.203(DBMET00625
)
|
Carboxypeptidase B inhibitor | 0.614(DB11296) 0.183(DB00230) 0.138(DB00129)
| 0.223(DBMET00502) 0.222(DBMET01483) 0.156(DB00123
)
|
NMDA receptor agonist | 0.921(DB06741) 0.868(METXBIODB01959) 0.657(METXBIODB01958)
| 0.926(METXBIODB02241) 0.868(DBMET01818) 0.614(DB00123
)
|
Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.545(DB00432) 0.276(CHEMBL917;DB00322) 0.144(CHEMBL991)
| 0.276(DBMET03584) 0.196(DBMET03190) 0.177(DBMET00496
)
|
Vitamin D receptor agonist | 0.930(CHEMBL846;DB00136) 0.921(METXBIODB02719) 0.782(DB00169)
| 0.977(CHEMBL3351075;CHEMBL3542403) 0.961(DBMET02435) 0.921(DBMET02434
)
|
Cholecystokinin agonist | 0.834(DB09268) 0.616(DB04574) 0.103(METXBIODB01674)
| 0.943(DBMET02101) 0.899(METXBIODB02254) 0.889(METXBIODB02557
)
|
Farnesoid X receptor agonist | 0.661(DB01586;METXBIODB00939) 0.646(DB02659;METXBIODB00251) 0.550(METXBIODB02278)
| 0.661(DB06777) 0.550(METXBIODB00941) 0.534(METXBIODB00250
)
|
GABA B receptor antagonist | 0.776(METXBIODB01947) 0.759(METXBIODB00075) 0.530(DB00181)
| 0.274(CHEMBL117) 0.220(METXBIODB01948) 0.216(METXBIODB01366
)
|
Thrombopoietin agonist | 0.069(CHEMBL898) 0.023(METXBIODB01301) 0.019(CHEMBL686;DB00784;DB01250)
| 0.050(DBMET00686) 0.026(DBMET03565) 0.024(CHEMBL1222314
)
|
Glucose-dependent insulinotropic receptor agonist | 0.116(DB01628) 0.108(METXBIODB00552) 0.089(METXBIODB00811)
| 0.089(DBMET00167) 0.071(DBMET03403) 0.056(CHEMBL3526729;METXBIODB00553
)
|
Melatonin 2 agonist | 0.981(METXBIODB02687) 0.972(METXBIODB02699) 0.952(METXBIODB02733;METXBIODB02772;METXBIODB02922)
| 0.732(DBMET01457) 0.452(DBMET00411) 0.430(DBMET01456
)
|
Antiprotozoal (Toxoplasma) | 0.991(CHEMBL532;DB00199) 0.987(CHEMBL1741;DB01211;METXBIODB00619) 0.959(DB00778;METXBIODB01286)
| 0.975(CHEMBL2063468;DBMET01656) 0.969(CHEMBL2022715;DBMET00357;METXBIODB00621) 0.961(CHEMBL1947257
)
|
NADH dehydrogenase inhibitor | 0.897(DB00640) 0.785(DB00242) 0.711(DB01280)
| 0.962(DB00171) 0.952(DBMET00485;DBMET03265) 0.895(DBMET00677
)
|
Bone morphogenic protein 1 inhibitor | 0.003(DB01124) 0.002(CHEMBL109;DB00313;METXBIODB00522;METXBIODB00577;METXBIODB01559) 0.001(DB02546;DB03017;DB06716;METXBIODB01149;METXBIODB01207;METXBIODB01450;METXBIODB01523)
| 0.761(CHEMBL3526346) 0.014(DBMET01121) 0.013(CHEMBL3527251
)
|
Retinoid X beta receptor antagonist | 0.798(DB00755;DB00982;METXBIODB00937) 0.617(METXBIODB01691) 0.363(DB06755)
| 0.798(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.493(DBMET03633) 0.432(METXBIODB00938
)
|
Leukotriene B4 antagonist | 0.428(METXBIODB02515) 0.408(METXBIODB01547) 0.255(DB11936)
| 0.528(METXBIODB01549) 0.470(DBMET01607;DBMET01608;DBMET01609;DBMET01610;METXBIODB00421;METXBIODB00422;METXBIODB00423;METXBIODB00424) 0.469(DBMET01593;DBMET01606;DBMET02087;METXBIODB00407;METXBIODB00420
)
|
Thymidine phosphorylase inhibitor | 0.873(DB00495) 0.744(CHEMBL917;DB00322) 0.726(DB09343)
| 0.744(DBMET03584) 0.718(CHEMBL54918;DBMET03591) 0.681(DBMET01435
)
|
Acetyl-CoA transferase inhibitor | 0.376(DB00818;METXBIODB01201) 0.371(METXBIODB00891) 0.366(METXBIODB01434)
| 0.909(DBMET01466) 0.381(CHEMBL3526310) 0.376(DBMET00625
)
|
Heme oxygenase inhibitor | 0.605(DB01026) 0.174(CHEMBL64391;DB01167;METXBIODB00524) 0.115(CHEMBL104)
| 0.812(DBMET02659) 0.603(DBMET02651) 0.421(DBMET02650
)
|
5-Alpha-reductase 1 inhibitor | 0.909(CHEMBL710;DB01216) 0.604(DB00396;METXBIODB01192) 0.560(DB00378)
| 0.794(CHEMBL3542374) 0.713(CHEMBL4525755) 0.533(DBMET03598
)
|
Calcium-dependent phospholipase A2 inhibitor | 0.209(METXBIODB00891) 0.193(DB11677) 0.172(DB06799)
| 0.279(DBMET03078) 0.148(DBMET00700) 0.143(DBMET00808
)
|
G protein-coupled receptor agonist | 0.160(METXBIODB00811) 0.159(DB01628) 0.139(METXBIODB00552)
| 0.160(DBMET00167) 0.143(DBMET01003) 0.093(DBMET00171;DBMET00172
)
|
Folate transporter 1 inhibitor | 0.898(DB11596) 0.797(CHEMBL34259) 0.768(DB00650)
| 0.399(DB00116) 0.341(CHEMBL3544661) 0.329(DBMET00528
)
|
2-Acylglycerol O-acyltransferase 2 inhibitor | 0.064(DB08912) 0.010(METXBIODB02919) 0.009(DB01015;METXBIODB01391)
| 0.028(DBMET03510) 0.018(DBMET03511) 0.013(METXBIODB00646
)
|
Melatonin 1 agonist | 0.636(DB01065) 0.183(METXBIODB02687) 0.179(METXBIODB02699)
| 0.719(DBMET01457) 0.473(DBMET00411) 0.352(DBMET01456
)
|
Guanylate cyclase inhibitor | 0.081(DB00640) 0.079(DB00581) 0.077(METXBIODB01011)
| 0.103(DB00171) 0.097(DBMET00769) 0.095(DBMET00485;DBMET03265
)
|
Histamine agonist | 0.950(DB00501) 0.611(DB00585) 0.567(DB00863;METXBIODB01235)
| 0.950(DBMET03242;DBMET03243) 0.548(CHEMBL901) 0.471(DBMET00959
)
|
GRP78 expression inhibitor | 0.091(DB00129) 0.086(DB11296) 0.071(CHEMBL3527223)
| 0.132(DBMET00502) 0.124(DBMET01483) 0.084(DB00123
)
|
Angiotensin-converting enzyme inhibitor | 0.948(DB01197) 0.901(DB00492) 0.889(CHEMBL1314;DB06823)
| 0.856(DBMET01138) 0.827(DBMET03082) 0.802(DBMET01139
)
|
Uridine phosphorylase inhibitor | 0.683(CHEMBL917;DB00322) 0.645(DB00495) 0.484(DB00432)
| 0.874(CHEMBL886;DBMET01999;DBMET03585) 0.849(CHEMBL474163;DBMET03586) 0.802(DB01861;DB03501
)
|
Elastase 3B inhibitor | 0.091(CHEMBL25;DB00945;DB01139) 0.088(METXBIODB02308) 0.077(DB00493)
| 0.099(DBMET01195;METXBIODB00605) 0.070(DBMET00641) 0.067(DBMET01501;DBMET02609;DBMET02622
)
|
Elastase 3A inhibitor | 0.091(CHEMBL25;DB00945;DB01139) 0.088(METXBIODB02308) 0.077(DB00493)
| 0.099(DBMET01195;METXBIODB00605) 0.070(DBMET00641) 0.067(DBMET01501;DBMET02609;DBMET02622
)
|
Elastase 2B inhibitor | 0.091(CHEMBL25;DB00945;DB01139) 0.088(METXBIODB02308) 0.077(DB00493)
| 0.099(DBMET01195;METXBIODB00605) 0.070(DBMET00641) 0.067(DBMET01501;DBMET02609;DBMET02622
)
|
Vasopressin 1B agonist | 0.019(DB09059) -0.005(DB01255;METXBIODB01173) -0.006(DB00330;DB01018;DB06824;METXBIODB03110)
| -0.001(DBMET02067) -0.002(CHEMBL3526373) -0.003(CHEMBL1379;DBMET00502;DBMET03446;METXBIODB01174
)
|
Chronic obstructive bronchitis treatment | 0.548(CHEMBL532;DB00199) 0.522(CHEMBL1741;DB01211;METXBIODB00619) 0.428(DB11855)
| 0.571(CHEMBL2063468;DBMET01656) 0.547(CHEMBL2022715;DBMET00357;METXBIODB00621) 0.468(CHEMBL3544830;DBMET00356;METXBIODB00620
)
|
Sphingosine 1-phosphate receptor 1 agonist | 0.918(DB12612) 0.810(DB12371) 0.639(DB12016)
| 0.789(DBMET03096) 0.525(DBMET03312) 0.484(DBMET03311
)
|
Cyclin A1 inhibitor | 0.979(DB09073) 0.111(DB00619) 0.109(DB06605)
| 0.971(DBMET02380) 0.962(DBMET02373) 0.884(DBMET02379
)
|
Cholecystokinin A agonist | 0.829(DB09268) 0.441(DB04574) 0.115(METXBIODB01674)
| 0.906(DBMET02101) 0.878(METXBIODB02254) 0.870(METXBIODB02557
)
|
Autism spectrum disorders treatment | 0.991(METXBIODB00817) 0.981(CHEMBL413;DB00877;METXBIODB01375) 0.968(DB06287)
| 0.985(METXBIODB00819) 0.981(DBMET00628;METXBIODB00818) 0.974(CHEMBL3544651;DBMET00389;DBMET01748;METXBIODB01376
)
|
Melatonin agonist | 0.832(METXBIODB02687) 0.811(METXBIODB02699) 0.722(METXBIODB02733;METXBIODB02772;METXBIODB02922)
| 0.697(DBMET01457) 0.454(DBMET00411) 0.325(DBMET01456
)
|
Death-associated protein kinase 2 inhibitor | 0.644(DB06595) 0.617(METXBIODB03012) 0.531(CHEMBL535)
| 0.617(DBMET01043) 0.616(DBMET01440) 0.609(DBMET01441
)
|
1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.270(DB09031) 0.230(CHEMBL6;DB00328;METXBIODB00921) 0.187(DB00605)
| 0.246(DBMET01002) 0.244(CHEMBL800;DBMET00156;METXBIODB00922) 0.234(DBMET00252
)
|
CXC chemokine 4 receptor agonist | 0.035(DB00458;METXBIODB00907) 0.032(DB01151;METXBIODB00909) 0.030(DB00129)
| 0.055(DBMET01959) 0.038(DBMET00502) 0.037(CHEMBL3526373
)
|
Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.818(DB00640) 0.679(DB01280) 0.619(CHEMBL1076930)
| 0.954(DB00171;DB01861;DB03501) 0.925(DBMET00485;DBMET03265) 0.910(CHEMBL3526610
)
|
Melanocortin 5 antagonist | 0.277(DB01195) 0.185(METXBIODB01951) 0.127(METXBIODB01173)
| 0.302(DBMET03194) 0.279(DBMET03192) 0.255(DBMET00840
)
|
Aminopeptidase A inhibitor | 0.139(DB01197) 0.114(DB06151) 0.071(DB00130)
| 0.420(DBMET00803) 0.252(DBMET01883) 0.235(DBMET00503;DBMET00508
)
|
CXC chemokine 5 receptor antagonist | 0.458(DB06652) 0.048(METXBIODB00552) 0.035(METXBIODB02370)
| 0.827(DBMET00080) 0.761(DBMET00083) 0.650(DBMET00078
)
|
Cholecystokinin antagonist | 0.770(METXBIODB00496) 0.612(METXBIODB00500) 0.340(DB09268)
| 0.945(DB11100) 0.723(METXBIODB00499) 0.718(METXBIODB00497;METXBIODB00498
)
|
NMDA 2C receptor antagonist | 0.758(METXBIODB02244) 0.725(DB01043) 0.540(METXBIODB01496)
| 0.770(CHEMBL1254766;DB14682;METXBIODB00708) 0.758(CHEMBL2105152;DBMET01318) 0.693(DBMET01317
)
|
Thymidine kinase inhibitor | 0.834(DB00495) 0.818(DB00432) 0.757(CHEMBL917;DB00322)
| 0.974(CHEMBL3526610) 0.970(DBMET03588) 0.965(DBMET03587
)
|
Transcription factor RelA inhibitor | 0.151(METXBIODB02986;METXBIODB03010) 0.148(METXBIODB00815) 0.144(METXBIODB02202)
| 0.151(CHEMBL214321;CHEMBL90568) 0.148(METXBIODB00816) 0.144(CHEMBL187265
)
|
Dihydroorotate oxidase inhibitor | 0.281(CHEMBL160;DB00091) 0.142(DB00499) 0.138(CHEMBL112;DB00316;METXBIODB02370)
| 0.807(DBMET00226) 0.226(METXBIODB01810) 0.225(CHEMBL3544879
)
|
Squalene epoxidase inhibitor | 0.403(DB00857) 0.361(METXBIODB02063) 0.295(METXBIODB02133)
| 0.432(DBMET01203) 0.425(DBMET01204) 0.359(DBMET00068
)
|
Thyroid hormone beta agonist | 0.475(DB00279;METXBIODB02434) 0.448(DB00451;DB00509;METXBIODB02811) 0.089(METXBIODB02990)
| 0.625(DBMET02275) 0.465(DBMET01365) 0.351(DBMET02273
)
|
Adenosine A1 receptor antagonist | 0.929(DB00640) 0.921(DB00242) 0.919(DB00631)
| 0.963(CHEMBL3526900) 0.812(DBMET00496) 0.738(DBMET01160
)
|
Microtubule formation inhibitor | 0.935(DB06772) 0.932(CHEMBL92;DB01248) 0.891(METXBIODB00466)
| 0.948(DBMET00998) 0.947(DBMET00999) 0.932(DBMET00633
)
|
3C-like protease (Human coronavirus) inhibitor | 0.424(METXBIODB02370) 0.414(DB04665) 0.408(METXBIODB00312;METXBIODB00858)
| 0.372(CHEMBL1222314) 0.355(DBMET00070) 0.347(DBMET01637;METXBIODB00308
)
|
Telomerase stimulant | 0.095(CHEMBL1783834) 0.066(DB11217) 0.061(DB00581)
| 0.356(CHEMBL3542279;CHEMBL3542281) 0.245(CHEMBL3542286;CHEMBL3542287) 0.095(CHEMBL3542280;CHEMBL4525725
)
|
Leukotriene antagonist | 0.980(CHEMBL787;DB00471) 0.732(METXBIODB00658) 0.540(METXBIODB02380)
| 0.985(CHEMBL3526239) 0.984(CHEMBL3526241;DBMET01246;DBMET01247;DBMET01707;DBMET01708) 0.983(CHEMBL3526481;DBMET01248;DBMET01249;DBMET01709
)
|
DOPA decarboxylase inhibitor | 0.620(DB00190) 0.573(DB00279;METXBIODB02434) 0.562(DB00451;DB00509;METXBIODB02811)
| 0.681(DBMET02273) 0.597(DBMET02274) 0.513(DBMET00251;METXBIODB00869
)
|
G-protein-coupled receptor 120 agonist | 0.211(DB01241;METXBIODB03090) 0.189(DB06819) 0.156(METXBIODB00762)
| 0.205(DBMET01597;METXBIODB00411) 0.204(DBMET02785) 0.180(DBMET00510
)
|
Cannabinoid receptor agonist | 0.360(DB00470) 0.261(METXBIODB00070) 0.202(DB00889;METXBIODB00874)
| 0.317(CHEMBL3706477) 0.283(DBMET00120;DBMET01785) 0.210(METXBIODB00200
)
|
Glutamate decarboxylase inhibitor | 0.967(CHEMBL1430) 0.945(DB00129) 0.914(CHEMBL1046;DB00513)
| 0.969(DBMET00503) 0.967(DBMET00508) 0.949(DB00123;DB00142
)
|
Integrin alphaVbeta6 antagonist | 0.622(METXBIODB01514) 0.021(DB00129;DB00130) 0.020(CHEMBL1046;DB00513)
| 0.524(METXBIODB01515) 0.335(METXBIODB01517) 0.100(METXBIODB01516
)
|
Antimetabolite | 0.811(DB00441) 0.773(DB00631) 0.753(DB01101)
| 0.969(CHEMBL3526610) 0.959(DBMET00859) 0.957(CHEMBL3638285
)
|
Glutamate (mGluR3) agonist | 0.122(CHEMBL109;DB00313;DB01235;METXBIODB01559) 0.105(DB13848) 0.099(DB00130)
| 0.193(DB00142) 0.161(DBMET00506) 0.146(DBMET01108
)
|
GABA uptake inhibitor | 0.323(DB05087) 0.275(METXBIODB00689) 0.161(DB06282)
| 0.161(DB00341) 0.150(METXBIODB00690) 0.141(CHEMBL3544654;DBMET00378
)
|
Melatonin 1 antagonist | 0.653(DB01074;METXBIODB00067) 0.502(DB01065) 0.495(METXBIODB02687)
| 0.558(DBMET01457) 0.301(DBMET00411) 0.233(DBMET00839;DBMET00914;DBMET01547;METXBIODB00068;METXBIODB00069
)
|
Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.721(DB00432) 0.465(CHEMBL917;DB00322) 0.414(DB00900)
| 0.680(DBMET00496) 0.491(DBMET01435) 0.465(DBMET03584
)
|
Factor XII inhibitor | 0.988(DB06799) 0.284(DB09059) 0.246(DB06176)
| 0.435(CHEMBL1379) 0.261(DBMET00502) 0.204(DBMET02067
)
|
3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.220(METXBIODB02337) 0.188(DB03793;METXBIODB02476) 0.178(DB00244)
| 0.269(DB02362;DBMET01429) 0.230(DBMET01128) 0.225(DBMET03556
)
|
Adenylate cyclase 1 stimulant | 0.000(METXBIODB02524) -0.001(DB02901;DB03852;DB06824;DB13178;METXBIODB00171;METXBIODB01643;METXBIODB02607;METXBIODB02813;METXBIODB02979) -0.002(DB13747;METXBIODB02562)
| -0.001(CHEMBL1213529;DB02817;DBMET00558;DBMET01146;DBMET01491;DBMET01573;DBMET01574;DBMET01812;DBMET02114;DBMET02381;DBMET02382;DBMET02832;DBMET02833;DBMET02834;DBMET03359;METXBIODB00172;METXBIODB00173;METXBIODB01640;METXBIODB01915) -0.002(CHEMBL3638321;DBMET02080;DBMET03358;DBMET03360) -0.003(CHEMBL1157;CHEMBL1367;CHEMBL3544550;CHEMBL3544564;CHEMBL3544778;CHEMBL3544797;CHEMBL610;CHEMBL721;DB01677;DB01955;DB02083;DB02325;DB04325;DB09401;DB09526;DB13169;DB13526;DBMET00060;DBMET00247;DBMET00392;DBMET00451;DBMET00501;DBMET00505;DBMET01126;DBMET01430;DBMET01456;DBMET01457;DBMET01477;DBMET01495;DBMET01497;DBMET01586;DBMET01762;DBMET01763;DBMET01828;DBMET01973;DBMET02012;DBMET02709;DBMET02710;DBMET02761;DBMET02831;DBMET02835;DBMET03083;DBMET03256;DBMET03257;METXBIODB00072;METXBIODB00170;METXBIODB00380;METXBIODB00395;METXBIODB00666;METXBIODB00814;METXBIODB01175;METXBIODB01437;METXBIODB01563;METXBIODB01644;METXBIODB01914;METXBIODB01998;METXBIODB03139
)
|
Antithrombocytopenic | 0.637(DB08877) 0.621(METXBIODB01691) 0.597(DB12010)
| 0.717(DBMET00345) 0.703(DBMET03261) 0.658(CHEMBL4525784
)
|
Uterine relaxant | 0.974(DB09059) 0.381(DB00871) 0.374(DB00816)
| 0.514(DBMET00840) 0.381(DBMET03275;DBMET03276) 0.323(DBMET03357
)
|
Toll-Like receptor 8 antagonist | 0.183(DB08865) 0.164(CHEMBL515387) 0.145(METXBIODB00006)
| 0.175(DBMET01944) 0.133(DBMET01613) 0.127(DBMET02020
)
|
Beta 3 adrenoreceptor antagonist | 0.528(DB00960) 0.512(DB00264;METXBIODB00121) 0.484(DB01136;METXBIODB00129)
| 0.607(DBMET00115;DBMET00119;METXBIODB00133) 0.557(DBMET00118;METXBIODB00131) 0.524(DBMET00740
)
|
Liver X receptor beta agonist | 0.215(METXBIODB01728) 0.182(METXBIODB00262) 0.167(DB00573)
| 0.204(DBMET01003) 0.197(DBMET00171;DBMET00172) 0.147(METXBIODB00263
)
|
Bcl-xL inhibitor | 0.188(METXBIODB02351) 0.160(METXBIODB00090;METXBIODB03094) 0.152(DB11581)
| 0.184(DBMET00789) 0.160(METXBIODB02352) 0.156(METXBIODB01603
)
|
Vitamin D receptor antagonist | 0.761(CHEMBL846;DB00136) 0.582(METXBIODB02719) 0.577(DB00169)
| 0.721(DBMET02435) 0.698(CHEMBL3542380;CHEMBL3542386) 0.688(CHEMBL3544529;DBMET00575
)
|
AMPA 3 receptor antagonist | 0.359(DB00129) 0.227(DB00130) 0.194(CHEMBL1046;DB00177;DB00513)
| 0.368(DB00123) 0.207(DB00142) 0.200(METXBIODB01281
)
|
Thiol protease inhibitor | 0.487(DB06670) 0.443(DB00881) 0.429(DB00584;METXBIODB00946)
| 0.651(DBMET01475) 0.595(CHEMBL3544766) 0.513(CHEMBL3526373
)
|
Carboxypeptidase B2 inhibitor | 0.497(DB11296) 0.128(DB00230) 0.045(DB00129)
| 0.165(DBMET01483) 0.087(DBMET00502) 0.059(DB00123
)
|
Cholecystokinin B antagonist | 0.815(METXBIODB00496) 0.615(METXBIODB00500) 0.326(DB09268)
| 0.908(DB11100) 0.750(METXBIODB00499) 0.740(METXBIODB00497;METXBIODB00498
)
|
Sodium-dependent vitamin C transporter 2 inhibitor | 0.666(CHEMBL139;DB00586;METXBIODB00345) 0.654(DB06736) 0.639(METXBIODB00729)
| 0.666(DBMET01501;DBMET02609;DBMET02622) 0.639(CHEMBL1030;DBMET00144) 0.631(CHEMBL1035;DBMET00146
)
|
Purinergic P2X1 antagonist | 0.482(DB00640) 0.287(DB01250) 0.260(DB00244)
| 0.883(DB00171) 0.790(DBMET00485;DBMET03265) 0.619(DBMET02967
)
|
DNA topoisomerase III inhibitor | 0.020(METXBIODB01177;METXBIODB02413) 0.019(METXBIODB02395) 0.018(DB04168;METXBIODB01121;METXBIODB02611)
| 0.020(DBMET00278;METXBIODB01842) 0.017(DBMET00498) 0.016(DBMET00285
)
|
M17 leucyl aminopeptidase inhibitor | 0.779(METXBIODB01947) 0.340(DB01250) 0.337(METXBIODB02721)
| 0.779(METXBIODB01948) 0.458(CHEMBL3527192) 0.445(CHEMBL3544771
)
|
Transcortin receptor antagonist | 0.939(DB04630) 0.937(DB00687) 0.922(DB00741;METXBIODB01729)
| 0.917(CHEMBL3542319;DBMET00353) 0.902(DBMET02900;DBMET02901;DBMET02902) 0.899(CHEMBL131;DBMET00627
)
|
Sphingosine 1-phosphate receptor agonist | 0.932(DB12612) 0.841(DB12371) 0.699(DB12016)
| 0.814(DBMET03096) 0.594(DBMET03312) 0.565(DBMET03311
)
|
Glutamate (mGluR6) agonist | 0.171(DB00130) 0.167(DB01235) 0.154(DB00129)
| 0.496(DB00142) 0.195(DBMET00486) 0.143(DB03091
)
|
AMPA receptor antagonist | 0.239(METXBIODB00273) 0.217(METXBIODB01893) 0.216(METXBIODB01030)
| 0.399(METXBIODB00897) 0.224(CHEMBL3542349) 0.222(METXBIODB01033
)
|
Histamine N-methyltransferase inhibitor | 0.568(DB00608;METXBIODB00114) 0.523(CHEMBL71;DB00477;METXBIODB00583) 0.501(DB01611)
| 0.669(DBMET00514) 0.517(DBMET02741;DBMET03063;METXBIODB01837;METXBIODB02047) 0.486(DBMET01362
)
|
Retinoid X alpha receptor antagonist | 0.708(DB00755;DB00982;METXBIODB00937) 0.521(METXBIODB01691) 0.334(METXBIODB03098)
| 0.708(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.517(DBMET03633) 0.406(DBMET00453
)
|
Peroxisome proliferator-activated receptor alpha antagonist | 0.756(CHEMBL186179;METXBIODB01057) 0.693(CHEMBL2104978) 0.229(CHEMBL672;DB01039)
| 0.756(CHEMBL4525110) 0.728(CHEMBL254989;METXBIODB01058) 0.693(CHEMBL4525111;CHEMBL4525112;CHEMBL4525113;CHEMBL4525114;CHEMBL4525116;CHEMBL4525117;CHEMBL4525118
)
|
Dopamine autoreceptor agonist | 0.754(DB05271) 0.695(DB01238) 0.397(DB09128)
| 0.558(DBMET01611) 0.482(DBMET01612) 0.459(DBMET02464
)
|
Purinergic P2Y1 agonist | 0.207(DB00242) 0.198(DB00640) 0.155(DB00631)
| 0.532(DBMET00677) 0.491(DB00171) 0.368(DBMET00485;DBMET03265
)
|
Melatonin antagonist | 0.708(DB01074;METXBIODB00067) 0.592(METXBIODB02687) 0.577(DB01065)
| 0.591(DBMET01457) 0.382(DBMET00411) 0.307(DBMET00839;DBMET00914;DBMET01547;METXBIODB00068;METXBIODB00069
)
|
Alpha 1 adrenoreceptor agonist | 0.725(DB00656) 0.706(DB00490) 0.694(METXBIODB02830)
| 0.660(METXBIODB02107) 0.638(DBMET02603;DBMET02604) 0.585(DBMET02991
)
|
Nicotinic receptor alpha3 subunit antagonist | 0.564(METXBIODB01541) 0.428(CHEMBL3;DB00184;METXBIODB02230) 0.415(DB01156;METXBIODB00109;METXBIODB01854)
| 0.666(DBMET03469;DBMET03471) 0.528(DBMET00840) 0.377(DBMET02065
)
|
Prostaglandin EP2 antagonist | 0.801(DB00770) 0.765(DB00929) 0.731(DB00905)
| 0.809(DB00917) 0.801(DBMET02086) 0.785(DBMET02637
)
|
Excitatory amino acid transporter 3 inhibitor | 0.118(DB00130) 0.066(CHEMBL109;DB00313;METXBIODB01559) 0.052(DB00129)
| 0.207(DB00142) 0.094(DBMET01401) 0.082(CHEMBL3706509;DBMET01109
)
|
Melanocortin 3 antagonist | 0.233(METXBIODB01173) 0.141(DB09059) 0.134(DB01018)
| 0.737(DBMET00840) 0.255(DBMET00502) 0.179(DBMET02067
)
|
Potassium channel (Voltage-sensitive) activator | 0.260(METXBIODB02391) 0.172(DB00740) 0.160(METXBIODB02793)
| 0.199(DBMET02248) 0.175(DBMET01579) 0.140(DBMET00091
)
|
HMG CoA reductase inhibitor | 0.939(METXBIODB01748) 0.929(CHEMBL1064;DB00641;METXBIODB01371) 0.913(CHEMBL503;DB00227;METXBIODB01008)
| 0.939(CHEMBL1201391;DBMET00388) 0.926(CHEMBL1201373) 0.922(DBMET01699
)
|
Kainate receptor 1 antagonist | 0.281(DB06741) 0.269(DB00129) 0.266(DB00130)
| 0.388(CHEMBL1367;DBMET00060;METXBIODB01563) 0.275(DB00123) 0.260(CHEMBL116111
)
|
Antiepileptic | 0.994(DB00273) 0.993(METXBIODB01490) 0.988(CHEMBL413;DB00877;METXBIODB01375)
| 0.989(DBMET02909;DBMET02910) 0.988(DBMET00628;METXBIODB00818) 0.987(CHEMBL3544651;DBMET00389;DBMET01748;METXBIODB00819;METXBIODB01376
)
|
Glutamate (mGluR1) antagonist | 0.319(METXBIODB01030) 0.293(METXBIODB01715) 0.204(DB00730)
| 0.264(METXBIODB01716) 0.223(METXBIODB01033) 0.191(DBMET00993
)
|
Potassium channel KCNQ activator | 0.167(METXBIODB02391) 0.063(METXBIODB01438;METXBIODB02345) 0.054(DB01012)
| 0.106(DBMET02248) 0.092(DBMET01579) 0.055(DBMET00091
)
|
Delayed rectifier potassium channel activator | 0.167(METXBIODB02391) 0.063(METXBIODB01438;METXBIODB02345) 0.054(DB01012)
| 0.106(DBMET02248) 0.092(DBMET01579) 0.055(DBMET00091
)
|
GABA transporter 3 inhibitor | 0.202(DB00129;DB06282) 0.193(CHEMBL1046;DB00513) 0.192(DB00557)
| 0.202(DB00341) 0.201(DB00123) 0.184(DBMET01193;METXBIODB00603
)
|
Retinoid X receptor antagonist | 0.721(DB00755;DB00982;METXBIODB00937) 0.539(METXBIODB01691) 0.361(METXBIODB03098)
| 0.721(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.539(DBMET03633) 0.433(DBMET00453
)
|
Apolipoprotein B inhibitor | 0.053(METXBIODB00006) 0.037(DB06698) 0.033(METXBIODB00295)
| 0.045(CHEMBL3526518) 0.031(DBMET01591) 0.025(DBMET01777
)
|
Toll-Like receptor 2 agonist | 0.234(DB11677) 0.231(DB00130;DB08887;DB13966) 0.227(DB00129)
| 0.371(DBMET01886;DBMET01887) 0.271(CHEMBL3706542) 0.255(DBMET00506
)
|
Cannabinoid CB2 receptor agonist | 0.298(DB00470) 0.247(METXBIODB00070) 0.207(METXBIODB00552)
| 0.182(CHEMBL3706477) 0.168(DBMET00120;DBMET01785) 0.156(CHEMBL3706522
)
|
Phosphodiesterase 4A inhibitor | 0.916(METXBIODB01645) 0.689(DB01656) 0.532(DB00862)
| 0.866(DBMET00997) 0.851(METXBIODB01646) 0.671(METXBIODB00936
)
|
Adenosine A2a receptor agonist | 0.462(DB00640) 0.271(DB00242) 0.190(DB00631)
| 0.215(CHEMBL3526900) 0.208(DBMET00485;DBMET03265) 0.145(DBMET00514
)
|
Antibiotic | 0.985(DB00778;METXBIODB01286) 0.970(METXBIODB01048) 0.955(CHEMBL532;DB00199)
| 0.977(METXBIODB01287) 0.970(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.966(CHEMBL3706534
)
|
Purinergic P2Y6 agonist | 0.028(CHEMBL917;DB00322) 0.009(DB00432) 0.006(CHEMBL853;DB00441)
| 0.851(DB01861;DB03501) 0.440(CHEMBL1774;DBMET02000;DBMET03590) 0.373(CHEMBL590981;DBMET03589
)
|
Lipid peroxidase inhibitor | 0.897(CHEMBL49563;DB00163) 0.868(DB14002) 0.832(DB14001)
| 0.903(CHEMBL527285;DBMET02040;DBMET02324) 0.854(DBMET02038;DBMET02322) 0.849(DBMET02036;DBMET02320
)
|
Cytokine production inhibitor | 0.769(METXBIODB00513) 0.574(CHEMBL269732;DB00864;METXBIODB00828) 0.495(DB06781)
| 0.674(DBMET00450) 0.661(METXBIODB00514) 0.654(CHEMBL3542318
)
|
Vanilloid agonist | 0.782(DB06716) 0.754(METXBIODB02045) 0.654(DB08921;METXBIODB00055)
| 0.754(DBMET01188;METXBIODB00057) 0.731(METXBIODB03158) 0.652(CHEMBL873;DBMET00148;METXBIODB00053
)
|
Bombesin 2 receptor antagonist | 0.277(DB11296) 0.137(METXBIODB02458) 0.129(DB00130)
| 0.261(DBMET01886;DBMET01887) 0.219(CHEMBL3544766) 0.201(DBMET03515
)
|
Peroxisome proliferator-activated receptor alpha agonist | 0.917(CHEMBL186179;METXBIODB01057) 0.849(CHEMBL2104978) 0.466(DB01241;METXBIODB03090)
| 0.917(CHEMBL4525110) 0.858(METXBIODB01059) 0.853(CHEMBL254989;METXBIODB01058
)
|
Glutamate (mGluR group II) antagonist | 0.405(METXBIODB02380) 0.133(DB05016) 0.126(DB00339)
| 0.154(CHEMBL3544524) 0.117(DBMET00005) 0.105(DBMET00693
)
|
Antineoplastic (brain cancer) | 0.966(DB01181;METXBIODB00963) 0.950(DB12902;METXBIODB00967) 0.944(CHEMBL88;DB00531;METXBIODB00960)
| 0.970(DBMET01580) 0.949(CHEMBL87658;DBMET00020;DBMET00021;METXBIODB00961;METXBIODB00964) 0.944(DBMET00022;DBMET01683;METXBIODB00965
)
|
Phosphodiesterase 1B inhibitor | 0.940(DB00203) 0.894(DB00862) 0.653(METXBIODB00471)
| 0.881(DBMET03640) 0.827(DBMET00182) 0.643(DBMET00421;METXBIODB01331
)
|
CD80 antagonist | 0.016(DB01435;METXBIODB00398) 0.008(METXBIODB00385) 0.007(METXBIODB02382;METXBIODB02646;METXBIODB02721)
| 0.159(METXBIODB00399) 0.117(DBMET01583;METXBIODB00386) 0.013(DBMET00003;DBMET01588;METXBIODB00400
)
|
Mannose-6-phosphate isomerase inhibitor | 0.511(DB01914;DB09419;DB11735) 0.452(DB00581) 0.387(DB00742;DB11195;METXBIODB02296)
| 0.977(DBMET01478) 0.886(DBMET02089) 0.524(DBMET02088
)
|
Estrogen-related receptor gamma agonist | 0.866(METXBIODB01404) 0.840(METXBIODB00268) 0.734(METXBIODB00269)
| 0.840(CHEMBL2137046;DBMET00030;METXBIODB01402) 0.787(CHEMBL4525766;METXBIODB00270) 0.758(METXBIODB01709
)
|
Histone deacetylase 10 inhibitor | 0.926(METXBIODB02294) 0.902(DB02546) 0.723(DB05015)
| 0.886(METXBIODB02295) 0.723(DBMET01443) 0.319(CHEMBL3527527
)
|
GABA receptor antagonist | 0.951(METXBIODB01490) 0.864(DB00683;METXBIODB01040) 0.800(DB00897)
| 0.942(METXBIODB01491) 0.922(METXBIODB01492) 0.801(DBMET00933
)
|
Matrix metalloproteinase (membrane-type) inhibitor | 0.142(CHEMBL116) 0.138(DB09292) 0.120(DB02546)
| 0.227(CHEMBL3544766) 0.221(CHEMBL3544779) 0.216(DBMET01401
)
|
Peroxisome proliferator-activated receptor gamma antagonist | 0.949(CHEMBL2104978) 0.802(CHEMBL186179;METXBIODB01057) 0.405(DB01132)
| 0.949(CHEMBL4525111;CHEMBL4525112;CHEMBL4525113;CHEMBL4525114;CHEMBL4525116;CHEMBL4525117;CHEMBL4525118) 0.923(CHEMBL3526971) 0.883(CHEMBL3526633
)
|
Purinergic P2Y antagonist | 0.913(DB08816) 0.485(DB00242) 0.432(DB00640)
| 0.972(DBMET00677) 0.965(CHEMBL3526652;DB03699) 0.958(DB00171
)
|
Alpha 2b adrenoreceptor antagonist | 0.995(DB13345) 0.992(DB00248) 0.986(METXBIODB00475)
| 0.954(METXBIODB00477) 0.896(DBMET02090) 0.820(DBMET02651
)
|
P2 nucleoside transporter inhibitor | 0.033(CHEMBL1455) 0.022(DB06824) 0.011(CHEMBL1046;DB00513)
| 0.109(CHEMBL3544873) 0.067(CHEMBL3544897;CHEMBL3544898) 0.064(CHEMBL3544872;CHEMBL457723
)
|
Thromboxane antagonist | 0.963(METXBIODB00744) 0.919(METXBIODB00097) 0.859(DB11660)
| 0.962(METXBIODB00746) 0.957(METXBIODB00745) 0.918(METXBIODB00099
)
|
1,3-Beta-glucan synthase inhibitor | 0.047(METXBIODB02646) 0.044(DB15694) 0.037(CHEMBL3527223;DB09059;DB13178;METXBIODB02472)
| 0.112(METXBIODB02254) 0.100(METXBIODB01642) 0.078(DBMET00549
)
|
Adenylate cyclase 1 inhibitor | 0.134(DB13952;METXBIODB02488) 0.125(METXBIODB01341;METXBIODB01387) 0.124(DB00783;METXBIODB01814)
| 0.124(DBMET00491;METXBIODB00083) 0.123(DBMET01573;DBMET01574;METXBIODB00172;METXBIODB00173) 0.122(DBMET00247
)
|
5 Hydroxytryptamine 5A antagonist | 0.904(METXBIODB02830) 0.897(METXBIODB01085) 0.699(DB00669)
| 0.718(CHEMBL3526504) 0.670(DBMET01362) 0.536(DBMET01361;METXBIODB01090
)
|
Melatonin 5 antagonist | 0.033(METXBIODB01173) 0.025(DB11296) 0.023(DB01255)
| 0.033(DBMET00840) 0.031(DBMET01778) 0.019(DBMET03446
)
|
Vascular adhesion protein 1 inhibitor | 0.169(DB00601) 0.152(DB00780) 0.129(DB01043)
| 0.185(CHEMBL724;DBMET00354;DBMET03729;METXBIODB00201) 0.158(CHEMBL3527414) 0.137(METXBIODB01366
)
|
Somatostatin 1 agonist | 0.315(DB09059) 0.246(DB00279;METXBIODB02434) 0.238(DB06824)
| 0.331(DB11100) 0.239(METXBIODB01762) 0.229(DBMET02067
)
|
Antiprotozoal (Babesia) | 0.476(DB00592) 0.473(DB00564) 0.467(METXBIODB02735)
| 0.451(DBMET03527) 0.445(METXBIODB01813) 0.399(DBMET02709;METXBIODB00395
)
|
Retinoprotector | 0.749(METXBIODB03034) 0.747(DB01586;METXBIODB00939;METXBIODB01504) 0.689(METXBIODB02278)
| 0.892(METXBIODB03035) 0.889(DBMET00553) 0.887(METXBIODB02547
)
|
Matrix metalloproteinase inhibitor | 0.222(CHEMBL1314;DB06823) 0.199(CHEMBL116) 0.180(DB06151)
| 0.347(DBMET02065) 0.329(DBMET02066) 0.297(CHEMBL3544779
)
|
Alpha 2b adrenoreceptor agonist | 0.852(DB00484;DB04948) 0.705(METXBIODB02856) 0.540(DB00575)
| 0.324(DBMET00464) 0.250(DBMET00468) 0.241(DBMET00465
)
|
Antibacterial (Helicobacter pylori) | 0.907(DB01129) 0.898(DB00448;DB05351;METXBIODB01955) 0.885(CHEMBL902;DB00927)
| 0.907(METXBIODB00032) 0.896(DBMET01494;METXBIODB01957) 0.854(METXBIODB00033
)
|
GABA A receptor antagonist | 0.947(METXBIODB01490) 0.869(DB00683;METXBIODB01040) 0.810(DB00897)
| 0.916(METXBIODB01491) 0.908(METXBIODB01492) 0.794(DBMET00933
)
|
Thyroid hormone alpha agonist | 0.758(DB00451;DB00509;METXBIODB02811) 0.710(DB00279;METXBIODB02434) 0.270(METXBIODB01202)
| 0.780(DBMET02275) 0.545(DBMET02273) 0.525(DBMET02578
)
|
Potassium channel (ATP-sensitive) activator | 0.231(METXBIODB00565) 0.139(DB00922) 0.125(CHEMBL498;DB00672)
| 0.364(METXBIODB00566) 0.162(DBMET00376) 0.130(CHEMBL3186899
)
|
Calcitonin receptor agonist | 0.121(DB09059) 0.111(DB11296) 0.090(DB01255)
| 0.158(CHEMBL3526373) 0.140(DBMET02065) 0.131(DBMET01886;DBMET01887
)
|
Histamine H2 receptor antagonist | 0.912(DB00501) 0.898(CHEMBL902;DB00927) 0.897(DB00585)
| 0.912(DBMET03242;DBMET03243) 0.911(DBMET02354) 0.852(DBMET01735;METXBIODB01236
)
|
Lysine carboxypeptidase inhibitor | 0.436(DB00129) 0.426(DB01197) 0.355(DB11296)
| 0.725(DBMET00502) 0.459(DB00123) 0.397(DBMET00508
)
|
Thromboxane A2 antagonist | 0.960(METXBIODB00744) 0.916(METXBIODB00097) 0.810(METXBIODB01452)
| 0.959(METXBIODB00746) 0.955(METXBIODB00745) 0.914(METXBIODB00099
)
|
AICAR transformylase inhibitor | 0.628(CHEMBL34259) 0.437(DB00158) 0.338(DB00650)
| 0.476(DBMET00485;DBMET03265) 0.465(CHEMBL1812063;DBMET01152) 0.444(CHEMBL3544661
)
|
Potassium channel (Inward rectifier) activator | 0.234(METXBIODB00565) 0.140(DB00922) 0.129(CHEMBL498;DB00672)
| 0.366(METXBIODB00566) 0.164(DBMET00376) 0.132(CHEMBL3186899
)
|
Diacylglycerol O-acyltransferase inhibitor | 0.153(DB02659;METXBIODB00251) 0.149(METXBIODB02871) 0.129(DB00712;DB05289;METXBIODB00141;METXBIODB02725)
| 0.140(DBMET02110) 0.120(DBMET01275) 0.115(DB09269;DBMET01431;METXBIODB03146
)
|
Thioredoxin inhibitor | 0.483(DB06799) 0.388(METXBIODB01928) 0.374(METXBIODB02033)
| 0.503(DBMET03682) 0.446(DBMET03683) 0.439(DBMET01434
)
|
Dihydroorotase inhibitor | 0.428(CHEMBL686;DB00784) 0.409(DB01097;METXBIODB01809) 0.400(DB09216)
| 0.669(DBMET00226) 0.621(CHEMBL237987) 0.436(DBMET00946
)
|
Carbonic anhydrase VB inhibitor | 0.900(DB00273) 0.758(CHEMBL902;DB00927) 0.749(DB00869)
| 0.871(DBMET02909;DBMET02910) 0.643(DBMET03010) 0.526(DBMET01349
)
|
Anticholelithogenic | 0.831(DB02659;METXBIODB00251) 0.794(DB01586;METXBIODB00939) 0.792(METXBIODB02278)
| 0.882(METXBIODB03035) 0.830(METXBIODB00250) 0.818(DBMET03599
)
|
Cholecystokinin B agonist | 0.888(DB09268) 0.638(DB04574) 0.156(DB00130)
| 0.989(DBMET02101) 0.982(METXBIODB02254) 0.976(METXBIODB02557
)
|
Prostaglandin antagonist | 0.957(METXBIODB00097;METXBIODB00744) 0.905(METXBIODB01452) 0.754(DB00770)
| 0.888(DB00917) 0.883(DBMET02588) 0.879(METXBIODB00746
)
|
Hypoxanthine phosphoribosyltransferase inhibitor | 0.243(CHEMBL184) 0.229(DB14126) 0.216(DB00787)
| 0.901(DBMET00769) 0.780(DBMET01155) 0.723(DB00171
)
|
NMDA receptor subunit 3B antagonist | 0.779(DB00451;DB00509;METXBIODB02811) 0.748(METXBIODB01959) 0.664(DB06741)
| 0.748(DBMET01818) 0.689(DBMET02273) 0.632(DBMET02578
)
|
Carcinogenic, group 2B | 0.978(CHEMBL1117) 0.977(CHEMBL417;CHEMBL53463;DB00997) 0.973(CHEMBL178;DB00694)
| 0.950(METXBIODB01862) 0.942(METXBIODB00356) 0.933(CHEMBL3526411
)
|
5 Hydroxytryptamine 1D agonist | 0.864(DB00315) 0.818(METXBIODB01680) 0.812(DB00669)
| 0.766(DBMET01792) 0.756(METXBIODB01682) 0.703(DBMET02585
)
|
Estrogen-related receptor gamma antagonist | 0.509(METXBIODB01404) 0.506(METXBIODB00268) 0.262(CHEMBL83;DB00675;METXBIODB01400)
| 0.506(CHEMBL2137046;DBMET00030;METXBIODB01402) 0.350(CHEMBL4525766;METXBIODB00270) 0.254(METXBIODB01709
)
|
Sphingosine 1-phosphate receptor 5 agonist | 0.598(DB08868) 0.454(DB12612) 0.447(DB05016)
| 0.866(DBMET03096) 0.610(DBMET01507) 0.527(CHEMBL3544550
)
|
Glutamate (mGluR2) antagonist | 0.406(METXBIODB02380) 0.111(DB00339) 0.106(DB05016)
| 0.092(DBMET00005) 0.080(DBMET00693;DBMET00814) 0.064(CHEMBL3544524
)
|
Bombesin 3 receptor antagonist | 0.350(DB00214) 0.201(DB01124) 0.199(CHEMBL498;DB00672)
| 0.307(DBMET02232) 0.306(DBMET02233) 0.293(DBMET02231
)
|
Purinergic P2Y2 agonist | 0.051(CHEMBL917;DB00322) 0.045(DB00242) 0.039(DB00631)
| 0.884(DB01861;DB03501) 0.637(CHEMBL1774;DBMET02000;DBMET03590) 0.582(CHEMBL590981;DBMET03589
)
|
5 Hydroxytryptamine 2B agonist | 0.786(DB04871) 0.327(DB00248) 0.299(METXBIODB01229)
| 0.879(CHEMBL3526304) 0.299(DBMET01732;DBMET01825;METXBIODB01849) 0.251(DBMET00377;METXBIODB01001
)
|
Aromatase inhibitor | 0.952(DB00294) 0.947(CHEMBL1200374) 0.927(METXBIODB00694)
| 0.944(CHEMBL3526952) 0.927(DBMET00723;DBMET00724;DBMET01642;DBMET01643;METXBIODB00695) 0.886(DBMET02931
)
|
Progesterone antagonist | 0.974(DB00834) 0.942(METXBIODB01739) 0.919(METXBIODB01134)
| 0.954(DBMET01704) 0.917(DBMET01703) 0.881(METXBIODB01740
)
|
Glycine transporter 2 inhibitor | 0.419(DB11296) 0.382(DB00129) 0.342(METXBIODB00762)
| 0.425(DB00123) 0.392(DBMET01886;DBMET01887) 0.364(CHEMBL3544766
)
|
Dopamine D2 antagonist | 0.988(DB13345) 0.982(DB06077) 0.973(DB08815)
| 0.950(METXBIODB02107) 0.937(DBMET01502;METXBIODB02109) 0.915(DBMET00323;METXBIODB01276
)
|
Factor XIII inhibitor | 0.036(METXBIODB01643) 0.031(METXBIODB02333) 0.030(METXBIODB02735)
| 0.031(DB00891;METXBIODB01644) 0.028(DBMET01579;DBMET02709;METXBIODB00395) 0.024(CHEMBL3184360;DBMET00014;DBMET00201
)
|
Thiazolidinedione | 0.871(DB01132) 0.814(DB00412) 0.802(CHEMBL3526905)
| 0.952(DBMET01300) 0.911(DBMET01365) 0.906(DBMET00942
)
|
Antihypermotility | 0.599(DB06480) 0.528(DB00778;METXBIODB01286) 0.443(CHEMBL532;DB00199)
| 0.624(DBMET02203) 0.603(DBMET02197) 0.590(DBMET02198
)
|
Sigma 2 receptor antagonist | 0.596(METXBIODB01821) 0.364(DB03701;METXBIODB01568) 0.336(METXBIODB00517)
| 0.336(CHEMBL1036;DBMET00104) 0.324(METXBIODB01569) 0.303(CHEMBL4525086;METXBIODB00519
)
|
Phosphodiesterase VIII inhibitor | 0.137(DB08816) 0.129(CHEMBL585;DB00384) 0.121(DB01162)
| 0.192(CHEMBL276521) 0.184(DBMET03171) 0.148(DBMET03170
)
|
Retinoid X receptor agonist | 0.834(DB00755;DB00982;METXBIODB00937) 0.729(METXBIODB01691) 0.530(METXBIODB03098)
| 0.834(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.750(DBMET03633) 0.584(DBMET00453
)
|
Glucagon receptor antagonist | 0.176(DB12255) 0.169(METXBIODB02468) 0.159(DB01218;METXBIODB00077)
| 0.214(DBMET00371;METXBIODB00078) 0.196(DBMET02164) 0.183(DBMET00725
)
|
NAT1 substrate | 0.957(DB01015;METXBIODB01391;METXBIODB02653) 0.933(METXBIODB02319) 0.932(METXBIODB02583)
| 0.975(DBMET00015;METXBIODB01392) 0.949(DBMET00017) 0.913(METXBIODB01390
)
|
Hyperparathyroidism treatment | 0.977(CHEMBL846;DB00136) 0.967(METXBIODB02719) 0.937(DB00153;METXBIODB01575;METXBIODB02762)
| 0.985(DBMET02435) 0.967(DBMET02434) 0.961(DBMET02436
)
|
Beta 2 adrenoreceptor agonist | 0.677(DB00938;METXBIODB01303) 0.637(DB09082) 0.560(DB09080)
| 0.641(DBMET02956) 0.553(DBMET01394) 0.543(DBMET00386;METXBIODB01304
)
|
Antiviral (Hepatitis A) | 0.831(CHEMBL160;DB00091) 0.765(METXBIODB00667) 0.579(METXBIODB01566)
| 0.830(CHEMBL2407584;CHEMBL3544881;CHEMBL3544883;DBMET02217) 0.829(CHEMBL3544879) 0.828(CHEMBL3544882;CHEMBL3544884
)
|
Beta 1 adrenoreceptor antagonist | 0.723(DB00264;METXBIODB00121) 0.685(DB00187) 0.634(METXBIODB00073;METXBIODB01835)
| 0.784(DBMET00319;METXBIODB00122) 0.648(DBMET00115;DBMET00119;METXBIODB00133) 0.585(DBMET00118;METXBIODB00131
)
|
Estrogen-related receptor alpha antagonist | 0.191(METXBIODB02180) 0.170(DB01132) 0.165(CHEMBL83;DB00675;METXBIODB01400;METXBIODB01404)
| 0.384(DBMET01300) 0.297(CHEMBL50995;DBMET02716) 0.244(DBMET01365
)
|
Benzodiazepine agonist | 0.952(METXBIODB00481) 0.894(DB09166;METXBIODB00801) 0.888(DB00683;METXBIODB01040)
| 0.829(METXBIODB00483) 0.816(METXBIODB00353) 0.807(DBMET03600;METXBIODB00217
)
|
Interleukin 4 antagonist | 0.873(DB01234;METXBIODB00696) 0.804(CHEMBL269732;DB00864;METXBIODB00828) 0.782(METXBIODB01399)
| 0.891(METXBIODB00750) 0.887(METXBIODB01811) 0.886(DBMET00826
)
|
Carbonic anhydrase III inhibitor | 0.984(DB00273) 0.905(DB00869) 0.893(DB09298)
| 0.980(DBMET02909;DBMET02910) 0.927(DBMET02911) 0.912(DBMET01841
)
|
Antifungal (Cryptococcus) | 0.967(DB11638) 0.961(DB06697) 0.953(METXBIODB00454)
| 0.967(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.963(METXBIODB00455) 0.833(DBMET00827
)
|
Adenosine A2 receptor agonist | 0.695(DB00640) 0.388(DB00242) 0.260(DB00631)
| 0.304(CHEMBL3526900) 0.247(DBMET00485;DBMET03265) 0.232(DBMET00514
)
|
Thrombin receptor antagonist | 0.144(CHEMBL493982;DB09030) 0.108(DB01255) 0.088(METXBIODB00522)
| 0.166(CHEMBL498785;DBMET01376) 0.106(DBMET02067) 0.099(CHEMBL3542381
)
|
Histamine H3 receptor antagonist | 0.600(DB01058) 0.550(DB11642) 0.436(CHEMBL515387)
| 0.335(CHEMBL3527229) 0.319(DBMET00840) 0.302(CHEMBL3526894
)
|
Kainate receptor antagonist | 0.355(DB06741) 0.347(DB00129) 0.346(DB00130)
| 0.561(DBMET01883) 0.409(CHEMBL1367;DBMET00060;METXBIODB01563) 0.348(DB00123
)
|
Calcium channel L-type activator | 0.738(CHEMBL193;DB01115) 0.731(DB00388;METXBIODB03123) 0.727(DB00668)
| 0.746(CHEMBL3544725) 0.737(CHEMBL1573;DBMET00380;DBMET02940) 0.727(DBMET02444
)
|
Antihelmintic (Fasciola) | 0.788(DB12245) 0.533(METXBIODB02615) 0.498(METXBIODB02912)
| 0.514(CHEMBL804;DBMET00977) 0.510(METXBIODB00195) 0.484(METXBIODB00194
)
|
Retinoid X alpha receptor agonist | 0.893(DB00755;DB00982;METXBIODB00937) 0.746(METXBIODB01691) 0.587(METXBIODB03098)
| 0.893(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.649(DBMET03633) 0.632(DBMET00453
)
|
Keratolytic | 0.773(DB00799) 0.769(DB00755;DB00982;METXBIODB00937) 0.665(METXBIODB03098)
| 0.811(DBMET01005) 0.769(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.742(DBMET00455;DBMET02550;DBMET02552;DBMET03635;DBMET03638
)
|
Alpha adrenoreceptor agonist | 0.940(DB00484) 0.912(DB13345) 0.903(DB00697;METXBIODB02082)
| 0.712(DBMET00465) 0.700(CHEMBL3544803) 0.659(DBMET00464
)
|
Neurokinin 1 agonist | 0.071(DB01255) 0.048(DB11296) 0.016(DB00129;DB00130)
| 0.102(DBMET02065) 0.054(DBMET02067) 0.051(CHEMBL3526373
)
|
AMPA 1 receptor antagonist | 0.310(DB00129) 0.267(DB00130) 0.226(DB11296)
| 0.326(DB00123) 0.302(DBMET00502) 0.237(DBMET02986
)
|
Potassium channel intermediate-conductance Ca-activated blocker | 0.374(CHEMBL104) 0.343(METXBIODB00452) 0.248(METXBIODB01203)
| 0.183(DBMET01591) 0.149(DBMET02228) 0.145(DBMET01199
)
|
HCV NS5B polymerase inhibitor | 0.964(DB08934) 0.434(DB14761) 0.162(DB00441)
| 0.915(DBMET01381) 0.912(DBMET01383) 0.858(DBMET01382
)
|
NMDA receptor glycine site agonist | 0.889(DB06741) 0.809(METXBIODB01959) 0.525(METXBIODB01958)
| 0.809(DBMET01818) 0.499(METXBIODB02241) 0.297(DBMET03557
)
|
5 Hydroxytryptamine 2A agonist | 0.864(METXBIODB00475) 0.795(DB13345) 0.662(METXBIODB00010)
| 0.951(CHEMBL3526304) 0.766(METXBIODB00477) 0.612(DBMET01359
)
|
Arylamine N-Acetyltransferase substrate | 0.973(METXBIODB01071) 0.910(METXBIODB01901) 0.898(METXBIODB01900)
| 0.967(CHEMBL3544870) 0.947(DBMET01050) 0.943(METXBIODB02521
)
|
Melatonin 3 antagonist | 0.276(METXBIODB01173) 0.139(DB01065) 0.065(DB01018)
| 0.203(DBMET03446) 0.190(METXBIODB01174) 0.180(DBMET00840
)
|
Bradykinin B1 receptor agonist | 0.003(DB01255) 0.002(DB00129) -0.001(DB00130)
| 0.009(CHEMBL3526373) 0.008(DBMET00502) 0.002(DB00123;DBMET02067
)
|
Nicotinic alpha4beta2 receptor agonist | 0.274(CHEMBL3;DB00184;METXBIODB02230) 0.159(METXBIODB01383) 0.090(METXBIODB00647)
| 0.257(CHEMBL6200;DBMET00520) 0.090(CHEMBL578211;DBMET00519) 0.084(DBMET03527
)
|
3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.792(METXBIODB02133) 0.633(METXBIODB02879) 0.601(METXBIODB01399)
| 0.838(DB03699) 0.766(DBMET03175) 0.676(METXBIODB02134;METXBIODB02135
)
|
Sigma 1 receptor antagonist | 0.766(DB03701;METXBIODB01568) 0.640(DB01075;METXBIODB00738) 0.632(METXBIODB02611)
| 0.680(METXBIODB01569) 0.532(METXBIODB01570) 0.516(DBMET00086
)
|
Human herpes virus 5 capsid protein P40 inhibitor | 0.047(METXBIODB00204) 0.046(METXBIODB02319) 0.043(METXBIODB02321)
| 0.128(METXBIODB00213) 0.106(METXBIODB00267) 0.097(METXBIODB00349
)
|
Gastric antisecretory | 0.985(DB01129) 0.978(DB00448;DB05351;METXBIODB01955) 0.965(DB00213;METXBIODB00543)
| 0.985(METXBIODB00032) 0.983(DBMET03755) 0.972(DBMET01494;METXBIODB01957
)
|
Caspase 8 inhibitor | 0.041(DB00121) 0.034(DB09292) 0.030(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450)
| 0.053(CHEMBL3544766) 0.040(DBMET01121;DBMET01401) 0.034(DBMET01119;DBMET03515
)
|
Phenylalanine 4-hydroxylase inhibitor | 0.819(DB01235) 0.815(DB00126) 0.788(DB00368)
| 0.841(DBMET00503) 0.788(DBMET02443) 0.719(DBMET02444
)
|
Pulmonary hypertension treatment | 0.947(DB15456) 0.756(METXBIODB01526) 0.754(DB00374)
| 0.947(DBMET03244;DBMET03245) 0.803(CHEMBL3526838) 0.787(METXBIODB01527
)
|
Cathepsin L1 inhibitor | 0.925(DB06670) 0.653(DB05521) 0.128(DB01255)
| 0.942(DBMET01475) 0.860(DBMET01472) 0.190(DBMET01469
)
|
Nav1.3 sodium channel blocker | 0.685(DB00836) 0.540(CHEMBL479;DB00679;METXBIODB02074) 0.527(CHEMBL71;DB00477;METXBIODB00583)
| 0.652(DBMET01697) 0.540(METXBIODB01314) 0.528(DBMET00825;METXBIODB00586
)
|
Vanilloid 2 antagonist | 0.290(CHEMBL151649;METXBIODB02558) 0.270(METXBIODB02270) 0.269(METXBIODB00762)
| 0.288(CHEMBL2074871) 0.277(DBMET01600;METXBIODB00414) 0.269(DBMET00546;METXBIODB00763
)
|
Nicotinic alpha4 receptor agonist | 0.238(CHEMBL3;DB00184;METXBIODB02230) 0.165(METXBIODB01383) 0.103(DB00592;METXBIODB01229)
| 0.252(CHEMBL6200;DBMET00520) 0.115(METXBIODB01278) 0.103(DBMET01732;DBMET01825;METXBIODB01849
)
|
Vesicular acetylcholine transporter inhibitor | 0.320(METXBIODB01821) 0.206(METXBIODB00517) 0.099(DB06217)
| 0.206(CHEMBL1036;DBMET00104) 0.184(METXBIODB01386) 0.100(CHEMBL1254766;DB14682;METXBIODB00708
)
|
Epoxide hydrolase inhibitor | 0.269(DB00398) 0.256(CHEMBL1076347) 0.219(DB01043)
| 0.262(DBMET03323) 0.185(CHEMBL3706477) 0.182(DBMET02153
)
|
Bulimia treatment | 0.397(DB00472;DB08472;DB08544;METXBIODB01953) 0.309(DB00289;METXBIODB00158) 0.262(DB01183)
| 0.396(DB06731;DBMET00197;DBMET01807;METXBIODB01954) 0.308(DBMET02304) 0.240(DBMET00321;METXBIODB01140
)
|
Prostaglandin H2 antagonist | 0.480(METXBIODB00744) 0.381(METXBIODB00097) 0.265(METXBIODB01452)
| 0.279(METXBIODB00746) 0.267(METXBIODB00745) 0.208(METXBIODB00099
)
|
Leukotriene synthesis inhibitor | 0.780(DB00744) 0.777(CHEMBL2105653) 0.637(CHEMBL787;DB00471)
| 0.655(DBMET00139;METXBIODB00065) 0.602(CHEMBL3526239) 0.595(CHEMBL3526240
)
|
Integrin alphaVbeta5 antagonist | 0.784(METXBIODB01514) 0.020(CHEMBL1046;DB00513) 0.017(METXBIODB01173)
| 0.633(METXBIODB01515) 0.285(METXBIODB01517) 0.158(METXBIODB01516
)
|
Beta 2 adrenoreceptor antagonist | 0.731(DB00983) 0.634(DB00264;METXBIODB00121) 0.599(DB00187)
| 0.779(DBMET02956) 0.702(DBMET00319;METXBIODB00122) 0.654(DBMET00740
)
|
Purine nucleoside phosphorylase inhibitor | 0.700(DB00787) 0.697(CHEMBL184) 0.253(DB02377)
| 0.700(DBMET02605) 0.533(DBMET01173;METXBIODB01188) 0.496(DBMET01174
)
|
Heparanase inhibitor | 0.217(DB11217) 0.182(DB11365) 0.156(METXBIODB01980)
| 0.518(DBMET00553) 0.501(CHEMBL3526428;CHEMBL3526429) 0.404(METXBIODB02280
)
|
Prolactin release inhibitor | 0.976(METXBIODB00475) 0.972(DB13345) 0.907(METXBIODB00369)
| 0.994(METXBIODB00275) 0.972(METXBIODB00477) 0.970(METXBIODB00476
)
|
Adenosine A2b receptor antagonist | 0.495(DB00277) 0.424(CHEMBL628;DB00806) 0.423(DB00201;METXBIODB00486)
| 0.569(CHEMBL3526900) 0.496(CHEMBL3544675;DBMET03234) 0.494(DBMET00222;DBMET00271
)
|
Shock treatment | 0.950(DB09059) 0.468(DB00129) 0.435(DB00130)
| 0.734(DBMET00502) 0.526(DBMET02067) 0.515(DBMET00486
)
|
NMDA 2A receptor antagonist | 0.529(METXBIODB01496) 0.500(DB01221;DB11823;METXBIODB00118) 0.494(METXBIODB01959)
| 0.599(DBMET00502) 0.494(DBMET01818) 0.491(DBMET02274
)
|
Antiprotozoal (Trichomonas) | 0.928(METXBIODB02781) 0.859(DB00916) 0.839(DB00448;DB05351;METXBIODB01955)
| 0.860(DBMET01494;METXBIODB01957) 0.816(DBMET00186;DBMET01657;METXBIODB00774) 0.803(METXBIODB00032
)
|
Kainate receptor 4 antagonist | 0.203(CHEMBL445990) 0.180(METXBIODB01280) 0.149(METXBIODB00278;METXBIODB00297)
| 0.204(METXBIODB00919) 0.168(DBMET00993) 0.129(DBMET00494;METXBIODB01282
)
|
Somatostatin 1 antagonist | 0.260(DB09059) 0.152(CHEMBL160;DB00091;DB06176) 0.102(DB00129)
| 0.369(DBMET03190) 0.195(DBMET02662) 0.160(CHEMBL3544640
)
|
Potassium channel Kv1.1 blocker | 0.223(DB00414) 0.221(METXBIODB00565) 0.186(DB00214)
| 0.457(METXBIODB00566) 0.171(DBMET02982) 0.142(DBMET01591
)
|
Melanocortin 4 antagonist | 0.322(METXBIODB01173) 0.141(DB09059) 0.090(DB01131)
| 0.611(DBMET00840) 0.228(DBMET02067) 0.127(DBMET00502
)
|
Diamine oxidase inhibitor | 0.440(METXBIODB00880) 0.419(DB00780) 0.299(METXBIODB01173)
| 0.240(DBMET01955) 0.225(DB13410;METXBIODB00881) 0.219(CHEMBL610;DB04325
)
|
Liver X receptor beta antagonist | 0.156(METXBIODB00811) 0.124(METXBIODB03047) 0.114(DB01628)
| 0.186(DBMET00171;DBMET00172) 0.156(DBMET00167;DBMET00693) 0.150(METXBIODB00521
)
|
Hemostatic | 0.950(DB15456) 0.770(METXBIODB01752) 0.716(DB06695)
| 0.950(DBMET03244;DBMET03245) 0.913(DBMET02415) 0.888(DBMET02416
)
|
Acetylcholine M2 receptor antagonist | 0.826(DB11855) 0.718(METXBIODB01623) 0.694(DB01591)
| 0.660(DBMET02191) 0.599(DBMET00746) 0.581(DBMET00381;METXBIODB00153
)
|
Apolipoprotein B-100 inhibitor | 0.042(METXBIODB00006) 0.030(CHEMBL3542265;METXBIODB00295) 0.028(CHEMBL455136)
| 0.035(CHEMBL3526518) 0.028(CHEMBL4525144;CHEMBL4525145;CHEMBL4525146;CHEMBL4525147;CHEMBL4525148;CHEMBL4525149;CHEMBL4525150;CHEMBL4525151;CHEMBL4525152;CHEMBL4525153;CHEMBL4525154;CHEMBL4525155;CHEMBL4525156;CHEMBL4525157;CHEMBL4525158;CHEMBL4525159) 0.024(DBMET01591
)
|
Antipruritic | 0.998(CHEMBL1473;DB00588) 0.997(DB08906) 0.995(DB06781)
| 0.995(DBMET00837) 0.992(DBMET02589) 0.986(DBMET02590
)
|
Epithelial sodium channel blocker | 0.285(METXBIODB01173) 0.182(DB01018) 0.155(DB13729)
| 0.270(METXBIODB01174) 0.187(DBMET01778) 0.176(DBMET00502
)
|
Metalloproteinase-3 inhibitor | 0.104(DB06151) 0.099(CHEMBL109;DB00313;METXBIODB01559) 0.086(DB02546;DB09292)
| 0.280(CHEMBL3526373) 0.219(CHEMBL3544766) 0.214(CHEMBL3544779
)
|
TRPA1 antagonist | 0.636(DB00201;METXBIODB00486) 0.546(CHEMBL628;DB00806) 0.384(CHEMBL151649;METXBIODB02558)
| 0.636(DBMET00535) 0.538(METXBIODB00716) 0.393(METXBIODB00490
)
|
Dihydropteroate synthase inhibitor | 0.453(DB00158) 0.446(DB01015;METXBIODB01391) 0.405(METXBIODB02919)
| 0.405(DBMET01049) 0.384(DBMET00017) 0.366(DBMET00016
)
|
Dipeptidyl peptidase II inhibitor | 0.564(DB01261) 0.517(DB04876) 0.242(CHEMBL515387)
| 0.250(DBMET02432) 0.195(CHEMBL3526894) 0.150(DBMET03319
)
|
Neuraminidase (Influenza A) inhibitor | 0.680(DB00198) 0.169(DB00742;DB11195) 0.137(METXBIODB02365)
| 0.715(DBMET02218) 0.193(DBMET03118) 0.148(CHEMBL3544842
)
|
Melanocortin antagonist | 0.329(METXBIODB01173) 0.221(DB09059) 0.143(DB01195)
| 0.532(DBMET00840) 0.271(DBMET03194) 0.257(DBMET02067
)
|
Corticotropin releasing factor 1 receptor antagonist | 0.095(METXBIODB01792) 0.087(METXBIODB00228) 0.076(CHEMBL1455)
| 0.077(CHEMBL4525761) 0.060(METXBIODB01640) 0.057(CHEMBL3527249
)
|
Dementia treatment | 0.917(DB00922) 0.901(DB01043) 0.777(DB01020)
| 0.974(DBMET02761) 0.870(DB12243) 0.762(DBMET03138;DBMET03151;DBMET03156
)
|
Vitamin D-like | 0.894(METXBIODB02719) 0.782(CHEMBL846;DB00136) 0.521(DB00153;METXBIODB01575;METXBIODB02762)
| 0.983(DBMET02435) 0.894(DBMET02434) 0.883(METXBIODB01576
)
|
5 Hydroxytryptamine 5 antagonist | 0.894(METXBIODB02830) 0.890(METXBIODB01085) 0.668(DB00669)
| 0.713(CHEMBL3526504) 0.661(DBMET01362) 0.529(DBMET01359
)
|
4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.046(METXBIODB01030) 0.035(METXBIODB03045) 0.032(CHEMBL1308;DB01213)
| 0.057(DBMET01195;METXBIODB00605) 0.038(DBMET01199) 0.037(METXBIODB01031
)
|
Growth hormone release inhibitor | 0.254(DB09059) 0.186(DB00279;METXBIODB02434) 0.121(DB06151)
| 0.201(DBMET00503) 0.166(DBMET02275) 0.142(DBMET02067
)
|
Ca2+/calmodulin-dependent kinase IV inhibitor | 0.912(METXBIODB01288) 0.801(DB06595) 0.408(DB12332)
| 0.856(METXBIODB01289) 0.764(DBMET01441) 0.757(DBMET01440
)
|
Vascular dementia treatment | 0.916(DB00922) 0.901(DB01043) 0.776(DB01020)
| 0.974(DBMET02761) 0.869(DB12243) 0.760(DBMET03138;DBMET03151;DBMET03156
)
|
HIV-1 integrase (Overall Integration) inhibitor | 0.404(METXBIODB03100) 0.387(DB00244) 0.343(DB01250)
| 0.651(CHEMBL3526411) 0.495(CHEMBL2030560) 0.387(DBMET00402
)
|
Apoptosis agonist | 0.978(DB06799) 0.962(METXBIODB00715) 0.959(CHEMBL3542194)
| 0.986(METXBIODB00716) 0.975(CHEMBL3544744) 0.966(DBMET03410
)
|
Ribonucleoside-diphosphate reductase inhibitor | 0.549(DB00631) 0.518(DB00441) 0.365(DB00242)
| 0.831(DBMET00858) 0.810(DBMET00419) 0.795(DBMET00859
)
|
Antibiotic Penem-like | 0.023(DB00303) 0.022(DB06211) 0.018(METXBIODB01600)
| 0.020(CHEMBL1207) 0.015(DBMET00641) 0.013(DBMET00646
)
|
Adrenaline agonist | 0.832(DB09080) 0.829(DB00983) 0.815(DB00938;METXBIODB01303)
| 0.884(DBMET02956) 0.785(DBMET00386;METXBIODB01304) 0.719(DBMET01394
)
|
Antiemphysemic | 0.497(METXBIODB01297) 0.399(CHEMBL1473;DB00588) 0.389(CHEMBL1370;DB01222;METXBIODB01745)
| 0.889(METXBIODB02429) 0.447(DBMET02761) 0.378(CHEMBL3542373;DBMET02914
)
|
Dopamine antagonist | 0.985(DB06077;DB13345) 0.969(DB08815) 0.966(DB08922;METXBIODB02106)
| 0.940(METXBIODB02107) 0.918(DBMET01502;METXBIODB02109) 0.916(DBMET00323;METXBIODB01276
)
|
Cathepsin L2 inhibitor | 0.488(DB06670) 0.425(DB05521) 0.354(DB11763)
| 0.415(DBMET01475) 0.397(DBMET01472) 0.390(DBMET03719
)
|
NMDA receptor glycine site antagonist | 0.971(DB06741) 0.951(METXBIODB01959) 0.781(METXBIODB01958)
| 0.951(DBMET01818) 0.539(METXBIODB02241) 0.469(DBMET02986
)
|
5 Hydroxytryptamine 2 antagonist | 0.994(DB13345) 0.980(DB00734;METXBIODB01274) 0.964(DB06077)
| 0.972(DBMET02984) 0.969(DBMET02090) 0.946(DBMET00323;METXBIODB01276
)
|
Ribonucleotide reductase inhibitor | 0.621(DB00631) 0.522(DB00441) 0.429(DB00242)
| 0.934(DBMET00859) 0.920(DBMET00858) 0.895(DBMET00677
)
|
Metalloproteinase-2 inhibitor | 0.323(DB05015) 0.228(DB01124) 0.222(DB01348)
| 0.351(DBMET01142) 0.334(CHEMBL3544779) 0.323(DBMET01443
)
|
NMDA receptor subunit 3A antagonist | 0.822(DB00451;DB00509;METXBIODB02811) 0.814(DB00279;METXBIODB02434) 0.759(METXBIODB01959)
| 0.759(DBMET01818) 0.748(DBMET02273) 0.704(DBMET02578
)
|
Phosphodiesterase VI inhibitor | 0.970(METXBIODB01526) 0.924(DB00203) 0.918(DB00862)
| 0.891(METXBIODB01527) 0.819(DBMET00421;METXBIODB01331) 0.815(DBMET03640
)
|
Phosphodiesterase 6C inhibitor | 0.990(DB00862) 0.752(DB00820) 0.370(DB00203)
| 0.990(DBMET03640) 0.752(DBMET03416) 0.437(DBMET00326
)
|
Bombesin 1 receptor agonist | 0.214(DB11296) 0.166(METXBIODB02544) 0.163(DB00130)
| 0.245(DBMET00506) 0.234(DBMET01483) 0.224(DBMET02166
)
|
Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.771(DB00655;METXBIODB02494) 0.688(METXBIODB00781) 0.626(DB00783;METXBIODB01814)
| 0.771(DBMET00490) 0.721(DBMET01664) 0.688(DBMET00248;DBMET01659
)
|
Kallikrein 7 inhibitor | 0.358(METXBIODB02420) 0.305(METXBIODB02449) 0.202(CHEMBL1454)
| 0.379(CHEMBL3526352) 0.226(METXBIODB02743) 0.177(CHEMBL4525808
)
|
Peroxisome proliferator-activated receptor delta agonist | 0.294(DB01241;METXBIODB03090) 0.196(CHEMBL672;DB01039) 0.195(METXBIODB02575)
| 0.289(DBMET02785) 0.230(CHEMBL981;DB13873) 0.225(DBMET03281
)
|
Histamine H4 receptor agonist | 0.904(DB00501) 0.203(METXBIODB02400) 0.137(DB00543)
| 0.904(DBMET03242;DBMET03243) 0.127(CHEMBL4525085) 0.111(CHEMBL3544897;CHEMBL3544898
)
|
Alpha 2c adrenoreceptor antagonist | 0.995(DB13345) 0.956(DB00248) 0.954(METXBIODB00475)
| 0.913(METXBIODB00477) 0.874(DBMET02603;DBMET02604) 0.855(DBMET02090
)
|
Amylase inhibitor | 0.934(CHEMBL3527223) 0.916(CHEMBL3527416) 0.897(METXBIODB03141)
| 0.937(CHEMBL3526295) 0.927(CHEMBL3526454) 0.924(CHEMBL3526995
)
|
Prostaglandin-E synthase inhibitor | 0.482(DB04725;METXBIODB00980) 0.451(METXBIODB00981) 0.406(METXBIODB00982)
| 0.484(CHEMBL237987) 0.451(DBMET01313) 0.406(DBMET01315
)
|
Antiviral (Trachoma) | 0.930(CHEMBL532;DB00199) 0.926(CHEMBL1741;DB01211;METXBIODB00619) 0.891(CHEMBL374478)
| 0.912(CHEMBL2063468;DBMET01656) 0.911(CHEMBL1947257) 0.904(CHEMBL2022715;DBMET00357;METXBIODB00621
)
|
Thyroid hormone alpha antagonist | 0.878(DB00279;METXBIODB02434) 0.686(DB00451;DB00509;METXBIODB02811) 0.388(METXBIODB01202)
| 0.960(DBMET02275) 0.511(DBMET02273) 0.443(DBMET01846;METXBIODB02080
)
|
Squalene synthetase inhibitor | 0.260(METXBIODB02568;METXBIODB02799) 0.188(METXBIODB02681) 0.157(DB00857)
| 0.301(METXBIODB00208) 0.197(METXBIODB02569) 0.194(DBMET01434
)
|
3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.058(CHEMBL710;DB01216) 0.046(DB00396;METXBIODB01192) 0.043(DB00378)
| 0.045(CHEMBL3542374;CHEMBL4525755) 0.037(DBMET01727;METXBIODB01197) 0.036(DBMET00369
)
|
Calcium channel T-type blocker | 0.311(DB00737) 0.262(DB04841) 0.251(DB00661;METXBIODB00712;METXBIODB01669)
| 0.209(DBMET01197) 0.175(DBMET02576) 0.151(DBMET01198
)
|
Sphingosine 1-phosphate receptor 3 agonist | 0.697(DB08868) 0.430(DB12016) 0.333(DB12371)
| 0.962(DBMET03096) 0.494(METXBIODB00593) 0.457(DBMET03309
)
|
Menstruation disorders treatment | 0.860(METXBIODB01137) 0.848(CHEMBL1201146) 0.832(DB00294)
| 0.812(CHEMBL1162) 0.788(DB09389) 0.786(CHEMBL241694;DBMET00851
)
|
Reverse transcriptase (HBV) inhibitor | 0.011(METXBIODB02345) 0.004(CHEMBL1140;DB01035;DB13747;METXBIODB02562;METXBIODB02953) 0.002(DB00705;DB01171;DB06637;DB06728;METXBIODB00446;METXBIODB00682)
| 0.006(DBMET02630;METXBIODB02346) 0.004(DBMET00946;DBMET01430;DBMET02629;DBMET03083) 0.002(CHEMBL3706522;DB01955;DBMET00363;DBMET00919;DBMET01777;DBMET02153;DBMET02709;METXBIODB00395;METXBIODB00741;METXBIODB01640
)
|
Purinergic P2Y12 antagonist | 0.834(DB08816) 0.384(CHEMBL1201772;DB06209) 0.258(DB00825;METXBIODB01997;METXBIODB02957)
| 0.873(DBMET03170) 0.868(DBMET03171) 0.670(DBMET00498
)
|
Dopamine beta hydroxylase inhibitor | 0.245(DB00763) 0.171(METXBIODB01512) 0.165(DB00988;METXBIODB01513)
| 0.140(DBMET00614) 0.136(CHEMBL610;DB04325) 0.131(DBMET03097
)
|
Human herpesvirus 2 protease inhibitor | 0.002(METXBIODB00458;METXBIODB01121) 0.001(DB11558;METXBIODB00446;METXBIODB01011;METXBIODB01146;METXBIODB02140;METXBIODB02144;METXBIODB02349) 0.000(METXBIODB00189;METXBIODB00276;METXBIODB01430;METXBIODB01859;METXBIODB02132;METXBIODB02138)
| 0.002(DBMET02761) 0.001(CHEMBL1222314) 0.000(CHEMBL3527184;DBMET00070;DBMET01630;METXBIODB00604;METXBIODB01644
)
|
Prostate disorders treatment | 0.933(CHEMBL710;DB01216) 0.731(METXBIODB00826) 0.663(CHEMBL1200374)
| 0.882(CHEMBL4525755) 0.881(CHEMBL3542374) 0.689(CHEMBL3544689;DBMET02481
)
|
Antibiotic Macrolide-like | 0.968(CHEMBL532;DB00199) 0.957(CHEMBL1741;DB01211;METXBIODB00619) 0.907(DB00778;METXBIODB01286)
| 0.908(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.895(CHEMBL2063468;DBMET01656) 0.871(CHEMBL2022715;DBMET00357;METXBIODB00621
)
|
Imidazoline I1 receptor antagonist | 0.593(DB04948) 0.571(DB00575) 0.288(DB13875)
| 0.158(CHEMBL4525123;CHEMBL4525124) 0.141(DBMET01360) 0.137(DBMET00468
)
|
Peptidyltransferase inhibitor | 0.899(DB07565) 0.804(CHEMBL532;DB00199) 0.800(CHEMBL1741;DB01211;METXBIODB00619)
| 0.949(DB00446) 0.909(DBMET03158) 0.898(DBMET03152
)
|
Purinergic P2T antagonist | 0.780(DB08816) 0.662(CHEMBL1201772;DB06209) 0.496(METXBIODB01752)
| 0.872(DBMET03170) 0.816(DBMET03171) 0.632(CHEMBL3526431
)
|
Lysine-specific demethylase 1A inhibitor | 0.338(DB15133) 0.171(DB01104) 0.124(DB00780)
| 0.361(DBMET03250) 0.188(CHEMBL3526372) 0.164(DBMET03249
)
|
Cocaine dependence treatment | 0.994(DB00921) 0.979(METXBIODB01912) 0.975(DB00704;METXBIODB03062)
| 0.979(DBMET00174) 0.976(DBMET00760) 0.961(DBMET03370
)
|
Glucocorticoid agonist | 0.989(CHEMBL1473;DB00588) 0.985(DB08906) 0.954(DB11921)
| 0.974(DBMET02573) 0.955(DBMET03675) 0.950(DBMET00450
)
|
Antidote, heavy metal | 0.636(CHEMBL1314;DB06823) 0.475(CHEMBL1430) 0.354(DB06151)
| 0.592(DBMET01886;DBMET01887) 0.463(DBMET01883) 0.373(CHEMBL2158192;DBMET01416
)
|
Proline transporter inhibitor | 0.039(METXBIODB01882) 0.031(METXBIODB01859) 0.030(METXBIODB02341)
| 0.048(CHEMBL724;DBMET00354;DBMET03729;METXBIODB00201) 0.040(DBMET01777;DBMET02646) 0.035(DBMET03726
)
|
CYP2C19 inhibitor | 0.910(DB00294) 0.903(CHEMBL1479;DB01406) 0.893(CHEMBL1393;DB00421)
| 0.875(DB09389) 0.856(CHEMBL1162) 0.852(DBMET03030
)
|
Protein 50S ribosomal subunit inhibitor | 0.976(CHEMBL532;DB00199) 0.971(CHEMBL1741;DB01211;METXBIODB00619) 0.934(DB00778;METXBIODB01286)
| 0.917(CHEMBL3706534) 0.908(CHEMBL2063468;DBMET01656) 0.901(CHEMBL3544830;DBMET00356;METXBIODB00620
)
|
Histamine H3 receptor agonist | 0.623(DB00501) 0.524(METXBIODB02856) 0.345(DB11296)
| 0.623(DBMET03242;DBMET03243) 0.450(DBMET00840) 0.314(DBMET01483
)
|
Metalloproteinase-9 inhibitor | 0.276(DB05015) 0.199(DB01124) 0.197(DB02546)
| 0.276(DBMET01443) 0.256(CHEMBL3544779) 0.217(CHEMBL3544766
)
|
LFA antagonist | 0.352(CHEMBL503;DB00227;METXBIODB01008) 0.117(CHEMBL1064;DB00641;METXBIODB01371) 0.110(DB00175)
| 0.245(CHEMBL1201373) 0.225(CHEMBL3544685) 0.161(DBMET01699
)
|
Hypolipemic | 0.989(CHEMBL1064;DB00641;METXBIODB01371) 0.988(METXBIODB01748) 0.980(CHEMBL503;DB00227;METXBIODB01008)
| 0.988(CHEMBL1201391;DBMET00388) 0.981(CHEMBL3544664;DBMET01699) 0.980(CHEMBL3544679;METXBIODB00716
)
|
Somatostatin 3 antagonist | 0.151(DB09059) 0.069(DB06176) 0.058(CHEMBL160;DB00091)
| 0.590(DBMET03190) 0.141(DBMET02205) 0.109(CHEMBL1207
)
|
Phosphodiesterase 6G inhibitor | 0.988(DB00862) 0.547(DB00820) 0.184(METXBIODB00471)
| 0.988(DBMET03640) 0.547(DBMET03416) 0.467(DBMET00326
)
|
Phosphodiesterase 6H inhibitor | 0.988(DB00862) 0.547(DB00820) 0.184(METXBIODB00471)
| 0.988(DBMET03640) 0.547(DBMET03416) 0.467(DBMET00326
)
|
Cyclin E2 inhibitor | 0.151(DB09073) 0.139(DB06595) 0.075(METXBIODB00917)
| 0.308(DBMET01440) 0.129(DBMET02371) 0.114(DBMET02378
)
|
D-Ala-D-Ala ligase inhibitor | 0.381(METXBIODB01399) 0.354(METXBIODB00861;METXBIODB02507) 0.346(METXBIODB00860)
| 0.336(CHEMBL442289) 0.329(CHEMBL3527009) 0.324(CHEMBL75589
)
|
Immunosuppressant Cyclosporine-like | 0.862(CHEMBL160;DB00091) 0.642(METXBIODB00667) 0.157(METXBIODB01566)
| 0.855(CHEMBL2407584;CHEMBL3544881;CHEMBL3544883;DBMET02217) 0.830(CHEMBL3544879) 0.821(CHEMBL3544882;CHEMBL3544884
)
|
Lipocortins synthesis agonist | 0.978(DB11921) 0.940(DB00764) 0.923(CHEMBL1473;DB00588)
| 0.981(DBMET02573) 0.940(DBMET02361) 0.927(DBMET02591
)
|
Factor V inhibitor | 0.254(DB01914;DB09419;DB11735) 0.229(DB14187) 0.220(METXBIODB03135)
| 0.489(METXBIODB00859) 0.331(CHEMBL721;DBMET01126) 0.305(METXBIODB00825
)
|
Sigma receptor antagonist | 0.868(DB00704) 0.839(DB01183) 0.836(DB01192)
| 0.836(DBMET00321;METXBIODB01140) 0.819(DBMET00760) 0.774(DBMET03370
)
|
Matrix metalloproteinase 1 inhibitor | 0.153(DB05015) 0.117(CHEMBL116) 0.114(DB06151)
| 0.227(CHEMBL3526373) 0.222(DBMET02065) 0.201(CHEMBL3527294
)
|
Histone deacetylase class IV inhibitor | 0.935(METXBIODB02294) 0.911(DB02546) 0.799(DB05015)
| 0.877(METXBIODB02295) 0.799(DBMET01443) 0.450(CHEMBL3527527
)
|
Histone deacetylase 11 inhibitor | 0.935(METXBIODB02294) 0.911(DB02546) 0.799(DB05015)
| 0.877(METXBIODB02295) 0.799(DBMET01443) 0.450(CHEMBL3527527
)
|
Nicotinic alpha3beta4 receptor agonist | 0.278(CHEMBL3;DB00184;METXBIODB02230) 0.184(METXBIODB01383) 0.117(METXBIODB00647)
| 0.360(CHEMBL6200;DBMET00520) 0.132(CHEMBL3544719;DBMET00526) 0.117(CHEMBL578211;DBMET00519
)
|
CDC25B inhibitor | 0.400(METXBIODB01580;METXBIODB01586) 0.249(METXBIODB00450;METXBIODB02219) 0.243(METXBIODB02453)
| 0.391(METXBIODB01583) 0.386(CHEMBL117487;CHEMBL3706510;DBMET00065) 0.376(METXBIODB01585;METXBIODB01588
)
|
GABA transporter 1 inhibitor | 0.125(DB06282) 0.118(DB00557) 0.085(DB03701;METXBIODB01568)
| 0.125(DB00341) 0.103(METXBIODB01570) 0.053(DBMET02644
)
|
Alpha 1d adrenoreceptor agonist | 0.268(CHEMBL762;DB00935) 0.151(METXBIODB02632) 0.145(DB00668)
| 0.268(CHEMBL4525123;CHEMBL4525124) 0.175(CHEMBL3526776) 0.156(CHEMBL3526775
)
|
Dipeptidyl peptidase IV inhibitor | 0.994(DB08882) 0.973(DB01261) 0.939(CHEMBL385517;DB06335)
| 0.953(CHEMBL3350936;DBMET00459) 0.944(DBMET02394) 0.938(DBMET02387
)
|
Histone deacetylase 8 inhibitor | 0.932(DB06176) 0.805(CHEMBL483254) 0.780(DB05015)
| 0.860(CHEMBL3526395) 0.780(DBMET01443) 0.673(CHEMBL3527527
)
|
Aggrecanase 2 inhibitor | 0.049(DB02546) 0.046(METXBIODB01087) 0.042(METXBIODB00204)
| 0.092(DBMET00056) 0.087(METXBIODB00349) 0.048(DBMET02228
)
|
Progesterone receptor A antagonist | 0.282(DB00603;METXBIODB02099) 0.214(DB00717) 0.202(DB00834)
| 0.214(CHEMBL1162) 0.204(CHEMBL241694;DBMET00851) 0.142(METXBIODB02005
)
|
Carbonic anhydrase VI inhibitor | 0.985(DB00273) 0.927(DB01194) 0.926(DB00869)
| 0.981(DBMET02909;DBMET02910) 0.918(DBMET02911) 0.882(DBMET01841
)
|
Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.895(METXBIODB01339) 0.532(DB09053) 0.201(DB00437)
| 0.707(DBMET02020) 0.560(DBMET02027) 0.551(DBMET02025
)
|
Carbonic anhydrase IV inhibitor | 0.627(DB00273) 0.531(DB00869) 0.402(DB01194)
| 0.477(DBMET02909;DBMET02910) 0.413(DBMET03010) 0.344(DBMET03671
)
|
Purinergic P2X4 antagonist | 0.324(DB01068) 0.150(DB00580;DB00640;DB12110) 0.121(CHEMBL490;DB00715;METXBIODB01819)
| 0.951(DB00171) 0.812(DBMET00485;DBMET03265) 0.593(DBMET02967
)
|
Glutamate (mGluR4) agonist | 0.223(METXBIODB02353;METXBIODB02842) 0.169(METXBIODB02333) 0.139(METXBIODB01389)
| 0.343(DB00142) 0.169(DB00891) 0.122(DBMET00508
)
|
Calcium channel L-type blocker | 0.881(METXBIODB02115) 0.879(DB00622) 0.865(CHEMBL1726;METXBIODB02040;METXBIODB02119)
| 0.810(DBMET01832) 0.782(DBMET01949) 0.781(METXBIODB02122
)
|
MAP kinase kinase 7 inhibitor | 0.196(DB09053) 0.163(DB06595) 0.156(DB00998)
| 0.170(DBMET01441) 0.167(DBMET02020) 0.156(DBMET00684
)
|
Antiprotozoal (Amoeba) | 0.864(DB06697) 0.818(METXBIODB00454) 0.752(DB11638)
| 0.752(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.741(METXBIODB00455) 0.571(DBMET01913;DBMET03143
)
|
Acetylcholine muscarinic antagonist | 0.826(DB11855) 0.805(DB01062;METXBIODB00150) 0.769(DB01591)
| 0.793(DBMET00746) 0.763(DBMET02191) 0.749(DBMET00381;METXBIODB00153
)
|
Acetylcholine agonist | 0.908(DB00185;METXBIODB00507) 0.659(DB01591) 0.604(METXBIODB01383)
| 0.908(DBMET00430;DBMET00431;DBMET00433) 0.841(METXBIODB00508) 0.494(DBMET00406;METXBIODB00876
)
|
Estradiol 17 beta-dehydrogenase inhibitor | 0.877(DB00655;METXBIODB02494) 0.810(METXBIODB00781) 0.778(METXBIODB02214)
| 0.877(DBMET00490) 0.810(DBMET00248;DBMET01659) 0.809(DBMET01664
)
|
Nav1.4 sodium channel blocker | 0.311(DB06176) 0.301(DB09059) 0.252(CHEMBL160;DB00091)
| 0.900(DBMET01096) 0.322(DBMET00840) 0.285(CHEMBL3542418
)
|
Somatostatin 4 antagonist | 0.318(DB09059) 0.106(METXBIODB02408) 0.105(DB06176)
| 0.949(DBMET03190) 0.271(DBMET02662) 0.161(DB11100
)
|
Collagenase 3 inhibitor | 0.102(DB02546;DB05015) 0.096(METXBIODB02233) 0.089(CHEMBL16;DB00252)
| 0.180(CHEMBL3527251) 0.169(CHEMBL3526346) 0.160(DBMET03082
)
|
GABA transporter inhibitor | 0.152(DB06282) 0.141(DB00557) 0.100(DB03701;METXBIODB01568)
| 0.152(DB00341) 0.120(METXBIODB01570) 0.077(DBMET02644
)
|
Acetylcholine M3 receptor antagonist | 0.770(DB11855) 0.636(DB01591) 0.539(DB01062;METXBIODB00150)
| 0.687(DBMET02191) 0.682(DBMET00746) 0.606(DBMET02956
)
|
Kainate receptor 3 antagonist | 0.333(CHEMBL109;DB00313;METXBIODB01559) 0.155(CHEMBL445990) 0.141(METXBIODB01861)
| 0.281(CHEMBL3706509;DBMET01109) 0.261(DBMET01108) 0.233(CHEMBL1367;DBMET00060;METXBIODB01563
)
|
Phosphoribosylglycinamide formyltransferase inhibitor | 0.088(DB00650) 0.083(DB00158) 0.074(DB11596)
| 0.174(DBMET01476) 0.158(DB00116) 0.121(CHEMBL1231106
)
|
CYP2A6 inhibitor | 0.654(METXBIODB01203) 0.602(METXBIODB00452) 0.594(METXBIODB01034)
| 0.583(CHEMBL3526330) 0.539(CHEMBL3542349) 0.488(DBMET00953
)
|
CC chemokine 1 receptor antagonist | 0.452(CHEMBL54;DB00502) 0.403(METXBIODB00517) 0.361(DB00836)
| 0.490(DBMET01697) 0.452(CHEMBL4525086;METXBIODB00519) 0.403(CHEMBL1036;DBMET00104
)
|
Carbonic anhydrase XV inhibitor | 0.972(DB00273) 0.967(DB01194) 0.964(DB00869)
| 0.970(DBMET02909;DBMET02910) 0.946(DBMET01349) 0.945(DBMET03671
)
|
Protein kinase C gamma inhibitor | 0.993(DB06595) 0.438(METXBIODB01288) 0.380(METXBIODB01205)
| 0.996(DBMET01440) 0.989(DBMET01441) 0.414(METXBIODB01289
)
|
CDK5/p25 inhibitor | 0.232(DB04168) 0.102(DB02377) 0.100(CHEMBL64;METXBIODB02327)
| 0.179(CHEMBL1442231;CHEMBL3526371) 0.129(CHEMBL3091852) 0.123(DBMET02372
)
|
Elastase 1 inhibitor | 0.295(METXBIODB00658) 0.239(DB05521) 0.224(DB01139)
| 0.305(METXBIODB00659) 0.197(METXBIODB01385) 0.184(DBMET01195;METXBIODB00605
)
|
Dihydrofolate reductase inhibitor | 0.995(CHEMBL34259) 0.944(DB00563) 0.856(DB11596)
| 0.974(CHEMBL3544661) 0.761(CHEMBL3544676) 0.725(DBMET00467
)
|
Antibiotic Tribactam-like | 0.005(DB00303;DB06211) 0.004(DB00796) 0.003(METXBIODB01754)
| 0.003(METXBIODB01755) 0.001(METXBIODB00208) 0.000(CHEMBL3544507;CHEMBL3544705;CHEMBL3544706;CHEMBL3544835;CHEMBL3638306;DBMET01407;DBMET02483;DBMET02484;DBMET02485;DBMET03697;METXBIODB00051
)
|
Protein kinase C zeta inhibitor | 0.923(DB06595) 0.582(METXBIODB01288) 0.352(METXBIODB02136)
| 0.976(DBMET01440) 0.831(DBMET01441) 0.495(METXBIODB01289
)
|
Leukotriene B4 receptor 2 antagonist | 0.806(METXBIODB01547) 0.440(METXBIODB00658) 0.126(METXBIODB02515)
| 0.756(METXBIODB01549) 0.599(METXBIODB01548) 0.490(METXBIODB00659
)
|
Carbonic anhydrase VA inhibitor | 0.920(DB00273) 0.744(CHEMBL902;DB00927) 0.683(DB00869)
| 0.891(DBMET02909;DBMET02910) 0.543(CHEMBL3544765) 0.537(DBMET03010
)
|
Alpha 2a adrenoreceptor agonist | 0.833(DB00697;METXBIODB02082) 0.737(DB00484) 0.658(DB04948)
| 0.473(DBMET00468) 0.439(CHEMBL4525123;CHEMBL4525124) 0.403(DBMET00465
)
|
Caspase 7 inhibitor | 0.164(METXBIODB00312) 0.162(METXBIODB00243) 0.158(CHEMBL1455)
| 0.166(CHEMBL724;DBMET00354;DBMET03729;METXBIODB00201) 0.164(METXBIODB00490) 0.160(CHEMBL3544872;CHEMBL457723
)
|
Glutamate (mGluR group III) agonist | 0.354(DB13848) 0.223(METXBIODB02353) 0.206(DB01235)
| 0.434(DB00142) 0.275(DBMET00486) 0.225(CHEMBL237987
)
|
Cyclin D1 inhibitor | 0.279(DB06595) 0.222(DB09073) 0.199(METXBIODB02968)
| 0.190(DBMET01441) 0.180(DBMET02380) 0.179(DBMET02363;DBMET02364
)
|
Somatostatin 4 agonist | 0.302(METXBIODB02408) 0.201(DB09185) 0.184(DB11296)
| 0.696(CHEMBL3706536) 0.184(METXBIODB01238) 0.164(DBMET03493
)
|
GABA receptor agonist | 0.994(METXBIODB01490) 0.881(METXBIODB00481) 0.817(DB00683;METXBIODB01040)
| 0.975(METXBIODB01491) 0.872(DBMET00135;DBMET00299;METXBIODB00791) 0.862(METXBIODB01492
)
|
Histamine H4 receptor antagonist | 0.504(DB00501) 0.437(CHEMBL42;DB00363;METXBIODB00638) 0.329(DB00370;METXBIODB01993)
| 0.504(DBMET03242;DBMET03243) 0.437(CHEMBL4525085) 0.306(CHEMBL845;DBMET00100
)
|
Mucolytic | 0.995(DB00778;METXBIODB01286) 0.994(CHEMBL532;DB00199) 0.993(CHEMBL1741;DB01211;METXBIODB00619)
| 0.988(METXBIODB01287) 0.986(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.984(DBMET00944
)
|
Melanocortin 4 agonist | 0.055(METXBIODB01173) 0.052(DB09059;DB11296) 0.043(DB01202)
| 0.425(DBMET00840) 0.106(DBMET02067) 0.071(DBMET00502
)
|
Dipeptidyl peptidase inhibitor | 0.988(DB08882) 0.972(DB01261) 0.945(CHEMBL385517;DB06335)
| 0.959(CHEMBL3350936;DBMET00459) 0.902(DBMET02394) 0.888(DBMET02387
)
|
Anticonvulsant | 0.993(DB00273) 0.992(METXBIODB01490) 0.955(METXBIODB00481)
| 0.989(METXBIODB01491) 0.988(DBMET02909;DBMET02910) 0.981(METXBIODB01492
)
|
Leukotriene B4 receptor 1 antagonist | 0.865(METXBIODB01547) 0.656(DB11936) 0.645(METXBIODB00658)
| 0.850(METXBIODB01549) 0.672(METXBIODB00659) 0.622(METXBIODB01548
)
|
Narcolepsy treatment | 0.380(CHEMBL1373;DB00745) 0.318(METXBIODB01085) 0.300(METXBIODB00046)
| 0.303(METXBIODB01086) 0.301(DBMET03284) 0.272(DBMET00406;METXBIODB00876
)
|
Sodium/glucose cotransporter 2 inhibitor | 0.946(DB09038) 0.938(CHEMBL1770248;DB11827) 0.869(DB12713)
| 0.989(CHEMBL3526185;CHEMBL3527604;DBMET01910;DBMET01911) 0.967(DBMET01912) 0.960(DBMET02143
)
|
Hematopoietic | 0.875(DB01221;DB11823;METXBIODB00118) 0.812(DB06595) 0.577(DB00742;DB11195)
| 0.855(DBMET00190;DBMET00191) 0.848(DBMET00192) 0.786(DBMET01440
)
|
Ca(v)3.2 blocker | 0.372(METXBIODB02717) 0.283(METXBIODB02190) 0.243(METXBIODB02183)
| 0.410(CHEMBL1710849;DBMET01641) 0.396(DBMET03671) 0.332(CHEMBL3542390;CHEMBL4525788
)
|
Liver X receptor alpha agonist | 0.344(METXBIODB02278) 0.289(DB01586;METXBIODB00939) 0.275(METXBIODB03047)
| 0.349(METXBIODB01981) 0.344(METXBIODB00941) 0.294(DBMET01003
)
|
Human rhinovirus A protease inhibitor | 0.568(DB05521) 0.343(DB08908) 0.311(CHEMBL114;DB01232)
| 0.292(CHEMBL3988903) 0.284(CHEMBL3706528;DBMET01549;DBMET01550) 0.281(CHEMBL3706529;DBMET01548
)
|
Carbonic anhydrase V inhibitor | 0.931(DB00273) 0.746(CHEMBL902;DB00927) 0.696(DB00869)
| 0.906(DBMET02909;DBMET02910) 0.680(DBMET00565;DBMET00573;DBMET02448;DBMET02449;METXBIODB02238) 0.612(CHEMBL1208633
)
|
Glucose-dependent insulinotropic receptor antagonist | 0.154(DB01189) 0.014(METXBIODB01438;METXBIODB01440) 0.011(DB01591)
| 0.014(DBMET00493) 0.013(DBMET02021) 0.009(CHEMBL380905
)
|
GABA A receptor agonist | 0.991(METXBIODB01490) 0.742(DB05087) 0.427(DB01215)
| 0.960(METXBIODB01491) 0.830(METXBIODB01492) 0.446(DBMET03442
)
|
Imidazoline I2 receptor antagonist | 0.399(DB04948) 0.072(DB00575) 0.040(DB00592;METXBIODB01620)
| 0.052(METXBIODB00725) 0.038(CHEMBL4525123;CHEMBL4525124) 0.028(DBMET01195;METXBIODB00605
)
|
Protein kinase C beta inhibitor | 0.970(DB06595) 0.419(METXBIODB01288) 0.182(DB00458;METXBIODB00907;METXBIODB01158)
| 0.986(DBMET01440) 0.973(DBMET01441) 0.372(METXBIODB01289
)
|
Benzodiazepine inverse agonist | 0.639(METXBIODB01490) 0.133(METXBIODB00858) 0.096(DB00683;METXBIODB01040)
| 0.620(METXBIODB01492) 0.554(METXBIODB01491) 0.242(METXBIODB00936
)
|
Melanocortin agonist | 0.097(METXBIODB01173) 0.079(DB09059) 0.074(DB11296)
| 0.621(DBMET00840) 0.143(DBMET02067) 0.126(DBMET00502
)
|
Nerve growth factor antagonist | 0.120(METXBIODB00178) 0.113(DB00627) 0.106(DB00836)
| 0.100(DBMET00103;METXBIODB00518) 0.097(DBMET01697) 0.095(METXBIODB00180
)
|
Phosphodiesterase 6B inhibitor | 0.990(DB00862) 0.564(DB00820) 0.248(METXBIODB00471)
| 0.990(DBMET03640) 0.564(DBMET03416) 0.504(DBMET00326
)
|
Glutaminyl-peptide cyclotransferase inhibitor | 0.081(DB00501) 0.047(METXBIODB00176) 0.043(METXBIODB02630)
| 0.081(DBMET03242;DBMET03243) 0.046(METXBIODB00534) 0.040(DBMET02770
)
|
Adenosine A2a receptor antagonist | 0.899(DB00640) 0.878(DB00631) 0.845(DB01280)
| 0.974(CHEMBL3526900) 0.641(DBMET00496) 0.584(METXBIODB00045
)
|
Prostaglandin EP3 antagonist | 0.576(DB00770) 0.489(DB00929) 0.475(DB00905)
| 0.619(DB00917) 0.576(DBMET02086) 0.559(DBMET02588
)
|
Neutrophil collagenase inhibitor | 0.171(DB06151) 0.156(DB02546) 0.153(CHEMBL498;DB00672)
| 0.310(CHEMBL3544779) 0.257(DBMET02066) 0.252(DBMET01045
)
|
MAP3K5 inhibitor | 0.089(DB06595) 0.076(METXBIODB02345) 0.064(METXBIODB02438)
| 0.089(DBMET01441) 0.077(DBMET02824) 0.068(METXBIODB02346
)
|
Xanthine dehydrogenase inhibitor | 0.510(DB04854) 0.488(METXBIODB02196) 0.478(DB01685;METXBIODB02526)
| 0.585(DBMET01498) 0.454(CHEMBL3544765) 0.406(CHEMBL75589
)
|
Fructose-1,6-bisphosphatase 1 inhibitor | 0.180(DB14126) 0.131(CHEMBL498;DB00672) 0.130(DB00530;METXBIODB01718)
| 0.252(DBMET01173;METXBIODB01188) 0.180(DBMET01425) 0.130(DBMET01790
)
|
Acetyl-CoA transferase 2 inhibitor | 0.142(METXBIODB01434) 0.137(METXBIODB00513) 0.136(METXBIODB00891)
| 0.219(METXBIODB03140) 0.185(METXBIODB01204) 0.165(METXBIODB00453
)
|
DNA methyltransferase I inhibitor | 0.764(DB00242) 0.718(DB00640) 0.698(DB01262)
| 0.925(DBMET00514) 0.739(METXBIODB02167) 0.728(METXBIODB02169
)
|
CXC chemokine 2 receptor antagonist | 0.112(CHEMBL1076347) 0.079(METXBIODB02509) 0.063(METXBIODB02754)
| 0.240(CHEMBL3527500;CHEMBL3527578) 0.128(CHEMBL3527579) 0.091(METXBIODB00193
)
|
Cytotoxic | 0.925(CHEMBL92;DB01248) 0.916(DB06772) 0.909(CHEMBL1783834)
| 0.952(METXBIODB02105) 0.941(DBMET03414) 0.938(DBMET03415
)
|
5 Hydroxytryptamine 3A antagonist | 0.663(DB00889;METXBIODB00874) 0.622(METXBIODB01508) 0.443(CHEMBL715;DB00334;METXBIODB01125)
| 0.455(DBMET00406;METXBIODB00876) 0.451(METXBIODB01511) 0.381(CHEMBL1125;DBMET00265
)
|
NAD(P)H dehydrogenase (quinone) inhibitor | 0.900(DB01418) 0.855(METXBIODB02161) 0.825(METXBIODB02163)
| 0.915(DBMET00037) 0.906(DBMET00038) 0.904(DBMET01042;METXBIODB01584;METXBIODB01585;METXBIODB01587;METXBIODB01588
)
|
Inducible nitric-oxide synthase inhibitor | 0.420(METXBIODB02871) 0.408(DB00121) 0.398(DB00129)
| 0.689(DBMET00502) 0.539(DBMET03073) 0.504(DBMET00486
)
|
Carbonic anhydrase II stimulant | 0.873(DB00273) 0.242(DB01124) 0.220(CHEMBL498;DB00672)
| 0.844(DBMET02909;DBMET02910) 0.798(DBMET02911) 0.194(DBMET00289
)
|
Antihyperaldosteronism | 0.887(CHEMBL1393;DB00421) 0.654(DB01395) 0.619(DB16165)
| 0.829(CHEMBL3544705;DBMET02483) 0.663(CHEMBL3638292) 0.617(DBMET02484;DBMET02485
)
|
Histamine H1 receptor antagonist | 0.910(DB01084) 0.849(DB00455) 0.808(DB11742)
| 0.792(DBMET00391) 0.773(METXBIODB00572) 0.757(DBMET00752;DBMET00761
)
|
Antibiotic Anthracycline-like | 0.966(METXBIODB02104) 0.921(CHEMBL417;CHEMBL53463;DB00997) 0.867(CHEMBL178;DB00694)
| 0.969(CHEMBL3508145) 0.960(CHEMBL3508142) 0.896(CHEMBL3508141;CHEMBL3508146;DBMET00647
)
|
CD45 antagonist | 0.472(CHEMBL898) 0.435(DB00244) 0.394(METXBIODB01301)
| 0.670(DBMET01120) 0.627(DBMET01119) 0.619(DBMET01121
)
|
Growth hormone releasing factor antagonist | 0.101(DB09059) 0.038(DB11296) 0.033(DB01255)
| 0.063(DBMET02067) 0.055(DBMET00506) 0.043(DBMET02065
)
|
Calpain 1 inhibitor | 0.060(DB14187) 0.047(DB01914;DB05521;DB09419;DB11735) 0.044(DB00121)
| 0.678(DB00166) 0.531(METXBIODB00859) 0.206(METXBIODB00825
)
|
Neuropeptide Y antagonist | 0.397(DB06016) 0.354(METXBIODB00330) 0.345(METXBIODB01183)
| 0.396(DBMET03492) 0.391(DBMET03491) 0.221(DBMET01778
)
|
11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.938(DB13751) 0.778(METXBIODB02993) 0.666(DB00378)
| 0.944(DBMET02110) 0.635(METXBIODB02994) 0.599(DBMET00286;METXBIODB01194
)
|
Metabolic disease treatment | 0.863(DB12713) 0.810(METXBIODB02278) 0.800(DB01586;METXBIODB00939)
| 0.819(METXBIODB01505) 0.810(METXBIODB00941) 0.804(DB00166
)
|
Urate transporter 1 inhibitor | 0.515(DB04854) 0.252(METXBIODB02564) 0.228(DB00795)
| 0.514(DBMET03281) 0.432(DBMET00303) 0.296(DBMET03279
)
|
Beta adrenoreceptor antagonist | 0.855(DB00983) 0.807(DB00264;METXBIODB00121) 0.792(DB00373;METXBIODB01469)
| 0.867(DBMET00319;METXBIODB00122) 0.857(DBMET02956) 0.792(DBMET00740
)
|
Benzodiazepine receptor peripheral-type antagonist | 0.717(DB00425) 0.232(DB00842) 0.228(DB00186)
| 0.477(DBMET01242) 0.473(DBMET01241) 0.468(DBMET01238
)
|
5 Hydroxytryptamine 1A antagonist | 0.965(DB13345) 0.958(DB08922;METXBIODB02106) 0.927(DB08815)
| 0.965(METXBIODB02107) 0.925(DBMET02984) 0.774(DBMET01502;METXBIODB02109
)
|
Protease activated receptor 1 antagonist | 0.822(CHEMBL493982;DB09030) 0.163(METXBIODB01173) 0.135(DB01018)
| 0.864(CHEMBL498785;DBMET01376) 0.811(DBMET01375) 0.799(CHEMBL3542381
)
|
GP IIb/IIIa receptor antagonist | 0.331(CHEMBL1430) 0.296(CHEMBL1046;DB00513) 0.286(CHEMBL169901;DB04840)
| 0.624(CHEMBL65267) 0.616(DBMET00502) 0.477(DBMET01535
)
|
5 Hydroxytryptamine 1B antagonist | 0.991(DB13345) 0.935(METXBIODB01680) 0.814(DB00315)
| 0.934(METXBIODB01682) 0.737(DBMET01792) 0.646(METXBIODB00959
)
|
Mediator release inhibitor | 0.757(CHEMBL3527416) 0.681(DB00768) 0.666(DB11217)
| 0.877(DBMET00879;DBMET00881;METXBIODB02996) 0.838(CHEMBL3526994) 0.825(CHEMBL3526996
)
|
Progesterone receptor B antagonist | 0.107(METXBIODB01134) 0.104(DB00834) 0.095(METXBIODB01044)
| 0.170(DBMET02237) 0.100(METXBIODB02005) 0.098(DBMET00695
)
|
Prostaglandin EP1 antagonist | 0.619(DB00770) 0.539(DB00905) 0.490(DB00287)
| 0.654(DB00917) 0.653(DBMET02588) 0.619(DBMET02086
)
|
Alpha 2c adrenoreceptor agonist | 0.765(DB00484) 0.740(DB00697;METXBIODB02082) 0.709(DB04948)
| 0.203(DBMET00464) 0.132(DBMET00465) 0.126(DBMET00468
)
|
RNA-directed RNA polymerase inhibitor | 0.962(DB08934) 0.122(METXBIODB02233) 0.113(METXBIODB02370)
| 0.919(DBMET01381) 0.885(DBMET01383) 0.841(DBMET01382
)
|
Angiogenesis stimulant | 0.888(CHEMBL3542194) 0.877(DB06697) 0.867(METXBIODB00454)
| 0.915(DBMET03082) 0.892(DBMET00509) 0.889(CHEMBL3542195
)
|
Ceramide glucosyltransferase inhibitor | 0.597(DB09039) 0.148(CHEMBL3527223) 0.101(CHEMBL417;CHEMBL53463;DB00997)
| 0.413(DBMET03450;DBMET03451;DBMET03454) 0.326(DBMET03455) 0.303(DBMET03453
)
|
Potassium channel (Inward rectifier) blocker | 0.510(DB00448;DB05351;METXBIODB01955) 0.475(METXBIODB01973) 0.472(CHEMBL1503;DB00338;DB00736;METXBIODB00771)
| 0.445(DBMET01494;METXBIODB01957) 0.424(DBMET00186;DBMET01657;METXBIODB00774) 0.405(DBMET01822
)
|
Somatostatin 2 antagonist | 0.332(DB09059) 0.128(DB06176) 0.122(DB00129)
| 0.955(DBMET03190) 0.244(DBMET02662) 0.204(DB11100
)
|
Tryptase inhibitor | 0.454(CHEMBL169901;DB04840) 0.306(METXBIODB01173) 0.115(DB00711)
| 0.421(CHEMBL3638292) 0.387(DBMET03118) 0.331(CHEMBL1710849;DBMET01641
)
|
Acetylcholine M3 receptor agonist | 0.983(DB00185;METXBIODB00507) 0.492(DB01085;METXBIODB01181) 0.336(DB06756)
| 0.983(DBMET00430;DBMET00431;DBMET00433) 0.943(METXBIODB00508) 0.310(DBMET01973
)
|
Glutamate (mGluR group I) agonist | 0.189(CHEMBL1140;DB05016;DB12184;METXBIODB00870) 0.156(METXBIODB00647) 0.142(DB01058)
| 0.189(DBMET02629) 0.156(CHEMBL578211;DBMET00519) 0.134(DBMET03758
)
|
Factor XIIIa inhibitor | 0.112(DB01255) 0.105(DB13747;METXBIODB00715) 0.092(DB00129)
| 0.191(CHEMBL3544622) 0.159(CHEMBL3544721) 0.156(CHEMBL3544600
)
|
Leukotriene D4 antagonist | 0.947(CHEMBL787;DB00471) 0.716(METXBIODB02380) 0.235(METXBIODB02970)
| 0.945(CHEMBL3526241;DBMET01246;DBMET01247;DBMET01707;DBMET01708) 0.917(CHEMBL3526240) 0.912(CHEMBL3526481;DBMET01248;DBMET01249;DBMET01709
)
|
Neurotensin receptor antagonist | 0.286(DB00129) 0.248(DB01255) 0.199(CHEMBL169901;DB04840)
| 0.465(CHEMBL3526373) 0.300(DBMET00502) 0.287(DB00123;DBMET02067
)
|
Dyspepsia treatment | 0.803(DB09089) 0.689(DB06480) 0.613(DB11739)
| 0.808(DBMET01505) 0.738(DBMET02203) 0.653(DBMET02197
)
|
Nicotinic receptor alpha7 subunit antagonist | 0.691(CHEMBL3;DB00184;METXBIODB02230) 0.639(METXBIODB01508) 0.554(DB01591)
| 0.563(DBMET00840) 0.554(CHEMBL6200;DBMET00520) 0.488(METXBIODB01511
)
|
Adenosine A2 receptor antagonist | 0.891(DB00640) 0.861(DB01280) 0.839(DB00631)
| 0.972(CHEMBL3526900) 0.696(DBMET00496) 0.672(METXBIODB00857
)
|
Transcription factor inhibitor | 0.713(DB00507) 0.696(DB01247) 0.676(DB00614)
| 0.944(CHEMBL3527192) 0.913(CHEMBL3544771) 0.736(DBMET01012
)
|
Cyclin T1 inhibitor | 0.045(METXBIODB02408) 0.041(METXBIODB00379) 0.036(METXBIODB02132)
| 0.062(METXBIODB00380) 0.053(DBMET01894) 0.048(CHEMBL276521
)
|
Cholinergic | 0.996(DB00185;METXBIODB00507) 0.963(DB00382) 0.944(METXBIODB01434)
| 0.996(DBMET00430;DBMET00431;DBMET00433;METXBIODB00508) 0.946(METXBIODB01435) 0.912(DBMET01757
)
|
Cyclophilin A inhibitor | 0.655(CHEMBL160;DB00091) 0.582(METXBIODB00667) 0.522(METXBIODB01566)
| 0.693(CHEMBL2407584;CHEMBL3544881;CHEMBL3544883;DBMET02217) 0.679(CHEMBL3544882;CHEMBL3544884) 0.638(CHEMBL3544879
)
|
Glutamate (mGluR5) agonist | 0.157(DB12184;METXBIODB00870) 0.142(METXBIODB00647) 0.135(DB05016)
| 0.142(CHEMBL578211;DBMET00519) 0.120(DBMET03758) 0.113(CHEMBL3706522
)
|
Histone deacetylase SIRT1 inhibitor | 0.692(METXBIODB01930) 0.409(CHEMBL1140) 0.329(DB00129;DB01255)
| 0.694(METXBIODB00240) 0.571(METXBIODB00304) 0.461(DBMET02067
)
|
Corticosteroid-like | 0.981(CHEMBL1473;DB00588) 0.974(DB08906) 0.973(DB00764)
| 0.973(DBMET02361) 0.958(DBMET02573) 0.954(DBMET00450
)
|
Integrin beta3 antagonist | 0.169(METXBIODB01514) 0.142(CHEMBL1046;DB00513) 0.125(DB00575)
| 0.438(DBMET00502) 0.383(DBMET01477) 0.325(CHEMBL1157;DBMET00501
)
|
Potassium channel Kv1.3 blocker | 0.453(METXBIODB00452) 0.369(METXBIODB01034) 0.283(METXBIODB01203)
| 0.195(DBMET01615) 0.188(DBMET00132;METXBIODB00430;METXBIODB01670) 0.185(METXBIODB00313
)
|
Monophenol monooxygenase inhibitor | 0.960(METXBIODB03141) 0.952(CHEMBL3527416) 0.948(DB09298)
| 0.986(CHEMBL3526295) 0.977(CHEMBL3526454) 0.976(METXBIODB02188;METXBIODB02189
)
|
Antibiotic Quinolone-like | 0.761(DB01155) 0.639(DB01044) 0.580(DB00685;METXBIODB02642)
| 0.650(DBMET02516) 0.503(DBMET03009) 0.437(CHEMBL3544746
)
|
Beta 1 adrenoreceptor agonist | 0.783(DB00938;METXBIODB01303) 0.768(DB09080) 0.766(DB09082)
| 0.791(DBMET02956) 0.582(DBMET01394) 0.443(DBMET00386;METXBIODB01304
)
|
Alkylator | 0.969(METXBIODB03049) 0.955(DB05109) 0.937(DB00385)
| 0.977(DBMET01100) 0.969(DBMET00024;METXBIODB00966) 0.959(CHEMBL3706539
)
|
Antiacne | 0.996(DB09096) 0.992(METXBIODB03098) 0.979(DB06755)
| 0.969(DBMET00454) 0.967(DB00523;DBMET01736;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.956(METXBIODB03099
)
|
5 Hydroxytryptamine 3B antagonist | 0.974(METXBIODB01085) 0.735(METXBIODB01508) 0.637(DB06148;METXBIODB01228;METXBIODB01848)
| 0.593(METXBIODB01086) 0.527(CHEMBL4525085) 0.488(DBMET02203
)
|
Cathepsin E inhibitor | 0.186(METXBIODB01177) 0.183(CHEMBL16;DB00252) 0.143(METXBIODB01179;METXBIODB01881)
| 0.183(DBMET01170) 0.146(DBMET02066) 0.145(CHEMBL3507703;DBMET03216
)
|
Urotensin II agonist | 0.086(DB09031) 0.063(DB00129;DB00924) 0.061(DB00215;DB01175)
| 0.119(CHEMBL4525771) 0.084(DBMET03073) 0.072(DBMET03072
)
|
Dopamine uptake inhibitor | 0.931(DB00907;METXBIODB00058) 0.811(DB00245) 0.770(DB01104)
| 0.861(METXBIODB00059) 0.855(DBMET00645) 0.783(METXBIODB01570
)
|
Carbonic anhydrase I inhibitor | 0.691(DB00273) 0.522(DB00869) 0.410(METXBIODB02492)
| 0.529(DBMET02909;DBMET02910) 0.483(DBMET03010) 0.434(DBMET00729
)
|
Free radical scavenger | 0.921(METXBIODB02879) 0.910(METXBIODB02136) 0.906(METXBIODB01399)
| 0.923(CHEMBL3544744) 0.918(DBMET03074) 0.913(METXBIODB02880
)
|
Interleukin 1 beta converting enzyme inhibitor | 0.231(DB09292) 0.182(DB06819) 0.179(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450)
| 0.274(CHEMBL3544766) 0.217(CHEMBL3526309) 0.215(DBMET01401
)
|
Geranylgeranyltransferase inhibitor | 0.125(CHEMBL104) 0.087(METXBIODB02568;METXBIODB02799) 0.085(DB11296)
| 0.113(DBMET00508) 0.092(DBMET00503) 0.085(DBMET00506
)
|
Potassium channel small-conductance Ca-activated blocker | 0.391(METXBIODB00008) 0.211(CHEMBL42;DB00363;METXBIODB00638) 0.175(DB13941)
| 0.514(DB06457) 0.428(DBMET00636) 0.211(CHEMBL4525085
)
|
Carbonic anhydrase IV stimulant | 0.130(DB01124) 0.122(CHEMBL498;DB00672) 0.096(DB11296)
| 0.103(DBMET00289) 0.093(CHEMBL3544714) 0.089(CHEMBL3544715
)
|
Bombesin 3 receptor agonist | 0.145(DB00214) 0.121(METXBIODB01623) 0.112(DB01685;METXBIODB02526)
| 0.153(METXBIODB01626) 0.130(DBMET02233) 0.129(DBMET02232
)
|
5 Hydroxytryptamine 7 agonist | 0.521(DB01238) 0.470(METXBIODB01089) 0.416(METXBIODB00287)
| 0.416(DBMET01359) 0.353(DBMET02464) 0.343(DBMET01362
)
|
CC chemokine 5 receptor antagonist | 0.755(DB06652) 0.269(DB00629) 0.196(DB01058)
| 0.894(DBMET00081) 0.883(DBMET00083) 0.874(DBMET00080
)
|
Endothelin-converting enzyme inhibitor | 0.402(CHEMBL1314;DB06823) 0.350(DB06151) 0.298(DB01197)
| 0.455(DBMET03082) 0.415(CHEMBL2158192;DBMET01416) 0.383(DBMET00503
)
|
Plasmepsin I inhibitor | 0.401(DB00742;DB11195) 0.115(DB01914;DB09419;DB11735) 0.090(METXBIODB00073;METXBIODB01835)
| 0.090(CHEMBL3706536) 0.081(CHEMBL3091852) 0.072(CHEMBL3706523
)
|
Tryptophan 5 hydroxylase inhibitor | 0.915(DB12095) 0.120(DB01235) 0.107(DB13848)
| 0.978(DBMET03552) 0.366(DBMET03553) 0.349(DBMET03554
)
|
Vasopressin 1A agonist | 0.389(DB09059) 0.075(METXBIODB02451) 0.048(DB00949)
| 0.075(DBMET00862) 0.072(DBMET02067) 0.061(METXBIODB00805
)
|
Platelet adhesion inhibitor | 0.904(CHEMBL1201772;DB06209) 0.889(METXBIODB01752) 0.833(METXBIODB01307)
| 0.901(DBMET00483) 0.898(DBMET01163) 0.897(DBMET00099;METXBIODB01308
)
|
Toll-Like receptor antagonist | 0.765(DB00704) 0.750(DB01183;DB01192) 0.723(DB00497;METXBIODB01139)
| 0.750(DBMET00321;METXBIODB01140) 0.617(METXBIODB00894) 0.564(DBMET00179;METXBIODB01969
)
|
Kainate receptor 5 antagonist | 0.280(CHEMBL445990) 0.262(METXBIODB02370) 0.257(METXBIODB02368)
| 0.252(METXBIODB00919) 0.251(DBMET00993) 0.233(DBMET00494
)
|
Nociceptin (N/OFQ) receptor agonist | 0.580(DB00921) 0.572(METXBIODB01912) 0.275(METXBIODB01170)
| 0.572(DBMET00174) 0.265(DBMET00176) 0.254(METXBIODB02676
)
|
5 Hydroxytryptamine 3 agonist | 0.491(DB01084) 0.359(METXBIODB02400) 0.335(CHEMBL2104993;DB09068)
| 0.400(DBMET00752;DBMET00761) 0.325(DBMET01778) 0.314(CHEMBL4525085
)
|
Carbonic anhydrase XIII inhibitor | 0.990(DB00273) 0.940(DB01194) 0.938(CHEMBL902;DB00927)
| 0.988(DBMET02909;DBMET02910) 0.859(CHEMBL3526295) 0.855(CHEMBL3526944
)
|
Parathyroid hormone antagonist | 0.799(METXBIODB02719) 0.750(CHEMBL846;DB00136) 0.559(DB00153;METXBIODB01575;METXBIODB02762)
| 0.881(DBMET02435) 0.799(DBMET02434) 0.697(CHEMBL3542380;CHEMBL3542386
)
|
Acetylcholine nicotinic antagonist | 0.824(DB11421) 0.787(METXBIODB00904) 0.766(METXBIODB01541)
| 0.787(DBMET00840) 0.711(METXBIODB01542) 0.663(CHEMBL6200;DBMET00520
)
|
Phosphoglycerate kinase inhibitor | 0.623(DB00640) 0.535(DB01280) 0.488(DB00441)
| 0.993(DB00171) 0.971(DBMET00485;DBMET03265) 0.710(CHEMBL3638285
)
|
Protease activated receptor agonist | 0.036(METXBIODB01173) 0.021(DB01255) 0.010(DB00130)
| 0.131(DBMET02067) 0.072(DBMET00502) 0.039(DB03091
)
|
5 Hydroxytryptamine 2B antagonist | 0.995(DB13345) 0.938(METXBIODB00369) 0.935(METXBIODB00475)
| 0.994(DBMET02090) 0.971(METXBIODB00370) 0.970(METXBIODB00476
)
|
5-Lipoxygenase inhibitor | 0.981(DB00744) 0.921(METXBIODB00064) 0.839(METXBIODB00328)
| 0.896(DBMET00138;METXBIODB00066) 0.860(DBMET00139;METXBIODB00065) 0.831(METXBIODB00329
)
|
Antiviral (Hepatitis C) | 0.977(DB11586) 0.916(DB08934) 0.884(CHEMBL1076930)
| 0.971(DBMET02051) 0.963(DBMET02050) 0.909(DBMET01381
)
|
Heat shock protein 90 beta antagonist | 0.989(CHEMBL383824) 0.300(CHEMBL467399) 0.225(DB02513;METXBIODB02078)
| 0.942(CHEMBL3526785) 0.941(CHEMBL3526786) 0.838(CHEMBL3526783
)
|
Adenylate cyclase inhibitor | 0.764(DB00242) 0.731(DB00640) 0.695(DB09299)
| 0.955(DBMET00677) 0.866(DB00171) 0.833(CHEMBL3526610
)
|
Peroxisome proliferator-activated receptor delta antagonist | 0.746(METXBIODB02575) 0.383(CHEMBL672;DB01039) 0.246(METXBIODB01209)
| 0.654(CHEMBL981;DB13873) 0.438(CHEMBL2106581;DBMET02798) 0.435(METXBIODB00805
)
|
Beta adrenoreceptor agonist | 0.808(DB00938;METXBIODB01303) 0.766(DB00983) 0.750(DB09082)
| 0.862(DBMET02956) 0.682(DBMET01394) 0.681(DBMET00386;METXBIODB01304
)
|
Bombesin agonist | 0.168(DB00214) 0.144(METXBIODB01623) 0.133(DB01685;METXBIODB02526)
| 0.181(METXBIODB01626) 0.152(DBMET02232;DBMET02233) 0.151(DBMET02231
)
|
Elastase 2A inhibitor | 0.120(DB01606) 0.092(METXBIODB00658) 0.086(METXBIODB02974)
| 0.101(DBMET00758) 0.093(METXBIODB00659) 0.063(DBMET03001
)
|
Elastase 2 inhibitor | 0.120(DB01606) 0.092(METXBIODB00658) 0.086(METXBIODB02974)
| 0.101(DBMET00758) 0.093(METXBIODB00659) 0.063(DBMET03001
)
|
Melanocortin 3 agonist | 0.076(DB11296) 0.074(METXBIODB01173) 0.064(DB01202)
| 0.572(DBMET00840) 0.096(DBMET00502) 0.069(DBMET01483
)
|
Histone deacetylase 4 inhibitor | 0.664(METXBIODB02294) 0.641(DB02546) 0.529(DB05015)
| 0.989(CHEMBL3526395) 0.985(CHEMBL3526396) 0.983(CHEMBL3526397
)
|
Integrin alpha2beta1 antagonist | 0.179(DB03088) 0.059(CHEMBL1076347) 0.056(DB13269)
| 0.134(DBMET00494) 0.101(CHEMBL3544779) 0.062(DBMET03556
)
|
Acetylcholine M2 receptor agonist | 0.841(DB00185;METXBIODB00507) 0.470(METXBIODB01383) 0.360(METXBIODB01623)
| 0.841(DBMET00430;DBMET00431;DBMET00433) 0.752(METXBIODB00508) 0.364(METXBIODB01624
)
|
11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.487(CHEMBL385517;DB06335) 0.441(DB04876) 0.385(DB01043)
| 0.607(DBMET03320) 0.556(CHEMBL3350936;DBMET00459) 0.525(CHEMBL3542408
)
|
Bromodomain-containing protein 2 inhibitor | 0.271(CHEMBL661;DB00404) 0.214(DB00897) 0.202(METXBIODB00041)
| 0.207(DBMET02821) 0.194(DBMET01944) 0.182(CHEMBL1313;DBMET00348
)
|
Alpha 2d adrenoreceptor agonist | 0.691(METXBIODB02856) 0.508(DB00484) 0.397(DB00763)
| 0.423(DBMET00464) 0.406(DBMET00465) 0.387(CHEMBL4525123;CHEMBL4525124
)
|
Calcineurin inhibitor | 0.854(CHEMBL160;DB00091) 0.737(CHEMBL269732;DB00864;METXBIODB00828) 0.598(METXBIODB00667)
| 0.828(CHEMBL3544879) 0.819(CHEMBL3544638) 0.784(CHEMBL2407580;DBMET00359
)
|
Growth factor receptor-bound protein 2 antagonist | 0.050(METXBIODB00896) 0.049(DB06716) 0.044(DB00130)
| 0.223(METXBIODB01152) 0.186(METXBIODB00593) 0.083(DBMET01816
)
|
Neuronal nicotinic receptor antagonist | 0.838(DB11421) 0.796(METXBIODB00904) 0.741(METXBIODB01541)
| 0.807(DBMET00840) 0.678(CHEMBL6200;DBMET00520) 0.654(CHEMBL3526370
)
|
Melanocortin 5 agonist | 0.108(METXBIODB02611) 0.106(DB11296) 0.089(METXBIODB01173)
| 0.729(DBMET00840) 0.128(DBMET00502) 0.120(DBMET01483
)
|
Somatostatin 5 antagonist | 0.289(DB09059) 0.113(DB06176) 0.102(CHEMBL160;DB00091)
| 0.430(DBMET03190) 0.220(DBMET02662) 0.142(DB00166
)
|
Glutathione S-transferase inhibitor | 0.410(DB14001) 0.349(DB14002) 0.305(METXBIODB02420)
| 0.579(CHEMBL3544870) 0.551(CHEMBL3706541) 0.550(CHEMBL3988901
)
|
Sleep apnea treatment | 0.467(DB09034) 0.315(CHEMBL1373;DB00745) 0.298(DB00909)
| 0.304(DBMET00335) 0.269(DB06777) 0.230(METXBIODB00940
)
|
NMDA receptor antagonist | 0.954(METXBIODB01959) 0.931(DB06741) 0.807(METXBIODB02244)
| 0.954(DBMET01818) 0.946(METXBIODB02241) 0.807(CHEMBL2105152;DBMET01318
)
|
Cystic fibrosis treatment | 0.988(CHEMBL532;DB00199) 0.984(CHEMBL1741;DB01211;METXBIODB00619) 0.983(DB00778;METXBIODB01286)
| 0.990(DBMET00944) 0.984(CHEMBL2063468;DBMET01656) 0.982(CHEMBL3544830;DBMET00356;METXBIODB00620
)
|
Fructose-1,6-bisphosphatase inhibitor | 0.314(DB00530) 0.306(METXBIODB01718) 0.247(DB14126)
| 0.319(DBMET01173;METXBIODB01188) 0.306(DBMET01790) 0.247(DBMET01425
)
|
Alpha-glucosidase inhibitor | 0.943(CHEMBL3527416) 0.940(METXBIODB03141) 0.873(CHEMBL3527223)
| 0.983(METXBIODB02135) 0.976(METXBIODB02134) 0.970(METXBIODB02880
)
|
NMDA 2 receptor antagonist | 0.825(METXBIODB01496) 0.665(METXBIODB02244) 0.561(DB01043)
| 0.734(DBMET01320;METXBIODB02246) 0.703(METXBIODB01497) 0.681(CHEMBL3527225;CHEMBL3527226
)
|
Peroxisome proliferator-activated receptor gamma agonist | 0.913(CHEMBL2104978) 0.905(CHEMBL186179;METXBIODB01057) 0.850(METXBIODB02575)
| 0.918(CHEMBL3526971) 0.913(CHEMBL4525111;CHEMBL4525112;CHEMBL4525113;CHEMBL4525114;CHEMBL4525116;CHEMBL4525117;CHEMBL4525118) 0.910(CHEMBL254989;METXBIODB01058
)
|
Vasopressin 1 agonist | 0.395(DB09059) 0.041(DB06176) 0.036(METXBIODB02451)
| 0.711(CHEMBL1379) 0.057(DBMET02067) 0.040(CHEMBL1207;CHEMBL3186899
)
|
Cholinergic antagonist | 0.859(DB13345) 0.842(METXBIODB00475) 0.836(DB01062;DB01591;METXBIODB00150)
| 0.866(METXBIODB00477) 0.846(DBMET00746) 0.828(DBMET00430;DBMET00431;DBMET00433
)
|
5 Hydroxytryptamine 1 antagonist | 0.981(DB13345) 0.925(DB08922;METXBIODB02106) 0.918(METXBIODB01680)
| 0.937(METXBIODB02107) 0.917(DBMET02984) 0.900(METXBIODB01682
)
|
Complement factor 1 inhibitor | 0.123(DB00250) 0.092(METXBIODB02449) 0.059(METXBIODB03012)
| 0.104(CHEMBL3526332) 0.059(DBMET01043) 0.030(DBMET00301
)
|
Acetylcholine antagonist | 0.857(DB13345) 0.838(DB01591) 0.829(DB00185;METXBIODB00507)
| 0.847(DBMET00746) 0.829(DBMET00430;DBMET00431;DBMET00433) 0.776(DBMET00381;METXBIODB00153
)
|
Elastase inhibitor | 0.220(DB01606) 0.213(CHEMBL1201772;DB06209) 0.203(DB01139)
| 0.441(CHEMBL3527031;DBMET00096) 0.376(DBMET02761) 0.207(METXBIODB01385;METXBIODB02254
)
|
p53 inhibitor | 0.393(CHEMBL696) 0.335(METXBIODB00050) 0.109(METXBIODB01859)
| 0.521(CHEMBL3544833) 0.281(CHEMBL3544798) 0.146(DBMET02789
)
|
Carbonic anhydrase II inhibitor | 0.860(DB00273) 0.858(DB00869) 0.736(DB01194)
| 0.828(DBMET03010) 0.733(DBMET02909;DBMET02910) 0.665(DBMET03671
)
|
Glycine transporter inhibitor | 0.321(DB00215;DB01175) 0.259(METXBIODB00691;METXBIODB01530) 0.238(DB00472;DB08472;DB08544;METXBIODB01953)
| 0.829(CHEMBL3526350) 0.580(CHEMBL3526349) 0.259(DBMET02781;DBMET03704
)
|
Plasminogen activator inhibitor antagonist | 0.783(DB00825;METXBIODB01997;METXBIODB02957) 0.255(DB03017;METXBIODB01149;METXBIODB01207;METXBIODB01450) 0.241(METXBIODB01301)
| 0.525(METXBIODB03158) 0.379(CHEMBL1157;DBMET00501) 0.349(DBMET01477
)
|
Antiviral (Coronavirus) | 0.292(METXBIODB02190) 0.257(METXBIODB02183) 0.253(DB01094;METXBIODB02187)
| 0.394(DB15686) 0.369(CHEMBL3527247) 0.327(METXBIODB03144
)
|
Antiviral (SARS coronavirus) | 0.292(METXBIODB02190) 0.257(METXBIODB02183) 0.253(DB01094;METXBIODB02187)
| 0.394(DB15686) 0.369(CHEMBL3527247) 0.327(METXBIODB03144
)
|
Glucokinase regulatory protein inhibitor | 0.006(DB00250) 0.005(METXBIODB02333) 0.003(METXBIODB01439)
| 0.007(CHEMBL804;DBMET00977) 0.006(CHEMBL574) 0.005(DB00891
)
|
AMP-activated protein kinase stimulant | 0.874(CHEMBL1783834) 0.784(DB09038) 0.733(DB13751)
| 0.867(DBMET02142) 0.862(CHEMBL3542282;CHEMBL3542283) 0.856(DBMET02143
)
|
Carbonic anhydrase VII inhibitor | 0.907(DB00273) 0.644(DB01194) 0.589(DB00869)
| 0.823(DBMET02909;DBMET02910) 0.507(DBMET01349) 0.493(CHEMBL3527060
)
|
Toll-Like receptor 4 antagonist | 0.671(DB00704;DB01183) 0.665(DB01192) 0.619(DB00497;METXBIODB01139)
| 0.665(DBMET00321;METXBIODB01140) 0.624(DBMET00424) 0.580(DBMET00342;METXBIODB01141
)
|
Phosphodiesterase 6A inhibitor | 0.993(DB00862) 0.337(DB00820) 0.215(METXBIODB01526)
| 0.993(DBMET03640) 0.767(DBMET00326) 0.411(METXBIODB00489
)
|
CC chemokine 2 receptor antagonist | 0.170(DB01171) 0.169(METXBIODB00552) 0.130(DB16217)
| 0.170(DBMET02153) 0.130(DBMET03652) 0.129(DBMET02568
)
|
Cathepsin K inhibitor | 0.993(DB06670) 0.243(DB05521) 0.179(DB11763)
| 0.980(DBMET01475) 0.959(DBMET01472) 0.850(DBMET01473
)
|
Egl nine homolog 1 inhibitor | 0.462(DB12255) 0.450(DB04847) 0.079(METXBIODB02739)
| 0.308(DBMET03433) 0.214(CHEMBL586) 0.185(DBMET02630
)
|
Amino-acid-polyamine-organocation (APC) transporter antagonist | 0.522(DB06824) 0.090(CHEMBL1046;DB00513) 0.088(DB00129)
| 0.279(METXBIODB01640) 0.209(DBMET02067) 0.160(DBMET01456
)
|
Potassium channel small-conductance Ca-activated activator | 0.179(DB00740) 0.136(METXBIODB00192) 0.126(CHEMBL42;DB00363;METXBIODB00638)
| 0.126(CHEMBL4525085) 0.110(DBMET01613) 0.108(DBMET00535
)
|
Nociceptin (N/OFQ) receptor antagonist | 0.680(DB00921) 0.630(METXBIODB01912) 0.544(METXBIODB00747)
| 0.794(CHEMBL3526374) 0.630(DBMET00174) 0.570(METXBIODB01184
)
|
Nucleoside transporters inhibitor | 0.586(DB00640) 0.267(DB01280) 0.211(DB06234)
| 0.412(DBMET01160) 0.363(DBMET01159) 0.264(DBMET03427
)
|
Follicle-stimulating hormone agonist | 0.168(CHEMBL49429) 0.073(DB00465) 0.060(DB01065)
| 0.172(CHEMBL3544832) 0.119(CHEMBL3706522) 0.095(DBMET01341
)
|
Melanocortin 1 agonist | 0.164(METXBIODB01173) 0.113(DB11296) 0.077(DB09059)
| 0.659(DBMET00840) 0.208(DBMET00502) 0.141(DBMET02067
)
|
Egl nine homolog 3 inhibitor | 0.214(DB12255) 0.041(DB04847) 0.034(DB00627;DB03793;DB11682;METXBIODB02476)
| 0.133(CHEMBL3542352) 0.122(DBMET02630) 0.116(DBMET01879
)
|
5 Hydroxytryptamine antagonist | 0.994(DB13345) 0.976(DB06077) 0.959(DB00246)
| 0.979(DBMET02984) 0.962(DBMET02090) 0.952(METXBIODB02107
)
|
Sodium/hydrogen exchanger 3 inhibitor | 0.903(DB11761) 0.114(CHEMBL498;DB00672) 0.087(METXBIODB00552)
| 0.164(METXBIODB00553) 0.148(CHEMBL3184360;DBMET00201) 0.110(CHEMBL804;DBMET00977
)
|
Alpha 2a adrenoreceptor antagonist | 0.996(DB13345) 0.990(METXBIODB00475) 0.979(DB00248)
| 0.944(DBMET02090) 0.930(METXBIODB00477) 0.896(DBMET02603;DBMET02604
)
|
Bombesin 1 receptor antagonist | 0.294(DB00191) 0.130(CHEMBL104) 0.080(DB11296)
| 0.310(DBMET02229) 0.156(DB01365) 0.099(DBMET02228
)
|
Expectorant | 0.997(DB00778;METXBIODB01286) 0.996(CHEMBL532;DB00199) 0.995(CHEMBL1741;DB01211;METXBIODB00619)
| 0.995(METXBIODB01287) 0.992(CHEMBL2063468;DBMET01656) 0.991(CHEMBL2022715;DBMET00357;DBMET00944;METXBIODB00621
)
|
Histidine decarboxylase inhibitor | 0.722(DB11296) 0.688(METXBIODB02190) 0.674(METXBIODB02133)
| 0.844(DBMET00503) 0.843(DBMET01483) 0.704(DBMET00253
)
|
ICAM 1 antagonist | 0.478(CHEMBL503;DB00227;METXBIODB01008) 0.150(CHEMBL1064;DB00641;METXBIODB01371) 0.072(METXBIODB02838)
| 0.289(CHEMBL3544685) 0.139(DBMET01699) 0.128(METXBIODB01010
)
|
MAP kinase kinase 9 inhibitor | 0.649(DB08881) 0.191(DB11763) 0.159(DB01685;METXBIODB02526)
| 0.300(DBMET03718) 0.262(DBMET03719) 0.258(DBMET01856
)
|
Thyroid hormone beta antagonist | 0.723(DB09282) 0.703(CHEMBL633;DB01118) 0.669(DB04831;METXBIODB01466)
| 0.839(CHEMBL3544771) 0.794(DBMET02275) 0.784(CHEMBL3526986
)
|
Thyroid hormone antagonist | 0.873(METXBIODB00720) 0.798(CHEMBL633;DB01118) 0.785(DB11412)
| 0.905(DBMET02275) 0.861(CHEMBL3526986) 0.819(CHEMBL3544771
)
|
Thioredoxin reductase inhibitor | 0.516(METXBIODB02687) 0.502(METXBIODB02699) 0.490(METXBIODB02733;METXBIODB02772;METXBIODB02922)
| 0.346(CHEMBL1201391;DBMET00388) 0.325(CHEMBL3544664) 0.324(CHEMBL3544679
)
|
Topoisomerase II beta inhibitor | 0.901(DB00773;METXBIODB00808) 0.619(DB00537) 0.593(CHEMBL417;CHEMBL53463;DB00997)
| 0.927(DBMET00367;DBMET01264;METXBIODB00809) 0.863(DBMET01265) 0.782(DBMET00853
)
|
Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.984(DB05812) 0.838(DB02789;METXBIODB01189) 0.790(DB01420)
| 0.799(METXBIODB01190) 0.735(DBMET02653) 0.716(METXBIODB01195
)
|
Carbonic anhydrase I stimulant | 0.241(DB01124) 0.228(CHEMBL498;DB00672) 0.210(DB11296)
| 0.204(DBMET00289) 0.189(CHEMBL3544714) 0.181(CHEMBL3544715
)
|
Chymotrypsin inhibitor | 0.623(METXBIODB02420) 0.590(DB00188) 0.493(DB01438)
| 0.762(DBMET02761) 0.661(CHEMBL3526352) 0.552(METXBIODB01385
)
|
Aldose reductase substrate | 0.996(DB01914;DB09419;DB11735) 0.968(DB00742;DB11195) 0.952(CHEMBL16;DB00252)
| 0.990(DBMET01476;DBMET01478) 0.978(DBMET01651) 0.972(DBMET02013
)
|
Carbonic anhydrase XIV inhibitor | 0.864(DB00273) 0.771(DB01194) 0.695(DB00869)
| 0.841(DBMET02909;DBMET02910) 0.758(DBMET02911) 0.681(DBMET03671
)
|
Cholesterol ester transfer protein antagonist | 0.087(METXBIODB02451) 0.082(METXBIODB02871) 0.077(DB08814)
| 0.122(DBMET03180) 0.112(DBMET03181) 0.100(DBMET00376
)
|
Estrogen antagonist | 0.991(METXBIODB00549) 0.943(CHEMBL411) 0.891(METXBIODB02070)
| 0.962(METXBIODB00551) 0.955(CHEMBL50995;DBMET02716) 0.919(METXBIODB00550
)
|
Antianemic | 0.860(DB04847) 0.825(DB12255) 0.814(DB11596)
| 0.855(DBMET03433) 0.597(CHEMBL586) 0.588(CHEMBL3542352
)
|
Hexokinase inhibitor | 0.733(DB00581) 0.670(DB11365) 0.550(DB11217)
| 0.877(DB00171) 0.802(DB01861;DB03501) 0.755(DBMET00485;DBMET03265
)
|
Carnitine palmitoyltransferase inhibitor | 0.189(DB05016) 0.083(DB09031) 0.073(METXBIODB01944)
| 0.083(CHEMBL1105;DBMET00764) 0.078(DBMET02986) 0.076(DBMET03557
)
|
KiSS-1 receptor agonist | 0.024(METXBIODB01173) 0.006(DB12783) 0.000(DB00130)
| 0.011(CHEMBL3091852;METXBIODB01174) 0.007(DBMET00502) 0.006(DBMET02067
)
|
Carbonic anhydrase inhibitor | 0.941(DB00869) 0.901(DB00273;DB01194) 0.534(METXBIODB02492)
| 0.900(DBMET03010) 0.823(DBMET03671) 0.802(DBMET02909;DBMET02910
)
|
Complement factor D inhibitor | 0.048(METXBIODB00039) 0.045(DB00564) 0.028(DB00339)
| 0.049(CHEMBL3527229) 0.043(DBMET02351;DBMET02358) 0.033(METXBIODB00040
)
|
Progesterone agonist | 0.931(DB14583) 0.862(DB04839) 0.815(METXBIODB01137)
| 0.895(DBMET02127) 0.817(DBMET02129;DBMET02130) 0.805(DB09389
)
|
Hypogonadism treatment | 0.462(DB13185) 0.341(DB08804) 0.325(DB00624;METXBIODB02276)
| 0.579(DBMET01495) 0.531(DBMET01496) 0.411(DB13169
)
|
Human T-cell leukemia virus type I protease inhibitor | 0.071(METXBIODB02347) 0.057(METXBIODB02349) 0.045(METXBIODB02353)
| 0.088(CHEMBL1237008) 0.081(DBMET02075) 0.071(DBMET00506
)
|
Carnitine palmitoyltransferase 1 inhibitor | 0.172(DB05016) 0.076(DB09031) 0.074(METXBIODB01944)
| 0.081(CHEMBL1105;DBMET00764) 0.078(DBMET02986) 0.074(DBMET01814;DBMET03557
)
|
Protease activated receptor 1 agonist | 0.013(DB01255;METXBIODB01173) 0.004(DB00130) 0.002(DB00129)
| 0.027(DBMET00502) 0.019(DBMET02067) 0.018(DB03091
)
|
CC chemokine 6 receptor agonist | 0.014(METXBIODB00935) 0.012(CHEMBL1140) 0.008(METXBIODB01093)
| 0.012(DBMET02629) 0.007(DBMET02982) 0.005(DBMET02816
)
|
Purinergic P2X3 antagonist | 0.179(DB00973;METXBIODB02285) 0.169(METXBIODB02562) 0.136(METXBIODB00925)
| 0.201(DBMET02116) 0.107(DBMET03497) 0.102(DBMET02275
)
|
Beta 3 adrenoreceptor agonist | 0.551(CHEMBL2095212;DB08893) 0.518(DB00983) 0.479(DB00938;METXBIODB01303)
| 0.649(DBMET02956) 0.551(DBMET03330;DBMET03331) 0.330(DBMET00118;METXBIODB00131
)
|
Histone deacetylase class I inhibitor | 0.963(CHEMBL483254) 0.944(DB06176) 0.830(DB02546)
| 0.891(CHEMBL3527527) 0.798(CHEMBL3526395) 0.760(DBMET01443
)
|
Guanylate cyclase 1 stimulant | 0.773(DB15456) 0.368(DB06154) 0.179(DB00727)
| 0.773(DBMET03244;DBMET03245) 0.181(DBMET02011) 0.179(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598
)
|
Retinoic acid beta receptor agonist | 0.933(DB06755) 0.900(DB00755;DB00982;METXBIODB00937) 0.847(METXBIODB01691)
| 0.900(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.850(DBMET03633) 0.812(DBMET00453
)
|
Neutral endopeptidase inhibitor | 0.802(CHEMBL1314;DB06823) 0.463(DB01197) 0.368(DB06151)
| 0.705(CHEMBL2158192;DBMET01416) 0.703(DBMET03082) 0.440(DBMET00503
)
|
Integrin beta2 antagonist | 0.365(CHEMBL503;DB00227;METXBIODB01008) 0.074(DB00731) 0.071(CHEMBL1064;DB00641;METXBIODB01371)
| 0.179(CHEMBL3544685) 0.097(METXBIODB01010) 0.090(CHEMBL3544669;DBMET01699
)
|
Estrone sulfatase inhibitor | 0.317(DB00273) 0.285(DB04574) 0.231(METXBIODB00781)
| 0.311(DBMET00642) 0.285(DBMET00530) 0.279(DBMET02908
)
|
Phosphodiesterase IV inhibitor | 0.907(DB01656) 0.858(METXBIODB01645) 0.839(METXBIODB01552)
| 0.963(DBMET00997) 0.866(METXBIODB01554) 0.803(METXBIODB01555;METXBIODB01646
)
|
DNA methylase inhibitor | 0.831(DB00242) 0.789(DB00640) 0.765(DB01262)
| 0.971(DBMET00514) 0.908(CHEMBL3526610) 0.787(DBMET00485;DBMET03265
)
|
Wound healing agent | 0.979(DB00727) 0.958(METXBIODB01177) 0.934(METXBIODB01179;METXBIODB01881)
| 0.979(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.953(DB11100) 0.934(DBMET00888
)
|
Endothelial nitric-oxide synthase inhibitor | 0.346(METXBIODB01173) 0.170(DB00129) 0.144(DB06698)
| 0.460(DBMET00502) 0.191(DBMET02708) 0.155(DBMET01778
)
|
Alpha 1b adrenoreceptor antagonist | 0.890(DB13345) 0.771(DB00246) 0.750(DB06077)
| 0.844(DBMET02984) 0.813(METXBIODB02107) 0.759(DBMET02985
)
|
Tetracycline antiport transporter antagonist | 0.154(DB01017) 0.002(METXBIODB00291) 0.000(DB13175;DB13178;METXBIODB02172)
| 0.142(DBMET03011) 0.111(DBMET03012) 0.063(DBMET03013
)
|
Aryl hydrocarbon receptor antagonist | 0.316(METXBIODB00228) 0.269(METXBIODB00452) 0.263(METXBIODB01792)
| 0.178(CHEMBL442289) 0.175(CHEMBL3527009) 0.162(DBMET03650
)
|
5 Hydroxytryptamine 3 antagonist | 0.892(METXBIODB01696) 0.881(DB00889;METXBIODB00874) 0.855(METXBIODB01815)
| 0.792(DBMET02203) 0.718(DBMET00406;METXBIODB00876) 0.704(METXBIODB01697
)
|
Alpha 1d adrenoreceptor antagonist | 0.949(DB13345) 0.906(DB08922;METXBIODB02106) 0.764(DB00490)
| 0.816(DBMET02984) 0.813(METXBIODB02107) 0.755(METXBIODB02108
)
|
Monocarboxylic acid transporter 1 inhibitor | 0.066(METXBIODB02453) 0.065(METXBIODB02180) 0.045(METXBIODB02283)
| 0.081(DBMET02079) 0.077(CHEMBL117487;CHEMBL3706510;DBMET00065) 0.066(CHEMBL3706507;DBMET01106
)
|
Monocarboxylic acid transporter inhibitor | 0.066(METXBIODB02453) 0.065(METXBIODB02180) 0.045(METXBIODB02283)
| 0.081(DBMET02079) 0.077(CHEMBL117487;CHEMBL3706510;DBMET00065) 0.066(CHEMBL3706507;DBMET01106
)
|
Histone deacetylase 2 inhibitor | 0.968(DB02546) 0.797(DB05015) 0.719(CHEMBL483254)
| 0.994(CHEMBL3526395) 0.982(CHEMBL3526396) 0.977(CHEMBL3526397
)
|
CF transmembrane conductance regulator antagonist | 0.086(METXBIODB02236) 0.083(DB05016) 0.076(METXBIODB02912)
| 0.129(METXBIODB00194) 0.105(DBMET02113) 0.086(METXBIODB00193
)
|
Aminopeptidase N inhibitor | 0.234(DB02546) 0.200(DB00492) 0.176(DB06151)
| 0.621(CHEMBL3544531) 0.545(CHEMBL3526186) 0.283(CHEMBL3544532
)
|
Integrin alpha2 antagonist | 0.170(DB03088) 0.076(CHEMBL1076347;CHEMBL498;DB00672) 0.068(DB13269;METXBIODB01518)
| 0.180(DBMET00494) 0.175(DBMET00725) 0.113(CHEMBL3544779
)
|
Glutamate receptor agonist | 0.470(DB05016) 0.395(METXBIODB02380) 0.379(METXBIODB02126)
| 0.578(DBMET01139) 0.514(DBMET03125) 0.510(DB14569
)
|
Antidiuretic hormone agonist | 0.637(DB09059) 0.242(CHEMBL49429) 0.146(DB06176)
| 0.829(CHEMBL1379) 0.301(CHEMBL1207) 0.267(DBMET02067
)
|
Angiotensin-converting enzyme 2 inhibitor | 0.658(CHEMBL1314;DB06823) 0.391(DB01197) 0.353(DB01348)
| 0.536(CHEMBL3544769) 0.468(CHEMBL2158192;DBMET01416) 0.412(DBMET01142
)
|
Somatostatin 5 agonist | 0.316(DB06824) 0.166(DB09059) 0.157(DB01202)
| 0.125(DBMET02067) 0.124(DBMET01115) 0.122(METXBIODB01221
)
|
Interleukin 8 antagonist | 0.995(CHEMBL532;DB00199;DB00778;METXBIODB01286) 0.993(CHEMBL1741;DB01211;METXBIODB00619) 0.830(METXBIODB00769)
| 0.996(METXBIODB01287) 0.995(CHEMBL2022715;CHEMBL2063468;DBMET00357;DBMET01656;METXBIODB00621) 0.976(DBMET00828
)
|
Vasopressin 2 agonist | 0.537(DB09059) 0.224(CHEMBL49429) 0.106(METXBIODB02451)
| 0.981(CHEMBL1379) 0.171(DBMET02067) 0.142(DBMET03689
)
|
Aminopeptidase microsomal inhibitor | 0.253(DB02546) 0.219(DB00492) 0.196(DB06151)
| 0.638(CHEMBL3544531) 0.564(CHEMBL3526186) 0.304(CHEMBL3544532
)
|
Constipation treatment | 0.900(METXBIODB01912) 0.898(DB00921) 0.880(DB00704)
| 0.900(DBMET00174) 0.894(DBMET02201) 0.871(DBMET00321;METXBIODB01140
)
|
Calcium-sensing receptor agonist | 0.338(DB01012) 0.255(METXBIODB01417) 0.109(DB00129)
| 0.400(DBMET01883) 0.136(METXBIODB01418) 0.094(DB00123;DBMET02153
)
|
Microsomal triglyceride transfer protein inhibitor | 0.133(METXBIODB00295) 0.070(CHEMBL455136) 0.048(DB01012)
| 0.070(CHEMBL4525144;CHEMBL4525145;CHEMBL4525146;CHEMBL4525147;CHEMBL4525148;CHEMBL4525149;CHEMBL4525150;CHEMBL4525151;CHEMBL4525152;CHEMBL4525153;CHEMBL4525154;CHEMBL4525155;CHEMBL4525156;CHEMBL4525157;CHEMBL4525158;CHEMBL4525159) 0.058(CHEMBL3542269) 0.045(DBMET03080
)
|
Integrin beta5 antagonist | 0.409(METXBIODB01514) 0.253(DB00575) 0.144(DB00181)
| 0.419(METXBIODB01515) 0.309(DBMET03118) 0.265(METXBIODB01516
)
|
Bombesin antagonist | 0.218(DB00214;DB11296) 0.077(DB00191) 0.062(DB00130;METXBIODB02458)
| 0.175(DBMET02233) 0.165(DBMET02231) 0.152(DBMET02232
)
|
Nitric-oxide synthase inhibitor | 0.488(DB00476) 0.474(METXBIODB01173) 0.417(METXBIODB01806)
| 0.674(DBMET00502) 0.458(DBMET00486) 0.424(DBMET03073
)
|
Kynurenine 3 monooxygenase inhibitor | 0.253(DB00356) 0.142(METXBIODB02353) 0.126(METXBIODB02564)
| 0.398(DBMET00252) 0.302(DBMET01676) 0.281(DBMET00327
)
|
Methionyl aminopeptidase 2 inhibitor | 0.124(METXBIODB02370) 0.102(CHEMBL686;DB00784) 0.101(METXBIODB02368)
| 0.098(CHEMBL1203) 0.093(CHEMBL3544508;DB02362;DBMET00728;DBMET01429) 0.092(DBMET00486
)
|
Estrogen receptor alpha agonist | 0.751(METXBIODB00549) 0.590(CHEMBL691;DB00977;METXBIODB01784) 0.567(DB00783;METXBIODB01814)
| 0.909(DBMET01207) 0.807(CHEMBL3638306;DBMET03697) 0.676(METXBIODB00551
)
|
Transcription factor AP-1 inhibitor | 0.568(DB06755) 0.531(DB00755;DB00982;METXBIODB00937) 0.504(DB00162;METXBIODB01254)
| 0.558(METXBIODB00938) 0.531(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.504(DBMET02045
)
|
Calcium channel blocker | 0.966(DB00622) 0.940(CHEMBL1726;METXBIODB02119) 0.929(METXBIODB02115)
| 0.904(DBMET01832) 0.891(DBMET01833) 0.849(METXBIODB02122
)
|
Histone deacetylase inhibitor | 0.962(CHEMBL483254) 0.960(DB06176) 0.872(DB05015)
| 0.893(CHEMBL3527527) 0.872(DBMET01443) 0.834(CHEMBL3526395
)
|
Neurokinin 2 agonist | 0.123(DB01202) 0.119(DB01255) 0.089(DB01037)
| 0.434(DBMET00506) 0.288(DBMET02067) 0.121(DB03091
)
|
5 Hydroxytryptamine 2A antagonist | 0.978(DB00734;METXBIODB01274) 0.964(DB13345) 0.942(METXBIODB00923)
| 0.965(DBMET02984) 0.942(DBMET00323;METXBIODB01276) 0.849(METXBIODB00924
)
|
CDC7 inhibitor | 0.195(CHEMBL1140) 0.177(DB01685;METXBIODB02526) 0.158(CHEMBL585;DB00384)
| 0.251(CHEMBL226396) 0.212(DBMET03531) 0.195(CHEMBL3040018;DBMET00025;DBMET02629
)
|
Beta glucuronidase inhibitor | 0.691(METXBIODB03141) 0.644(DB01094;METXBIODB02187) 0.560(METXBIODB02190)
| 0.931(METXBIODB02188) 0.930(METXBIODB02189) 0.913(METXBIODB02191
)
|
Phosphodiesterase 4C inhibitor | 0.742(DB00862) 0.644(DB01656) 0.530(METXBIODB01645)
| 0.759(DBMET00997) 0.754(DBMET03640) 0.493(METXBIODB00936
)
|
Transforming growth factor beta 2 antagonist | 0.110(METXBIODB01020) 0.063(DB11793;METXBIODB00935) 0.053(DB00339)
| 0.054(CHEMBL3706522) 0.053(METXBIODB01022) 0.051(DB13526
)
|
Dopamine D2 agonist | 0.995(DB13345) 0.994(METXBIODB00475) 0.990(METXBIODB00369)
| 0.996(METXBIODB00275) 0.993(METXBIODB00477) 0.991(METXBIODB00476
)
|
Age-related macular degeneration treatment | 0.538(DB06595) 0.524(DB06755) 0.428(METXBIODB02546)
| 0.614(DBMET02935;METXBIODB00573) 0.467(DBMET01440) 0.465(DBMET01441
)
|
Acetylcholine nicotinic agonist | 0.569(CHEMBL3;DB00184;METXBIODB02230) 0.478(METXBIODB01383) 0.399(DB01591)
| 0.672(DBMET00406;METXBIODB00876) 0.585(CHEMBL6200;DBMET00520) 0.307(CHEMBL578211;DBMET00519
)
|
CC chemokine 4 receptor antagonist | 0.236(CHEMBL64391;DB01167;METXBIODB00524) 0.146(DB01184) 0.145(CHEMBL104)
| 0.236(CHEMBL4525087;CHEMBL4525088) 0.143(METXBIODB00526) 0.134(DBMET00374;METXBIODB00525
)
|
Acetylcholinesterase inhibitor | 0.984(DB00382) 0.975(METXBIODB01434) 0.903(METXBIODB00591)
| 0.976(METXBIODB01435) 0.945(DBMET01757) 0.922(DBMET01756
)
|
Histone deacetylase 3 inhibitor | 0.960(DB02546) 0.781(METXBIODB02294) 0.731(DB06176)
| 0.994(CHEMBL3526395) 0.983(CHEMBL3526396) 0.979(CHEMBL3526397
)
|
Maillard reaction inhibitor | 0.767(DB13853) 0.634(CHEMBL49563;DB00163) 0.605(CHEMBL64;METXBIODB02327)
| 0.803(DBMET02057) 0.664(CHEMBL527285;DBMET02040;DBMET02324) 0.620(CHEMBL1237008
)
|
Cyclin A inhibitor | 0.906(DB09073) 0.391(DB11697) 0.314(DB00619)
| 0.890(DBMET02380) 0.837(DBMET02365) 0.791(DBMET02373
)
|
Thymidylate synthase inhibitor | 0.549(CHEMBL34259) 0.490(DB00158) 0.395(DB00650)
| 0.526(DB00116) 0.505(CHEMBL886;DBMET01999;DBMET03585) 0.503(CHEMBL3544661
)
|
Autotaxin inhibitor | 0.377(DB00356) 0.349(METXBIODB01151) 0.331(DB00779)
| 0.837(METXBIODB00722) 0.570(CHEMBL3526411) 0.532(DBMET00345
)
|
Stearoyl-CoA desaturase inhibitor | 0.150(DB06201) 0.130(DB00656) 0.095(DB00398)
| 0.194(DB14569) 0.160(CHEMBL3526187) 0.146(DBMET03127
)
|
Cathepsin B inhibitor | 0.955(DB06670) 0.300(DB05521) 0.229(METXBIODB00946)
| 0.997(METXBIODB00716) 0.954(DBMET01475) 0.908(DBMET01472
)
|
Potassium channel (ATP-sensitive) blocker | 0.975(DB00448;DB05351;METXBIODB01955) 0.956(DB00213;METXBIODB00543) 0.952(CHEMBL1503;DB00338;DB00736;METXBIODB00771)
| 0.967(DBMET01494;METXBIODB01957) 0.920(DBMET00186;DBMET01657;METXBIODB00774) 0.879(METXBIODB00032
)
|
Phosphate transporter inhibitor | 0.281(DB00492) 0.203(METXBIODB02347) 0.139(METXBIODB02709)
| 0.613(DBMET01139) 0.464(DBMET02075) 0.160(METXBIODB00897
)
|
Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.584(METXBIODB02842) 0.582(DB01424) 0.577(METXBIODB02507;METXBIODB02821)
| 0.629(CHEMBL3527192) 0.625(METXBIODB01654) 0.616(DBMET02071
)
|
5 Hydroxytryptamine 1D antagonist | 0.873(METXBIODB01680) 0.867(DB00315) 0.723(DB00953)
| 0.898(METXBIODB01682) 0.765(DBMET01792) 0.614(DBMET01362
)
|
Cognition disorders treatment | 0.996(DB00185;METXBIODB00507) 0.949(DB12473) 0.893(DB01591;DB13345)
| 0.996(DBMET00430;DBMET00431;DBMET00433;METXBIODB00508) 0.949(CHEMBL3526601) 0.920(CHEMBL3526510
)
|
Prostacyclin antagonist | 0.850(DB00575) 0.626(DB00484) 0.569(DB00697;METXBIODB02082)
| 0.736(DBMET00468) 0.596(DB00917) 0.497(CHEMBL3544654;DBMET00378
)
|
Plasmin inhibitor | 0.720(CHEMBL169901;DB04840) 0.227(METXBIODB01173) 0.186(DB00188)
| 0.583(CHEMBL3527068) 0.551(CHEMBL1710849;DBMET01641) 0.544(CHEMBL3527225;CHEMBL3527226
)
|
Gastritis treatment | 0.839(DB11739) 0.740(DB00863;METXBIODB01235) 0.673(DB00585)
| 0.753(DBMET02354) 0.703(DBMET01735;METXBIODB01236) 0.652(DBMET01494;METXBIODB01957
)
|
GHS receptor antagonist | 0.558(DB00191) 0.311(DB12466) 0.253(METXBIODB01087)
| 0.568(DB01365) 0.354(DBMET02227) 0.138(DB12243
)
|
Phosphodiesterase 9A inhibitor | 0.137(DB00862) 0.059(DB00437) 0.025(DB00203)
| 0.993(CHEMBL3526601) 0.149(DBMET03640) 0.110(DBMET00414
)
|
Cyclin A2 inhibitor | 0.912(DB09073) 0.397(DB11697) 0.270(METXBIODB03014)
| 0.875(DBMET02380) 0.865(DBMET02365) 0.802(DBMET02373
)
|
Hexokinase stimulant | 0.068(METXBIODB02345) 0.039(DB01628) 0.035(METXBIODB00811)
| 0.097(DBMET01536) 0.070(DBMET03403) 0.053(DBMET01537
)
|
CC chemokine 9 receptor antagonist | 0.086(METXBIODB00568) 0.075(DB01628) 0.061(METXBIODB02333)
| 0.116(DBMET00166) 0.061(DB00891) 0.054(METXBIODB00570
)
|
Glucose-6-phosphate dehydrogenase inhibitor | 0.829(METXBIODB02749) 0.714(DB05087) 0.685(DB02789;METXBIODB01189)
| 0.851(METXBIODB01191) 0.849(DBMET02830) 0.833(DBMET01727;METXBIODB01197
)
|
Calcium-sensing receptor antagonist | 0.449(METXBIODB01550) 0.400(DB09080) 0.375(DB08808)
| 0.678(DB01365) 0.496(DBMET01507) 0.455(DBMET01505
)
|
Alpha 1a adrenoreceptor antagonist | 0.981(DB13345) 0.915(DB08922;METXBIODB02106) 0.893(DB00590)
| 0.895(METXBIODB02107) 0.893(DBMET02603;DBMET02604) 0.883(DBMET00477;DBMET02984
)
|
Vanilloid 4 antagonist | 0.075(DB00705;METXBIODB00682) 0.071(METXBIODB00006) 0.035(DB01012)
| 0.151(CHEMBL3526366) 0.106(CHEMBL3527291) 0.054(METXBIODB00683
)
|
Cytidine deaminase inhibitor | 0.868(DB15694) 0.767(CHEMBL917;DB00322) 0.764(DB00441)
| 0.955(CHEMBL1774;DBMET02000;DBMET03590) 0.953(DBMET03588) 0.952(DBMET00859
)
|
Sirtuin 1 inhibitor | 0.211(DB11296) 0.192(DB00129) 0.189(DB00599)
| 0.620(METXBIODB00240) 0.431(METXBIODB00304) 0.296(METXBIODB01336
)
|
Antitreponemal | 0.314(DB04817) 0.260(METXBIODB02611) 0.251(DB00581)
| 0.358(CHEMBL3706534) 0.268(METXBIODB00072) 0.256(DBMET01434
)
|
5 Hydroxytryptamine 2C antagonist | 0.992(DB13345) 0.954(DB06077) 0.919(DB00246)
| 0.795(METXBIODB01366) 0.788(DBMET00106) 0.783(METXBIODB02107
)
|
Antifungal | 0.990(DB00196) 0.982(DB00582) 0.966(DB01294)
| 0.972(DBMET00071) 0.969(DBMET00072) 0.945(DB11633
)
|
Urease inhibitor | 0.382(DB02546) 0.299(DB00916) 0.248(METXBIODB02879)
| 0.372(CHEMBL3526839) 0.262(CHEMBL804;DBMET00977) 0.258(METXBIODB01654
)
|
CDK2/cyclin A3 inhibitor | 0.030(METXBIODB02333) 0.019(CHEMBL727;DB01035;DB02377;METXBIODB02953) 0.018(DB06728;METXBIODB00266;METXBIODB01389;METXBIODB02873;METXBIODB03012)
| 0.039(DBMET03666) 0.030(DB00891) 0.027(CHEMBL574
)
|
Alpha 2 adrenoreceptor agonist | 0.934(DB00484) 0.889(DB00697;METXBIODB02082) 0.759(METXBIODB02856)
| 0.669(DBMET00465) 0.633(DBMET00464) 0.581(DBMET00468
)
|
Integrin alpha4beta1 antagonist | 0.125(METXBIODB00029) 0.097(DB00731) 0.046(DB01050;DB09213;METXBIODB00134;METXBIODB01970)
| 0.146(DBMET01121) 0.123(CHEMBL3544779) 0.115(DBMET01401
)
|
Nav1.1 sodium channel blocker | 0.834(DB00532) 0.786(DB00568;METXBIODB00600) 0.757(CHEMBL16;DB00252)
| 0.991(DBMET01096) 0.916(DBMET00056) 0.757(DBMET01170
)
|
Neurokinin 3 agonist | 0.006(DB01255) 0.005(DB11296) 0.003(CHEMBL1046;DB00130;DB00513)
| 0.272(DBMET00506) 0.028(DB03091) 0.024(DBMET02067
)
|
Phosphodiesterase IX inhibitor | 0.153(DB00862) 0.055(DB00437) 0.026(DB00238)
| 0.991(CHEMBL3526601) 0.167(DBMET03640) 0.138(DBMET00414
)
|
Alpha 2d adrenoreceptor antagonist | 0.383(DB04948) 0.340(METXBIODB02856) 0.290(METXBIODB02632)
| 0.231(METXBIODB02633) 0.203(CHEMBL4525123;CHEMBL4525124) 0.189(METXBIODB01388
)
|
MAO A inhibitor | 0.875(METXBIODB02196) 0.769(METXBIODB00464;METXBIODB02430) 0.729(DB01645;METXBIODB00465)
| 0.792(DBMET00251;METXBIODB00869) 0.713(METXBIODB00272) 0.703(METXBIODB00555
)
|
Aminopeptidase P inhibitor | 0.061(DB06151) 0.054(DB01197) 0.050(DB00182;DB01576;METXBIODB01904)
| 0.327(DBMET01202) 0.099(CHEMBL3706527;DBMET02776) 0.098(DBMET00503
)
|
Glucocorticoid antagonist | 0.995(METXBIODB01531) 0.954(DB00834) 0.939(DB00687)
| 0.995(METXBIODB01532) 0.948(METXBIODB02005) 0.932(DB00443
)
|
ADAM10 endopeptidase inhibitor | 0.157(DB02546) 0.128(DB01591) 0.091(METXBIODB00178)
| 0.195(DBMET02228) 0.097(DBMET03179) 0.090(DBMET01554;METXBIODB01847
)
|
Hepatoprotectant | 0.906(DB13853) 0.813(CHEMBL3542194) 0.793(DB13751)
| 0.911(DBMET02057) 0.891(CHEMBL3706475) 0.865(METXBIODB00716
)
|
Carbonic anhydrase XII inhibitor | 0.678(DB00273) 0.549(DB01194) 0.476(METXBIODB02492)
| 0.623(DBMET00813) 0.567(CHEMBL3544878;METXBIODB02493) 0.523(DBMET02909;DBMET02910
)
|
Calcium channel (voltage-sensitive) blocker | 0.902(DB00622) 0.888(CHEMBL1726;METXBIODB02119) 0.846(METXBIODB02040)
| 0.759(DBMET01832) 0.754(METXBIODB02122) 0.740(DBMET01833
)
|
N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.609(CHEMBL109;DB00313;METXBIODB01559) 0.532(DB00121) 0.182(DB06151)
| 0.685(CHEMBL3706509;DBMET01109) 0.636(DBMET01108) 0.448(DBMET00508
)
|
Cyclin B3 inhibitor | 0.583(DB09073) 0.373(METXBIODB01436) 0.353(METXBIODB02968)
| 0.751(DBMET02378) 0.749(DBMET02372) 0.702(DBMET01440
)
|
Carbonic anhydrase IX inhibitor | 0.818(DB00273) 0.523(METXBIODB02492) 0.507(CHEMBL118;DB00482)
| 0.689(DBMET02909;DBMET02910) 0.576(DBMET00813) 0.552(CHEMBL3544878;METXBIODB02493
)
|
5 Hydroxytryptamine 2 agonist | 0.883(DB13345) 0.721(DB04871) 0.705(METXBIODB00475)
| 0.795(CHEMBL3526304) 0.684(DBMET01732;DBMET01825;METXBIODB01849) 0.566(METXBIODB00477
)
|
MAP3K8 inhibitor | 0.067(METXBIODB02395) 0.058(DB06201) 0.057(METXBIODB00230)
| 0.128(METXBIODB01325) 0.049(DBMET03127) 0.048(CHEMBL3542327;DBMET02631
)
|
Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.220(DB11763) 0.196(METXBIODB03014) 0.179(DB11986)
| 0.260(DBMET00399) 0.216(DBMET03709) 0.213(DBMET03250
)
|
Apoptosis antagonist | 0.795(CHEMBL1783834;CHEMBL3542194) 0.738(DB00581) 0.736(CHEMBL503;DB00227;METXBIODB01008)
| 0.888(DBMET00986) 0.880(DB00166) 0.863(CHEMBL3542284
)
|
Protein kinase (CK2) beta inhibitor | 0.111(METXBIODB01399) 0.109(METXBIODB00860) 0.107(METXBIODB02912)
| 0.112(CHEMBL244377) 0.108(CHEMBL1203;CHEMBL3544872;CHEMBL457723) 0.091(CHEMBL1222314
)
|
Nitric oxide donor | 0.993(DB00727) 0.989(DB06154) 0.947(DB01020)
| 0.993(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.956(DBMET02011) 0.889(DB13400
)
|
CC chemokine 10 receptor antagonist | 0.021(CHEMBL498;DB00672) 0.020(METXBIODB01873) 0.019(DB01124)
| 0.036(DBMET00920) 0.024(CHEMBL3184360;DBMET00201) 0.021(CHEMBL3544543;DBMET00840
)
|
Secretase beta inhibitor | 0.143(DB01656) 0.135(DB01236;METXBIODB00562) 0.129(METXBIODB02451)
| 0.178(CHEMBL3186899) 0.174(DBMET01124) 0.172(DBMET01081
)
|
AMPA 2 receptor antagonist | 0.365(CHEMBL445990) 0.226(DB03088) 0.224(METXBIODB01280)
| 0.352(DBMET00993) 0.278(METXBIODB00919) 0.276(DBMET00494
)
|
5 Hydroxytryptamine 6 agonist | 0.274(DB00669) 0.135(DB00216) 0.124(DB13345)
| 0.189(DBMET01362) 0.121(DBMET00088) 0.118(DBMET02585
)
|
Botulinum neurotoxin type A inhibitor | 0.465(METXBIODB01504) 0.438(METXBIODB00115;METXBIODB02046) 0.403(DB02659;METXBIODB00251)
| 0.547(DBMET02741;DBMET03063;METXBIODB01837;METXBIODB02047) 0.438(DBMET01559;DBMET02739) 0.425(METXBIODB00252
)
|
Protein 30S ribosomal subunit inhibitor | 0.946(DB01017) 0.246(DB01190) 0.198(METXBIODB00622)
| 0.943(DBMET03011) 0.891(DBMET03012) 0.802(DBMET03013
)
|
Myasthenia Gravis treatment | 0.637(CHEMBL160;DB00091) 0.528(DB16217) 0.423(CHEMBL269732;DB00864;METXBIODB00828)
| 0.624(CHEMBL3544879) 0.529(CHEMBL3544638) 0.528(DBMET03652
)
|
CC chemokine 3 receptor antagonist | 0.297(DB01016) 0.226(CHEMBL54;DB00502) 0.218(METXBIODB00517)
| 0.351(DBMET03491) 0.226(CHEMBL4525086;METXBIODB00519) 0.218(CHEMBL1036;DBMET00104
)
|
Alkaline phosphatase inhibitor | 0.541(METXBIODB02194) 0.503(METXBIODB02153) 0.502(METXBIODB02603)
| 0.631(METXBIODB02508) 0.618(METXBIODB03059) 0.600(METXBIODB03033
)
|
Potassium channel activator | 0.453(METXBIODB00565) 0.355(METXBIODB01324) 0.300(METXBIODB02353)
| 0.819(METXBIODB00566) 0.393(DBMET03610) 0.358(METXBIODB00845
)
|
Calcium release-activated channel blocker | 0.159(DB01097;METXBIODB01809) 0.078(METXBIODB02345) 0.048(METXBIODB00935;METXBIODB01430)
| 0.075(DBMET03127) 0.073(CHEMBL237987) 0.071(DBMET01536
)
|
Estrogen receptor beta agonist | 0.740(METXBIODB00549) 0.562(DB00783;METXBIODB01814) 0.546(METXBIODB00778;METXBIODB02190)
| 0.632(METXBIODB00551) 0.573(METXBIODB00550) 0.562(DBMET00491;METXBIODB00083
)
|
Renin inhibitor | 0.992(CHEMBL1639) 0.199(DB11296) 0.103(DB00742;DB11195)
| 0.989(CHEMBL3507701) 0.988(CHEMBL3507699;CHEMBL3507700) 0.987(CHEMBL3507703
)
|
TRPM8 blocker | 0.261(DB08921;METXBIODB00055) 0.198(METXBIODB02370) 0.159(METXBIODB02368)
| 0.213(METXBIODB00149) 0.211(CHEMBL1222314) 0.181(DBMET03565
)
|
Antiviral (Bovine viral diarrhea virus) | 0.127(DB00296) 0.124(DB00297) 0.115(CHEMBL42;DB00363;METXBIODB00638)
| 0.217(CHEMBL3526603) 0.115(CHEMBL4525085) 0.105(CHEMBL3706476
)
|
Growth stimulant | 0.666(DB14669) 0.656(DB00581) 0.636(DB01234;METXBIODB00696)
| 0.805(METXBIODB01088) 0.688(CHEMBL3544715) 0.663(DBMET00826
)
|
Growth hormone releasing factor agonist | 0.342(DB00191) 0.164(DB08868) 0.152(CHEMBL459;DB00968)
| 0.268(DB01365) 0.200(DBMET02227) 0.196(CHEMBL3544728
)
|
Alpha 1 adrenoreceptor antagonist | 0.975(DB13345) 0.919(DB08922;METXBIODB02106) 0.911(DB00590)
| 0.911(DBMET02603;DBMET02604) 0.899(METXBIODB02107) 0.897(DBMET00477
)
|
Toll-Like receptor 9 antagonist | 0.435(METXBIODB01205) 0.427(CHEMBL42;DB00363;METXBIODB00638) 0.394(DB01183)
| 0.446(METXBIODB01206) 0.430(METXBIODB01159) 0.427(CHEMBL4525085
)
|
DNA gyrase subunit B inhibitor | 0.339(DB01155) 0.272(DB00537) 0.250(DB01044)
| 0.183(CHEMBL3544742;DBMET00631;METXBIODB01154) 0.182(DBMET02517) 0.173(METXBIODB01321
)
|
Alpha 2 adrenoreceptor antagonist | 0.995(DB13345) 0.975(METXBIODB00475) 0.954(DB00248)
| 0.900(DBMET02090) 0.894(METXBIODB00477) 0.858(DBMET02603;DBMET02604
)
|
Interleukin 2 antagonist | 0.877(CHEMBL269732;DB00864;METXBIODB00828) 0.834(METXBIODB00831) 0.805(CHEMBL413;DB00877;METXBIODB01375)
| 0.875(CHEMBL3544693;DBMET00390) 0.872(CHEMBL3544708;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.870(CHEMBL3544838
)
|
HCV polyprotein inhibitor | 0.480(DB06799) 0.415(DB11586) 0.273(METXBIODB00664;METXBIODB02097)
| 0.538(DBMET02051) 0.417(DBMET02050) 0.385(DBMET02049
)
|
Butyrylcholinesterase inhibitor | 0.974(DB00382) 0.947(METXBIODB02033) 0.938(METXBIODB00591)
| 0.925(METXBIODB01929) 0.905(DBMET01757) 0.869(DBMET00902
)
|
Gonadotropin-releasing hormone receptor agonist | 0.147(METXBIODB01631) 0.145(METXBIODB02070) 0.128(METXBIODB01173)
| 0.328(DBMET00513) 0.301(CHEMBL3706522) 0.183(CHEMBL3526347
)
|
Antineoplastic alkaloid | 0.810(METXBIODB02544) 0.807(DB00570) 0.696(DB11641)
| 0.858(DBMET00398;DBMET00401) 0.810(DBMET01143;DBMET02055) 0.685(DBMET02029
)
|
Vesicle monoamine transporter inhibitor | 0.433(DB04844) 0.363(DB01228) 0.359(METXBIODB01946)
| 0.359(DBMET01815) 0.338(DBMET00458;DBMET00800;DBMET01448) 0.328(DBMET01814
)
|
Thrombolytic | 0.581(DB00129) 0.572(DB11296) 0.555(CHEMBL109;DB00313;METXBIODB01559)
| 0.679(DBMET00502) 0.581(DB00123) 0.565(CHEMBL3544550;DBMET01108
)
|
Antiviral (Herpes) | 0.883(DB14126) 0.857(DB00300) 0.853(CHEMBL184)
| 0.922(CHEMBL3544772) 0.908(DBMET01173;METXBIODB01188) 0.885(DB00369
)
|
Retinoid X gamma receptor antagonist | 0.835(DB00755;DB00982;METXBIODB00937) 0.798(DB06755) 0.641(METXBIODB03098)
| 0.835(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.690(DBMET03633) 0.689(DBMET00455;DBMET02550;DBMET02552;DBMET03635;DBMET03638
)
|
ATR kinase inhibitor | 0.057(METXBIODB00917) 0.055(CHEMBL1258517) 0.051(DB01628)
| 0.065(DBMET02020) 0.049(DBMET01043) 0.042(METXBIODB00553
)
|
5 Hydroxytryptamine 1A agonist | 0.978(DB08922;METXBIODB02106) 0.960(DB08815) 0.897(DB00490)
| 0.977(DBMET00890;DBMET02989;METXBIODB01765) 0.973(METXBIODB02107) 0.929(METXBIODB02108
)
|
Adenosine kinase inhibitor | 0.929(DB00640) 0.530(DB00242) 0.278(DB01280)
| 0.995(DB00171) 0.994(DBMET00769) 0.985(DBMET02967
)
|
Transcription factor STAT3 inhibitor | 0.651(CHEMBL250785;DB00390) 0.641(METXBIODB00730) 0.530(METXBIODB02142)
| 0.689(CHEMBL517341) 0.651(DBMET02502;METXBIODB00731) 0.640(CHEMBL3526207
)
|
Histone deacetylase 5 inhibitor | 0.908(DB02546) 0.873(DB05015) 0.685(CHEMBL483254)
| 0.873(DBMET01443) 0.554(CHEMBL3527527) 0.545(CHEMBL4525771
)
|
Cyclin-dependent kinase 6 inhibitor | 0.796(DB09073) 0.162(DB00619) 0.160(DB06595)
| 0.670(DBMET02373) 0.665(DBMET02363;DBMET02364) 0.607(DBMET02380
)
|
Antineoplastic (endocrine cancer) | 0.889(CHEMBL88;DB00531;METXBIODB00960) 0.749(DB12902;METXBIODB00967) 0.730(DB13751)
| 0.889(DBMET01683) 0.830(CHEMBL3544546;DBMET01076) 0.826(CHEMBL3706538
)
|
Ca(v)3.3 blocker | 0.462(METXBIODB01183) 0.442(DB06739;METXBIODB00580;METXBIODB03056) 0.438(DB01018)
| 0.475(DBMET03299) 0.413(DBMET01626;METXBIODB00582) 0.401(DBMET00905
)
|
Gastroesophageal reflux disease treatment | 0.951(CHEMBL532;DB00199) 0.933(CHEMBL1741;DB01211;METXBIODB00619) 0.913(METXBIODB00769)
| 0.924(CHEMBL2063468;DBMET01656) 0.902(CHEMBL2022715;DBMET00357;METXBIODB00621) 0.870(METXBIODB00770
)
|
Premenstrual syndrome treatment | 0.397(DB01395) 0.391(DB04839) 0.378(DB06700)
| 0.378(METXBIODB00164) 0.371(DBMET02409) 0.368(DBMET02410
)
|
Antiviral (Hepatitis) | 0.981(DB11586) 0.953(CHEMBL1076930) 0.932(DB08934)
| 0.978(DBMET02051) 0.969(DBMET02050) 0.929(DBMET01381
)
|
Free fatty acid receptor 1 agonist | 0.295(DB01132) 0.246(CHEMBL3526905) 0.241(METXBIODB03150)
| 0.860(CHEMBL3527206) 0.651(DBMET01365) 0.607(DBMET01300
)
|
I kappa B kinase 2 inhibitor | 0.262(DB11793) 0.159(DB00998) 0.144(DB08828;METXBIODB01389)
| 0.200(DBMET03719) 0.184(METXBIODB00553) 0.144(CHEMBL3526631
)
|
Mineralocorticoid receptor antagonist | 0.879(DB01395) 0.875(CHEMBL1393;DB00421) 0.857(METXBIODB02832)
| 0.853(CHEMBL3544705;DBMET02483) 0.836(DBMET00741;METXBIODB02833) 0.821(DBMET02484;DBMET02485
)
|
Antibiotic Aminoglycoside-like | 0.149(DB00581) 0.148(DB01190) 0.139(METXBIODB00622)
| 0.169(DBMET00509) 0.167(CHEMBL3544571;DBMET00855;DBMET02006;DBMET03583) 0.156(DBMET02088
)
|
Vascular (periferal) disease treatment | 0.941(CHEMBL1201772;DB06209) 0.903(METXBIODB01752) 0.846(CHEMBL1393;DB00421)
| 0.972(METXBIODB01308) 0.971(DBMET01163) 0.966(DBMET00483
)
|
Aggrecanase 1 inhibitor | 0.522(METXBIODB01087) 0.197(METXBIODB00204) 0.136(METXBIODB02729)
| 0.301(METXBIODB00349) 0.283(DBMET00056) 0.261(METXBIODB01088
)
|
Integrin alphaVbeta3 antagonist | 0.711(METXBIODB01514) 0.214(DB00575) 0.135(DB00181)
| 0.989(METXBIODB01516) 0.739(METXBIODB01515) 0.447(METXBIODB01517
)
|
Plasminogen activator inhibitor | 0.508(CHEMBL169901;DB04840) 0.428(DB00188) 0.158(METXBIODB01173)
| 0.306(CHEMBL3527068) 0.258(CHEMBL3527225;CHEMBL3527226) 0.244(CHEMBL3527010
)
|
Estrogen receptor beta antagonist | 0.994(METXBIODB00549) 0.865(CHEMBL411) 0.845(DB00481;METXBIODB01232)
| 0.949(METXBIODB00551) 0.908(METXBIODB00550) 0.833(METXBIODB01234
)
|
Dopamine D3 agonist | 0.697(DB13345) 0.685(METXBIODB00475) 0.625(DB05271)
| 0.856(DBMET01613) 0.607(METXBIODB00477) 0.589(METXBIODB00476
)
|
Phosphorylase inhibitor | 0.757(METXBIODB02871) 0.640(DB00581) 0.410(CHEMBL917;DB00322)
| 0.996(DB01861;DB03501) 0.991(DBMET03592) 0.988(CHEMBL1774;DBMET02000;DBMET03590
)
|
Transcription factor STAT6 inhibitor | 0.477(CHEMBL1117) 0.407(CHEMBL178;DB00694) 0.318(METXBIODB00860)
| 0.483(DBMET01158) 0.387(DBMET01160) 0.366(DBMET00485;DBMET03265
)
|
Nicotinic neuronal receptor agonist | 0.481(CHEMBL3;DB00184;METXBIODB02230) 0.388(METXBIODB01383) 0.334(DB01591)
| 0.623(DBMET00406;METXBIODB00876) 0.504(CHEMBL6200;DBMET00520) 0.224(CHEMBL578211;DBMET00519
)
|
CDC-like kinase 3 inhibitor | 0.837(METXBIODB00382) 0.818(METXBIODB02059) 0.626(METXBIODB01431)
| 0.734(METXBIODB02060) 0.676(METXBIODB00384) 0.553(METXBIODB00383
)
|
Potassium channel subfamily K member 3 blocker | 0.129(DB00465) 0.097(DB00379;DB07129;METXBIODB01843) 0.094(DB04725;METXBIODB00980)
| 0.119(METXBIODB01325) 0.117(DBMET00978) 0.101(CHEMBL3527292
)
|
Neuropeptide agonist | 0.686(DB00629) 0.361(METXBIODB00880) 0.204(METXBIODB01173)
| 0.233(DBMET00502) 0.193(CHEMBL3527294) 0.182(DBMET02065
)
|
Postmenopausal disorders treatment | 0.904(DB01395) 0.887(METXBIODB02832) 0.868(DB00717)
| 0.868(CHEMBL1162) 0.859(DB09389) 0.857(DBMET00741;METXBIODB02833
)
|
Epoxide hydrolase 2 inhibitor | 0.141(CHEMBL1076347) 0.043(DB00414) 0.037(DB01067)
| 0.050(CHEMBL3527500;CHEMBL3527578) 0.048(DBMET01972;DBMET03491) 0.047(METXBIODB00240
)
|
Orexin receptor 2 antagonist | 0.721(DB09034) 0.400(CHEMBL1272307) 0.207(CHEMBL455136)
| 0.232(CHEMBL3527303) 0.207(CHEMBL4525144;CHEMBL4525145;CHEMBL4525146;CHEMBL4525147;CHEMBL4525148;CHEMBL4525149;CHEMBL4525150;CHEMBL4525151;CHEMBL4525152;CHEMBL4525153;CHEMBL4525154;CHEMBL4525155;CHEMBL4525156;CHEMBL4525157;CHEMBL4525158;CHEMBL4525159) 0.159(CHEMBL3526808
)
|
Cathepsin F inhibitor | 0.937(DB06670) 0.080(DB00228;METXBIODB00116) 0.069(DB05521)
| 0.722(DBMET01475) 0.635(DBMET01472) 0.491(DBMET01470
)
|
Retinoid X gamma receptor agonist | 0.786(METXBIODB01691) 0.779(DB00755;DB00982;METXBIODB00937) 0.713(DB06755)
| 0.779(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.647(DBMET00455;DBMET02550;DBMET02552;DBMET03633;DBMET03635;DBMET03638) 0.636(DBMET00453
)
|
Antiviral (Dengue virus) | 0.455(DB13178) 0.406(DB00640) 0.400(CHEMBL3527223)
| 0.916(CHEMBL3526603) 0.572(CHEMBL80254) 0.513(CHEMBL3526604
)
|
Nitric oxide antagonist | 0.872(CHEMBL3542194) 0.871(METXBIODB02871) 0.862(DB13751)
| 0.877(CHEMBL3542275) 0.875(METXBIODB02872) 0.872(CHEMBL3542195;CHEMBL4525142;CHEMBL4525143
)
|
Estrogen agonist | 0.976(METXBIODB01947) 0.969(DB00648) 0.889(METXBIODB02004)
| 0.956(CHEMBL3544578;DBMET03031) 0.951(CHEMBL1450936;DBMET01368) 0.929(DBMET03032
)
|
DNA polymerase beta inhibitor | 0.744(METXBIODB00041) 0.727(METXBIODB00856) 0.703(DB00695)
| 0.970(CHEMBL3527192) 0.947(CHEMBL3544771) 0.798(CHEMBL3706470
)
|
Obsessive-compulsive disorder treatment | 0.668(DB00273) 0.658(METXBIODB00923) 0.510(DB00215;DB01175)
| 0.658(DBMET00323;METXBIODB01276) 0.567(METXBIODB00924) 0.485(DBMET02781;DBMET03704
)
|
Alpha adrenoreceptor antagonist | 0.994(DB13345) 0.940(DB08922;METXBIODB02106) 0.939(DB00590)
| 0.987(DBMET02090) 0.939(DBMET02603;DBMET02604) 0.938(METXBIODB00476
)
|
Nicotinic alpha7 receptor agonist | 0.374(CHEMBL3;DB00184;METXBIODB02230) 0.290(METXBIODB00877) 0.250(DB01591)
| 0.685(DBMET00406;METXBIODB00876) 0.173(CHEMBL578211;CHEMBL6200;DBMET00519;DBMET00520) 0.163(METXBIODB00878
)
|
Glycogen synthase kinase-3 alpha inhibitor | 0.458(DB01685;METXBIODB02526) 0.350(DB00437) 0.325(DB08877)
| 0.715(DBMET02099) 0.587(DBMET02094) 0.583(DBMET02095
)
|
Antioxidant | 0.954(CHEMBL49563;DB00163) 0.947(METXBIODB02879) 0.941(DB14002)
| 0.984(METXBIODB00716) 0.956(DB00166) 0.955(CHEMBL527285;DBMET02040;DBMET02324
)
|
Histone deacetylase class IIa inhibitor | 0.925(DB02546) 0.889(DB05015) 0.641(CHEMBL483254)
| 0.971(CHEMBL3526395) 0.944(CHEMBL3526396) 0.938(CHEMBL3526397
)
|
Glucagon-like peptide 1 receptor antagonist | 0.224(METXBIODB00291) 0.218(METXBIODB01440) 0.176(METXBIODB02378)
| 0.328(CHEMBL1222314) 0.155(DBMET02012) 0.153(DBMET00725
)
|
Antibiotic Tetracycline-like | 0.840(DB01017) 0.038(CHEMBL174) 0.037(METXBIODB00291)
| 0.799(DBMET03011) 0.641(DBMET03012;DBMET03013) 0.036(DBMET03197
)
|
Guanylate cyclase stimulant | 0.900(DB15456) 0.786(DB00727) 0.678(DB06154)
| 0.900(DBMET03244;DBMET03245) 0.786(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.349(DBMET02011
)
|
Bronchodilator | 0.947(DB01001) 0.932(DB00871) 0.930(DB09080)
| 0.934(DBMET01386) 0.932(DBMET03275;DBMET03276) 0.920(DBMET00386;METXBIODB01304
)
|
DNA directed DNA polymerase inhibitor | 0.919(DB00709) 0.832(CHEMBL374478) 0.829(METXBIODB00041)
| 0.992(DBMET00899) 0.972(CHEMBL1201384) 0.965(DBMET00898
)
|
Retinoic acid gamma receptor agonist | 0.911(DB06755) 0.861(DB00755;DB00982;METXBIODB00937) 0.692(METXBIODB00323;METXBIODB01252)
| 0.861(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.752(DBMET03633) 0.713(DBMET00455;DBMET02550;DBMET02552;DBMET03635;DBMET03638
)
|
Antineoplastic antibiotic | 0.940(CHEMBL1117) 0.902(DB06263) 0.890(CHEMBL178;DB00694)
| 0.909(CHEMBL3544590) 0.879(METXBIODB02105) 0.877(CHEMBL3544591
)
|
Streptokinase A inhibitor | 0.887(DB00698) 0.884(CHEMBL104) 0.785(METXBIODB02721)
| 0.786(CHEMBL3091852) 0.774(CHEMBL1442231) 0.735(DBMET02707
)
|
Calcium channel N-type blocker | 0.433(DB04841) 0.338(DB00568;METXBIODB00600) 0.302(DB00737)
| 0.294(DBMET01198) 0.271(DBMET01197) 0.242(DBMET01124
)
|
Dual specificity phosphatase inhibitor | 0.668(METXBIODB02132) 0.656(METXBIODB01081) 0.652(CHEMBL820)
| 0.790(DBMET01434) 0.750(METXBIODB02429) 0.707(CHEMBL3526411
)
|
Cyclin B2 inhibitor | 0.647(DB02377) 0.352(DB09073) 0.191(CHEMBL585;DB00384)
| 0.698(DBMET00493) 0.614(DBMET02372) 0.535(DBMET02378
)
|
NMDA 2D receptor antagonist | 0.361(METXBIODB02370) 0.335(METXBIODB02368) 0.322(METXBIODB02611)
| 0.318(METXBIODB02506) 0.272(CHEMBL1208633) 0.264(DBMET02101
)
|
Phosphodiesterase 4B inhibitor | 0.847(DB01656) 0.822(METXBIODB01552) 0.694(METXBIODB01645)
| 0.934(DBMET00997) 0.844(METXBIODB01555) 0.816(METXBIODB01554
)
|
Poly(ADP-ribose) polymerase 2 inhibitor | 0.678(DB09074) 0.473(DB01261) 0.435(DB12332)
| 0.716(DBMET03439) 0.594(DBMET03519) 0.559(DBMET03441
)
|
Retinoid X beta receptor agonist | 0.850(METXBIODB01691) 0.785(DB00755;DB00982;METXBIODB00937) 0.705(DB06755)
| 0.785(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.651(DBMET03633) 0.643(DBMET00455;DBMET02550;DBMET02552;DBMET03635;DBMET03638
)
|
Acetyl-CoA carboxylase inhibitor | 0.659(METXBIODB01344) 0.287(METXBIODB00328) 0.100(CHEMBL1308;DB01213)
| 0.636(METXBIODB01345) 0.246(METXBIODB00329) 0.114(DBMET01457
)
|
Dual specificity phosphatase 3 inhibitor | 0.707(METXBIODB02132) 0.690(CHEMBL820) 0.554(METXBIODB02879)
| 0.796(DBMET01434) 0.747(METXBIODB02429) 0.681(CHEMBL3526411
)
|
Liver X receptor agonist | 0.796(METXBIODB02132) 0.564(DB00532) 0.386(DB06700)
| 0.386(DBMET00056;METXBIODB00164) 0.374(DBMET02409) 0.348(DBMET02410
)
|
Factor Xa inhibitor | 0.788(CHEMBL1269025) 0.667(DB12364) 0.522(DB06605)
| 0.814(CHEMBL3548175) 0.717(CHEMBL3550090) 0.658(CHEMBL3550091
)
|
Cathepsin S inhibitor | 0.825(DB06670) 0.121(METXBIODB00946) 0.120(DB11763)
| 0.812(DBMET01475) 0.763(DBMET01472) 0.498(DBMET01473
)
|
Liver X receptor alpha antagonist | 0.759(METXBIODB02132) 0.246(METXBIODB01155) 0.156(METXBIODB00289)
| 0.320(METXBIODB01156) 0.233(DBMET00693) 0.180(METXBIODB00521
)
|
Antiprotozoal activity enhancer | 0.847(DB06697) 0.820(METXBIODB00454) 0.818(DB11638)
| 0.818(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.806(METXBIODB00455) 0.685(DBMET00827
)
|
Folate antagonist | 0.861(CHEMBL34259) 0.671(DB00563) 0.598(CHEMBL585;DB00384)
| 0.840(CHEMBL3544676) 0.786(CHEMBL1231106) 0.723(CHEMBL3544661
)
|
5 Hydroxytryptamine 6 antagonist | 0.403(DB13345) 0.394(METXBIODB01085) 0.356(METXBIODB00475)
| 0.291(CHEMBL3526332) 0.267(METXBIODB01314) 0.250(CHEMBL1125;DBMET00265
)
|
Polo-like kinase-1 inhibitor | 0.272(DB00619) 0.258(DB11763) 0.237(DB09073)
| 0.331(DBMET03528) 0.296(DBMET03530) 0.294(DBMET03719
)
|
Psychosexual dysfunction treatment | 0.710(DB00539) 0.692(METXBIODB02451) 0.654(DB00126)
| 0.699(DBMET00394) 0.692(DBMET00862) 0.675(CHEMBL50995;DBMET02716
)
|
Acetyl-CoA carboxylase 1 inhibitor | 0.294(METXBIODB01344) 0.182(METXBIODB00328) 0.083(CHEMBL1308;DB01213)
| 0.256(METXBIODB01345) 0.163(METXBIODB00329) 0.048(DBMET02815
)
|
Glutamate (mGluR2) agonist | 0.388(DB00339) 0.268(METXBIODB02380) 0.214(DB06201)
| 0.593(DBMET02522) 0.277(METXBIODB01626) 0.260(CHEMBL3526838
)
|
Orexin receptor 1 antagonist | 0.690(DB09034) 0.609(CHEMBL1272307) 0.245(CHEMBL455136)
| 0.313(CHEMBL3527303) 0.245(CHEMBL4525144;CHEMBL4525145;CHEMBL4525146;CHEMBL4525147;CHEMBL4525148;CHEMBL4525149;CHEMBL4525150;CHEMBL4525151;CHEMBL4525152;CHEMBL4525153;CHEMBL4525154;CHEMBL4525155;CHEMBL4525156;CHEMBL4525157;CHEMBL4525158;CHEMBL4525159) 0.238(CHEMBL3526736
)
|
Glutamate (mGluR group II) agonist | 0.394(DB00339) 0.272(METXBIODB02380) 0.219(DB06201)
| 0.600(DBMET02522) 0.281(METXBIODB01626) 0.274(CHEMBL3526838
)
|
Aryl hydrocarbon receptor agonist | 0.896(METXBIODB00464;METXBIODB02430) 0.854(METXBIODB02821) 0.849(DB01645;METXBIODB00465)
| 0.859(DBMET00251;METXBIODB00869) 0.843(DBMET01536) 0.842(CHEMBL75589
)
|
Motilin receptor antagonist | 0.670(CHEMBL1741;DB01211;METXBIODB00619) 0.668(CHEMBL532;DB00199) 0.548(METXBIODB00769)
| 0.844(CHEMBL3706534) 0.568(CHEMBL2022715;DBMET00357;METXBIODB00621) 0.567(CHEMBL2063468;DBMET01656
)
|
Granulocyte colony stimulating factor receptor agonist | 0.033(METXBIODB00008) 0.029(DB04168;METXBIODB01220) 0.028(METXBIODB00199)
| 0.046(CHEMBL2030560) 0.040(DBMET02318) 0.033(CHEMBL3542349
)
|
Focal adhesion kinase 2 inhibitor | 0.717(DB12267) 0.474(CHEMBL535) 0.415(DB12072)
| 0.437(CHEMBL3542399) 0.413(CHEMBL3542333) 0.389(CHEMBL3542344
)
|
Contraceptive male | 0.810(DB14583) 0.785(DB00294) 0.783(DB00367)
| 0.975(CHEMBL3706475) 0.845(DBMET01495) 0.801(DBMET01496
)
|
CC chemokine 8 receptor antagonist | 0.030(METXBIODB01452) 0.028(METXBIODB02842) 0.027(METXBIODB01389)
| 0.132(CHEMBL3527292) 0.032(METXBIODB00183;METXBIODB01097) 0.030(METXBIODB00936
)
|
Beta lactamase inhibitor | 0.943(DB01606) 0.884(DB00417) 0.774(METXBIODB00835)
| 0.979(CHEMBL3527192) 0.969(CHEMBL3544771) 0.844(CHEMBL3706470
)
|
Skin whitener | 0.821(METXBIODB02190) 0.798(DB00126) 0.766(DB01094;METXBIODB02187)
| 0.829(METXBIODB03144) 0.826(DBMET00253) 0.795(METXBIODB03155
)
|
Cyclin B1 inhibitor | 0.672(DB02377) 0.563(DB09073) 0.206(CHEMBL585;DB00384)
| 0.733(DBMET02378) 0.721(DBMET00493) 0.640(DBMET02372
)
|
DNA repair enzyme inhibitor | 0.960(CHEMBL417;CHEMBL53463;DB00997) 0.931(CHEMBL178;DB00694) 0.923(CHEMBL1117)
| 0.978(CHEMBL3508145) 0.941(DBMET00952) 0.902(DBMET00853
)
|
Transplant rejection treatment | 0.980(DB08868) 0.908(CHEMBL160;DB00091) 0.906(DB08877)
| 0.980(DBMET03096) 0.901(CHEMBL3544879) 0.886(CHEMBL2407580;DBMET00359
)
|
ICAM1 expression inhibitor | 0.761(DB06154) 0.704(CHEMBL1064;DB00641;METXBIODB01371) 0.677(DB01234;METXBIODB00696)
| 0.702(CHEMBL3542275) 0.691(METXBIODB01656) 0.677(CHEMBL3544664;CHEMBL3544679;DB00443
)
|
MAO B inhibitor | 0.869(METXBIODB00300) 0.863(METXBIODB00262) 0.794(METXBIODB00554)
| 0.807(METXBIODB00555) 0.736(METXBIODB01611) 0.688(METXBIODB00272
)
|
Antineoplastic (bone cancer) | 0.841(DB06670) 0.773(DB01043) 0.672(DB06287)
| 0.895(CHEMBL525;DBMET01147) 0.868(CHEMBL3706540;DBMET01123) 0.865(CHEMBL1593;DBMET00658
)
|
Nav1.5 sodium channel blocker | 0.536(DB14881) 0.379(METXBIODB01389) 0.295(METXBIODB02842)
| 0.418(DBMET03206) 0.352(DBMET03208) 0.313(METXBIODB01366
)
|
Trypsin II inhibitor | 0.093(CHEMBL169901;DB04840) 0.069(METXBIODB01173) 0.062(DB01018)
| 0.118(CHEMBL65267) 0.097(DBMET03379) 0.089(DBMET01535
)
|
Endothelin B receptor antagonist | 0.831(CHEMBL1111;DB06403) 0.756(METXBIODB02579) 0.651(DB00559)
| 0.802(CHEMBL3706460) 0.800(CHEMBL3706461) 0.756(CHEMBL3706459;DBMET00460
)
|
Erythropoietin receptor agonist | 0.532(DB09059) 0.467(DB11366) 0.436(DB06685)
| 0.581(DBMET00840) 0.459(DBMET01695) 0.453(DBMET01691
)
|
Renal disease treatment | 0.858(DB15456) 0.776(CHEMBL1393;DB00421) 0.773(DB00700)
| 0.858(DBMET03244;DBMET03245) 0.785(DBMET01540) 0.783(DBMET01655
)
|
Protein kinase (CK1) epsilon inhibitor | 0.138(CHEMBL1140) 0.124(DB00730) 0.095(CHEMBL715;DB00334;METXBIODB01125)
| 0.138(DBMET02629) 0.131(CHEMBL724;DBMET00354;DBMET03729;METXBIODB00201) 0.105(DBMET02020
)
|
Kallikrein inhibitor | 0.569(DB00188) 0.213(DB06201) 0.208(DB01202)
| 0.344(DBMET03379) 0.275(CHEMBL3526352) 0.273(DBMET03378
)
|
Protease activated receptor antagonist | 0.536(CHEMBL493982;DB09030) 0.253(METXBIODB01593) 0.230(CHEMBL275391)
| 0.567(CHEMBL498785;DBMET01376) 0.527(DBMET01375) 0.516(CHEMBL3542381
)
|
Fibroblast growth factor 2 antagonist | 0.966(DB12147) 0.339(DB06616) 0.254(METXBIODB00866)
| 0.894(DBMET03649) 0.782(DBMET03650) 0.307(DBMET03737
)
|
GABA transporter 2 inhibitor | 0.272(DB01202) 0.213(DB00568;METXBIODB00600) 0.187(CHEMBL445990)
| 0.253(DBMET01115) 0.240(DBMET01193;METXBIODB00603) 0.205(DBMET01197
)
|
Growth hormone release promoting | 0.284(DB00191) 0.109(DB08868) 0.104(CHEMBL459;DB00968)
| 0.364(DB01365) 0.146(CHEMBL3544728) 0.144(DBMET02227
)
|
Integrin alphaVbeta1 antagonist | 0.430(METXBIODB01514) 0.184(DB00575) 0.138(DB00484)
| 0.451(METXBIODB01515) 0.233(METXBIODB01516) 0.221(METXBIODB01517
)
|
Diacylglycerol O-acyltransferase 1 inhibitor | 0.316(DB11936) 0.192(DB01241;METXBIODB03090) 0.186(CHEMBL2105653)
| 0.255(CHEMBL3544586) 0.231(CHEMBL3544587) 0.225(DB09269;DBMET01431;METXBIODB03146
)
|
Antibiotic Glycopeptide-like | 0.242(DB11217) 0.240(DB00581) 0.226(CHEMBL3527223)
| 0.242(DBMET02417) 0.237(METXBIODB02178) 0.235(METXBIODB02255
)
|
Retinoic acid receptor agonist | 0.985(DB06755) 0.971(DB00755;DB00982;METXBIODB00937) 0.938(METXBIODB00323;METXBIODB01252)
| 0.982(DBMET00454) 0.971(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.948(DBMET03633
)
|
Tumour necrosis factor antagonist | 0.606(DB05676) 0.567(DB01656) 0.541(METXBIODB01531)
| 0.662(DBMET00997) 0.574(DBMET00056) 0.550(CHEMBL3544501
)
|
Vasopressin 1B antagonist | 0.593(DB01744;DB11345;METXBIODB01913) 0.494(DB09059) 0.313(DB00918)
| 0.304(DBMET00347) 0.222(METXBIODB00690) 0.186(DBMET02067
)
|
Tubulin agonist | 0.114(CHEMBL428647;DB01229) 0.110(METXBIODB01414) 0.101(CHEMBL92;DB01248)
| 0.207(METXBIODB00072) 0.110(CHEMBL122465;CHEMBL307088;DBMET01760) 0.107(DBMET01746;METXBIODB01373
)
|
MAO inhibitor | 0.885(METXBIODB02196) 0.860(METXBIODB00300) 0.832(METXBIODB00262)
| 0.839(METXBIODB00555) 0.776(METXBIODB01611) 0.775(METXBIODB00272
)
|
CYP1A2 inhibitor | 0.980(METXBIODB01398;METXBIODB03058) 0.976(METXBIODB02194) 0.975(METXBIODB02507)
| 0.977(CHEMBL75589) 0.972(CHEMBL74898) 0.967(CHEMBL442289
)
|
Kinesin antagonist | 0.281(DB06824) 0.270(CHEMBL1430) 0.255(DB00820)
| 0.433(DBMET00513) 0.361(CHEMBL3544531) 0.343(DBMET00486
)
|
Kinesin-like protein 1 inhibitor | 0.281(DB06824) 0.270(CHEMBL1430) 0.255(DB00820)
| 0.433(DBMET00513) 0.361(CHEMBL3544531) 0.343(DBMET00486
)
|
5 Hydroxytryptamine 1F antagonist | 0.852(DB13345) 0.829(DB00924) 0.827(METXBIODB00369)
| 0.809(DBMET02090) 0.753(METXBIODB00370) 0.705(METXBIODB00477
)
|
Neuraminidase inhibitor | 0.927(DB00198) 0.298(DB00742;DB11195) 0.279(METXBIODB02982)
| 0.944(DBMET02218) 0.390(DBMET01340) 0.370(DBMET02769
)
|
Transforming growth factor beta 1 antagonist | 0.198(DB00730) 0.115(METXBIODB01220) 0.109(METXBIODB00935)
| 0.168(CHEMBL3526187) 0.147(DBMET03650) 0.114(DBMET01768
)
|
Cathepsin D inhibitor | 0.246(METXBIODB02451) 0.176(CHEMBL1163) 0.159(METXBIODB02531)
| 0.458(CHEMBL1207) 0.314(CHEMBL3186899) 0.269(CHEMBL3526896
)
|
Alpha 1L adrenoreceptor antagonist | 0.380(DB00261) 0.110(DB00656) 0.108(DB00818;METXBIODB01201)
| 0.297(DBMET00772) 0.126(METXBIODB01123) 0.118(DBMET02351;DBMET02358
)
|
Somatostatin 3 agonist | 0.034(METXBIODB00244) 0.029(DB01221;DB11823;METXBIODB00118) 0.028(METXBIODB01146)
| 0.032(DBMET00189;METXBIODB00119) 0.022(DBMET01362) 0.020(DBMET01310
)
|
Potassium channel (Ca-activated) activator | 0.609(METXBIODB02793) 0.423(DB06716) 0.410(DB00613)
| 0.471(DBMET01338) 0.445(DBMET03556) 0.428(METXBIODB00274
)
|
Vitronectin receptor antagonist | 0.816(METXBIODB01514) 0.541(DB00575) 0.311(DB00484)
| 0.982(METXBIODB01516) 0.838(METXBIODB01515) 0.832(METXBIODB01517
)
|
Sodium/hydrogen exchanger 2 inhibitor | 0.034(DB00533) 0.029(DB01628) 0.025(DB08828)
| 0.062(CHEMBL3186899) 0.057(CHEMBL3544507) 0.031(DBMET01292
)
|
Inosine monophosphate dehydrogenase inhibitor | 0.845(DB01024;METXBIODB01063) 0.569(DB00688) 0.328(DB00640)
| 0.845(DBMET02606) 0.825(DBMET00485;DBMET03265) 0.815(DB00171
)
|
Dopamine D4 agonist | 0.555(DB00245) 0.500(DB00737) 0.443(DB11742)
| 0.838(METXBIODB01222) 0.722(DBMET01948) 0.650(DBMET01947
)
|
Viral attachment inhibitor | 0.904(DB11796) 0.853(DB06652) 0.225(DB01320)
| 0.915(DBMET03183) 0.896(DBMET00080) 0.890(DBMET00081
)
|
Neuraminidase (influenza) inhibitor | 0.774(DB00198) 0.360(DB06799) 0.336(DB00742;DB11195)
| 0.818(DBMET02218) 0.376(DBMET01340) 0.355(DBMET03118
)
|
Cyclin B inhibitor | 0.595(DB02377) 0.471(DB09073) 0.223(CHEMBL585;DB00384)
| 0.659(METXBIODB01084) 0.638(DBMET00493;DBMET02378) 0.548(DBMET02372
)
|
Female sexual dysfunction treatment | 0.851(DB00539) 0.755(METXBIODB01526) 0.752(DB00820)
| 0.869(DBMET00394) 0.810(CHEMBL50995;DBMET02716) 0.770(METXBIODB01527
)
|
Prostaglandin D2 antagonist | 0.945(METXBIODB00097) 0.938(METXBIODB00744) 0.889(METXBIODB01452)
| 0.799(DB09269;DBMET01431;METXBIODB03146) 0.780(METXBIODB00099) 0.769(METXBIODB00746
)
|
5 Hydroxytryptamine 1 agonist | 0.971(METXBIODB01680) 0.878(DB00315) 0.876(METXBIODB00957)
| 0.988(METXBIODB01682) 0.942(METXBIODB00959) 0.869(METXBIODB01681
)
|
Melanin-concentrating hormone receptor 1 antagonist | 0.451(DB00637) 0.195(DB06016) 0.182(DB11978)
| 0.254(DB06457) 0.243(DBMET01618) 0.193(CHEMBL3542260
)
|
Bone formation stimulant | 0.634(METXBIODB00896) 0.633(METXBIODB02719) 0.588(METXBIODB01514)
| 0.671(METXBIODB00593) 0.656(METXBIODB00897) 0.649(DBMET02435
)
|
Microtubule stabilization | 0.959(CHEMBL92;DB01248) 0.951(CHEMBL428647;DB01229) 0.915(DB06772)
| 0.959(DBMET00633) 0.915(DBMET00998) 0.912(CHEMBL3706530;DBMET01649
)
|
ABCA1 expression enhancer | 0.890(DB00755;DB00982;METXBIODB00937) 0.873(DB06755) 0.845(METXBIODB02963)
| 0.890(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.868(DBMET03633) 0.856(DBMET00455;DBMET02550;DBMET02552;DBMET03635;DBMET03638
)
|
Pim-2 kinase inhibitor | 0.122(METXBIODB00639) 0.115(METXBIODB00935) 0.112(METXBIODB02345)
| 0.231(CHEMBL3526506) 0.197(DBMET01855) 0.159(DBMET01944
)
|
HIV-1 protease inhibitor | 0.820(CHEMBL116) 0.727(DB00224) 0.714(CHEMBL163;DB00503)
| 0.897(CHEMBL1235368;DBMET00983) 0.870(CHEMBL1237008) 0.684(CHEMBL3544831;DBMET01183
)
|
Liver X receptor antagonist | 0.653(METXBIODB02132) 0.215(METXBIODB01155) 0.170(DB00533)
| 0.279(METXBIODB01156) 0.249(DBMET00693) 0.228(DBMET00171;DBMET00172
)
|
Protease inhibitor | 0.899(CHEMBL116) 0.846(CHEMBL1163) 0.597(CHEMBL163;DB00503)
| 0.876(CHEMBL3526718) 0.866(CHEMBL3526719) 0.805(CHEMBL3526787
)
|
Selectin antagonist | 0.649(DB00581) 0.618(CHEMBL3527223) 0.561(DB11217)
| 0.798(DBMET00509) 0.663(METXBIODB03142;METXBIODB03143) 0.617(DBMET02088
)
|
Pim-3 kinase inhibitor | 0.212(METXBIODB02345) 0.183(DB11640) 0.182(DB06637)
| 0.274(DBMET01855) 0.240(CHEMBL3526506) 0.224(DBMET01944
)
|
AMPA receptor agonist | 0.696(DB12473) 0.144(CHEMBL445990) 0.131(METXBIODB02963)
| 0.552(DBMET03765) 0.512(DBMET03764) 0.267(CHEMBL2158192;DBMET01416
)
|
Heat shock protein 90 alpha antagonist | 0.960(CHEMBL383824) 0.811(CHEMBL467399) 0.524(METXBIODB02376)
| 0.937(CHEMBL3526785) 0.922(CHEMBL3526786) 0.877(CHEMBL3527105
)
|
Collagenase inhibitor | 0.233(DB02546) 0.178(CHEMBL1314;DB06823) 0.142(DB05015)
| 0.222(CHEMBL3527251) 0.206(DBMET01338) 0.182(DBMET03179
)
|
Catechol O-methyltransferase inhibitor | 0.970(DB11632) 0.860(METXBIODB02283) 0.731(METXBIODB02774)
| 0.953(DBMET03238) 0.938(DBMET03236) 0.936(DBMET03237
)
|
Erectile dysfunction treatment | 0.951(DB00862) 0.948(DB00727) 0.932(DB00820)
| 0.963(CHEMBL3526838) 0.952(DBMET03640) 0.948(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598
)
|
Antihemorrhagic | 0.919(METXBIODB03141) 0.908(CHEMBL3527416) 0.715(METXBIODB02136)
| 0.914(CHEMBL3526994) 0.908(CHEMBL3526749;CHEMBL4525115) 0.902(METXBIODB02880
)
|
Plasma kallikrein inhibitor | 0.271(DB06201) 0.166(DB01202) 0.119(METXBIODB00562)
| 0.252(CHEMBL3527402) 0.240(CHEMBL3544524) 0.165(CHEMBL3526187
)
|
Macrophage elastase inhibitor | 0.459(CHEMBL109;DB00313;METXBIODB01559) 0.267(DB02546) 0.169(DB00230)
| 0.959(CHEMBL3706502;DBMET00062;METXBIODB01562) 0.777(DBMET02168) 0.600(DBMET01108
)
|
Purinergic P2 antagonist | 0.595(DB08816) 0.327(DB11121) 0.306(DB01261)
| 0.634(DBMET03170) 0.610(DBMET03171) 0.472(DBMET00677
)
|
Cyclin-dependent kinase 8 inhibitor | 0.512(DB05812) 0.393(DB08877) 0.328(DB11793)
| 0.312(DBMET03262) 0.306(CHEMBL3526899) 0.286(DBMET02824
)
|
Endothelin receptor antagonist | 0.883(CHEMBL1111;DB06403) 0.818(METXBIODB02579) 0.693(DB00559)
| 0.863(CHEMBL3706461) 0.818(CHEMBL3706459;DBMET00460) 0.801(CHEMBL3706460
)
|
Prostaglandin E2 antagonist | 0.748(DB00770) 0.558(DB00929) 0.547(DB00905)
| 0.803(DB00917) 0.748(DBMET02086) 0.711(DBMET02588
)
|
Diabetic nephropathy treatment | 0.779(DB12713) 0.693(CHEMBL1770248;DB11827) 0.691(CHEMBL413;DB00877;METXBIODB01375)
| 0.782(DB03947) 0.763(DB09401) 0.730(CHEMBL3527603;DBMET01906
)
|
Insulin secretagoues | 0.679(METXBIODB00079;METXBIODB00371) 0.643(METXBIODB00080;METXBIODB00372) 0.612(METXBIODB02871)
| 0.741(CHEMBL3527206) 0.684(METXBIODB01150;METXBIODB01208;METXBIODB01451) 0.665(METXBIODB00892
)
|
Antiviral (CMV) | 0.921(DB06697) 0.902(METXBIODB00454) 0.900(DB11638)
| 0.900(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.893(METXBIODB00455) 0.806(DBMET01913;DBMET03143
)
|
Caspase 2 inhibitor | 0.079(DB00130) 0.074(DB09348) 0.069(DB06218)
| 0.186(DBMET00169;DBMET01838) 0.178(DBMET00170) 0.158(DBMET01477
)
|
GHS receptor agonist | 0.366(DB00191) 0.141(DB11296) 0.139(DB06824)
| 0.252(DBMET02227) 0.183(DBMET02067) 0.167(DBMET03340
)
|
Integrin beta6 antagonist | 0.171(DB00575) 0.119(DB00484) 0.091(DB00697;METXBIODB02082)
| 0.160(CHEMBL219497;DBMET00655;DBMET02004;DBMET03581) 0.149(DBMET00468) 0.082(DBMET00465
)
|
Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.867(METXBIODB00382) 0.820(METXBIODB02059) 0.499(METXBIODB01431)
| 0.683(METXBIODB02060) 0.633(METXBIODB00384) 0.385(METXBIODB00383
)
|
Baculoviral IAP repeat-containing protein inhibitor | 0.426(DB01577;METXBIODB01797) 0.239(DB00852;DB01364) 0.145(METXBIODB01521)
| 0.426(DB09571;DBMET00634) 0.165(DBMET00735;METXBIODB01522;METXBIODB01798) 0.146(METXBIODB00018;METXBIODB02013
)
|
Antiobesity | 0.966(METXBIODB01543) 0.947(CHEMBL1770248;DB11827) 0.910(METXBIODB01533)
| 0.956(CHEMBL3527603;DBMET01906) 0.948(CHEMBL4525781;CHEMBL4525782;DBMET01904;DBMET01905) 0.934(DBMET01909
)
|
I kappa B kinase epsilon inhibitor | 0.700(DB08877) 0.410(DB08865) 0.341(DB00619)
| 0.642(DBMET03263) 0.587(DBMET02094) 0.562(DBMET03262
)
|
Antibiotic beta Lactam-like | 0.953(DB01413) 0.846(DB00493) 0.715(DB06211)
| 0.749(DBMET00646) 0.318(DBMET00758) 0.283(CHEMBL3526531
)
|
Antiischemic, cerebral | 0.865(DB01043) 0.856(METXBIODB01496) 0.848(METXBIODB02793)
| 0.892(DBMET01740) 0.844(METXBIODB01497) 0.798(CHEMBL1207
)
|
Histone-lysine N-methyltransferase EZH2 inhibitor | 0.928(DB12887) 0.069(DB01429) 0.048(METXBIODB02339)
| 0.438(DBMET02978) 0.066(DBMET01811) 0.056(DBMET01810
)
|
I kappa B kinase inhibitor | 0.350(DB11793) 0.266(DB08877) 0.207(DB00998)
| 0.333(DBMET03719) 0.307(DBMET03718) 0.255(CHEMBL3526631
)
|
Purinergic P2Y4 agonist | 0.024(DB15661) 0.005(CHEMBL917;DB00322) 0.004(DB09144)
| 0.456(CHEMBL1774;DBMET02000;DBMET03590) 0.348(DB01861;DB03501) 0.327(CHEMBL590981;DBMET03589
)
|
Purinergic P2Y14 antagonist | 0.411(DB03793;METXBIODB02476) 0.218(METXBIODB00295) 0.205(METXBIODB01620)
| 0.411(DBMET01437) 0.256(CHEMBL1203) 0.241(DB02746
)
|
Baculoviral IAP repeat-containing protein 3 inhibitor | 0.147(DB01577;METXBIODB01797) 0.058(DB00852;DB01364) 0.046(METXBIODB01521)
| 0.147(DB09571;DBMET00634) 0.049(DBMET00735;METXBIODB01522;METXBIODB01798) 0.048(CHEMBL3544554
)
|
Orexin receptor antagonist | 0.782(DB09034) 0.781(CHEMBL1272307) 0.369(CHEMBL455136)
| 0.392(CHEMBL3527303) 0.369(CHEMBL4525144;CHEMBL4525145;CHEMBL4525146;CHEMBL4525147;CHEMBL4525148;CHEMBL4525149;CHEMBL4525150;CHEMBL4525151;CHEMBL4525152;CHEMBL4525153;CHEMBL4525154;CHEMBL4525155;CHEMBL4525156;CHEMBL4525157;CHEMBL4525158;CHEMBL4525159) 0.327(CHEMBL3526736
)
|
Inosine monophosphate dehydrogenase 2 inhibitor | 0.835(DB01024;METXBIODB01063) 0.384(DB00688) 0.192(DB00640)
| 0.835(DBMET02606) 0.783(DBMET00485;DBMET03265) 0.777(DB00171
)
|
Amyotrophic lateral sclerosis treatment | 0.943(CHEMBL269732;DB00864;METXBIODB00828) 0.922(DB13345) 0.816(METXBIODB00831)
| 0.940(CHEMBL3544693;DBMET00390) 0.928(CHEMBL3544708;DBMET00670;DBMET01667;DBMET01668;METXBIODB00829;METXBIODB00830) 0.925(DBMET02090
)
|
Peristaltic stimulant | 0.884(DB00585) 0.833(CHEMBL532;DB00199) 0.829(DB00863;METXBIODB01235)
| 0.904(DBMET00959) 0.848(DBMET02203) 0.847(CHEMBL3706534
)
|
Vasopressin 2 antagonist | 0.604(DB01744;DB11345;METXBIODB01913) 0.602(CHEMBL49429) 0.510(DB09059)
| 0.619(CHEMBL237772) 0.361(CHEMBL3526965) 0.166(CHEMBL392363;DBMET00840
)
|
Urolithiasis treatment | 0.928(CHEMBL88;DB00531;METXBIODB00960) 0.909(DB00700) 0.895(CHEMBL1393;DB00421)
| 0.928(DBMET01683) 0.882(DBMET01654) 0.879(DBMET01655
)
|
Phosphodiesterase III inhibitor | 0.977(DB00922) 0.889(METXBIODB00340) 0.695(DB00261)
| 0.973(DBMET00498) 0.959(DBMET00973) 0.931(DBMET00974
)
|
Dipeptidyl peptidase I inhibitor | 0.160(METXBIODB00350) 0.155(METXBIODB02687) 0.145(METXBIODB02699)
| 0.157(DBMET02260) 0.142(DBMET02261) 0.131(DBMET01475
)
|
Endothelin A receptor antagonist | 0.886(CHEMBL1111;DB06403) 0.832(METXBIODB02579) 0.621(DB00559)
| 0.868(CHEMBL3706461) 0.832(CHEMBL3706459;DBMET00460) 0.823(CHEMBL3706460
)
|
Motilin receptor agonist | 0.861(CHEMBL532;DB00199) 0.833(CHEMBL1741;DB01211;METXBIODB00619) 0.812(METXBIODB00769)
| 0.819(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.791(CHEMBL2063468;DBMET01656) 0.779(CHEMBL2022715;DBMET00357;METXBIODB00621
)
|
Dopamine agonist | 0.994(DB13345) 0.989(METXBIODB00475) 0.970(METXBIODB00369)
| 0.989(METXBIODB00476) 0.983(METXBIODB00477) 0.979(DBMET02090
)
|
Protein-tyrosine phosphatase 1B inhibitor | 0.720(CHEMBL820) 0.688(METXBIODB02871) 0.477(DB13751)
| 0.627(CHEMBL3706503;DBMET00066;DBMET00067) 0.615(METXBIODB00356) 0.611(DBMET02110
)
|
Dopamine transporter inhibitor | 0.986(DB00245) 0.951(DB00907;METXBIODB00058) 0.708(DB01075;METXBIODB00738)
| 0.976(DBMET03469;DBMET03471) 0.961(DBMET02260) 0.908(METXBIODB00059
)
|
Purinergic P2X antagonist | 0.254(DB11121) 0.248(METXBIODB00192) 0.217(METXBIODB00189;METXBIODB02132)
| 0.220(DBMET01613) 0.201(DBMET02116) 0.172(DBMET03497
)
|
Toll-Like receptor 3 antagonist | 0.419(DB00289;METXBIODB00158) 0.408(DB06728) 0.398(DB08865)
| 0.427(DBMET01200;METXBIODB02009) 0.408(DBMET02709;METXBIODB00395) 0.396(DBMET00319;METXBIODB00122
)
|
CC chemokine receptor 2B antagonist | 0.612(DB00763) 0.324(METXBIODB00189) 0.278(METXBIODB00192)
| 0.385(DBMET00480) 0.353(DBMET02770) 0.235(DBMET02571
)
|
Histone deacetylase SIRT2 inhibitor | 0.871(CHEMBL104) 0.539(CHEMBL1140) 0.437(METXBIODB01930)
| 0.539(DBMET02629) 0.244(CHEMBL3542327;DBMET02631) 0.238(CHEMBL3542314;DBMET02634
)
|
Beta amyloid protein antagonist | 0.627(METXBIODB02544) 0.441(DB00762;METXBIODB00933) 0.435(CHEMBL3542194)
| 0.670(METXBIODB02545) 0.627(DBMET01143) 0.461(CHEMBL3542279;CHEMBL3542281
)
|
MAP kinase kinase 10 inhibitor | 0.533(DB08881) 0.433(DB00580) 0.268(METXBIODB02395)
| 0.561(DBMET01344) 0.476(DBMET01342) 0.448(DBMET01347
)
|
Pyruvate kinase inhibitor | 0.625(METXBIODB02548) 0.588(METXBIODB00464;METXBIODB02430) 0.584(METXBIODB02507)
| 0.732(DBMET01478) 0.620(DBMET00769) 0.612(CHEMBL3526411
)
|
AXL receptor tyrosine kinase inhibitor | 0.344(DB08865) 0.325(DB12141) 0.242(CHEMBL585;DB00384)
| 0.861(CHEMBL244377) 0.854(CHEMBL1231106) 0.831(CHEMBL3544897;CHEMBL3544898
)
|
Excitatory amino acid transporter 2 inhibitor | 0.452(DB00130) 0.412(DB00129) 0.360(CHEMBL109;DB00313;METXBIODB01559)
| 0.480(DB00142) 0.383(DB00123) 0.315(CHEMBL3706509;DBMET01109
)
|
Falcipain inhibitor | 0.923(DB06697) 0.918(DB11638) 0.895(METXBIODB00454)
| 0.998(METXBIODB00716) 0.918(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.909(METXBIODB00455
)
|
CDK6/cyclin D3 inhibitor | 0.867(DB09073) 0.054(DB00592;DB08864) 0.053(DB12010)
| 0.805(DBMET02373) 0.761(DBMET02380) 0.675(DBMET02379
)
|
Anxiolytic | 0.992(DB00402;DB01198;METXBIODB02096) 0.989(DB06799) 0.980(DB13872)
| 0.992(DBMET00300) 0.989(DBMET02412) 0.988(DBMET00135;DBMET00299;METXBIODB00791
)
|
Nicotinic receptor beta4 subunit antagonist | 0.866(DB01156;METXBIODB00109;METXBIODB01854) 0.243(DB06176) 0.221(METXBIODB01741)
| 0.959(DBMET03469;DBMET03471) 0.826(DBMET03482;DBMET03483) 0.813(METXBIODB00113;METXBIODB01858
)
|
Protein kinase C beta II inhibitor | 0.437(METXBIODB01288) 0.133(DB06595) 0.074(METXBIODB02395)
| 0.285(METXBIODB01289) 0.224(DBMET01441) 0.107(DBMET01440
)
|
Transcription factor NF kappa B stimulant | 0.799(DB00709) 0.782(DB00879) 0.595(DB13960)
| 0.790(DBMET00898) 0.783(DBMET00899) 0.735(DBMET02870
)
|
Glucose-6-phosphate translocase inhibitor | 0.548(METXBIODB02170) 0.490(DB11672;METXBIODB00660) 0.478(METXBIODB02168)
| 0.490(DBMET01640;METXBIODB00661) 0.373(METXBIODB02171) 0.349(METXBIODB02167
)
|
Hypoxia-inducible factor 1 alpha inhibitor | 0.995(CHEMBL1504;CHEMBL1512;DB06781;DB14512) 0.994(DB00394;DB00764) 0.989(DB01234;METXBIODB00696)
| 0.995(DBMET00759;DBMET00837) 0.994(DBMET02361;DBMET02589) 0.992(DBMET02590;DBMET02591
)
|
Somatostatin agonist | 0.359(DB09059) 0.268(DB06824) 0.261(DB01074;METXBIODB00067)
| 0.545(CHEMBL3706536) 0.319(DBMET03446) 0.259(DBMET00088
)
|
Antieczematic | 0.978(DB00764) 0.971(DB14512) 0.964(DB00394)
| 0.978(DBMET02361) 0.966(DBMET00759;DBMET02591) 0.962(DBMET02589
)
|
Antitussive | 0.981(DB00704) 0.970(DB00921;DB01192) 0.969(DB00497;METXBIODB01139)
| 0.994(DB06409;DBMET00176;DBMET00660;METXBIODB02727;METXBIODB02826) 0.992(METXBIODB03063) 0.990(METXBIODB02827
)
|
Premature ejaculation treatment | 0.648(DB06700) 0.614(DB00285;METXBIODB00162) 0.502(METXBIODB02677)
| 0.648(METXBIODB00164) 0.631(DBMET02409) 0.606(DBMET02410
)
|
Transcription factor STAT inhibitor | 0.668(DB00390) 0.667(CHEMBL250785) 0.652(METXBIODB00730)
| 0.707(CHEMBL3526373) 0.697(CHEMBL517341) 0.668(DBMET02502;METXBIODB00731
)
|
Atherosclerosis treatment | 0.970(CHEMBL2105653) 0.946(DB06154) 0.944(DB00727)
| 0.994(METXBIODB00716) 0.959(DBMET01163) 0.956(DBMET01973
)
|
Nicotinamide phosphoribosyltransferase inhibitor | 0.280(DB00250) 0.181(DB00711) 0.166(METXBIODB03012)
| 0.182(DBMET00014) 0.166(DBMET01043) 0.134(METXBIODB00566
)
|
Histone deacetylase class III inhibitor | 0.826(CHEMBL104) 0.721(METXBIODB01930) 0.542(CHEMBL1140)
| 0.730(METXBIODB00240) 0.542(DBMET02629) 0.394(DBMET02067
)
|
Integrin alpha1beta1 antagonist | 0.291(METXBIODB02132) 0.104(DB00731;METXBIODB01155) 0.075(DB04831;METXBIODB01466)
| 0.116(DBMET01108) 0.097(DBMET01323;DBMET01324;DBMET01831) 0.093(DBMET01477
)
|
Potassium channel (Inward rectifier) 11 blocker | 0.140(METXBIODB00565) 0.067(METXBIODB01439) 0.035(DB00501)
| 0.364(METXBIODB00566) 0.039(METXBIODB01437) 0.035(DBMET03242;DBMET03243
)
|
Phosphodiesterase 3B inhibitor | 0.876(DB00922) 0.774(DB00261) 0.688(DB00862)
| 0.972(DBMET00498) 0.918(DBMET01009;DBMET01161) 0.886(DBMET00973
)
|
Falcipain 2 inhibitor | 0.923(DB06697) 0.917(DB11638) 0.895(METXBIODB00454)
| 0.998(METXBIODB00716) 0.917(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.908(METXBIODB00455
)
|
Factor XI inhibitor | 0.120(DB01202) 0.096(DB03088) 0.091(DB00356)
| 0.933(CHEMBL3527402) 0.263(METXBIODB00936) 0.105(METXBIODB02254
)
|
Phosphodiesterase 3A inhibitor | 0.859(DB00922) 0.721(DB00862) 0.631(METXBIODB00340)
| 0.870(DBMET00973) 0.835(DBMET00974) 0.726(DBMET03640
)
|
Poly(ADP-ribose) polymerase 1 inhibitor | 0.879(DB09074) 0.528(DB00972;METXBIODB00107;METXBIODB01852) 0.504(CHEMBL3527000)
| 0.924(DBMET00949) 0.921(DBMET03439) 0.719(DBMET02815
)
|
Activin receptor-like kinase 2 inhibitor | 0.523(DB08865) 0.315(DB09073) 0.305(METXBIODB00176)
| 0.489(DBMET02351;DBMET02358) 0.468(DBMET03537) 0.314(CHEMBL3040018;DBMET00025
)
|
Secretase gamma inhibitor | 0.151(METXBIODB00216) 0.143(METXBIODB02298) 0.117(METXBIODB01436)
| 0.657(CHEMBL3526811) 0.636(CHEMBL3544729) 0.579(DBMET00171;DBMET00172
)
|
MAP kinase 3 inhibitor | 0.391(DB00352) 0.369(CHEMBL727) 0.286(DB02377)
| 0.391(DBMET02095) 0.381(DBMET02094) 0.357(DBMET02099
)
|
Sodium channel (voltage-gated) blocker | 0.411(METXBIODB01389) 0.397(CHEMBL118;DB00482) 0.388(METXBIODB02333)
| 0.388(DB00891) 0.371(DBMET01730) 0.365(CHEMBL745;DBMET00165
)
|
Phosphodiesterase 2A inhibitor | 0.451(DB00862) 0.341(DB00853) 0.321(METXBIODB00487)
| 0.462(DBMET03640) 0.383(DBMET00498) 0.341(DBMET03266;DBMET03267;DBMET03268;DBMET03269
)
|
Syk tyrosine kinase inhibitor | 0.391(DB12010) 0.240(DB12141) 0.236(DB11763)
| 0.664(DBMET02094) 0.663(DBMET02099) 0.561(DBMET02095
)
|
p38 MAP kinase inhibitor | 0.641(METXBIODB00513) 0.595(DB04951) 0.469(METXBIODB00295)
| 0.674(DBMET01199) 0.593(DBMET01434) 0.541(METXBIODB01222
)
|
LIM domain kinase 1 inhibitor | 0.689(DB08912) 0.345(CHEMBL741;DB00555) 0.329(METXBIODB00293)
| 0.508(DBMET03510) 0.463(DBMET03512) 0.423(CHEMBL3526371
)
|
Immunomodulator | 0.965(CHEMBL88;DB00531;METXBIODB00960) 0.962(DB12473) 0.894(DB00631)
| 0.982(CHEMBL3526838) 0.965(DBMET01683) 0.923(CHEMBL3706475
)
|
Heat shock protein 90 antagonist | 0.994(CHEMBL383824) 0.857(CHEMBL467399) 0.517(METXBIODB02376)
| 0.990(CHEMBL3526785) 0.982(CHEMBL3526786) 0.976(CHEMBL3527105
)
|
DNA polymerase III polC-type inhibitor | 0.518(METXBIODB02699) 0.478(METXBIODB02733;METXBIODB02772;METXBIODB02922) 0.337(DB14921)
| 0.293(DBMET03497) 0.290(DBMET03496) 0.074(DBMET03498
)
|
Male reproductive disfunction treatment | 0.950(DB00862) 0.947(DB00727) 0.926(DB00820)
| 0.965(CHEMBL3526838) 0.951(DBMET03640) 0.947(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598
)
|
Opioid kappa receptor antagonist | 0.994(DB00921) 0.979(DB00704) 0.975(METXBIODB01912)
| 0.975(DBMET00174) 0.957(DBMET00321;METXBIODB01140) 0.939(DBMET00760
)
|
Opioid mu receptor antagonist | 0.994(DB00704) 0.987(DB00921;DB01192) 0.972(DB01183)
| 0.987(DBMET00321;METXBIODB01140) 0.974(DBMET00760) 0.947(DBMET00427;DBMET02514
)
|
Protein kinase (CK2) alpha inhibitor | 0.484(DB00962;METXBIODB01722) 0.466(DB01685;METXBIODB02526) 0.405(METXBIODB02932)
| 0.594(DBMET00399) 0.570(DBMET03526) 0.506(METXBIODB01723
)
|
Polo-like kinase-2 inhibitor | 0.173(DB06595) 0.157(DB00889;METXBIODB00874) 0.143(METXBIODB01425)
| 0.337(DBMET02759) 0.189(CHEMBL3542324) 0.153(DBMET03436
)
|
Nav1.7 sodium channel blocker | 0.282(METXBIODB01389) 0.264(METXBIODB02333) 0.259(METXBIODB00568)
| 0.264(DB00891) 0.228(METXBIODB00569) 0.223(METXBIODB01366
)
|
5 Hydroxytryptamine 7 antagonist | 0.932(METXBIODB00475) 0.922(DB13345) 0.845(METXBIODB00369)
| 0.928(METXBIODB00477) 0.926(METXBIODB00476) 0.832(DBMET02090
)
|
Vanilloid antagonist | 0.446(DB00705;METXBIODB00682) 0.423(DB12015) 0.324(DB09048)
| 0.382(DBMET02571) 0.366(DBMET01380) 0.365(DBMET00360;METXBIODB00684
)
|
Caspase 6 inhibitor | 0.047(DB09149) 0.036(DB00121) 0.033(DB03766)
| 0.055(CHEMBL3526370;DBMET00169;DBMET01838) 0.054(DBMET01427;DBMET01477) 0.053(DBMET01476
)
|
Phosphodiesterase 5A inhibitor | 0.950(DB00862) 0.942(DB00820) 0.936(DB00203)
| 0.949(DBMET03640) 0.942(DBMET03416) 0.941(DBMET00421;METXBIODB01331
)
|
Phosphodiesterase V inhibitor | 0.953(DB00820) 0.948(DB00862) 0.934(DB00203)
| 0.953(DBMET03416) 0.947(DBMET03640) 0.940(DBMET00421;METXBIODB01331
)
|
Phosphodiesterase II inhibitor | 0.466(DB00862) 0.350(DB00853) 0.331(METXBIODB00487)
| 0.475(DBMET03640) 0.392(DBMET00498) 0.350(DBMET03266;DBMET03267;DBMET03268;DBMET03269
)
|
Retinoic acid receptor antagonist | 0.890(DB06755) 0.887(DB00755;DB00982;METXBIODB00937) 0.812(METXBIODB01691)
| 0.887(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.867(DBMET03633) 0.838(DBMET00455;DBMET02550;DBMET02552;DBMET03635;DBMET03638
)
|
Antiamyloidogenic | 0.884(METXBIODB02544) 0.858(DB00762;METXBIODB00933) 0.782(DB09298)
| 0.913(METXBIODB02545) 0.907(DBMET01681;METXBIODB00934) 0.884(DBMET01143
)
|
Antischistosomal | 0.835(DB11638) 0.824(DB06697) 0.810(METXBIODB00454)
| 0.835(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.831(METXBIODB00455) 0.795(DBMET00827
)
|
Purinergic P2X agonist | 0.253(DB00242) 0.220(DB00631) 0.137(DB00640)
| 0.590(DBMET00677) 0.528(DB00171) 0.429(DBMET00769
)
|
Caspase 9 inhibitor | 0.176(DB05521) 0.163(DB06154) 0.157(DB03766)
| 0.652(DBMET00986) 0.275(DBMET01476) 0.232(DBMET01477
)
|
5 Hydroxytryptamine 1B agonist | 0.943(DB13345) 0.917(METXBIODB00475) 0.908(METXBIODB00369)
| 0.955(DBMET02090) 0.942(METXBIODB00476) 0.936(METXBIODB00370
)
|
KiSS-1 receptor antagonist | 0.037(DB06824) 0.035(DB12783) 0.026(METXBIODB01173)
| 0.063(DBMET02761) 0.044(DBMET02067) 0.030(DBMET00502
)
|
Fibroblast growth factor 3 antagonist | 0.959(DB12147) 0.293(DB00619) 0.243(DB14840)
| 0.889(DBMET03649) 0.744(DBMET03650) 0.293(CHEMBL941
)
|
Potassium channel (Inward rectifier) 1 blocker | 0.060(DB00533) 0.058(DB09348) 0.056(DB00688)
| 0.059(DBMET02690) 0.058(DBMET00767;METXBIODB01064) 0.056(DBMET02607
)
|
Antiviral (Influenza A) | 0.921(DB13997) 0.893(DB00198) 0.806(DB06799)
| 0.934(DB15675) 0.910(DBMET02218) 0.674(DBMET03320
)
|
ATPase (Vacuolar H+) inhibitor | 0.232(DB00581) 0.203(METXBIODB00831) 0.199(METXBIODB01833)
| 0.281(METXBIODB01144) 0.219(DBMET03415) 0.203(CHEMBL3544602;CHEMBL3544709;CHEMBL3544837;DBMET01753;METXBIODB00832;METXBIODB01381
)
|
Adenine nucleotide translocase inhibitor | 0.796(CHEMBL1430) 0.369(METXBIODB01301) 0.203(DB01250)
| 0.867(CHEMBL3544554) 0.823(CHEMBL3544532) 0.759(CHEMBL3544531
)
|
Histone deacetylase 1 inhibitor | 0.987(DB02546) 0.938(DB05015) 0.874(CHEMBL483254)
| 0.994(CHEMBL3526395) 0.964(CHEMBL3526396) 0.941(CHEMBL3526943
)
|
MAP kinase kinase 2 inhibitor | 0.891(DB11689) 0.834(DB08911) 0.641(CHEMBL535)
| 0.914(DBMET03643) 0.905(DBMET03641) 0.840(DBMET03102
)
|
Integrin alpha5beta1 antagonist | 0.525(METXBIODB01514) 0.466(CHEMBL1430) 0.195(DB06151)
| 0.554(METXBIODB01515) 0.301(DBMET00503) 0.285(METXBIODB01517
)
|
Dopamine D5 antagonist | 0.983(METXBIODB00475) 0.904(DB13345) 0.855(DB00714)
| 0.974(METXBIODB00477) 0.973(METXBIODB00476) 0.941(CHEMBL3527031;DBMET00096
)
|
Opioid delta receptor antagonist | 0.985(DB00704) 0.971(DB01192) 0.953(DB01183)
| 0.971(DBMET00321;METXBIODB01140) 0.934(DBMET00760) 0.915(DBMET00424
)
|
Antibiotic Penicillin-like | 0.369(CHEMBL174) 0.311(DB01060) 0.310(CHEMBL29;DB01053)
| 0.667(DBMET00758) 0.374(DBMET02999) 0.296(DBMET02997
)
|
Opioid antagonist | 0.994(DB00921) 0.992(DB00704) 0.984(DB01192)
| 0.984(DBMET00321;METXBIODB01140) 0.981(DBMET00174) 0.973(DBMET00760
)
|
Antiprotozoal (Histomonas) | 0.824(DB00614) 0.630(METXBIODB02480) 0.561(DB12265)
| 0.601(DBMET01012) 0.527(DBMET03402;DBMET03403) 0.406(METXBIODB02481
)
|
Myocardial infarction treatment | 0.960(CHEMBL1201772;DB06209) 0.958(DB00727) 0.882(METXBIODB01752)
| 0.966(DBMET00483) 0.961(DBMET01163) 0.959(METXBIODB01308
)
|
Antihypertriglyceridemic | 0.846(CHEMBL672;DB01039) 0.829(DB11936) 0.824(METXBIODB00169)
| 0.850(CHEMBL3544523) 0.845(DBMET01300) 0.827(DBMET01365
)
|
Opioid mu receptor agonist | 0.994(DB00921) 0.989(METXBIODB01912) 0.942(METXBIODB03062)
| 0.989(DBMET00174) 0.942(DBMET00176) 0.930(DBMET00321;METXBIODB01140
)
|
H+/K+-transporting ATPase inhibitor | 0.962(CHEMBL1503;DB00338;DB00736;METXBIODB00771) 0.938(DB00213;METXBIODB00543) 0.927(METXBIODB01973)
| 0.926(DBMET00186;DBMET01657;METXBIODB00774) 0.865(METXBIODB00032) 0.862(DBMET01822
)
|
Cyclin-dependent kinase 9 inhibitor | 0.408(DB09073) 0.342(METXBIODB02333) 0.283(DB08912)
| 0.382(DBMET02380) 0.344(DBMET00028) 0.342(DB00891
)
|
DNA polymerase III inhibitor | 0.442(DB14921) 0.401(METXBIODB02699) 0.386(METXBIODB02733;METXBIODB02772;METXBIODB02922)
| 0.379(DBMET03496;DBMET03497) 0.265(METXBIODB01456) 0.239(DBMET03498
)
|
Xanthine oxidase substrate | 0.894(CHEMBL727) 0.857(DB01033) 0.793(DB00352)
| 0.976(CHEMBL1426) 0.909(CHEMBL1230639) 0.875(DBMET00611
)
|
NOS3 expression enhancer | 0.992(METXBIODB00715) 0.794(METXBIODB02717) 0.770(DB01234;METXBIODB00696)
| 0.930(METXBIODB00716) 0.784(DBMET01434) 0.770(DB00443
)
|
Antiprotozoal (Leishmania) | 0.952(DB06697) 0.951(DB11638) 0.942(METXBIODB00454)
| 0.951(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.947(METXBIODB00455) 0.913(CHEMBL3706540;DBMET01123
)
|
Sodium/hydrogen exchanger 5 inhibitor | 0.322(DB11362) 0.239(METXBIODB00562) 0.212(METXBIODB01173)
| 0.346(DBMET01403) 0.294(CHEMBL3544893;DBMET02468) 0.280(DBMET02144
)
|
Excitatory amino acid transporter 1 inhibitor | 0.365(DB00130) 0.337(DB00129) 0.112(CHEMBL109;DB00313;METXBIODB01559)
| 0.414(DB00142) 0.295(DB00123) 0.224(DBMET00486
)
|
CDK4/cyclin D3 inhibitor | 0.544(DB09073) 0.050(METXBIODB02408) 0.049(METXBIODB01812)
| 0.536(DBMET02373) 0.481(DBMET02380) 0.280(DBMET02376
)
|
Histone deacetylase class IIb inhibitor | 0.975(DB02546) 0.821(DB05015) 0.539(CHEMBL483254)
| 0.994(CHEMBL3526395) 0.948(CHEMBL3526396) 0.924(CHEMBL3526397
)
|
Histone deacetylase class II inhibitor | 0.970(DB02546) 0.916(DB05015) 0.690(CHEMBL483254)
| 0.986(CHEMBL3526395) 0.916(DBMET01443) 0.864(CHEMBL3526396
)
|
Analgesic, opioid | 0.993(DB00921) 0.987(DB00704;METXBIODB01912) 0.983(DB01192)
| 0.987(DBMET00174) 0.986(DBMET00424) 0.983(DBMET00321;METXBIODB01140
)
|
Histone deacetylase 6 inhibitor | 0.976(DB02546) 0.821(DB05015) 0.536(CHEMBL483254)
| 0.994(CHEMBL3526395) 0.950(CHEMBL3526396) 0.925(CHEMBL3526397
)
|
Prokinetic | 0.908(CHEMBL532;DB00199) 0.900(CHEMBL1741;DB01211;METXBIODB00619) 0.888(DB00778;METXBIODB01286)
| 0.896(CHEMBL3544830;DBMET00356;METXBIODB00620) 0.890(CHEMBL2063468;DBMET01656) 0.889(CHEMBL3706534
)
|
Trypsin I inhibitor | 0.750(CHEMBL169901;DB04840) 0.224(DB13729) 0.120(METXBIODB01173)
| 0.620(CHEMBL3527068) 0.602(CHEMBL1710849;DBMET01641) 0.576(CHEMBL3527224
)
|
Phosphodiesterase 4D inhibitor | 0.860(DB01656) 0.792(METXBIODB01645) 0.765(DB00862)
| 0.925(DBMET00997) 0.853(CHEMBL1207) 0.781(DBMET03640
)
|
Complement C3a chemotactic receptor antagonist | 0.234(METXBIODB01173) 0.178(DB00129) 0.156(METXBIODB00562)
| 0.567(DBMET02708) 0.470(DBMET00502) 0.461(DBMET02707
)
|
mTOR inhibitor | 0.771(CHEMBL1258517) 0.597(METXBIODB00817) 0.529(CHEMBL413;DB00877;METXBIODB01375)
| 0.706(CHEMBL3526762) 0.584(METXBIODB00819) 0.529(DBMET00628;METXBIODB00818
)
|
Fibrosis treatment | 0.727(METXBIODB01514) 0.720(DB15456) 0.638(CHEMBL1308;DB01213)
| 0.733(METXBIODB01515) 0.720(DBMET03244;DBMET03245) 0.656(METXBIODB01517
)
|
Poly(ADP-ribose) polymerase inhibitor | 0.903(DB09074) 0.557(DB00972;METXBIODB00107;METXBIODB01852) 0.556(CHEMBL3527000)
| 0.939(DBMET03439) 0.932(DBMET00949) 0.755(DBMET02815
)
|
Neurokinin 3 antagonist | 0.341(DB09048) 0.266(CHEMBL515387) 0.131(DB01058)
| 0.333(DBMET01379) 0.313(CHEMBL3526734) 0.283(DBMET01380
)
|
Dipeptidyl peptidase VIII inhibitor | 0.733(DB01261) 0.667(DB04876) 0.616(CHEMBL385517;DB06335)
| 0.608(CHEMBL3350936;DBMET00459) 0.326(CHEMBL3542418) 0.320(DBMET02432
)
|
Andropause treatment | 0.463(DB00539) 0.189(METXBIODB00273) 0.173(METXBIODB02451)
| 0.405(DBMET00394) 0.269(DBMET01828;METXBIODB01998) 0.177(DBMET00249
)
|
Protein kinase (CK2) inhibitor | 0.343(DB00962;METXBIODB01722) 0.339(DB01685;METXBIODB02526) 0.307(METXBIODB02932)
| 0.468(DBMET03526) 0.451(DBMET00399) 0.382(METXBIODB01723
)
|
Dipeptidyl peptidase IX inhibitor | 0.662(DB04876) 0.661(CHEMBL385517;DB06335) 0.605(DB01261)
| 0.651(CHEMBL3350936;DBMET00459) 0.287(CHEMBL3542418) 0.184(DBMET03322
)
|
Purinergic P2Y agonist | 0.064(DB15661) 0.050(DB00640) 0.043(CHEMBL1076930)
| 0.749(DB00171) 0.712(CHEMBL1774;DBMET02000;DBMET03590) 0.611(DB01861;DB03501
)
|
Baculoviral IAP repeat-containing protein 2 inhibitor | 0.164(DB01577;METXBIODB01797) 0.039(DB00852;DB01364) 0.031(METXBIODB01521)
| 0.164(DB09571;DBMET00634) 0.030(DBMET00735;METXBIODB01522;METXBIODB01798) 0.026(CHEMBL3544890;DBMET02973
)
|
Prostatic (benign) hyperplasia treatment | 0.975(CHEMBL710;DB01216) 0.894(METXBIODB00826) 0.826(CHEMBL1200374)
| 0.936(CHEMBL4525755) 0.932(CHEMBL3542374) 0.865(DBMET00369
)
|
Interleukin 6 antagonist | 0.874(CHEMBL532;DB00199) 0.873(CHEMBL1741;DB01211;METXBIODB00619) 0.868(DB00778;METXBIODB01286)
| 0.861(CHEMBL2063468;DBMET01656) 0.859(CHEMBL2022715;DBMET00357;METXBIODB00621) 0.855(METXBIODB01287
)
|
Sodium channel blocker | 0.453(METXBIODB01389) 0.435(METXBIODB02333) 0.418(DB01015;METXBIODB01391)
| 0.435(DB00891) 0.367(DBMET01730) 0.362(DBMET03575
)
|
CC chemokine receptor antagonist | 0.934(DB06652) 0.570(DB00836) 0.481(METXBIODB00192)
| 0.975(DBMET00080) 0.966(DBMET00083) 0.958(DBMET00081
)
|
5 Hydroxytryptamine 1F agonist | 0.382(METXBIODB00178) 0.230(DB00669) 0.142(METXBIODB02345)
| 0.477(DBMET03516) 0.200(DBMET03527) 0.112(METXBIODB00180
)
|
MAP kinase kinase 1 inhibitor | 0.741(DB11689) 0.447(DB08911) 0.305(DB06616)
| 0.708(DBMET03102) 0.548(DBMET03641) 0.469(DBMET03643
)
|
Purinergic P2 agonist | 0.073(DB15661) 0.060(DB00640) 0.053(DB00631)
| 0.757(DB00171) 0.714(CHEMBL1774;DBMET02000;DBMET03590) 0.608(DB01861;DB03501
)
|
Purinergic receptor agonist | 0.073(DB15661) 0.060(DB00640) 0.053(DB00631)
| 0.757(DB00171) 0.714(CHEMBL1774;DBMET02000;DBMET03590) 0.608(DB01861;DB03501
)
|
Contraceptive | 0.992(METXBIODB01137) 0.974(DB00294) 0.969(DB00367)
| 0.978(METXBIODB01138) 0.969(DB09389) 0.964(DBMET00723;DBMET00724;DBMET01642;DBMET01643;METXBIODB00695
)
|
Potassium channel (Ca-activated) blocker | 0.902(CHEMBL104) 0.403(METXBIODB00008) 0.375(METXBIODB02426)
| 0.437(DBMET00675) 0.334(DB06457) 0.328(CHEMBL2030560
)
|
CXC chemokine 1 receptor antagonist | 0.357(CHEMBL104) 0.257(METXBIODB00075) 0.230(METXBIODB00793)
| 0.260(METXBIODB00076) 0.256(CHEMBL1379) 0.235(METXBIODB00794
)
|
Acute neurologic disorders treatment | 0.908(METXBIODB02793) 0.843(METXBIODB01471) 0.834(CHEMBL49563;DB00163)
| 0.855(METXBIODB02794) 0.845(CHEMBL527285;DBMET02040;DBMET02324) 0.835(DBMET02039;DBMET02323
)
|
Cardioprotectant | 0.998(DB01236) 0.990(DB00727) 0.976(DB09282)
| 0.990(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.986(DB13400) 0.938(METXBIODB01068
)
|
Retinopathy treatment | 0.843(DB00700) 0.747(DB00727) 0.652(DB01194)
| 0.765(DBMET01655) 0.761(DBMET01654) 0.747(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598
)
|
Egl nine homolog 2 inhibitor | 0.098(DB11901) 0.083(DB11682) 0.080(CHEMBL467399)
| 0.107(DBMET03639) 0.101(DBMET01923) 0.087(CHEMBL375462
)
|
CYP2D6 inhibitor | 0.894(CHEMBL163;DB00503) 0.840(DB00468;DB00908;METXBIODB01215;METXBIODB01218) 0.827(DB00857)
| 0.877(DBMET01731;METXBIODB01217) 0.875(CHEMBL3544832) 0.840(DBMET00382;DBMET00383;METXBIODB01216;METXBIODB01219
)
|
Protein kinase C beta I inhibitor | 0.722(METXBIODB01288) 0.133(DB06595) 0.046(METXBIODB01320)
| 0.614(METXBIODB01289) 0.276(DBMET01440) 0.092(DBMET01441
)
|
Dopamine D1 agonist | 0.483(DB00714) 0.400(DB13345) 0.288(METXBIODB00369)
| 0.423(DBMET03133) 0.333(METXBIODB02098) 0.327(METXBIODB00665
)
|
Leucine-rich repeat kinase 2 inhibitor | 0.480(DB12267) 0.365(DB08877) 0.188(DB11986)
| 0.288(DBMET02094) 0.270(DBMET03650) 0.224(DBMET03710
)
|
Free fatty acid receptor 2 antagonist | 0.014(METXBIODB01939) 0.012(METXBIODB01859) 0.007(METXBIODB01882;METXBIODB02132)
| 0.011(METXBIODB01941) 0.010(METXBIODB01940) 0.008(DBMET01477
)
|
Protein kinase C alpha inhibitor | 0.970(DB06595) 0.425(METXBIODB01288) 0.297(DB00437)
| 0.970(DBMET01440) 0.969(DBMET01441) 0.745(CHEMBL3544902;DBMET02826
)
|
Retinoic acid receptor gamma antagonist | 0.934(DB06755) 0.914(DB00755;DB00982;METXBIODB00937) 0.873(METXBIODB01691)
| 0.914(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.867(DBMET03633) 0.839(DBMET00453
)
|
Purinergic P2X7 antagonist | 0.206(METXBIODB02132) 0.203(DB11121) 0.202(METXBIODB00192)
| 0.183(DBMET01613) 0.128(DBMET02432) 0.116(METXBIODB00566
)
|
MAP kinase kinase kinase inhibitor | 0.353(DB08865) 0.328(DB14840) 0.269(DB06201)
| 0.376(DBMET03101) 0.340(METXBIODB01325) 0.335(CHEMBL3526371
)
|
Estrogen-related receptor beta antagonist | 0.506(CHEMBL83;DB00675;METXBIODB01400) 0.473(METXBIODB00268) 0.453(METXBIODB01404)
| 0.913(CHEMBL50995;DBMET02716) 0.539(DBMET02715) 0.473(CHEMBL2137046;DBMET00030;METXBIODB01402
)
|
CXC chemokine receptor agonist | 0.507(DB00730) 0.054(DB11932) 0.049(METXBIODB00628)
| 0.211(DBMET01768) 0.092(CHEMBL3706522) 0.071(CHEMBL3706476
)
|
Oxytocin antagonist | 0.682(DB01744;DB11345;METXBIODB01913) 0.633(DB09059) 0.299(DB00918)
| 0.288(DBMET00347) 0.276(CHEMBL237772) 0.244(DBMET00840
)
|
Integrin antagonist | 0.870(METXBIODB01514) 0.790(METXBIODB00029) 0.531(DB00731)
| 0.968(METXBIODB01516) 0.888(METXBIODB01515) 0.684(METXBIODB00030
)
|
Retinoic acid alpha receptor antagonist | 0.908(DB00755;DB00982;METXBIODB00937) 0.902(DB06755) 0.835(METXBIODB01691)
| 0.908(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.889(DBMET03633) 0.847(DBMET00453
)
|
Protein kinase C eta inhibitor | 0.960(DB06595) 0.342(METXBIODB01288) 0.203(DB00495;METXBIODB02133)
| 0.965(DBMET01440) 0.907(DBMET01441) 0.302(METXBIODB01289
)
|
Acute respiratory distress syndrome (ARDS) treatment | 0.805(DB06756) 0.794(CHEMBL532;DB00199) 0.786(METXBIODB01297)
| 0.995(METXBIODB02429) 0.773(CHEMBL2063468;DBMET01656) 0.758(CHEMBL2022715;DBMET00357;METXBIODB00621
)
|
CYP24 inhibitor | 0.642(CHEMBL820) 0.566(CHEMBL846;DB00136) 0.534(DB00153;METXBIODB01575;METXBIODB02762)
| 0.574(CHEMBL3544529;DBMET00575) 0.540(CHEMBL3351075;CHEMBL3542403) 0.536(DBMET02435
)
|
Neurokinin 2 antagonist | 0.254(CHEMBL515387) 0.192(DB00216) 0.179(DB01058)
| 0.405(CHEMBL3526734) 0.357(CHEMBL3527515) 0.264(CHEMBL3526894
)
|
Acetyl-CoA carboxylase 2 inhibitor | 0.637(METXBIODB01344) 0.292(METXBIODB00328) 0.067(CHEMBL1308;DB01213)
| 0.620(METXBIODB01345) 0.257(METXBIODB00329) 0.086(DBMET01457
)
|
DNA polymerase III subunit alpha inhibitor | 0.046(METXBIODB01455) 0.023(METXBIODB00487) 0.021(METXBIODB02420)
| 0.202(METXBIODB01456) 0.034(DBMET00498) 0.028(METXBIODB01458
)
|
MAP kinase kinase inhibitor | 0.909(DB11689) 0.662(DB08911) 0.485(DB08881)
| 0.861(DBMET03102) 0.748(DBMET03641) 0.720(DBMET03643
)
|
Adenosine A3 receptor agonist | 0.573(DB00242) 0.516(DB00631) 0.421(DB00640)
| 0.305(DBMET00419) 0.276(CHEMBL3526900) 0.274(DBMET00677
)
|
Bipolar disorder treatment | 0.870(DB00273) 0.850(METXBIODB00255) 0.808(CHEMBL715;DB00334;METXBIODB01125)
| 0.972(DBMET01310) 0.970(DBMET00189;METXBIODB00119) 0.945(DBMET01309
)
|
Stroke treatment | 0.962(METXBIODB02424) 0.952(DB13853) 0.922(METXBIODB01752)
| 0.993(METXBIODB01298) 0.963(DBMET02057) 0.942(DBMET00483
)
|
Antineoplastic (sarcoma) | 0.984(DB01181;METXBIODB00963) 0.980(METXBIODB03049) 0.975(DB12902;METXBIODB00967)
| 0.992(DBMET01127) 0.980(DBMET00024;METXBIODB00966) 0.977(CHEMBL87658;DBMET00020;DBMET00021;METXBIODB00961;METXBIODB00964
)
|
Adrenaline uptake inhibitor | 0.973(METXBIODB01237) 0.906(DB06700) 0.892(CHEMBL259209;DB04896;DB08918)
| 0.984(DBMET03469;DBMET03471) 0.977(METXBIODB01238) 0.959(DBMET02412
)
|
Antiprotozoal (Trypanosoma) | 0.975(DB11637) 0.946(DB05154) 0.816(DB01131)
| 0.912(CHEMBL3526480;CHEMBL4525783) 0.815(DBMET01683) 0.773(CHEMBL3706540;DBMET01123
)
|
TRKA antagonist | 0.452(DB08865) 0.437(DB06595) 0.267(CHEMBL535)
| 0.404(DBMET03537) 0.341(DBMET01441) 0.321(CHEMBL3542333
)
|
Trypsin inhibitor | 0.787(CHEMBL169901;DB04840) 0.419(METXBIODB02662) 0.282(METXBIODB00034)
| 0.748(METXBIODB00590) 0.643(CHEMBL3527068) 0.613(CHEMBL1710849;DBMET01641
)
|
Bcr-Abl kinase inhibitor | 0.807(DB00619) 0.579(DB01254) 0.227(DB00398)
| 0.807(CHEMBL941) 0.682(DBMET00028) 0.647(CHEMBL3040018;DBMET00025
)
|
Chemokine receptor agonist | 0.558(DB00730) 0.548(CHEMBL104) 0.111(DB06652)
| 0.275(DBMET01768) 0.184(DBMET00080) 0.156(CHEMBL3706522
)
|
Antiviral (Hepatitis D) | 0.720(METXBIODB01187) 0.582(DB00300) 0.532(DB09299)
| 0.495(DBMET03569) 0.471(DBMET01177) 0.461(DBMET01425
)
|
Insulin like growth factor 1 antagonist | 0.996(DB12267) 0.259(DB05294) 0.240(DB00619;DB11986)
| 0.263(DBMET02094) 0.240(CHEMBL941) 0.228(DBMET00935
)
|
Bcl2 antagonist | 0.900(DB11581) 0.312(CHEMBL88;DB00531;METXBIODB00960) 0.302(METXBIODB02351)
| 0.358(DBMET02996) 0.312(DBMET01683) 0.302(METXBIODB01918
)
|
Cyclin D3 inhibitor | 0.869(DB09073) 0.193(DB12010) 0.152(DB00592)
| 0.849(DBMET02380) 0.848(DBMET02373) 0.841(DBMET02378
)
|
Vasopressin 1A antagonist | 0.702(DB01744;DB11345;METXBIODB01913) 0.594(CHEMBL49429) 0.588(DB09059)
| 0.336(CHEMBL237772) 0.270(CHEMBL3526965) 0.262(CHEMBL3246317;DBMET00112
)
|
Toll-Like receptor 7 antagonist | 0.414(CHEMBL1455) 0.239(DB00592) 0.215(METXBIODB01229)
| 0.241(CHEMBL3544874) 0.229(DBMET03527) 0.215(DBMET01732;DBMET01825;METXBIODB01849
)
|
Rho-associated kinase I inhibitor | 0.308(DB08877) 0.182(DB00619) 0.168(METXBIODB00935)
| 0.282(CHEMBL3040018;DBMET00025) 0.280(DBMET00360;METXBIODB00684) 0.233(DBMET02815
)
|
MAP3K9 inhibitor | 0.855(DB06595) 0.373(METXBIODB00724;METXBIODB01778) 0.320(DB12332)
| 0.828(DBMET01441) 0.547(DBMET01440) 0.322(DBMET03519
)
|
Hypoglycemic | 0.926(CHEMBL1770248;DB11827) 0.923(DB01914;DB09419;DB11735) 0.917(METXBIODB00090;METXBIODB03094)
| 0.995(METXBIODB00716) 0.934(CHEMBL3527603;DBMET01906) 0.928(DBMET01300
)
|
Glutamate (mGluR) agonist | 0.528(DB00347) 0.441(DB00339) 0.396(DB00799)
| 0.555(DBMET01139) 0.486(DBMET01005) 0.449(DBMET03065
)
|
Antiemetic | 0.982(DB09291) 0.975(DB00673) 0.920(METXBIODB00037)
| 0.992(DBMET01398) 0.920(DBMET00349;DBMET01590) 0.912(METXBIODB00038
)
|
Opioid kappa receptor agonist | 0.990(DB00921) 0.957(METXBIODB01912) 0.908(METXBIODB03062)
| 0.957(DBMET00174) 0.885(DBMET00176) 0.834(METXBIODB02676
)
|
Insulin growth factor antagonist | 0.996(DB12267) 0.265(DB05294) 0.259(DB11986)
| 0.269(DBMET02094) 0.243(CHEMBL941) 0.236(DBMET02095
)
|
Antiviral (RSV) | 0.331(DB00709) 0.297(DB14761) 0.277(DB00879)
| 0.371(DB11100) 0.351(DBMET00899) 0.320(DBMET00898
)
|
MAP kinase kinase 8 inhibitor | 0.193(DB00730) 0.135(DB11763) 0.127(METXBIODB00935)
| 0.292(DB00166) 0.287(CHEMBL3186899) 0.235(DB06457
)
|
Kallikrein 1 inhibitor | 0.499(CHEMBL169901;DB04840) 0.189(METXBIODB01173) 0.159(DB13729)
| 0.475(DBMET03379) 0.452(DBMET03378) 0.298(CHEMBL3527068
)
|
Phosphodiesterase XI inhibitor | 0.750(DB00862) 0.695(DB00820) 0.259(DB01058)
| 0.759(DBMET03640) 0.695(DBMET03416) 0.293(CHEMBL3526358
)
|
Phosphodiesterase 11A inhibitor | 0.750(DB00862) 0.695(DB00820) 0.259(DB01058)
| 0.759(DBMET03640) 0.695(DBMET03416) 0.293(CHEMBL3526358
)
|
Amyloid beta precursor protein antagonist | 0.862(DB06799) 0.712(DB00712;DB05289;METXBIODB00141;METXBIODB02725) 0.696(METXBIODB03069)
| 0.731(DBMET01434) 0.710(DBMET00155;METXBIODB00136;METXBIODB01971) 0.696(DBMET00151;DBMET01566;METXBIODB00142
)
|
Leukotriene A4 hydrolase inhibitor | 0.811(DB01197) 0.644(DB06151) 0.399(METXBIODB00328)
| 0.706(DBMET00803) 0.623(DBMET00508) 0.608(DBMET00503
)
|
Thrombin inhibitor | 0.806(CHEMBL169901;DB04840) 0.415(DB00188) 0.397(DB06695)
| 0.672(METXBIODB00590) 0.614(CHEMBL3527068) 0.585(CHEMBL1710849;DBMET01641
)
|
Topoisomerase I inhibitor | 0.979(METXBIODB02544) 0.851(DB00762;METXBIODB00933) 0.752(DB09117)
| 0.979(DBMET01143) 0.875(METXBIODB02545) 0.761(DBMET01681;METXBIODB00934
)
|
Glucagon agonist | 0.023(DB00130) 0.017(DB11296) 0.014(METXBIODB00189)
| 0.073(CHEMBL3706506;DBMET01110) 0.063(DBMET00506) 0.040(DBMET01483
)
|
HCV NS5A inhibitor | 0.082(DB11978) 0.061(DB11703) 0.050(CHEMBL385517;DB06335)
| 0.086(DBMET02889) 0.078(DBMET03658) 0.061(DBMET02884
)
|
Vasopressin 1 antagonist | 0.693(DB01744;DB11345;METXBIODB01913) 0.643(DB09059) 0.562(CHEMBL49429)
| 0.378(CHEMBL237772) 0.341(CHEMBL3246317;DBMET00112) 0.317(DBMET00396
)
|
Protein-tyrosine phosphatase inhibitor | 0.767(METXBIODB01081) 0.734(CHEMBL820) 0.659(METXBIODB02871)
| 0.745(METXBIODB00356) 0.722(DBMET01434) 0.714(METXBIODB02931
)
|
5 Hydroxytryptamine agonist | 0.911(DB13345) 0.905(METXBIODB01229) 0.885(METXBIODB01680)
| 0.992(CHEMBL3526304) 0.954(METXBIODB01682) 0.905(DBMET01732;DBMET01825;METXBIODB01849
)
|
Antineurogenic pain | 0.958(DB00909;DB01221;DB11823;METXBIODB00118) 0.939(METXBIODB01177) 0.915(METXBIODB01179;METXBIODB01881)
| 0.980(DBMET00189;DBMET01310;METXBIODB00119) 0.965(DBMET00190;DBMET01309) 0.962(DBMET01308
)
|
EphB4 antagonist | 0.678(CHEMBL554) 0.677(METXBIODB00866) 0.647(DB05294)
| 0.678(CHEMBL3526614;CHEMBL3526615) 0.599(CHEMBL3527095) 0.579(METXBIODB00868
)
|
Lck kinase inhibitor | 0.662(DB01254) 0.561(DB00575) 0.559(DB08864)
| 0.816(CHEMBL244377) 0.766(CHEMBL1231106) 0.742(DBMET03622
)
|
Granulocyte macrophage colony stimulating factor antagonist | 0.546(DB00619) 0.469(DB12267) 0.355(DB06616)
| 0.559(DBMET00028) 0.546(CHEMBL941) 0.516(DBMET03528
)
|
Heme oxygenase stimulant | 0.222(METXBIODB01177) 0.194(METXBIODB01179;METXBIODB01881) 0.193(METXBIODB01879)
| 0.531(CHEMBL3706457) 0.196(DBMET02110) 0.194(DBMET00888
)
|
Tyrosine-protein kinase receptor antagonist | 0.511(DB06595) 0.507(DB08865) 0.453(DB08877)
| 0.469(DBMET03537) 0.445(DBMET02020) 0.404(DBMET02094
)
|
Cushing's syndrome treatment | 0.983(DB00648) 0.906(DB01011) 0.777(DB00834)
| 0.757(METXBIODB02005) 0.717(DBMET01703) 0.673(DBMET01704
)
|
Amyloid beta aggregation inhibitor | 0.954(METXBIODB02376) 0.933(METXBIODB02142) 0.914(METXBIODB02170)
| 0.958(DB12243) 0.943(DBMET01757) 0.942(METXBIODB03144
)
|
Phosphodiesterase 7B inhibitor | 0.450(METXBIODB02126) 0.447(DB01029;METXBIODB00929) 0.442(METXBIODB02380)
| 0.491(METXBIODB01626) 0.432(DBMET01057) 0.419(DBMET01053;METXBIODB00932
)
|
Complement C5a chemotactic receptor antagonist | 0.184(DB01429) 0.140(DB01591) 0.130(METXBIODB00295)
| 0.201(CHEMBL3527154) 0.167(DBMET01811) 0.124(DBMET01810
)
|
Hepatocyte growth factor antagonist | 0.780(DB08865) 0.541(CHEMBL377300) 0.316(CHEMBL270995)
| 0.698(DBMET03537) 0.632(CHEMBL3526252) 0.631(CHEMBL380905
)
|
Factor III inhibitor | 0.180(METXBIODB02767) 0.168(METXBIODB02294) 0.157(DB14186)
| 0.234(DBMET01180;METXBIODB02015) 0.173(DBMET01535) 0.157(METXBIODB00460
)
|
Telomerase inhibitor | 0.556(METXBIODB02879) 0.543(CHEMBL58) 0.520(METXBIODB02877)
| 0.998(METXBIODB00716) 0.765(METXBIODB01596) 0.623(DBMET00513
)
|
Insulin receptor antagonist | 0.970(DB12267) 0.490(DB11986) 0.336(DB00619)
| 0.336(CHEMBL941) 0.280(CHEMBL3040018;DBMET00025) 0.274(DBMET02746
)
|
Purinergic P2Y1 antagonist | 0.145(DB00242) 0.069(DB06716) 0.066(DB00631)
| 0.298(DBMET00677) 0.245(DBMET02089) 0.241(DBMET00419
)
|
Factor XIa inhibitor | 0.136(CHEMBL169901;DB04840) 0.128(DB00356) 0.126(DB01202)
| 0.689(CHEMBL3527402) 0.316(METXBIODB00936) 0.148(DBMET00166
)
|
Antibiotic Naphthyridine-like | 0.956(DB01155) 0.850(DB00685;METXBIODB02642) 0.170(DB00537)
| 0.600(DBMET00922) 0.364(METXBIODB02643) 0.144(DBMET02516
)
|
Growth hormone secretagogue receptor antagonist | 0.894(DB00191) 0.215(METXBIODB01087) 0.155(DB01255)
| 0.766(DBMET02227) 0.476(DB01365) 0.282(CHEMBL1231106
)
|
Cell adhesion molecule inhibitor | 0.497(METXBIODB01514) 0.445(DB00731) 0.432(METXBIODB00029)
| 0.696(DBMET02880) 0.545(DBMET02881) 0.544(CHEMBL3544550
)
|
Retinoic acid alpha receptor agonist | 0.798(DB06755) 0.788(DB00755;DB00982;METXBIODB00937) 0.771(METXBIODB01691)
| 0.788(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.756(DBMET03633) 0.701(DBMET00453
)
|
Cyclin E1 inhibitor | 0.228(DB09073) 0.170(METXBIODB03012) 0.159(CHEMBL58)
| 0.570(DBMET02996) 0.384(METXBIODB01432) 0.276(DBMET02378
)
|
Opioid agonist | 0.995(DB00921) 0.993(METXBIODB01912) 0.962(METXBIODB03062)
| 0.993(DBMET00174) 0.958(DBMET00176) 0.954(DBMET00424
)
|
HIV-1 integrase (3'-Processing) inhibitor | 0.780(METXBIODB02351) 0.678(METXBIODB02170) 0.649(METXBIODB01964)
| 0.825(CHEMBL1176) 0.744(DBMET03078) 0.739(METXBIODB02254
)
|
NMDA 2B receptor antagonist | 0.686(DB00356) 0.669(DB01221;DB11823;METXBIODB00118) 0.656(DB09343)
| 0.734(METXBIODB02506) 0.674(DBMET01411) 0.673(DBMET02101
)
|
Neutropenia treatment | 0.412(METXBIODB01691) 0.382(DB00242) 0.357(CHEMBL64391;DB01167;METXBIODB00524)
| 0.421(CHEMBL3526890) 0.357(CHEMBL4525087;CHEMBL4525088) 0.331(METXBIODB01692;METXBIODB01693
)
|
Smo receptor antagonist | 0.449(DB01026) 0.320(DB08828) 0.275(DB11932)
| 0.527(DBMET02668) 0.508(DBMET00827) 0.458(DBMET02651
)
|
CXC chemokine 3 receptor agonist | 0.031(DB00730) 0.014(METXBIODB00628) 0.006(METXBIODB00070)
| 0.023(DBMET01768) 0.012(CHEMBL3544803) 0.010(METXBIODB00629
)
|
Antidiuretic hormone antagonist | 0.673(DB09059) 0.618(CHEMBL49429) 0.586(DB01744;DB11345;METXBIODB01913)
| 0.632(CHEMBL237772) 0.403(CHEMBL3526965) 0.289(CHEMBL392363
)
|
Renal failure treatment | 0.896(DB15456) 0.802(CHEMBL1639) 0.730(CHEMBL1393;DB00421)
| 0.896(DBMET03244;DBMET03245) 0.881(DBMET01540) 0.798(CHEMBL3507699
)
|
Integrin beta7 antagonist | 0.591(METXBIODB00029) 0.291(METXBIODB02016;METXBIODB02571) 0.118(METXBIODB00253)
| 0.552(METXBIODB00030) 0.248(METXBIODB02018) 0.192(METXBIODB02017
)
|
Growth hormone secretagogue receptor agonist | 0.198(DB00191) 0.134(DB00216) 0.120(METXBIODB00010)
| 0.189(DBMET00088) 0.144(DBMET03226) 0.142(DBMET00081
)
|
Cyclin E inhibitor | 0.578(CHEMBL104) 0.219(DB09073) 0.188(CHEMBL58)
| 0.503(DBMET02996) 0.329(METXBIODB01432) 0.257(DBMET02378
)
|
MAP kinase 11 inhibitor | 0.757(METXBIODB00513) 0.332(DB13228) 0.260(DB12245)
| 0.776(METXBIODB00515) 0.584(METXBIODB00514) 0.396(CHEMBL3544872;CHEMBL457723
)
|
Factor IX inhibitor | 0.039(METXBIODB00207;METXBIODB01680) 0.037(METXBIODB00562) 0.035(METXBIODB00957)
| 0.049(METXBIODB01681) 0.048(DBMET03379;METXBIODB01682) 0.046(DBMET02165
)
|
Sepsis treatment | 0.732(DB02703) 0.720(DB01221;DB11823;METXBIODB00118) 0.712(DB06590)
| 0.734(DBMET03082) 0.673(DBMET00191) 0.671(DBMET03096
)
|
5 Hydroxytryptamine uptake inhibitor | 0.968(METXBIODB01237) 0.951(DB00245) 0.945(METXBIODB00739)
| 0.970(METXBIODB01238) 0.948(DBMET02260) 0.945(DBMET00086
)
|
O6-alkylguanine-DNA alkyltransferase inhibitor | 0.694(DB02377) 0.194(DB00352) 0.135(DB01280)
| 0.823(DBMET03666) 0.231(DBMET00493) 0.153(CHEMBL226396
)
|
mTOR complex 1 inhibitor | 0.981(CHEMBL413;DB00877;METXBIODB01375) 0.974(METXBIODB00817) 0.960(DB06287)
| 0.981(DBMET00628;METXBIODB00818) 0.980(CHEMBL3544651;DBMET00389;DBMET01748;METXBIODB01376) 0.978(CHEMBL3544688;DBMET01749;METXBIODB01377
)
|
Endometrios treatment | 0.918(DB00717) 0.911(METXBIODB03119) 0.905(CHEMBL1201146)
| 0.953(DBMET01496) 0.930(DBMET01495) 0.918(CHEMBL1162
)
|
Prostate cancer treatment | 0.934(DB08899) 0.897(DB06755) 0.893(DB05109;DB06176)
| 0.942(DBMET03550;DBMET03551) 0.912(DBMET03549) 0.906(DBMET01580
)
|
Glucagon-like peptide 1 agonist | 0.169(DB11296) 0.151(DB00130) 0.132(DB09059)
| 0.990(METXBIODB01388) 0.753(METXBIODB00485) 0.191(DBMET01483
)
|
Neuropeptide Y5 antagonist | 0.271(METXBIODB01731) 0.177(METXBIODB01085) 0.136(DB00414)
| 0.397(METXBIODB01732) 0.166(METXBIODB01086) 0.162(CHEMBL3706536
)
|
Dysmenorrhea treatment | 0.537(METXBIODB02451) 0.511(CHEMBL661;DB00404) 0.499(DB00897)
| 0.537(DBMET00862) 0.518(METXBIODB00890) 0.508(DBMET01082;DBMET01084;DBMET01085;DBMET01086
)
|
Antibiotic Carbacephem-like | 0.051(DB00493) 0.050(DB01413) 0.036(DB06590)
| 0.024(DBMET00646) 0.020(DBMET03002) 0.019(DBMET03001
)
|
Glutamate (mGluR group I) antagonist | 0.493(DB00799) 0.252(METXBIODB01030) 0.245(METXBIODB01893)
| 0.507(DBMET01005) 0.317(DB14028;DBMET00831) 0.275(METXBIODB00629
)
|
Antimigraine | 0.989(DB13345) 0.983(METXBIODB00475) 0.974(METXBIODB00369)
| 0.983(METXBIODB00476) 0.981(DBMET02090;METXBIODB00477) 0.974(METXBIODB00370
)
|
Opioid delta receptor agonist | 0.988(DB00921) 0.979(METXBIODB01912) 0.931(DB00704)
| 0.979(DBMET00174) 0.953(DBMET00424) 0.929(DBMET00321;METXBIODB01140
)
|
MAP kinase kinase 3 inhibitor | 0.667(DB06595) 0.446(DB00339) 0.387(DB06728)
| 0.607(DBMET01440) 0.593(DBMET01441) 0.490(DBMET00376
)
|
Multidrug resistance-associated protein 1 inhibitor | 0.417(METXBIODB02273) 0.393(DB00580) 0.381(METXBIODB02879)
| 0.398(DBMET01340;DBMET01341) 0.381(CHEMBL3526945;CHEMBL3527008) 0.379(METXBIODB02274;METXBIODB02275
)
|
Calcitonin gene-related peptide antagonist | 0.177(METXBIODB01350) 0.159(DB01184) 0.134(CHEMBL16;DB00252)
| 0.893(METXBIODB01351) 0.148(METXBIODB01184) 0.134(DBMET01170
)
|
Antinephritic | 0.669(DB01914;DB09419;DB11735) 0.601(CHEMBL3542194) 0.559(DB01656)
| 0.654(CHEMBL3542345) 0.613(CHEMBL3542195) 0.612(CHEMBL3542317
)
|
CXC chemokine 4 receptor antagonist | 0.358(DB06824) 0.353(METXBIODB01173) 0.323(DB00592)
| 0.362(DBMET01778) 0.324(DBMET01959) 0.303(DBMET00502;DBMET00840
)
|
Antiallergic | 0.995(CHEMBL1473;DB00588;DB08906) 0.993(METXBIODB01531) 0.992(DB00764)
| 0.993(DBMET03675) 0.992(DBMET02361) 0.991(CHEMBL3542318;DBMET02591
)
|
Sleep disorders treatment | 0.956(DB09034) 0.896(CHEMBL1373;DB00745) 0.863(DB00402;DB01198;METXBIODB02096)
| 0.869(CHEMBL3527303) 0.857(DBMET00300) 0.843(DBMET00135;DBMET00299;METXBIODB00791
)
|
Nicotinic receptor alpha4 subunit antagonist | 0.934(METXBIODB00904) 0.866(DB11421) 0.701(DB01156;METXBIODB00109;METXBIODB01854)
| 0.975(DBMET03469;DBMET03471) 0.908(METXBIODB00906) 0.768(METXBIODB00905
)
|
Glutamate (mGluR) antagonist | 0.496(DB00799) 0.414(DB12466) 0.400(DB00339)
| 0.564(CHEMBL3544524) 0.517(DBMET01005) 0.322(DBMET03125
)
|
DNA topoisomerase IV inhibitor | 0.444(DB01155) 0.387(DB01044) 0.376(DB00685;METXBIODB02642)
| 0.463(DBMET00451) 0.376(DBMET00434) 0.343(DBMET01098
)
|
Phosphodiesterase inhibitor | 0.933(METXBIODB01645) 0.845(DB00922) 0.844(DB00862)
| 0.954(DBMET00997) 0.882(METXBIODB01646) 0.852(DBMET03640
)
|
MAP kinase 14 inhibitor | 0.793(METXBIODB00513) 0.297(DB12245) 0.294(METXBIODB00935)
| 0.791(METXBIODB00515) 0.630(METXBIODB00514) 0.619(METXBIODB01222
)
|
Alpha tubulin antagonist | 0.806(DB00773;METXBIODB00808) 0.744(METXBIODB02619) 0.701(METXBIODB02212)
| 0.827(METXBIODB00687) 0.819(DBMET00367;DBMET01264;METXBIODB00809) 0.763(DBMET01265
)
|
Aurora-B kinase inhibitor | 0.436(METXBIODB01487) 0.383(METXBIODB00866) 0.362(DB00619)
| 0.462(DBMET02094) 0.443(DBMET03650) 0.438(METXBIODB01489
)
|
Gonadotropin-releasing hormone receptor antagonist | 0.534(DB01011) 0.184(CHEMBL1741;DB01211;METXBIODB00619) 0.171(CHEMBL532;DB00199)
| 0.152(CHEMBL2022715;DBMET00357;METXBIODB00621) 0.144(CHEMBL3526373) 0.142(DBMET00909
)
|
Antineoplastic enhancer | 0.978(DB06799) 0.973(DB06595) 0.955(DB09343)
| 0.992(DBMET01459) 0.987(DBMET01440) 0.974(DBMET01441
)
|
Caspase 3 stimulant | 0.879(CHEMBL252915;CHEMBL43469;METXBIODB02982) 0.868(METXBIODB00685) 0.834(CHEMBL622;DB00749;METXBIODB00052;METXBIODB02522)
| 0.904(DBMET01630;METXBIODB00604) 0.883(METXBIODB00859) 0.879(CHEMBL4525081;CHEMBL4525082;CHEMBL4525083;CHEMBL4525084
)
|
Catenin beta inhibitor | 0.792(CHEMBL622;DB00749;METXBIODB00052;METXBIODB02522) 0.465(DB01250) 0.414(CHEMBL1455)
| 0.777(CHEMBL873;DBMET00148;METXBIODB00053) 0.767(CHEMBL875;DBMET00149;METXBIODB00054) 0.742(CHEMBL874
)
|
Antibiotic Oxazolidinone-like | 0.765(DB00601) 0.058(DB09042) 0.007(DB00614)
| 0.192(DBMET03356) 0.152(CHEMBL1207) 0.137(DBMET03355
)
|
Bromodomain-containing protein 3 inhibitor | 0.264(CHEMBL661;DB00404) 0.243(DB00897) 0.224(DB09166;METXBIODB00801)
| 0.233(DBMET02821) 0.220(CHEMBL1313;DBMET00348) 0.208(DBMET00395
)
|
Somatostatin 2 agonist | 0.341(DB01074;METXBIODB00067) 0.142(METXBIODB01792) 0.077(METXBIODB00228)
| 0.161(DBMET03446) 0.105(DBMET00088) 0.103(DBMET00839;DBMET00914;DBMET01547;METXBIODB00068;METXBIODB00069
)
|
Geranylgeranyltransferase I inhibitor | 0.220(DB01085;METXBIODB01181) 0.184(METXBIODB02568;METXBIODB02799) 0.166(CHEMBL104)
| 0.289(DBMET00376) 0.267(DBMET03745) 0.241(DBMET00503
)
|
Mannitol 2-dehydrogenase inhibitor | 0.771(DB00742;DB11195) 0.422(DB01914;DB09419;DB11735) 0.036(DB00874;DB06716)
| 0.952(DB03947) 0.906(DBMET03077) 0.597(DBMET03075
)
|
Cyclin-dependent kinase 3 inhibitor | 0.610(DB06595) 0.371(CHEMBL817) 0.358(DB00580)
| 0.557(DBMET01440) 0.543(DBMET01441) 0.520(CHEMBL804;DBMET00977
)
|
Factor VIIa inhibitor | 0.347(CHEMBL169901;DB04840) 0.187(METXBIODB01173) 0.151(DB01018)
| 0.653(CHEMBL3544523) 0.313(DBMET03379) 0.265(CHEMBL3544524
)
|
Antineoplastic (lymphocytic leukemia) | 0.988(DB00526) 0.883(METXBIODB02420) 0.848(DB00773;METXBIODB00808)
| 0.994(DBMET03683) 0.969(DBMET02075) 0.939(CHEMBL913;DBMET01125
)
|
Aldose reductase inhibitor | 0.595(CHEMBL16;DB00252) 0.495(METXBIODB02879) 0.458(METXBIODB02365)
| 0.700(DBMET01300) 0.650(DBMET01365) 0.595(DBMET01170
)
|
Factor X inhibitor | 0.881(DB12364) 0.770(CHEMBL169901;DB04840) 0.567(CHEMBL1269025)
| 0.979(DBMET01535) 0.885(DBMET01533) 0.541(CHEMBL3526352
)
|
Chemokine receptor antagonist | 0.923(DB06652) 0.541(DB00836) 0.506(METXBIODB00192)
| 0.972(DBMET00080) 0.964(DBMET00081;DBMET00083) 0.953(DBMET00078
)
|
VLA-4 antagonist | 0.798(METXBIODB00029) 0.270(METXBIODB02016;METXBIODB02571) 0.202(DB00731)
| 0.760(METXBIODB00030) 0.280(DBMET01064) 0.214(METXBIODB02018
)
|
Retinoic acid beta receptor antagonist | 0.903(METXBIODB01691) 0.893(DB00755;DB00982;DB06755;METXBIODB00937) 0.671(METXBIODB00323;METXBIODB01252)
| 0.893(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.856(DBMET03633) 0.796(DBMET00453
)
|
Farnesyltransferase inhibitor | 0.875(DB06448) 0.459(DB01085;METXBIODB01181) 0.333(METXBIODB02681)
| 0.887(DBMET03218) 0.864(DBMET03217) 0.465(DBMET00506
)
|
Activin receptor-like kinase 4 inhibitor | 0.482(METXBIODB01020) 0.450(METXBIODB00935) 0.395(DB06595)
| 0.302(METXBIODB01022) 0.278(CHEMBL724;DBMET00354;DBMET03729;METXBIODB00201) 0.275(DBMET01440
)
|
Protein kinase C epsilon inhibitor | 0.982(DB06595) 0.287(METXBIODB01288) 0.199(DB06637)
| 0.983(DBMET01440) 0.956(DBMET01441) 0.257(METXBIODB01289
)
|
Substance P antagonist | 0.951(METXBIODB00820) 0.928(DB00673) 0.918(METXBIODB00616)
| 0.918(METXBIODB00821) 0.901(METXBIODB00822) 0.886(METXBIODB00618
)
|
Calcitonin gene-related peptide 1 receptor antagonist | 0.260(METXBIODB01350) 0.178(DB01184) 0.165(METXBIODB00747)
| 0.226(METXBIODB01184) 0.159(DBMET00364;METXBIODB00749) 0.138(METXBIODB00748
)
|
Complement factor 1r inhibitor | 0.098(METXBIODB02449) 0.082(METXBIODB02611) 0.075(METXBIODB02370)
| 0.047(DBMET01492) 0.046(CHEMBL3526371;DBMET00468) 0.043(METXBIODB02371
)
|
Excitatory amino acid transporter 4 inhibitor | 0.025(DB00130) 0.024(DB00129) 0.021(METXBIODB00858;METXBIODB01659)
| 0.042(DBMET02241) 0.037(METXBIODB01660) 0.031(DB00142
)
|
Glycine transporter 1 inhibitor | 0.343(METXBIODB01170) 0.250(DB00215;DB01175) 0.220(DB00472;DB08472;DB08544;METXBIODB01953)
| 0.872(CHEMBL3526350) 0.501(CHEMBL3526349) 0.242(DB02083
)
|
VCAM antagonist | 0.263(METXBIODB01224) 0.260(METXBIODB00207) 0.239(METXBIODB00029)
| 0.274(METXBIODB01225) 0.271(METXBIODB01226) 0.206(METXBIODB00030
)
|
Glutamate (mGluR5) antagonist | 0.456(DB00799) 0.195(DB00829) 0.179(METXBIODB01893)
| 0.477(DBMET01005) 0.235(METXBIODB00629) 0.199(DB14028;DBMET00831
)
|
HIV-1 integrase (Strand Transfer) inhibitor | 0.655(METXBIODB02351) 0.640(METXBIODB02170) 0.603(METXBIODB03100)
| 0.800(DBMET03078) 0.628(CHEMBL1176) 0.625(METXBIODB02254
)
|
Acid-sensing ion channel blocker | 0.567(METXBIODB00230) 0.136(METXBIODB01620) 0.104(METXBIODB02739)
| 0.237(METXBIODB00231) 0.124(CHEMBL3527278) 0.092(DBMET03015
)
|
VCAM-1 antagonist | 0.262(METXBIODB01224) 0.258(METXBIODB00207) 0.236(METXBIODB00029)
| 0.273(METXBIODB01225) 0.269(METXBIODB01226) 0.204(METXBIODB00030
)
|
Antineoplastic (cervical cancer) | 0.915(DB00361) 0.892(METXBIODB00685) 0.890(DB00570)
| 0.910(DBMET02029) 0.884(METXBIODB00686;METXBIODB00687) 0.871(DBMET01263
)
|
CDK2/cyclin E2 inhibitor | 0.268(CHEMBL1308;DB01213) 0.211(METXBIODB03014) 0.203(CHEMBL585;DB00384)
| 0.313(CHEMBL3526813) 0.224(METXBIODB00380) 0.207(DBMET03271
)
|
Transforming growth factor beta 3 antagonist | 0.779(DB11640) 0.238(DB06637) 0.154(METXBIODB00935)
| 0.281(DBMET02179) 0.204(DBMET02177) 0.198(DBMET02650
)
|
HDL-cholesterol increasing | 0.644(DB01579) 0.605(DB09282) 0.458(METXBIODB02451)
| 0.503(CHEMBL3544523) 0.500(METXBIODB01325) 0.458(DBMET00862
)
|
Neurokinin antagonist | 0.974(DB00673) 0.943(METXBIODB00820) 0.940(METXBIODB00037)
| 0.976(DBMET01398) 0.940(DBMET00349;DBMET01590) 0.888(METXBIODB00821
)
|
Antiosteoporotic | 0.966(METXBIODB02719) 0.965(DB06670) 0.963(CHEMBL846;DB00136)
| 0.975(DBMET02435) 0.966(DBMET02434) 0.953(CHEMBL3544529;DBMET00575
)
|
Cell adhesion inhibitor | 0.528(DB00731) 0.518(METXBIODB00029) 0.516(CHEMBL3542194)
| 0.573(DBMET02880) 0.565(CHEMBL3526604) 0.538(DBMET01477
)
|
Follicle-stimulating hormone antagonist | 0.170(CHEMBL49429) 0.040(METXBIODB02458) 0.036(METXBIODB00244)
| 0.166(CHEMBL3526411) 0.100(CHEMBL3544832) 0.097(DBMET01341
)
|
Dependence treatment | 0.965(DB00921) 0.955(DB00704) 0.948(DB01192)
| 0.948(DBMET00321;METXBIODB01140) 0.947(DBMET00174) 0.926(DBMET00760
)
|
Factor VII inhibitor | 0.117(METXBIODB01173) 0.107(DB00669) 0.092(CHEMBL169901;DB04840)
| 0.187(DBMET03379) 0.166(DBMET01535) 0.161(DBMET03378
)
|
Restenosis treatment | 0.929(METXBIODB02556) 0.917(CHEMBL1111;DB06403) 0.895(CHEMBL413;DB00877;METXBIODB01375)
| 0.915(CHEMBL3706461) 0.895(DBMET00628;METXBIODB00818) 0.894(CHEMBL3544651;DBMET00389;DBMET01748;METXBIODB01376
)
|
Urotensin II antagonist | 0.533(DB05676) 0.055(CHEMBL455136) 0.036(METXBIODB02615)
| 0.400(DBMET01392) 0.240(DBMET00900) 0.070(DBMET02625
)
|
DNA intercalator | 0.975(DB09117) 0.962(CHEMBL1117) 0.960(CHEMBL417;CHEMBL53463;DB00997)
| 0.976(DBMET00513) 0.936(DBMET00952) 0.933(DBMET01143
)
|
MAP kinase kinase 4 inhibitor | 0.833(DB08881) 0.604(DB06595) 0.564(METXBIODB02518)
| 0.722(DBMET01856) 0.710(DBMET01854) 0.516(DBMET01441
)
|
5 Hydroxytryptamine 2C agonist | 0.848(METXBIODB01229) 0.845(DB00592) 0.795(DB04871)
| 0.983(CHEMBL3526304) 0.848(DBMET01732;DBMET01825;METXBIODB01849) 0.681(METXBIODB01885
)
|
Bradykinin B2 receptor agonist | 0.117(METXBIODB01731) 0.067(METXBIODB01173) 0.059(DB00129)
| 0.197(METXBIODB01732) 0.148(DBMET00502) 0.116(DBMET02067
)
|
Antidiabetic (type 1) | 0.830(CHEMBL846;DB00136) 0.773(DB06799) 0.768(DB00169)
| 0.805(DB00146) 0.800(CHEMBL3542380;CHEMBL3542386) 0.796(CHEMBL3544529;DBMET00575
)
|
Interleukin antagonist | 0.960(CHEMBL1430) 0.733(DB06151) 0.662(CHEMBL1741;CHEMBL532;DB00199;DB01211;METXBIODB00619)
| 0.842(DBMET03115) 0.741(CHEMBL1379) 0.734(DBMET00503
)
|
Cyclin H inhibitor | 0.132(DB08912) 0.107(DB09073) 0.096(DB06595)
| 0.179(CHEMBL244377) 0.131(DBMET03512) 0.128(CHEMBL574
)
|
Attention deficit/hyperactivity disorder treatment | 0.935(METXBIODB01237) 0.903(DB01236) 0.863(DB12473)
| 0.932(METXBIODB01238) 0.885(METXBIODB01239;METXBIODB01240) 0.847(DBMET01734;DBMET01826;METXBIODB01231;METXBIODB01851
)
|
Antiarrhythmic | 0.956(DB00373;METXBIODB01469) 0.897(CHEMBL633;DB01118) 0.883(DB04855)
| 0.901(METXBIODB01470) 0.897(CHEMBL4525130;CHEMBL4525131;CHEMBL4525132;CHEMBL4525133;CHEMBL4525134;CHEMBL4525135;CHEMBL4525136;CHEMBL4525137;CHEMBL4525138) 0.873(DBMET02840
)
|
Carnitine palmitoyltransferase 1B inhibitor | 0.126(METXBIODB03147) 0.109(METXBIODB03148) 0.107(METXBIODB01859)
| 0.174(DB09269;DBMET01431;METXBIODB03146) 0.153(DBMET00688) 0.133(DBMET03556
)
|
Phosphodiesterase 10A inhibitor | 0.309(DB00862) 0.190(CHEMBL512306) 0.182(DB01685;METXBIODB02526)
| 0.335(DBMET03640) 0.261(DBMET02821) 0.238(CHEMBL3526547
)
|
Phosphodiesterase X inhibitor | 0.309(DB00862) 0.190(CHEMBL512306) 0.182(DB01685;METXBIODB02526)
| 0.335(DBMET03640) 0.261(DBMET02821) 0.238(CHEMBL3526547
)
|
ErbB-1 antagonist | 0.879(DB00530) 0.848(METXBIODB02932) 0.841(METXBIODB03041)
| 0.840(DBMET01790) 0.807(CHEMBL3526326) 0.784(CHEMBL3526614;CHEMBL3526615
)
|
Alpha 1b adrenoreceptor agonist | 0.538(CHEMBL762;DB00935) 0.519(METXBIODB02632) 0.484(DB04948)
| 0.538(CHEMBL4525123;CHEMBL4525124) 0.472(CHEMBL3526775) 0.420(METXBIODB02633
)
|
MAP kinase 1 inhibitor | 0.773(DB06616) 0.682(DB11763) 0.675(DB00619)
| 0.755(DBMET03737) 0.731(DBMET03736) 0.690(DBMET03650
)
|
Interleukin 1b antagonist | 0.794(METXBIODB00458) 0.694(METXBIODB02142) 0.652(METXBIODB02140;METXBIODB02144)
| 0.893(DBMET03115) 0.877(CHEMBL1207) 0.868(DBMET03181
)
|
MAP-kinase-activated kinase 5 inhibitor | 0.735(DB06595) 0.514(DB09079) 0.422(CHEMBL413;DB00877;METXBIODB01375)
| 0.789(DBMET01440) 0.706(DBMET01441) 0.547(DBMET02778
)
|
T cell inhibitor | 0.993(DB06697) 0.992(DB11638) 0.990(METXBIODB00454)
| 0.992(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.991(METXBIODB00455) 0.938(DBMET01913;DBMET03143
)
|
Diabetic retinopathy treatment | 0.982(DB00869) 0.981(DB00727) 0.891(CHEMBL1504)
| 0.986(DBMET03010) 0.981(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.863(CHEMBL3542337;DBMET03671
)
|
MAP kinase kinase 5 inhibitor | 0.557(DB06595) 0.453(DB09079) 0.371(DB06799)
| 0.503(DBMET01440) 0.488(DBMET01441) 0.462(DBMET02778
)
|
Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.814(DB06595) 0.804(METXBIODB01288) 0.520(DB12332)
| 0.949(DBMET01440) 0.788(METXBIODB01289) 0.781(DBMET01441
)
|
Bone diseases treatment | 0.958(METXBIODB02719) 0.956(CHEMBL846;DB00136) 0.950(DB00153;METXBIODB01575;METXBIODB02762)
| 0.964(DBMET02435) 0.958(DBMET02434) 0.955(METXBIODB01576
)
|
Antineoplastic (non-Hodgkin's lymphoma) | 0.982(CHEMBL88;DB00531;METXBIODB00960) 0.942(DB12902;METXBIODB00967) 0.936(DB06263)
| 0.982(DBMET01683) 0.957(CHEMBL3544546;CHEMBL3706538;DBMET01076) 0.955(CHEMBL731;DBMET00019
)
|
M18 aspartyl aminopeptidase inhibitor | 0.493(CHEMBL817) 0.477(DB01120) 0.468(METXBIODB01176)
| 0.486(CHEMBL1330852) 0.482(CHEMBL3544596) 0.481(CHEMBL1502560
)
|
Factor IXa inhibitor | 0.131(METXBIODB00562) 0.129(DB00581) 0.122(METXBIODB00207)
| 0.439(DBMET02908) 0.285(METXBIODB02645) 0.265(METXBIODB02293
)
|
Carnitine palmitoyltransferase 1A inhibitor | 0.186(DB05016) 0.081(DB00583) 0.069(DB06756)
| 0.068(DBMET01532) 0.057(DBMET02884) 0.056(DBMET02889
)
|
Src kinase inhibitor | 0.743(DB06616) 0.696(DB01254) 0.625(DB08864)
| 0.753(DBMET03622) 0.744(CHEMBL244377) 0.732(DBMET03736
)
|
VEGFR2 expression inhibitor | 0.159(DB00437) 0.150(DB00398) 0.123(CHEMBL1076347)
| 0.124(DBMET03578) 0.116(CHEMBL3526308) 0.103(CHEMBL380905
)
|
Integrin alpha4beta7 antagonist | 0.803(METXBIODB00029) 0.260(METXBIODB02016;METXBIODB02571) 0.193(DB00731)
| 0.756(METXBIODB00030) 0.257(DBMET01064) 0.209(METXBIODB02018
)
|
Aminoacyl-tRNA synthetase inhibitor | 0.635(CHEMBL1430) 0.606(DB00410) 0.481(DB00640)
| 0.700(DB00171) 0.682(DBMET00769) 0.654(DBMET00677
)
|
Integrin alpha4 antagonist | 0.763(METXBIODB00029) 0.356(DB00731) 0.289(METXBIODB02016;METXBIODB02571)
| 0.674(METXBIODB00030) 0.402(DBMET01064) 0.287(DBMET01323;DBMET01831
)
|
Transforming growth factor antagonist | 0.432(METXBIODB01020) 0.392(DB00730) 0.254(DB11640)
| 0.266(DBMET02777) 0.259(DBMET02778) 0.254(METXBIODB01022
)
|
Chelator | 0.844(CHEMBL1430) 0.769(METXBIODB02376) 0.722(CHEMBL1314;DB06823)
| 0.739(DBMET01974) 0.715(DB02083) 0.699(CHEMBL3544531
)
|
MAP kinase 12 inhibitor | 0.842(METXBIODB00513) 0.432(DB12245) 0.419(DB13228)
| 0.837(METXBIODB00515) 0.621(METXBIODB00514) 0.426(DBMET01440
)
|
Interleukin 12 antagonist | 0.448(DB11638) 0.437(DB06697) 0.423(DB09274;METXBIODB01712)
| 0.832(DBMET01117) 0.789(DBMET01116) 0.631(DBMET01115
)
|
Adrenaline antagonist | 0.981(DB04948) 0.980(DB13345) 0.979(DB00373;METXBIODB01469)
| 0.993(DBMET02990) 0.987(DBMET02229) 0.965(METXBIODB00476
)
|
Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.877(DB00379;DB07129;METXBIODB01843) 0.634(DB00697;METXBIODB02082) 0.475(METXBIODB00935)
| 0.973(DBMET03336) 0.958(DBMET03335) 0.812(DBMET00260;DBMET01551;METXBIODB01844
)
|
Antidiabetic symptomatic | 0.943(DB00727) 0.871(DB00869) 0.825(DB01132)
| 0.943(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.906(DBMET01300) 0.903(DBMET03010
)
|
Antiadrenergic | 0.982(DB04948) 0.980(DB13345) 0.979(DB00373;METXBIODB01469)
| 0.993(DBMET02990) 0.988(DBMET02229) 0.965(METXBIODB00476
)
|
Systemic lupus erythematosus treatment | 0.998(DB01294) 0.877(CHEMBL88;DB00531;METXBIODB00960) 0.738(DB16650)
| 0.877(DBMET01683) 0.748(DBMET03547) 0.684(CHEMBL3526246;DBMET00092
)
|
MAP-kinase-activated kinase 2 inhibitor | 0.340(DB12332) 0.307(METXBIODB00004) 0.301(DB00592)
| 0.359(DBMET03519) 0.357(DBMET03517) 0.330(DBMET03522
)
|
Antianginal | 0.990(DB06154;DB09282) 0.987(DB00727) 0.979(DB01020)
| 0.995(DB13400) 0.987(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.956(DBMET02011
)
|
Janus tyrosine kinase 1 inhibitor | 0.544(DB08877) 0.482(DB11697) 0.381(DB14973)
| 0.543(DBMET03436) 0.478(DBMET03261) 0.443(DBMET03438
)
|
DNA helicase inhibitor | 0.191(DB09167) 0.140(DB06737;METXBIODB02093;METXBIODB02934) 0.133(METXBIODB01099)
| 0.285(CHEMBL1529857) 0.243(CHEMBL3544654;DBMET00378) 0.203(DBMET00219
)
|
Antiviral (Influenza) | 0.987(DB13997) 0.916(DB00198) 0.873(DB12466)
| 0.991(DB15675) 0.924(DBMET02218) 0.674(DBMET03065
)
|
CDK2/cyclin A inhibitor | 0.534(DB09073) 0.478(DB11697) 0.310(METXBIODB02929)
| 0.699(DBMET03436) 0.643(DBMET03666) 0.567(CHEMBL3526813
)
|
Glutamate receptor antagonist | 0.852(DB01043) 0.697(DB01221;DB11823;METXBIODB00118) 0.685(DB00356)
| 0.675(CHEMBL3544524) 0.642(DBMET01818) 0.585(DBMET00189;METXBIODB00119
)
|
Antipsychotic | 0.982(DB08815) 0.977(DB08922;METXBIODB02106) 0.962(DB00246)
| 0.989(DBMET00890;DBMET02989;METXBIODB01765) 0.985(DBMET01502;METXBIODB02109) 0.980(DBMET02990
)
|
MAP kinase 10 inhibitor | 0.420(METXBIODB03012) 0.335(METXBIODB00513) 0.259(METXBIODB02395)
| 0.540(CHEMBL3544805) 0.420(DBMET01043) 0.262(DBMET03650
)
|
Inosine monophosphate dehydrogenase 1 inhibitor | 0.765(DB01024;METXBIODB01063) 0.560(DB00688) 0.115(DB00640)
| 0.770(DBMET00767;METXBIODB01064) 0.765(DBMET02606) 0.567(DBMET00662
)
|
Interleukin 1 antagonist | 0.782(METXBIODB00458) 0.688(DB00605) 0.685(METXBIODB02142)
| 0.892(DBMET03115) 0.873(CHEMBL1207) 0.853(CHEMBL3526764;DBMET03181
)
|
Ca(v)2.2 blocker | 0.565(DB00737) 0.558(DB00568;METXBIODB00600) 0.529(DB04841)
| 0.649(DBMET01193;METXBIODB00603) 0.624(DBMET01197) 0.450(DBMET02577
)
|
Platelet activating factor antagonist | 0.974(METXBIODB00481) 0.967(DB09166;METXBIODB00801) 0.897(DB00897)
| 0.958(METXBIODB00483) 0.943(METXBIODB00802) 0.942(DBMET01525;METXBIODB00803
)
|
Alzheimer's disease treatment | 0.976(DB01236) 0.942(DB00185;METXBIODB00507) 0.913(METXBIODB02903)
| 0.968(CHEMBL3526601) 0.942(DBMET00430;DBMET00431;DBMET00433) 0.940(METXBIODB01596
)
|
EphB2 antagonist | 0.861(DB06595) 0.671(DB12874) 0.668(DB01033)
| 0.774(METXBIODB00515) 0.770(DBMET01440) 0.755(DBMET01441
)
|
Protocollagen prolyl hydroxylase inhibitor | 0.750(DB12255) 0.747(DB04847) 0.596(DB11682)
| 0.706(DBMET03433) 0.564(DBMET00507) 0.503(DBMET02630
)
|
Neurokinin 1 antagonist | 0.976(DB00673) 0.953(METXBIODB00820) 0.952(METXBIODB00037)
| 0.982(DBMET01398) 0.952(DBMET00349;DBMET01590) 0.905(METXBIODB00821
)
|
c-Src kinase inhibitor | 0.736(DB06616) 0.577(DB12267) 0.572(METXBIODB01339)
| 0.719(DBMET03736) 0.625(DBMET03737) 0.601(CHEMBL3544806
)
|
Potassium channel large-conductance Ca-activated activator | 0.920(METXBIODB02793) 0.646(DB06756) 0.622(DB06716)
| 0.785(METXBIODB02794) 0.700(DBMET01338) 0.668(DBMET01342
)
|
MAP-kinase-activated kinase inhibitor | 0.374(DB12332) 0.337(METXBIODB00004) 0.333(DB00592)
| 0.397(DBMET03519) 0.392(DBMET03517) 0.363(DBMET03522
)
|
Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.935(DB06595) 0.767(METXBIODB01288) 0.663(DB08877)
| 0.959(DBMET01440) 0.918(DBMET01441) 0.728(METXBIODB01289
)
|
Antineoplastic (renal cancer) | 0.880(DB11638) 0.874(DB06697) 0.844(METXBIODB02420)
| 0.903(CHEMBL525;DBMET01147) 0.902(CHEMBL3706540;DBMET01123) 0.880(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713
)
|
Antineoplastic (multiple myeloma) | 0.960(CHEMBL88;DB00531;METXBIODB00960) 0.933(DB12902;METXBIODB00967) 0.920(DB00188)
| 0.960(DBMET01683) 0.927(CHEMBL3706538) 0.912(CHEMBL3544546;DBMET01076
)
|
Tumour necrosis factor alpha release inhibitor | 0.938(DB05676) 0.850(DB00400) 0.830(DB00480)
| 0.963(CHEMBL1207) 0.928(DBMET01392) 0.914(DBMET02625
)
|
SULT1E1 substrate | 0.774(DB09268) 0.732(DB04574) 0.558(DB00481;METXBIODB01232)
| 0.927(DBMET02101) 0.896(METXBIODB02254) 0.880(CHEMBL1208633
)
|
Tryptophan hydroxylase 1 inhibitor | 0.902(DB12095) 0.180(DB01235) 0.131(DB13848)
| 0.971(DBMET03552) 0.866(DBMET03553) 0.809(DBMET03554
)
|
Antineoplastic (breast cancer) | 0.972(CHEMBL383824) 0.956(CHEMBL428647;CHEMBL92;DB01229;DB01248) 0.953(DB06772)
| 0.981(CHEMBL87658;DBMET00020;DBMET00021;METXBIODB00961;METXBIODB00964) 0.969(CHEMBL3526785) 0.961(CHEMBL3526786;CHEMBL3527105
)
|
Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.374(DB00870;METXBIODB02067) 0.330(METXBIODB00207) 0.319(DB04831;METXBIODB01466)
| 0.489(METXBIODB00024) 0.301(METXBIODB01345) 0.298(DBMET00163;METXBIODB02069
)
|
Antipsoriatic | 0.985(CHEMBL846;DB00136) 0.980(METXBIODB03098) 0.978(METXBIODB02719)
| 0.989(DBMET02435;METXBIODB01576) 0.978(DBMET02434) 0.975(CHEMBL3542380;CHEMBL3542386
)
|
Myocardial ischemia treatment | 0.993(DB06154) 0.992(DB09282) 0.989(DB00727)
| 0.995(DB13400) 0.989(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.962(DBMET02011
)
|
DNA gyrase subunit A inhibitor | 0.422(DB01155) 0.365(DB01044) 0.188(DB00537)
| 0.478(DBMET00451) 0.421(DBMET00434) 0.361(DBMET01098
)
|
Myc inhibitor | 0.140(DB00592) 0.125(DB00330) 0.093(DB04871)
| 0.406(CHEMBL3526354) 0.138(DBMET00095) 0.136(CHEMBL3550090
)
|
Breast cancer-resistant protein inhibitor | 0.808(CHEMBL1370;DB01222;METXBIODB01745) 0.788(METXBIODB00461) 0.768(METXBIODB01409)
| 0.798(CHEMBL3542395;DBMET00476;METXBIODB01746) 0.796(CHEMBL3542373;DBMET02914) 0.766(METXBIODB00463
)
|
Cachexia treatment | 0.555(DB05676) 0.526(CHEMBL1272;DB00912) 0.438(METXBIODB01246)
| 0.559(CHEMBL4525742) 0.468(DBMET01392) 0.459(METXBIODB01249
)
|
Rhinitis treatment | 0.989(CHEMBL1473;DB00588) 0.985(DB08906) 0.913(CHEMBL1512)
| 0.972(DBMET03675) 0.887(CHEMBL3542337) 0.881(CHEMBL3542213
)
|
Insulin like growth factor 3 antagonist | 0.033(METXBIODB02739) 0.015(METXBIODB01176;METXBIODB02805) 0.011(METXBIODB03045)
| 0.014(METXBIODB03149) 0.013(CHEMBL1432;METXBIODB02740) 0.012(CHEMBL3544545;DBMET01195;METXBIODB00605
)
|
Liver cirrhosis treatment | 0.680(METXBIODB02451) 0.656(CHEMBL1393;DB00421) 0.646(DB00564)
| 0.693(CHEMBL3526499;CHEMBL4525805;DBMET02803;DBMET02804) 0.680(DBMET00862) 0.659(CHEMBL313120;CHEMBL315985;DBMET01020;DBMET01408;DBMET01410;DBMET02148;DBMET02802
)
|
Growth factor agonist | 0.716(DB00396;METXBIODB01192) 0.715(DB11596) 0.693(DB08881)
| 0.790(DB00166) 0.733(CHEMBL50995;DBMET02716) 0.676(DBMET02715
)
|
Antineoplastic (lymphoma) | 0.916(CHEMBL88;DB00531;METXBIODB00960) 0.888(METXBIODB01643) 0.866(DB06697)
| 0.916(DBMET01683) 0.866(CHEMBL913;DBMET01125) 0.850(CHEMBL3706538
)
|
S-adenosyl-L-homocysteine hydrolase inhibitor | 0.423(DB00640) 0.233(DB01914;DB09419;DB11735) 0.228(DB00242)
| 0.325(METXBIODB02147) 0.308(CHEMBL3544842) 0.295(METXBIODB02698
)
|
Bradykinin B2 receptor antagonist | 0.120(DB00500) 0.057(DB13306) 0.052(DB01131)
| 0.997(METXBIODB00275) 0.072(DBMET02067) 0.063(CHEMBL3544779
)
|
Topoisomerase II alpha inhibitor | 0.967(CHEMBL417;CHEMBL53463;DB00997) 0.952(CHEMBL1117) 0.932(CHEMBL178;DB00694)
| 0.929(DBMET00952;METXBIODB01758;METXBIODB01760) 0.925(METXBIODB01759) 0.923(CHEMBL3508153;DBMET01078
)
|
HIV-1 reverse transcriptase inhibitor | 0.961(CHEMBL223228;DB00625) 0.921(METXBIODB00319) 0.909(METXBIODB02947)
| 0.961(CHEMBL4525162) 0.933(CHEMBL1309;DBMET01653) 0.930(CHEMBL3526537
)
|
Allergic rhinitis treatment | 0.993(CHEMBL1473;DB00588) 0.991(DB08906) 0.943(CHEMBL1512)
| 0.988(DBMET03675) 0.938(CHEMBL3542373;DBMET02914) 0.931(CHEMBL3542395;DBMET00476;METXBIODB01746
)
|
Mcl-1 antagonist | 0.789(DB11121) 0.702(METXBIODB02353) 0.600(METXBIODB01861)
| 0.680(CHEMBL3544545) 0.660(CHEMBL1432) 0.586(METXBIODB00184;METXBIODB00185
)
|
Antineoplastic (bladder cancer) | 0.903(DB04168) 0.889(DB06263) 0.753(CHEMBL185)
| 0.984(CHEMBL525;DBMET01147) 0.972(CHEMBL3706540;DBMET01123) 0.971(CHEMBL1593;DBMET00658
)
|
Integrin alphaLbeta2 antagonist | 0.522(CHEMBL503;DB00227;METXBIODB01008) 0.408(CHEMBL2104993;DB09068) 0.360(CHEMBL1064;DB00641;METXBIODB01371)
| 0.731(METXBIODB02350) 0.403(CHEMBL3544685) 0.377(CHEMBL1201373
)
|
DNA gyrase inhibitor | 0.513(DB01044) 0.481(DB00685;METXBIODB02642) 0.477(DB01137)
| 0.487(DBMET03009) 0.409(METXBIODB01321) 0.367(DBMET03008
)
|
CXC chemokine receptor antagonist | 0.536(DB06652) 0.345(CHEMBL104) 0.320(DB15071)
| 0.652(DBMET00081) 0.631(DBMET00080) 0.576(DBMET00083
)
|
Antineoplastic (lung cancer) | 0.963(METXBIODB00685) 0.945(DB00361) 0.940(DB11641)
| 0.970(CHEMBL87658;DBMET00020;DBMET00021;METXBIODB00961;METXBIODB00964) 0.962(METXBIODB00687) 0.952(METXBIODB00686;METXBIODB00688
)
|
CDK3/cyclin E inhibitor | 0.220(CHEMBL1308;DB01213) 0.214(DB06595) 0.209(DB00740)
| 0.220(METXBIODB01632) 0.219(DBMET02815) 0.204(CHEMBL3276272;DBMET00736
)
|
Potassium channel Kv1.5 blocker | 0.303(DB15071) 0.284(CHEMBL1393;DB00421) 0.169(METXBIODB00189)
| 0.330(DBMET03559) 0.224(CHEMBL804;DBMET00977) 0.223(DBMET00451
)
|
CC chemokine 6 receptor antagonist | 0.203(METXBIODB02395) 0.194(METXBIODB03128) 0.191(DB13751)
| 0.198(CHEMBL3542275) 0.189(METXBIODB03129) 0.186(METXBIODB02872
)
|
Protein kinase (CK1) gamma 3 inhibitor | 0.520(DB06595) 0.500(DB06637) 0.405(METXBIODB00935)
| 0.820(DBMET03336) 0.762(DBMET03335) 0.519(DB13526
)
|
Tyk2 inhibitor | 0.681(DB11697) 0.616(DB16650) 0.520(DB06799)
| 0.710(DBMET03436) 0.669(DBMET03437) 0.665(DBMET03435;DBMET03438
)
|
MAP kinase 8 inhibitor | 0.498(METXBIODB02480) 0.459(DB00507) 0.294(METXBIODB02343)
| 0.821(CHEMBL3544805) 0.577(DBMET01012) 0.368(DBMET03719
)
|
Polo-like kinase-3 inhibitor | 0.343(DB00339) 0.327(DB00619) 0.313(DB00889;DB11763;METXBIODB00874)
| 0.568(DBMET00960) 0.465(DBMET00836) 0.433(DBMET03336
)
|
Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.537(DB00379;DB07129;METXBIODB01843) 0.451(DB06637) 0.446(METXBIODB00935)
| 0.945(DBMET02617) 0.673(DBMET03336) 0.590(DBMET03335
)
|
Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.487(DB11697) 0.464(DB08865) 0.440(METXBIODB00935)
| 0.788(DBMET03336) 0.691(DBMET03335) 0.636(DBMET03436
)
|
Cyclin-dependent kinase 5 inhibitor | 0.514(METXBIODB00382) 0.511(METXBIODB02059) 0.415(CHEMBL64;METXBIODB02327)
| 0.751(CHEMBL3091852) 0.566(CHEMBL1442231) 0.506(METXBIODB01084
)
|
DNA-dependent protein kinase inhibitor | 0.483(METXBIODB01339) 0.269(METXBIODB02723) 0.254(METXBIODB02149)
| 0.314(DBMET02020) 0.270(DBMET02028) 0.260(DBMET02027
)
|
CDK1/cyclin B1 inhibitor | 0.422(DB09073) 0.402(DB02377) 0.278(CHEMBL727)
| 0.751(DBMET03666) 0.451(DBMET00493) 0.388(CHEMBL226396
)
|
CDK1/cyclin B inhibitor | 0.548(DB02377) 0.350(CHEMBL585;DB00384) 0.332(DB09073)
| 0.724(DBMET03666) 0.517(DBMET00493) 0.494(CHEMBL1231106
)
|
Antiischemic | 0.994(DB06154;DB09282) 0.991(DB00727) 0.984(DB01020)
| 0.995(DB13400) 0.991(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.967(DBMET02011
)
|
Antineoplastic (glioblastoma multiforme) | 0.846(METXBIODB02420) 0.817(DB06176;DB11638) 0.807(DB06697)
| 0.850(CHEMBL3526352) 0.817(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.808(METXBIODB00455
)
|
Alpha 1L adrenoreceptor agonist | 0.436(CHEMBL762;DB00935) 0.357(DB04948) 0.267(METXBIODB02632)
| 0.436(CHEMBL4525123;CHEMBL4525124) 0.354(CHEMBL3526775) 0.239(DBMET03228
)
|
Fibroblast growth factor 4 antagonist | 0.945(DB12147) 0.348(METXBIODB02632) 0.300(METXBIODB01643)
| 0.861(DBMET03649) 0.526(DBMET03650) 0.273(METXBIODB02633
)
|
HERG channel blocker | 0.941(DB08903) 0.857(DB01074;METXBIODB00067) 0.794(METXBIODB00769)
| 0.940(CHEMBL3527233) 0.934(DBMET03738) 0.907(CHEMBL3527437
)
|
CXC chemokine 3 receptor antagonist | 0.341(DB01744;DB11345;METXBIODB01913) 0.202(DB11219) 0.166(METXBIODB00070)
| 0.151(DBMET02092) 0.137(DBMET02091) 0.135(DBMET02865
)
|
Bromodomain-containing protein 4 inhibitor | 0.367(DB00580) 0.319(CHEMBL661;DB00404) 0.318(DB09166;METXBIODB00801)
| 0.350(CHEMBL3542314;DBMET02634) 0.336(DBMET02821) 0.334(DBMET01338
)
|
Antifibrinolytic | 0.916(METXBIODB01752) 0.864(DB15456) 0.838(CHEMBL1201772;DB06209)
| 0.916(CHEMBL3526430) 0.864(DBMET03244;DBMET03245) 0.850(CHEMBL3542415
)
|
Antineoplastic (liver cancer) | 0.916(DB00526) 0.911(DB13853) 0.812(METXBIODB02583)
| 0.914(DBMET02057) 0.832(METXBIODB01867) 0.825(METXBIODB01898
)
|
Cyclin-dependent kinase 7 inhibitor | 0.401(METXBIODB02968) 0.392(DB12267) 0.312(DB00619)
| 0.773(CHEMBL3526813) 0.524(CHEMBL3526899) 0.496(CHEMBL226396
)
|
CDK2/cyclin E inhibitor | 0.196(CHEMBL585;DB00384) 0.184(DB09073) 0.122(DB00740)
| 0.257(METXBIODB00380) 0.204(DBMET02372) 0.191(DBMET02371
)
|
Platelet activating factor alpha antagonist | 0.694(DB09079) 0.520(CHEMBL535) 0.494(METXBIODB02699)
| 0.687(DBMET02777) 0.627(DBMET02778) 0.562(DBMET01384
)
|
Bradykinin B1 receptor antagonist | 0.112(DB01104) 0.111(METXBIODB02132) 0.075(DB01394)
| 0.187(METXBIODB01325) 0.125(CHEMBL3526370) 0.067(CHEMBL3526187
)
|
Phenylethanolamine N methyltransferase inhibitor | 0.180(METXBIODB02132) 0.128(METXBIODB01155) 0.118(DB01074;METXBIODB00067)
| 0.208(CHEMBL3527402) 0.107(CHEMBL219497;DBMET00655;DBMET02004;DBMET03581) 0.103(CHEMBL80254
)
|
Vasculitis treatment | 0.969(CHEMBL88;DB00531;METXBIODB00960) 0.776(DB12902;METXBIODB00967) 0.656(DB00993)
| 0.969(DBMET01683) 0.897(CHEMBL3544546;DBMET01076) 0.888(CHEMBL3706538
)
|
Mood disorders treatment | 0.973(DB09291) 0.972(DB01221;DB11823;METXBIODB00118) 0.970(METXBIODB02903)
| 0.992(DBMET02412) 0.988(DBMET00189;METXBIODB00119) 0.986(DBMET01310
)
|
Protein kinase C delta inhibitor | 0.993(DB09348) 0.921(DB06595) 0.416(DB01685;METXBIODB02526)
| 0.937(DBMET01440) 0.852(DBMET01441) 0.291(CHEMBL3544877;DBMET02829
)
|
Multiple sclerosis treatment | 0.987(DB01236) 0.881(DB08911) 0.767(DB01017)
| 0.903(DBMET01507) 0.887(DBMET03641) 0.861(DBMET01474
)
|
Sodium/hydrogen exchanger 1 inhibitor | 0.251(METXBIODB00562) 0.183(DB00629) 0.154(CHEMBL355862)
| 0.137(METXBIODB00563) 0.136(CHEMBL3526475) 0.131(METXBIODB00564
)
|
Antineoplastic (gastric cancer) | 0.992(DB00526) 0.874(DB13853) 0.776(DB00727)
| 0.994(DBMET03683) 0.877(CHEMBL3544522) 0.858(DBMET02057
)
|
Death-associated protein kinase 3 inhibitor | 0.690(DB08877) 0.579(DB06595) 0.495(DB00379;DB07129;METXBIODB01843)
| 0.740(DBMET03336) 0.726(CHEMBL226396) 0.667(DBMET03335
)
|
Antidepressant | 0.973(DB01221;DB11823;METXBIODB00118) 0.972(METXBIODB02903) 0.971(DB09291)
| 0.993(DBMET02412) 0.988(DBMET00189;METXBIODB00119) 0.986(DBMET01310
)
|
MAP3K7 inhibitor | 0.546(DB01189) 0.412(METXBIODB00350) 0.311(DB08865)
| 0.442(CHEMBL1213529;DBMET01146) 0.431(DBMET01440) 0.326(METXBIODB01644
)
|
Glycogen synthase kinase-3 beta inhibitor | 0.892(CHEMBL727) 0.512(DB01685;METXBIODB02526) 0.338(DB02377)
| 0.836(CHEMBL1426) 0.472(DBMET02815) 0.452(DBMET00414
)
|
Antiviral (HIV) | 0.991(DB00709) 0.986(DB00879) 0.954(DB00495)
| 0.985(DBMET00899) 0.983(DBMET00898) 0.942(DBMET03569
)
|
Glycogen synthase kinase-3 inhibitor | 0.908(CHEMBL727) 0.552(DB01685;METXBIODB02526) 0.439(CHEMBL1308;DB01213)
| 0.845(CHEMBL1426) 0.514(DBMET02815) 0.486(DBMET01583;METXBIODB00386
)
|
Antineoplastic (small cell lung cancer) | 0.967(DB06263) 0.958(DB09117) 0.954(DB00444;DB00773;METXBIODB00808)
| 0.998(DBMET01127) 0.982(DBMET01102) 0.978(DBMET00792
)
|
Vanilloid 1 antagonist | 0.671(DB12015) 0.434(METXBIODB03128) 0.334(CHEMBL1076347)
| 0.661(DBMET02571) 0.401(DBMET00693) 0.260(DBMET00909
)
|
Potassium channel blocker | 0.856(DB08903) 0.710(DB00213;METXBIODB00543) 0.707(DB01074;METXBIODB00067)
| 0.853(CHEMBL3527233) 0.828(DBMET03738) 0.784(METXBIODB00566
)
|
Beta tubulin antagonist | 0.701(METXBIODB00509) 0.670(METXBIODB02619) 0.668(DB01394)
| 0.712(DBMET00398;DBMET00401) 0.705(DBMET02757;METXBIODB00510;METXBIODB00512) 0.681(DBMET02756;METXBIODB00511
)
|
MAP kinase 7 inhibitor | 0.156(DB09079) 0.153(DB06595) 0.121(METXBIODB00039)
| 0.142(DBMET02777) 0.140(DBMET01384) 0.139(DBMET02778
)
|
Hedgehog signaling inhibitor | 0.951(CHEMBL64391;DB01167;METXBIODB00524) 0.773(DB01026) 0.627(DB08828)
| 0.952(DBMET00374;METXBIODB00525) 0.951(CHEMBL4525087;CHEMBL4525088) 0.929(METXBIODB00526
)
|
Purinergic P2X2 antagonist | 0.322(METXBIODB01202) 0.321(DB00451;DB00509;METXBIODB02811) 0.317(DB00279;METXBIODB02434)
| 0.377(METXBIODB02350;METXBIODB02355) 0.336(DBMET02275) 0.330(DB00171
)
|
Protein kinase C theta inhibitor | 0.472(DB06595) 0.341(METXBIODB00917) 0.339(DB01685;METXBIODB02526)
| 0.497(DBMET01440) 0.480(CHEMBL3544902;DBMET02826) 0.391(DBMET01441
)
|
5 Lipoxygenase activating protein inhibitor | 0.046(METXBIODB02380) 0.044(DB05016) 0.018(DB11932)
| 0.166(CHEMBL1231106) 0.026(CHEMBL3544874) 0.022(CHEMBL3544897;CHEMBL3544898
)
|
ATM kinase inhibitor | 0.254(METXBIODB01884) 0.182(METXBIODB00310) 0.160(METXBIODB01593)
| 0.296(DBMET00513) 0.200(METXBIODB01144) 0.195(METXBIODB00311
)
|
Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.653(METXBIODB01288) 0.611(DB06595) 0.546(DB06824)
| 0.804(DBMET01440) 0.630(METXBIODB01289) 0.585(DBMET03336
)
|
Protein kinase B gamma inhibitor | 0.458(DB13931) 0.396(DB06824) 0.268(DB00181)
| 0.688(CHEMBL244377) 0.651(DBMET02043) 0.598(CHEMBL3544897;CHEMBL3544898
)
|
Protein kinase C mu inhibitor | 0.953(DB06595) 0.417(DB00592) 0.374(METXBIODB00935)
| 0.967(DBMET01440) 0.861(DBMET01441) 0.502(DBMET02759
)
|
Cyclin-dependent kinase 4 inhibitor | 0.915(DB09073) 0.326(DB00592) 0.217(DB12010)
| 0.876(DBMET02365) 0.873(DBMET02373) 0.850(DBMET02380
)
|
MAP kinase kinase 6 inhibitor | 0.919(DB06595) 0.754(METXBIODB01288) 0.746(CHEMBL817)
| 0.893(DBMET01440) 0.891(DBMET01441) 0.754(METXBIODB01813
)
|
Protein kinase (CK1) gamma 1 inhibitor | 0.484(CHEMBL1076347) 0.478(DB06595) 0.475(DB06637)
| 0.716(DBMET03336) 0.694(CHEMBL1231106) 0.646(DBMET03335
)
|
Huntington's disease treatment | 0.900(CHEMBL104) 0.784(DB04844) 0.746(DB11915)
| 0.989(CHEMBL3526601) 0.817(DB12243) 0.761(DBMET00458;DBMET00800;DBMET01448
)
|
Potassium channel (Voltage-sensitive) blocker | 0.920(DB08903) 0.826(DB01074;METXBIODB00067) 0.821(CHEMBL104)
| 0.920(CHEMBL3527233) 0.912(DBMET03738) 0.883(CHEMBL3527437
)
|
Alpha 1a adrenoreceptor agonist | 0.463(CHEMBL762;DB00935) 0.450(METXBIODB02632) 0.430(DB04948)
| 0.463(CHEMBL4525123;CHEMBL4525124) 0.330(CHEMBL3526775) 0.295(METXBIODB02633
)
|
Protein kinase C nu inhibitor | 0.974(DB06595) 0.615(DB08877) 0.477(METXBIODB00935)
| 0.981(DBMET01440) 0.924(DBMET01441) 0.550(CHEMBL226396
)
|
Urologic disorders treatment | 0.981(METXBIODB00334) 0.956(DB01062;METXBIODB00150) 0.945(DB00280)
| 0.986(DBMET01568;DBMET03354;METXBIODB00151) 0.975(METXBIODB00335) 0.972(METXBIODB00336
)
|
Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.701(DB01254) 0.695(CHEMBL741;DB00555) 0.554(METXBIODB02879)
| 0.717(DBMET03622) 0.685(DBMET03625) 0.681(DBMET03437
)
|
Tyrosine-protein kinase EMT inhibitor | 0.576(DB09053) 0.567(CHEMBL1308;DB01213) 0.431(METXBIODB01643)
| 0.475(CHEMBL244377) 0.382(DBMET02094) 0.380(CHEMBL1231106
)
|
Janus tyrosine kinase 3 inhibitor | 0.909(DB08877) 0.836(DB11697) 0.694(DB14973)
| 0.880(DBMET03436) 0.848(DBMET03261) 0.802(DBMET03263
)
|
Urinary incontinence treatment | 0.981(METXBIODB00334) 0.951(DB01062;METXBIODB00150) 0.935(DB00280)
| 0.985(DBMET01568;DBMET03354;METXBIODB00151) 0.973(METXBIODB00335) 0.968(METXBIODB00336
)
|
Antineoplastic (non-small cell lung cancer) | 0.928(DB01181;METXBIODB00963) 0.915(METXBIODB02544) 0.865(DB06263)
| 0.954(CHEMBL3706540;DBMET01123) 0.940(CHEMBL525;DBMET01147) 0.938(CHEMBL1593;DBMET00658
)
|
Phosphodiesterase 7A inhibitor | 0.175(CHEMBL16;DB00252) 0.120(DB00972;METXBIODB00107;METXBIODB01852) 0.079(METXBIODB00635)
| 0.429(CHEMBL3706470) 0.179(DBMET03340) 0.175(DBMET01170
)
|
Histone deacetylase stimulant | 0.838(DB13853) 0.639(CHEMBL1783834) 0.458(METXBIODB00715)
| 0.854(DBMET02057) 0.669(CHEMBL3542280;CHEMBL4525725) 0.563(CHEMBL3542285;CHEMBL4525726
)
|
Histone deacetylase SIRT1 stimulant | 0.838(DB13853) 0.639(CHEMBL1783834) 0.458(METXBIODB00715)
| 0.854(DBMET02057) 0.669(CHEMBL3542280;CHEMBL4525725) 0.563(CHEMBL3542285;CHEMBL4525726
)
|
Cardiotonic | 0.963(DB00727) 0.958(DB00373;METXBIODB01469) 0.948(DB00922)
| 0.963(DBMET02594;DBMET02595;DBMET02596;DBMET02597;DBMET02598) 0.937(DBMET02502;METXBIODB00731) 0.921(DBMET00973
)
|
Antineoplastic (glioma) | 0.848(DB11638) 0.843(DB06697) 0.838(METXBIODB02420)
| 0.848(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.843(CHEMBL3526352) 0.842(METXBIODB00455
)
|
Cyclin-dependent kinase 2 inhibitor | 0.747(DB09073) 0.694(DB11697) 0.434(DB01438)
| 0.858(DBMET03436) 0.712(DBMET02378) 0.705(DBMET02373
)
|
Platelet growth factor antagonist | 0.864(METXBIODB02699) 0.841(DB12072) 0.840(CHEMBL535)
| 0.883(CHEMBL3542196) 0.839(CHEMBL3542344) 0.829(CHEMBL3542399
)
|
Urokinase inhibitor | 0.281(METXBIODB00562) 0.219(CHEMBL169901;DB04840) 0.210(METXBIODB01173)
| 0.435(DBMET03118) 0.273(DBMET01778) 0.269(METXBIODB01825
)
|
Nootropic | 0.980(DB00185;METXBIODB00507) 0.859(DB13345) 0.801(METXBIODB00369)
| 0.980(DBMET00430;DBMET00431;DBMET00433) 0.928(METXBIODB00508) 0.848(CHEMBL3526811
)
|
MAP kinase 9 inhibitor | 0.464(DB01685;METXBIODB02526) 0.424(METXBIODB02343) 0.396(METXBIODB00513)
| 0.815(CHEMBL3544805) 0.449(DBMET03719) 0.426(METXBIODB00515
)
|
Janus tyrosine kinase 2 inhibitor | 0.784(DB11697) 0.773(DB08877) 0.617(DB14973)
| 0.802(DBMET03436) 0.768(DBMET03438) 0.767(DBMET03437
)
|
LIM domain kinase 2 inhibitor | 0.253(METXBIODB00244) 0.129(METXBIODB00565) 0.095(CHEMBL2103817)
| 0.246(CHEMBL3526890) 0.128(CHEMBL3526891) 0.081(CHEMBL3527277
)
|
Bradykinin antagonist | 0.163(METXBIODB02132) 0.130(DB00228;METXBIODB00116) 0.128(DB00500)
| 0.998(METXBIODB00275) 0.168(CHEMBL3544779) 0.138(DBMET02067
)
|
Protein kinase (CK1) delta inhibitor | 0.478(CHEMBL585;DB00384) 0.378(DB00740) 0.325(METXBIODB00935)
| 0.579(CHEMBL1231106) 0.491(CHEMBL3544897;CHEMBL3544898) 0.452(CHEMBL244377
)
|
Nav1.8 sodium channel blocker | 0.431(METXBIODB02615) 0.405(DB12466) 0.343(METXBIODB00039)
| 0.455(DBMET03065) 0.384(DBMET00415) 0.336(METXBIODB02617
)
|
Purinergic P2Y2 antagonist | 0.151(DB01320) 0.123(METXBIODB02999) 0.122(DB06716)
| 0.310(CHEMBL1426) 0.230(CHEMBL1774;DBMET02000;DBMET03590) 0.223(CHEMBL3638285
)
|
CDK4/cyclin D inhibitor | 0.865(DB09073) 0.198(DB00592) 0.157(METXBIODB02611)
| 0.843(DBMET02373) 0.826(DBMET02380) 0.818(DBMET02365
)
|
Inflammatory Bowel disease treatment | 0.903(DB01236) 0.858(DB16650) 0.802(CHEMBL104)
| 0.994(METXBIODB00716) 0.966(DBMET01398) 0.848(DBMET03547
)
|
Protein kinase C iota inhibitor | 0.632(DB06595) 0.255(DB06824) 0.222(DB06153)
| 0.668(DBMET01440) 0.525(DBMET01441) 0.274(CHEMBL3526308
)
|
Abl kinase inhibitor | 0.678(METXBIODB01339) 0.611(DB00437) 0.466(METXBIODB00935)
| 0.543(DBMET03622) 0.522(DBMET02020) 0.493(CHEMBL3544806
)
|
Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.679(METXBIODB01339) 0.612(DB00437) 0.466(METXBIODB00935)
| 0.543(DBMET03622) 0.523(DBMET02020) 0.493(CHEMBL3544806
)
|
MAP kinase 13 inhibitor | 0.820(METXBIODB00513) 0.432(DB13228) 0.361(METXBIODB00935)
| 0.811(METXBIODB00515) 0.605(METXBIODB00514) 0.448(DBMET01440
)
|
Protein kinase (CK1) gamma 2 inhibitor | 0.349(CHEMBL1076347) 0.342(METXBIODB00935) 0.336(DB00697;METXBIODB02082)
| 0.676(DBMET03336) 0.657(CHEMBL1231106) 0.558(DBMET03335
)
|
Protein kinase (CK1) gamma inhibitor | 0.453(DB06637) 0.426(CHEMBL1076347) 0.415(METXBIODB00935)
| 0.660(DBMET03336) 0.652(CHEMBL1231106) 0.558(DBMET03335
)
|
Heart failure treatment | 0.966(DB00922) 0.936(DB00727) 0.895(DB15456)
| 0.977(CHEMBL3526601) 0.963(DBMET01338) 0.955(DBMET01342
)
|
Fibroblast growth factor 1 antagonist | 0.961(DB12147) 0.690(METXBIODB02632) 0.613(DB09079)
| 0.918(DBMET03649) 0.774(DBMET03650) 0.670(CHEMBL3527569
)
|
Tyrosine kinase inhibitor | 0.958(DB08877) 0.940(DB08865) 0.930(DB11697)
| 0.942(DBMET03261;DBMET03436) 0.921(DBMET03537) 0.917(DBMET03437
)
|
Check point kinase 2 inhibitor | 0.627(METXBIODB00880) 0.429(DB00730) 0.397(CHEMBL1140)
| 0.530(CHEMBL2030560) 0.519(DBMET00376) 0.495(CHEMBL3527286
)
|
Cyclin-dependent kinase 1 inhibitor | 0.663(DB09073) 0.657(DB01438) 0.633(DB02377)
| 0.884(DBMET02996) 0.712(DBMET02378) 0.587(DBMET02380
)
|
Prokineticin receptor 1 antagonist | 0.033(DB01131;METXBIODB00330) 0.032(METXBIODB01173) 0.021(DB01189;METXBIODB01455;METXBIODB02090)
| 0.038(DBMET01778) 0.026(DBMET03020;METXBIODB01174) 0.025(METXBIODB00331
)
|
Adenosine A2b receptor agonist | 0.654(DB00640) 0.617(DB00242) 0.536(DB00631)
| 0.372(CHEMBL3526900) 0.302(DBMET01159) 0.283(DBMET00485;DBMET03265
)
|
Raf kinase B inhibitor | 0.891(DB08881) 0.819(DB08912) 0.731(CHEMBL685;DB00643)
| 0.758(DBMET03512) 0.698(DBMET03510) 0.676(DBMET01854
)
|
Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.859(DB06595) 0.831(METXBIODB01288) 0.608(DB00379;DB07129;METXBIODB01843)
| 0.946(DBMET01440) 0.818(DBMET01441) 0.816(DBMET02759
)
|
Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.841(DB00190) 0.835(DB01074;METXBIODB00067) 0.544(DB08877)
| 0.677(DBMET00839;DBMET00914;DBMET01547;METXBIODB00068;METXBIODB00069) 0.574(CHEMBL3544806) 0.559(CHEMBL1231106
)
|
Stem cell growth factor agonist | 0.647(DB08881) 0.432(DB00585) 0.391(DB00863;METXBIODB01235)
| 0.523(DBMET01856) 0.511(DBMET01854) 0.429(DBMET00959
)
|
Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.546(CHEMBL535) 0.493(DB00398) 0.374(DB00619)
| 0.527(CHEMBL3542344) 0.508(CHEMBL3542333) 0.492(CHEMBL3542399
)
|
Protein kinase A inhibitor | 0.991(DB06595) 0.484(DB13931) 0.396(DB06824)
| 0.994(DBMET01440) 0.970(DBMET01441) 0.588(DBMET02043
)
|
Check point kinase 1 inhibitor | 0.655(DB01685;METXBIODB02526) 0.401(DB06595) 0.371(DB00592)
| 0.768(DBMET02815) 0.534(DBMET00414) 0.492(DBMET00513
)
|
Ca2+/calmodulin-dependent protein kinase inhibitor | 0.883(DB06595) 0.753(METXBIODB01288) 0.668(DB06824)
| 0.937(DBMET01440) 0.829(DBMET01441) 0.824(DBMET00920
)
|
Liver fibrosis treatment | 0.804(DB06755) 0.783(CHEMBL64391;DB01167;METXBIODB00524) 0.768(DB00755;DB00982;METXBIODB00937)
| 0.783(CHEMBL4525087;CHEMBL4525088) 0.768(DB00523;DBMET02046;DBMET02548;METXBIODB00324;METXBIODB01253) 0.747(METXBIODB00526
)
|
Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.813(METXBIODB01288) 0.794(DB06595) 0.578(METXBIODB00880)
| 0.769(METXBIODB01289) 0.719(DBMET01441) 0.687(DBMET01440
)
|
Phosphatidylinositol 3-kinase delta inhibitor | 0.956(DB09054) 0.412(METXBIODB01339) 0.366(CHEMBL727)
| 0.789(DBMET01387) 0.665(CHEMBL1178) 0.538(CHEMBL1172777
)
|
Topoisomerase II inhibitor | 0.973(CHEMBL1117) 0.971(DB00773;METXBIODB00808) 0.970(CHEMBL417;CHEMBL53463;DB00997;DB09117)
| 0.970(DBMET00367;DBMET01264;METXBIODB00809) 0.968(DBMET01265) 0.953(CHEMBL3508145
)
|
Antiparkinsonian | 0.979(DB11632) 0.978(DB00190) 0.974(DB13345)
| 0.974(DBMET03238) 0.973(DBMET03236) 0.971(DBMET03237
)
|
Phosphodiesterase VII inhibitor | 0.559(DB00862) 0.272(CHEMBL16;DB00252) 0.159(DB00972;METXBIODB00107;METXBIODB01852)
| 0.560(DBMET03640) 0.544(CHEMBL3706470) 0.272(DBMET01170
)
|
Protein kinase B beta inhibitor | 0.358(DB01685;METXBIODB02526) 0.350(DB01043) 0.201(DB00437)
| 0.448(DBMET00189;METXBIODB00119) 0.411(CHEMBL3526890) 0.361(DBMET01310
)
|
Antineoplastic (squamous cell carcinoma) | 0.856(METXBIODB00685) 0.810(DB06697) 0.806(DB00773;METXBIODB00808)
| 0.855(METXBIODB00687) 0.844(METXBIODB00688) 0.842(METXBIODB00686
)
|
Protein kinase (CK1) inhibitor | 0.544(DB00339) 0.461(CHEMBL585;DB00384) 0.424(DB08877)
| 0.591(CHEMBL1231106) 0.512(DBMET03065) 0.490(CHEMBL3544897;CHEMBL3544898
)
|
Tyrosine-protein kinase receptor FLT3 inhibitor | 0.978(DB11697) 0.891(DB12874) 0.843(DB12147)
| 0.986(DBMET03436) 0.962(DBMET03437) 0.960(DBMET03435
)
|
Antieczematic atopic | 0.826(CHEMBL1473;DB00588) 0.804(DB00764) 0.802(DB06756)
| 0.895(DB03947) 0.819(DBMET00997) 0.804(DBMET02361
)
|
ALK inhibitor | 0.979(DB12267) 0.731(DB11363) 0.481(DB08865)
| 0.719(DBMET02145) 0.597(DBMET01404) 0.542(DBMET02147
)
|
CDC-like kinase 1 inhibitor | 0.861(METXBIODB00382) 0.806(METXBIODB02059) 0.493(METXBIODB01431)
| 0.724(METXBIODB02060) 0.713(DBMET01868) 0.689(METXBIODB00384
)
|
CDC-like kinase 4 inhibitor | 0.701(METXBIODB00858) 0.613(DB08877) 0.560(METXBIODB00385)
| 0.634(CHEMBL226396) 0.502(CHEMBL3526631) 0.501(METXBIODB00387
)
|
TRKB antagonist | 0.465(DB08877) 0.370(DB15305) 0.368(METXBIODB02929)
| 0.374(DBMET03262) 0.355(CHEMBL3544806) 0.347(DBMET03263
)
|
Sodium/calcium exchanger inhibitor | 0.289(METXBIODB02735) 0.224(DB01429) 0.212(DB06728)
| 0.246(METXBIODB00274) 0.212(DBMET02709;METXBIODB00395) 0.199(DBMET03561
)
|
CDK4/cyclin D1 inhibitor | 0.886(DB09073) 0.239(DB00592) 0.236(METXBIODB02611)
| 0.856(DBMET02373) 0.839(DBMET02365) 0.822(DBMET02380
)
|
Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.725(DB01685;METXBIODB02526) 0.469(DB06595) 0.441(DB00592)
| 0.791(DBMET02815) 0.583(DBMET01440) 0.569(DBMET00414
)
|
TIE-2 antagonist | 0.418(CHEMBL685;DB00643) 0.390(DB00398) 0.380(CHEMBL1076347)
| 0.971(CHEMBL244377) 0.942(CHEMBL3544897;CHEMBL3544898) 0.863(CHEMBL3544872;CHEMBL457723
)
|
Bruton tyrosine kinase inhibitor | 0.958(DB11703) 0.946(DB09053) 0.905(METXBIODB01643)
| 0.918(DBMET02888) 0.909(DBMET02890) 0.847(DBMET02027
)
|
CDC-like kinase 2 inhibitor | 0.714(DB08877) 0.493(METXBIODB00935) 0.421(DB06637)
| 0.733(CHEMBL226396) 0.593(DBMET03336) 0.503(DBMET03263
)
|
Macular degeneration treatment | 0.943(DB00869) 0.905(DB01236) 0.846(DB01194)
| 0.955(DBMET03010) 0.825(DBMET03671) 0.728(DBMET01736
)
|
TRKC antagonist | 0.644(DB08877) 0.551(DB00437) 0.518(CHEMBL535)
| 0.570(DBMET03262) 0.559(DBMET03263) 0.543(CHEMBL3542333
)
|
TIE antagonist | 0.434(DB00398) 0.431(CHEMBL685;DB00643) 0.397(CHEMBL1076347)
| 0.972(CHEMBL244377) 0.942(CHEMBL3544897;CHEMBL3544898) 0.864(CHEMBL3544872;CHEMBL457723
)
|
Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.790(METXBIODB00209) 0.676(DB08877) 0.463(METXBIODB00935)
| 0.896(DBMET00830) 0.685(METXBIODB00210) 0.671(METXBIODB00211
)
|
CDK/cyclin complex inhibitor | 0.911(DB09073) 0.398(DB11697) 0.361(CHEMBL585;DB00384)
| 0.899(DBMET02373) 0.889(DBMET02380) 0.867(DBMET02365
)
|
Protein kinase B alpha inhibitor | 0.312(DB01685;METXBIODB02526) 0.296(DB00437) 0.295(DB00379;DB07129;METXBIODB01843)
| 0.442(CHEMBL3526890) 0.369(DBMET00189;METXBIODB00119) 0.253(CHEMBL3526891
)
|
Raf kinase inhibitor | 0.908(DB08881) 0.829(DB08912) 0.774(CHEMBL685;DB00643)
| 0.778(DBMET03512) 0.728(DBMET01854) 0.719(DBMET03510
)
|
Sodium/hydrogen exchanger inhibitor | 0.356(METXBIODB00562) 0.352(DB11761) 0.277(CHEMBL355862)
| 0.214(CHEMBL3526475) 0.180(METXBIODB00563) 0.178(DBMET01778
)
|
Antineoplastic (osteosarcoma) | 0.956(DB00400) 0.773(CHEMBL185) 0.742(DB09256)
| 0.920(DBMET00765) 0.773(DB00544;DBMET00449) 0.740(METXBIODB00147
)
|
Ribosomal protein S6 kinase inhibitor | 0.535(DB00437) 0.496(DB00629) 0.494(DB06595)
| 0.457(DBMET01441) 0.445(DBMET01500) 0.426(DBMET00499
)
|
Polo-like kinase-4 inhibitor | 0.415(DB11697) 0.299(DB00261) 0.274(DB12072)
| 0.483(DBMET03436) 0.433(DBMET03438) 0.408(DBMET03435
)
|
Vascular endothelial growth factor 1 antagonist | 0.493(DB09079) 0.424(DB05294) 0.399(CHEMBL535)
| 0.456(DBMET02777) 0.432(DBMET00935) 0.421(CHEMBL3542257
)
|
Raf kinase C inhibitor | 0.747(CHEMBL685;DB00643) 0.722(DB00518) 0.697(DB08881)
| 0.731(CHEMBL2059159) 0.720(DBMET00791) 0.632(DBMET01854
)
|
ErbB-3 antagonist | 0.790(METXBIODB00715) 0.406(DB06154) 0.394(DB00530)
| 0.942(DBMET01434) 0.689(DB13526) 0.563(DBMET02769
)
|
DNA directed RNA polymerase inhibitor | 0.886(DB00709) 0.856(DB12301) 0.852(CHEMBL223228;DB00625;DB08864)
| 0.924(DBMET00899) 0.890(DBMET00898) 0.852(CHEMBL4525162
)
|
Pim-1 kinase inhibitor | 0.313(DB11640) 0.305(METXBIODB00935) 0.289(DB00592)
| 0.512(DBMET01855) 0.482(METXBIODB00380) 0.357(DBMET02824
)
|
ErbB-4 antagonist | 0.909(DB11963) 0.781(METXBIODB01643) 0.507(DB00530)
| 0.867(DBMET02190) 0.424(DBMET01790) 0.371(METXBIODB00387
)
|
Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.834(DB09079) 0.684(DB06595) 0.329(METXBIODB00724;METXBIODB01778)
| 0.898(DBMET02778) 0.821(DBMET02777) 0.799(DBMET01384
)
|
Growth factor antagonist | 0.941(DB12147) 0.933(METXBIODB01643) 0.905(DB12267)
| 0.920(DBMET03650) 0.890(DBMET03649) 0.880(CHEMBL380905
)
|
Antineoplastic (uterine cancer) | 0.843(CHEMBL1117) 0.834(CHEMBL417;CHEMBL53463;DB00997) 0.820(CHEMBL178;DB00694)
| 0.804(CHEMBL3544591) 0.800(CHEMBL3508153;DBMET01078) 0.783(DBMET00952
)
|
Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.983(DB08865) 0.140(CHEMBL377300) 0.107(METXBIODB00935)
| 0.950(DBMET03537) 0.585(DBMET02823) 0.359(DBMET02821
)
|
Antibiotic Cephalosporin-like | 0.930(DB01413) 0.790(DB00493) 0.511(DB06590)
| 0.473(DBMET00646) 0.190(DBMET00641) 0.034(DBMET00758
)
|
Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.922(DB08881) 0.871(DB08912) 0.788(CHEMBL685;DB00643)
| 0.820(DBMET03512) 0.769(DBMET03510) 0.766(DBMET01854
)
|
Chronic obstructive pulmonary disease treatment | 0.985(CHEMBL1473;DB00588) 0.981(DB08906) 0.942(CHEMBL1512)
| 0.978(CHEMBL3706466) 0.967(DBMET03675) 0.953(DBMET01568;DBMET03354;METXBIODB00151
)
|
Focal adhesion kinase 1 inhibitor | 0.957(DB12267) 0.151(METXBIODB02395) 0.149(DB14845)
| 0.449(DBMET02125) 0.179(DBMET03213) 0.172(DBMET02094
)
|
Clk dual-specificity kinase inhibitor | 0.822(METXBIODB00382) 0.766(METXBIODB02059) 0.585(DB08877)
| 0.810(DBMET01868) 0.763(DBMET01864) 0.755(DBMET01865
)
|
Antineoplastic (ovarian cancer) | 0.997(DB00526) 0.979(CHEMBL92;DB01248) 0.977(CHEMBL428647;DB01229)
| 0.999(DBMET03683) 0.991(DBMET03682) 0.979(DBMET00633
)
|
Toll-Like receptor agonist | 0.994(CHEMBL1473;DB00588;DB08906) 0.991(METXBIODB01531) 0.983(CHEMBL1504;CHEMBL1512)
| 0.993(DBMET03675) 0.988(CHEMBL3542300) 0.987(CHEMBL3542318
)
|
Cyclin-dependent kinase inhibitor | 0.904(DB09073) 0.431(DB11697) 0.411(CHEMBL1308;DB01213)
| 0.883(DBMET02373) 0.873(DBMET02380) 0.872(DBMET02365
)
|
Protein-tyrosine kinase Lyn inhibitor | 0.622(DB01254) 0.510(CHEMBL1455) 0.488(DB00437)
| 0.684(DBMET03622) 0.655(CHEMBL1231106) 0.594(DBMET03625
)
|
Adenosine A1 receptor agonist | 0.834(DB00242) 0.805(DB00640) 0.766(DB00631)
| 0.650(DBMET00485;DBMET03265) 0.612(DBMET00419) 0.582(DBMET01159
)
|
Rho-associated kinase inhibitor | 0.685(CHEMBL1308;DB01213) 0.586(DB13931) 0.509(METXBIODB00935)
| 0.740(DBMET02043) 0.713(DBMET02815) 0.618(METXBIODB01534
)
|
Equilibrative nucleoside transport protein inhibitor | 0.489(DB00640) 0.484(METXBIODB02474) 0.374(DB01280)
| 0.966(DBMET01160) 0.739(CHEMBL1178) 0.624(DBMET01159
)
|
Rho-associated kinase II inhibitor | 0.768(CHEMBL1308;DB01213) 0.559(DB13931) 0.479(METXBIODB00935)
| 0.758(DBMET02815) 0.732(METXBIODB01534) 0.665(DBMET02043
)
|
Antibiotic Trimethoprim-like | 0.831(DB00440) 0.082(METXBIODB00281) 0.066(CHEMBL585;DB00384)
| 0.737(DBMET03021) 0.719(DBMET03026) 0.551(DBMET03019
)
|
Antiprotozoal (Plasmodium) | 0.994(DB06697;DB11638) 0.993(METXBIODB00454) 0.984(DB09274;METXBIODB01712)
| 0.994(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.993(METXBIODB00455) 0.978(DBMET00827
)
|
EphA2 antagonist | 0.569(DB09185) 0.487(DB06799) 0.382(DB05294)
| 0.484(DBMET03493) 0.428(DB09401) 0.389(DBMET00935
)
|
Toll-Like receptor 7 agonist | 0.994(CHEMBL1473;DB00588;DB08906) 0.991(METXBIODB01531) 0.983(CHEMBL1512)
| 0.993(DBMET03675) 0.988(CHEMBL3542300) 0.986(CHEMBL3542318;DBMET02403
)
|
CDK7/cyclin H inhibitor | 0.133(DB08912) 0.120(DB00619) 0.119(DB11763)
| 0.223(CHEMBL244377) 0.178(DBMET03713) 0.141(DBMET03719
)
|
Tubulin antagonist | 0.944(DB00570) 0.935(DB00361) 0.925(DB11641)
| 0.953(DBMET00398;DBMET00401) 0.941(DBMET02055) 0.922(DBMET02029
)
|
RET inhibitor | 0.609(DB00437) 0.591(DB00530) 0.583(DB08877)
| 0.756(CHEMBL3544806) 0.692(CHEMBL1231106) 0.663(CHEMBL244377
)
|
Antineoplastic (melanoma) | 0.931(DB06697) 0.928(DB06176) 0.917(DB11638)
| 0.969(CHEMBL913;DBMET01125) 0.917(DBMET00443;DBMET00793;METXBIODB00457;METXBIODB01713) 0.907(METXBIODB00455
)
|
Aurora-A kinase inhibitor | 0.720(METXBIODB01487) 0.604(CHEMBL1308;DB01213) 0.316(METXBIODB02395)
| 0.728(METXBIODB01489) 0.611(METXBIODB01488) 0.568(DBMET02094
)
|
Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.867(METXBIODB00382) 0.846(METXBIODB02059) 0.730(METXBIODB00935)
| 0.788(CHEMBL1231106) 0.784(METXBIODB02060) 0.762(DBMET00830
)
|
Dyrk kinase inhibitor | 0.865(METXBIODB00382) 0.839(METXBIODB02059) 0.735(METXBIODB00935)
| 0.839(DBMET02617) 0.783(CHEMBL1231106) 0.771(METXBIODB02060
)
|
Antineoplastic (colon cancer) | 0.981(DB00570) 0.976(DB00361) 0.968(METXBIODB01414)
| 0.973(DBMET00398;DBMET00401;DBMET02029) 0.964(METXBIODB01416) 0.958(METXBIODB01415
)
|
Vascular endothelial growth factor 3 antagonist | 0.659(DB05294) 0.650(DB09079) 0.520(CHEMBL535)
| 0.707(DBMET00935) 0.659(DBMET02777) 0.626(DBMET02778
)
|
ZAP-70 protein tyrosine kinase inhibitor | 0.327(DB12267) 0.190(DB08864) 0.137(DB00214)
| 0.226(DBMET02094) 0.210(DBMET01868) 0.185(DBMET01864
)
|
Phosphatidylinositol 3-kinase gamma inhibitor | 0.943(CHEMBL1258517) 0.535(DB12015) 0.277(DB09054)
| 0.800(CHEMBL3526762) 0.421(DBMET02571) 0.211(DBMET02020
)
|
Vascular endothelial growth factor antagonist | 0.891(DB12147) 0.825(CHEMBL535) 0.722(CHEMBL377300)
| 0.832(CHEMBL3542344) 0.825(CHEMBL3542333;DBMET03649) 0.819(CHEMBL380905
)
|
Macrophage colony-stimulating factor 1 receptor antagonist | 0.504(DB08865) 0.340(DB00339) 0.327(DB01097;METXBIODB01809)
| 0.436(DBMET03537) 0.426(CHEMBL3542326;DBMET02633) 0.303(CHEMBL3526899
)
|
Aurora-C kinase inhibitor | 0.297(METXBIODB03012) 0.289(DB12010) 0.284(CHEMBL535)
| 0.346(DBMET02099) 0.339(DBMET02094) 0.328(DBMET02095
)
|
Vascular endothelial growth factor 2 antagonist | 0.890(DB12147) 0.778(CHEMBL535) 0.704(CHEMBL377300)
| 0.826(DBMET03649) 0.802(CHEMBL380905) 0.784(CHEMBL3542344
)
|
Antineoplastic (colorectal cancer) | 0.981(DB00570) 0.976(DB00361) 0.968(METXBIODB01414)
| 0.973(DBMET00398;DBMET00401;DBMET02029) 0.965(METXBIODB01416) 0.959(METXBIODB01415
)
|
Platelet activating factor beta antagonist | 0.816(DB09079) 0.802(CHEMBL535) 0.790(DB12072)
| 0.939(METXBIODB02385) 0.806(DBMET02777) 0.792(CHEMBL3542344
)
|
Phosphatidylinositol 3-kinase alpha inhibitor | 0.958(CHEMBL1258517) 0.209(DB12015) 0.184(DB12483)
| 0.827(CHEMBL3526762) 0.305(CHEMBL1231106) 0.280(CHEMBL3544897;CHEMBL3544898
)
|
Phosphatidylinositol kinase inhibitor | 0.957(CHEMBL1258517) 0.686(DB09054) 0.407(DB12015)
| 0.835(CHEMBL3526762) 0.447(CHEMBL1231106) 0.403(DBMET01387
)
|
Antiviral (Hepatitis B) | 0.960(DB09299) 0.955(DB00300) 0.926(METXBIODB01187)
| 0.947(DBMET03569) 0.916(DBMET00898) 0.910(DBMET00899
)
|
Antiasthmatic | 0.994(CHEMBL1473;DB00588;DB08906) 0.991(METXBIODB01531) 0.983(CHEMBL1512)
| 0.993(DBMET03675) 0.989(CHEMBL3542300) 0.986(CHEMBL3542318;DBMET02403
)
|
Antineoplastic (solid tumors) | 0.996(DB01181;METXBIODB00963) 0.995(DB00648) 0.992(METXBIODB03049)
| 0.997(DBMET01127) 0.993(DBMET00022;DBMET01077;METXBIODB00965) 0.992(DBMET00024;METXBIODB00966
)
|
HIV-1 integrase inhibitor | 0.800(CHEMBL1229211;DB08930) 0.769(DB11751) 0.505(METXBIODB02170)
| 0.902(DBMET03078) 0.838(CHEMBL3526572;DBMET01873) 0.769(DBMET03246;DBMET03247
)
|
Antineoplastic (myeloid leukemia) | 0.972(CHEMBL820) 0.968(DB15694) 0.953(CHEMBL727;DB13345)
| 0.968(DBMET03186) 0.944(METXBIODB00477) 0.941(METXBIODB00476
)
|
Phosphatidylinositol 3-kinase beta inhibitor | 0.596(METXBIODB01339) 0.518(DB12483) 0.439(DB12015)
| 0.588(DBMET03731) 0.485(DBMET03730) 0.433(DBMET03734
)
|
I kappa B kinase 1 inhibitor | 0.352(DB06824) 0.295(METXBIODB00935) 0.257(DB00909)
| 0.367(CHEMBL3544897;CHEMBL3544898) 0.346(CHEMBL244377) 0.328(DBMET02585
)
|
Antiprotozoal | 0.995(DB06697) 0.994(DB11638;METXBIODB00454) 0.987(DB09274;METXBIODB01712)
| 0.994(DBMET00443;DBMET00793;METXBIODB00455;METXBIODB00457;METXBIODB01713) 0.983(DBMET00827) 0.973(CHEMBL3544736
)
|
CDK9/cyclin T1 inhibitor | 0.301(METXBIODB02968) 0.212(DB09073) 0.203(METXBIODB00896)
| 0.326(DBMET03719) 0.260(DBMET03713) 0.238(DBMET03710
)
|
Epidermal growth factor antagonist | 0.993(METXBIODB01643) 0.911(DB11963) 0.881(DB00530)
| 0.875(CHEMBL3706540;DBMET01123) 0.871(DBMET02190) 0.830(CHEMBL1593;DBMET00658
)
|
Antineoplastic (carcinoma) | 0.889(CHEMBL92;DB01248) 0.886(CHEMBL428647;DB01229) 0.884(METXBIODB00685)
| 0.889(DBMET00633) 0.883(DBMET00999;METXBIODB00687) 0.881(DBMET00998
)
|
ErbB-2 antagonist | 0.891(CHEMBL554) 0.800(DB11963) 0.784(DB00530)
| 0.993(CHEMBL3706540;DBMET01123) 0.987(CHEMBL1593;DBMET00658) 0.979(CHEMBL525;DBMET01147
)
|
Ephrin antagonist | 0.676(METXBIODB01339) 0.635(DB09185) 0.522(DB00530;METXBIODB00866)
| 0.531(DBMET03493) 0.501(DBMET00935) 0.492(DB09401
)
|
Epidermal growth factor receptor kinase inhibitor | 0.937(DB00530) 0.918(DB11963) 0.907(METXBIODB03041)
| 0.896(DBMET02190) 0.868(DBMET01790) 0.762(DBMET00935;METXBIODB00867
)
|
Antileukemic | 0.965(CHEMBL88;DB00531;METXBIODB00960) 0.949(DB01181;METXBIODB00963) 0.945(DB12902;METXBIODB00967)
| 0.993(CHEMBL87658;DBMET00020;DBMET00021;METXBIODB00961;METXBIODB00964) 0.971(METXBIODB00716) 0.967(CHEMBL731;DBMET00019
)
|
Angiogenesis inhibitor | 0.935(CHEMBL428647;DB01229) 0.934(CHEMBL377300) 0.924(DB06697)
| 0.970(CHEMBL3527569) 0.963(CHEMBL3526270) 0.958(CHEMBL3527397
)
|
Antimitotic | 0.991(CHEMBL428647;CHEMBL92;DB01229;DB01248) 0.988(DB06772) 0.983(METXBIODB01414)
| 0.991(DBMET00633) 0.987(DBMET00998) 0.986(CHEMBL122465;CHEMBL307088;DBMET01760
)
|